[
    {
        "text": "Seven point mutations were introduced into the conserved motif in the second extracellular loop ([GENE]ECII[\\GENE]) of EP3, resulting in acquisition of [CHEMICAL]GTP[\\CHEMICAL]-sensitive agonist binding.",
        "label": 2,
        "major": 5,
        "len": 24
    },
    {
        "text": "Seven point mutations were introduced into the conserved motif in the second extracellular loop (ECII) of [GENE]EP3[\\GENE], resulting in acquisition of [CHEMICAL]GTP[\\CHEMICAL]-sensitive agonist binding.",
        "label": 2,
        "major": 2,
        "len": 24
    },
    {
        "text": "Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the [GENE]W203A[\\GENE] receptor, conditions where high [CHEMICAL]GTP[\\CHEMICAL] levels are present; however, high affinity binding [(3)H]PGE(2) was observed in broken cell preparations washed free of GTP.",
        "label": 2,
        "major": 2,
        "len": 39
    },
    {
        "text": "Blood pressure was increased in rats exposed to IH, and treatment with the [GENE]PDK-1[\\GENE] inhibitor [CHEMICAL]OSU-03012[\\CHEMICAL] [2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-acetamide] (33 mg/day) lowered blood pressure in IH but not sham group rats.",
        "label": 4,
        "major": 10,
        "len": 29
    },
    {
        "text": "Blood pressure was increased in rats exposed to IH, and treatment with the [GENE]PDK-1[\\GENE] inhibitor OSU-03012 [[CHEMICAL]2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-acetamide[\\CHEMICAL]] (33 mg/day) lowered blood pressure in IH but not sham group rats.",
        "label": 4,
        "major": 3,
        "len": 29
    },
    {
        "text": "Following CdCl\u2082 treatment, ICAM2 was found to be upregulated during restructuring of the seminiferous epithelium, with round spermatids becoming increasingly immunoreactive for ICAM2 by 6-16 h. Interestingly, there was a loss in the binding of [GENE]ICAM2[\\GENE] to actin during [CHEMICAL]CdCl\u2082[\\CHEMICAL]-induced germ cell loss, suggesting that a loss of ICAM2-actin interactions might have facilitated junction restructuring.",
        "label": 2,
        "major": 3,
        "len": 55
    },
    {
        "text": "Following [CHEMICAL]CdCl\u2082[\\CHEMICAL] treatment, [GENE]ICAM2[\\GENE] was found to be upregulated during restructuring of the seminiferous epithelium, with round spermatids becoming increasingly immunoreactive for ICAM2 by 6-16 h. Interestingly, there was a loss in the binding of ICAM2 to actin during CdCl\u2082-induced germ cell loss, suggesting that a loss of ICAM2-actin interactions might have facilitated junction restructuring.",
        "label": 3,
        "major": 3,
        "len": 55
    },
    {
        "text": "Following CdCl\u2082 treatment, ICAM2 was found to be upregulated during restructuring of the seminiferous epithelium, with round spermatids becoming increasingly immunoreactive for ICAM2 by 6-16 h. Interestingly, there was a loss in the binding of ICAM2 to [GENE]actin[\\GENE] during [CHEMICAL]CdCl\u2082[\\CHEMICAL]-induced germ cell loss, suggesting that a loss of ICAM2-actin interactions might have facilitated junction restructuring.",
        "label": 4,
        "major": 3,
        "len": 55
    },
    {
        "text": "The reaction was inhibited by the specific [GENE]CYP2D[\\GENE] inhibitors [CHEMICAL]quinine[\\CHEMICAL] and fluoxetine.",
        "label": 4,
        "major": 4,
        "len": 12
    },
    {
        "text": "The reaction was inhibited by the specific [GENE]CYP2D[\\GENE] inhibitors quinine and [CHEMICAL]fluoxetine[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 12
    },
    {
        "text": "Of the rat CYP isoforms studied, [GENE]CYP2D[\\GENE] isoforms were the most efficient in catalyzing the O-demethylation of 5-methoxytryptamine to [CHEMICAL]serotonin[\\CHEMICAL], but they were less effective than the human isoform CYP2D6.",
        "label": 9,
        "major": 9,
        "len": 30
    },
    {
        "text": "Of the rat CYP isoforms studied, CYP2D isoforms were the most efficient in catalyzing the O-demethylation of 5-methoxytryptamine to [CHEMICAL]serotonin[\\CHEMICAL], but they were less effective than the [GENE]human isoform CYP2D6[\\GENE].",
        "label": 9,
        "major": 9,
        "len": 30
    },
    {
        "text": "The catalytic competence of [GENE]cytochrome P450[\\GENE] in the synthesis of [CHEMICAL]serotonin[\\CHEMICAL] from 5-methoxytryptamine in the brain: an in vitro study.",
        "label": 9,
        "major": -1,
        "len": 20
    },
    {
        "text": "Human liver microsomes of the wild-type [GENE]CYP2D6[\\GENE] metabolized 5-methoxytryptamine to [CHEMICAL]serotonin[\\CHEMICAL] more effectively than did the defective CYP2D6*4*4 ones.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "Human liver microsomes of the wild-type CYP2D6 metabolized 5-methoxytryptamine to [CHEMICAL]serotonin[\\CHEMICAL] more effectively than did the defective [GENE]CYP2D6[\\GENE]*4*4 ones.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "The obtained results indicate that [GENE]rat brain CYP2D[\\GENE] isoforms catalyze the formation of [CHEMICAL]serotonin[\\CHEMICAL] from 5-methoxytryptamine, and that the deficit or genetic defect of CYP2D may affect serotonin metabolism in the brain.",
        "label": 9,
        "major": 9,
        "len": 32
    },
    {
        "text": "The obtained results indicate that rat brain CYP2D isoforms catalyze the formation of serotonin from 5-methoxytryptamine, and that the deficit or genetic defect of [GENE]CYP2D[\\GENE] may affect [CHEMICAL]serotonin[\\CHEMICAL] metabolism in the brain.",
        "label": 9,
        "major": 9,
        "len": 32
    },
    {
        "text": "Of the rat CYP isoforms studied, [GENE]CYP2D[\\GENE] isoforms were the most efficient in catalyzing the [CHEMICAL]O[\\CHEMICAL]-demethylation of 5-methoxytryptamine to serotonin, but they were less effective than the human isoform CYP2D6.",
        "label": 9,
        "major": 9,
        "len": 30
    },
    {
        "text": "Of the rat CYP isoforms studied, CYP2D isoforms were the most efficient in catalyzing the [CHEMICAL]O[\\CHEMICAL]-demethylation of 5-methoxytryptamine to serotonin, but they were less effective than the [GENE]human isoform CYP2D6[\\GENE].",
        "label": 9,
        "major": 9,
        "len": 30
    },
    {
        "text": "Of the rat CYP isoforms studied, [GENE]CYP2D[\\GENE] isoforms were the most efficient in catalyzing the O-demethylation of [CHEMICAL]5-methoxytryptamine[\\CHEMICAL] to serotonin, but they were less effective than the human isoform CYP2D6.",
        "label": 9,
        "major": 9,
        "len": 30
    },
    {
        "text": "Of the rat CYP isoforms studied, CYP2D isoforms were the most efficient in catalyzing the O-demethylation of [CHEMICAL]5-methoxytryptamine[\\CHEMICAL] to serotonin, but they were less effective than the [GENE]human isoform CYP2D6[\\GENE].",
        "label": 9,
        "major": 9,
        "len": 30
    },
    {
        "text": "The catalytic competence of [GENE]cytochrome P450[\\GENE] in the synthesis of serotonin from [CHEMICAL]5-methoxytryptamine[\\CHEMICAL] in the brain: an in vitro study.",
        "label": 9,
        "major": -1,
        "len": 20
    },
    {
        "text": "Human liver microsomes of the wild-type [GENE]CYP2D6[\\GENE] metabolized [CHEMICAL]5-methoxytryptamine[\\CHEMICAL] to serotonin more effectively than did the defective CYP2D6*4*4 ones.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "Human liver microsomes of the wild-type CYP2D6 metabolized [CHEMICAL]5-methoxytryptamine[\\CHEMICAL] to serotonin more effectively than did the defective [GENE]CYP2D6[\\GENE]*4*4 ones.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "The obtained results indicate that [GENE]rat brain CYP2D[\\GENE] isoforms catalyze the formation of serotonin from [CHEMICAL]5-methoxytryptamine[\\CHEMICAL], and that the deficit or genetic defect of CYP2D may affect serotonin metabolism in the brain.",
        "label": 9,
        "major": 9,
        "len": 32
    },
    {
        "text": "In breast cancer (BC) epithelial cells, the mitogenic action of [CHEMICAL]estradiol[\\CHEMICAL] is transduced through binding to two receptors, [GENE]ER\u03b1[\\GENE] and ER\u03b2, which act as transcription factors.",
        "label": 2,
        "major": 2,
        "len": 26
    },
    {
        "text": "In breast cancer (BC) epithelial cells, the mitogenic action of [CHEMICAL]estradiol[\\CHEMICAL] is transduced through binding to two receptors, ER\u03b1 and [GENE]ER\u03b2[\\GENE], which act as transcription factors.",
        "label": 2,
        "major": 2,
        "len": 26
    },
    {
        "text": "[CHEMICAL]Estrogen[\\CHEMICAL] effects are mediated not only through nuclear [GENE]ERs[\\GENE] but also through cytoplasmic/membrane ERs and G-protein-coupled ERs.",
        "label": 2,
        "major": 10,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Estrogen[\\CHEMICAL] effects are mediated not only through nuclear ERs but also through cytoplasmic/membrane [GENE]ERs[\\GENE] and G-protein-coupled ERs.",
        "label": 2,
        "major": 10,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Estrogen[\\CHEMICAL] effects are mediated not only through nuclear ERs but also through cytoplasmic/membrane ERs and [GENE]G-protein[\\GENE]-coupled ERs.",
        "label": 2,
        "major": 10,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Estrogen[\\CHEMICAL] effects are mediated not only through nuclear ERs but also through cytoplasmic/membrane ERs and G-protein-coupled [GENE]ERs[\\GENE].",
        "label": 2,
        "major": 10,
        "len": 17
    },
    {
        "text": "Taken together, our study suggested, for the first time, that the pro-apoptotic effects of [CHEMICAL]TSN[\\CHEMICAL] on HL-60 cells were mediated through [GENE]JNK[\\GENE] signaling pathway.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Toosendanin[\\CHEMICAL] induces apoptosis through suppression of [GENE]JNK[\\GENE] signaling pathway in HL-60 cells.",
        "label": 4,
        "major": 3,
        "len": 12
    },
    {
        "text": "Western blot analysis indicated that [CHEMICAL]TSN[\\CHEMICAL] inhibits the [GENE]CDC42[\\GENE]/MEKK1/JNK pathway.",
        "label": 4,
        "major": 4,
        "len": 10
    },
    {
        "text": "Western blot analysis indicated that [CHEMICAL]TSN[\\CHEMICAL] inhibits the CDC42/[GENE]MEKK1[\\GENE]/JNK pathway.",
        "label": 4,
        "major": 4,
        "len": 10
    },
    {
        "text": "Western blot analysis indicated that [CHEMICAL]TSN[\\CHEMICAL] inhibits the CDC42/MEKK1/[GENE]JNK[\\GENE] pathway.",
        "label": 4,
        "major": 4,
        "len": 10
    },
    {
        "text": "Administration of low, but not high, doses of oral [CHEMICAL]nicotine[\\CHEMICAL] in DSS-treated mice resulted in a significant decrease in disease severity, histologic damage scores, as well as colonic level of [GENE]tumor necrosis factor-\u03b1[\\GENE].",
        "label": 3,
        "major": 10,
        "len": 33
    },
    {
        "text": "Keap1 is expressed in differentiating osteoclast-like cells and the S349T mutation selectively impairs the SQSTM1-Keap1 interaction in co-immunoprecipitations, which molecular modelling indicates results from effects on critical [CHEMICAL]hydrogen[\\CHEMICAL] bonds required to stabilise the [GENE]KIR[\\GENE]-Keap1 complex.",
        "label": 1,
        "major": 2,
        "len": 35
    },
    {
        "text": "Keap1 is expressed in differentiating osteoclast-like cells and the S349T mutation selectively impairs the SQSTM1-Keap1 interaction in co-immunoprecipitations, which molecular modelling indicates results from effects on critical [CHEMICAL]hydrogen[\\CHEMICAL] bonds required to stabilise the KIR-[GENE]Keap1[\\GENE] complex.",
        "label": 1,
        "major": 2,
        "len": 35
    },
    {
        "text": "[GENE]Orexin-A[\\GENE] (a [CHEMICAL]glucose[\\CHEMICAL]-sensing neuropeptide in the hypothalamus) and brain-derived neurotrophic factor (BDNF; a member of the neurotrophin family) play roles in many physiologic functions, including regulation of glucose metabolism.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The MCAO-induced decrease in insulin receptor levels in the liver and skeletal muscle on day 1 was recovered to control levels by orexin-A, and this effect of [GENE]orexin-A[\\GENE] was reversed by the administration of [CHEMICAL]SB334867[\\CHEMICAL] as well as by hypothalamic BDNF knockdown.",
        "label": 4,
        "major": 4,
        "len": 42
    },
    {
        "text": "The MCAO-induced decrease in [GENE]insulin receptor[\\GENE] levels in the liver and skeletal muscle on day 1 was recovered to control levels by orexin-A, and this effect of orexin-A was reversed by the administration of [CHEMICAL]SB334867[\\CHEMICAL] as well as by hypothalamic BDNF knockdown.",
        "label": 4,
        "major": 4,
        "len": 42
    },
    {
        "text": "Small interfering RNA directed BDNF, orexin-A, and [CHEMICAL]SB334867[\\CHEMICAL] [N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl urea; a specific [GENE]orexin-1 receptor[\\GENE] antagonist] were administered directly into the hypothalamus.",
        "label": 6,
        "major": 6,
        "len": 21
    },
    {
        "text": "Small interfering RNA directed BDNF, orexin-A, and SB334867 [[CHEMICAL]N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl urea[\\CHEMICAL]; a specific [GENE]orexin-1 receptor[\\GENE] antagonist] were administered directly into the hypothalamus.",
        "label": 6,
        "major": 6,
        "len": 21
    },
    {
        "text": "Filtering and analysis of data identified three oncogenic pathways interfered by [CHEMICAL]5-ASA[\\CHEMICAL]: MAPK/ERK pathway, cell adhesion and [GENE]\u03b2-catenin[\\GENE]/Wnt signaling.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Filtering and analysis of data identified three oncogenic pathways interfered by [CHEMICAL]5-ASA[\\CHEMICAL]: MAPK/ERK pathway, cell adhesion and \u03b2-catenin/[GENE]Wnt[\\GENE] signaling.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Filtering and analysis of data identified three oncogenic pathways interfered by [CHEMICAL]5-ASA[\\CHEMICAL]: [GENE]MAPK[\\GENE]/ERK pathway, cell adhesion and \u03b2-catenin/Wnt signaling.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Filtering and analysis of data identified three oncogenic pathways interfered by [CHEMICAL]5-ASA[\\CHEMICAL]: MAPK/[GENE]ERK[\\GENE] pathway, cell adhesion and \u03b2-catenin/Wnt signaling.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "[GENE]PAK1[\\GENE] emerged as a consensus target of [CHEMICAL]5-ASA[\\CHEMICAL], orchestrating these pathways.",
        "label": 2,
        "major": -1,
        "len": 11
    },
    {
        "text": "Our data demonstrates novel pharmacological mechanism of [CHEMICAL]mesalamine[\\CHEMICAL] in modulation of cell adhesion and role of [GENE]PAK1[\\GENE] in APC(min) polyposis.",
        "label": 2,
        "major": 7,
        "len": 20
    },
    {
        "text": "Moreover, [CHEMICAL]5-ASA[\\CHEMICAL] treatment restored membranous expression of adhesion molecules [GENE]E-cadherin[\\GENE] and \u03b2-catenin.",
        "label": 3,
        "major": -1,
        "len": 12
    },
    {
        "text": "Moreover, [CHEMICAL]5-ASA[\\CHEMICAL] treatment restored membranous expression of adhesion molecules E-cadherin and [GENE]\u03b2-catenin[\\GENE].",
        "label": 3,
        "major": -1,
        "len": 12
    },
    {
        "text": "[GENE]PAK1[\\GENE] expression was elevated in APC(min) polyps and [CHEMICAL]5-ASA[\\CHEMICAL] treatment reduced its expression.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "We propose that inhibition of [GENE]PAK1[\\GENE] expression by [CHEMICAL]5-ASA[\\CHEMICAL] can impede with neoplastic progression in colorectal carcinogenesis.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Mesalamine[\\CHEMICAL] modulates intercellular adhesion through inhibition of [GENE]p-21 activated kinase-1[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 10
    },
    {
        "text": "The mechanism of [GENE]PAK1[\\GENE] inhibition and induction of membranous translocation of adhesion proteins by [CHEMICAL]5-ASA[\\CHEMICAL] might be independent of its known anti-inflammatory action.",
        "label": 4,
        "major": 3,
        "len": 23
    },
    {
        "text": "This study shows ability of [CHEMICAL]EGCG[\\CHEMICAL] to raise plasma bile acid concentrations, mainly through [GENE]Cyp7a1[\\GENE] upregulation, and to decrease bile production through reduction in Mrp2-mediated bile acid-independent bile flow.",
        "label": 3,
        "major": 4,
        "len": 29
    },
    {
        "text": "In contrast, [CHEMICAL]EGCG[\\CHEMICAL] markedly downregulated major [GENE]bile acid transporters[\\GENE] (Asbt and Ost\u03b1) and regulatory molecules (Shp and Fgf15) in the ileum.",
        "label": 4,
        "major": 9,
        "len": 21
    },
    {
        "text": "In contrast, [CHEMICAL]EGCG[\\CHEMICAL] markedly downregulated major bile acid transporters ([GENE]Asbt[\\GENE] and Ost\u03b1) and regulatory molecules (Shp and Fgf15) in the ileum.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In contrast, [CHEMICAL]EGCG[\\CHEMICAL] markedly downregulated major bile acid transporters (Asbt and [GENE]Ost\u03b1[\\GENE]) and regulatory molecules (Shp and Fgf15) in the ileum.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In contrast, [CHEMICAL]EGCG[\\CHEMICAL] markedly downregulated major bile acid transporters (Asbt and Ost\u03b1) and regulatory molecules ([GENE]Shp[\\GENE] and Fgf15) in the ileum.",
        "label": 4,
        "major": 9,
        "len": 21
    },
    {
        "text": "In contrast, [CHEMICAL]EGCG[\\CHEMICAL] markedly downregulated major bile acid transporters (Asbt and Ost\u03b1) and regulatory molecules (Shp and [GENE]Fgf15[\\GENE]) in the ileum.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "The serotonin (5-HT) receptors of type 6 ([GENE]5-HT6[\\GENE]) are quite different from all other 5-HT receptors, as they include a short third cytoplasmatic loop and a long [CHEMICAL]C[\\CHEMICAL]-terminal tail, and one intron located in the middle of the third cytoplasmatic loop.",
        "label": 1,
        "major": -1,
        "len": 41
    },
    {
        "text": "The [GENE]serotonin (5-HT) receptors[\\GENE] of type 6 (5-HT6) are quite different from all other 5-HT receptors, as they include a short third cytoplasmatic loop and a long [CHEMICAL]C[\\CHEMICAL]-terminal tail, and one intron located in the middle of the third cytoplasmatic loop.",
        "label": 1,
        "major": -1,
        "len": 41
    },
    {
        "text": "These results reveal, for the first time, the differential distribution of P-CREB in fast- and slow-twitch muscles, which might support the crucial role of [CHEMICAL]cAMP[\\CHEMICAL]-dependent signaling in controlling the synapse-specific expression of [GENE]ColQ-1a[\\GENE] in fast-twitch muscles.",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "[GENE]ColQ-1a[\\GENE] is expressed at the neuromuscular junction (NMJ) in fast-twitch muscle, and this expression depends on trophic factors supplied by motor neurons signaling via a [CHEMICAL]cAMP[\\CHEMICAL]-dependent pathway in muscle.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "Data at transcriptional level also demonstrated that [CHEMICAL]catalpol[\\CHEMICAL] potently attenuated gene expressions involved in inflammation, such as [GENE]iNOS[\\GENE], COX-2 and TLR4.",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "Data at transcriptional level also demonstrated that [CHEMICAL]catalpol[\\CHEMICAL] potently attenuated gene expressions involved in inflammation, such as iNOS, [GENE]COX-2[\\GENE] and TLR4.",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "Data at transcriptional level also demonstrated that [CHEMICAL]catalpol[\\CHEMICAL] potently attenuated gene expressions involved in inflammation, such as iNOS, COX-2 and [GENE]TLR4[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 21
    },
    {
        "text": "In addition, our exploration further revealed that the suppressive action of [CHEMICAL]catalpol[\\CHEMICAL] on inflammation was mediated via inhibiting nuclear factor-\u03baB ([GENE]NF-\u03baB[\\GENE]) activation.",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "In addition, our exploration further revealed that the suppressive action of [CHEMICAL]catalpol[\\CHEMICAL] on inflammation was mediated via inhibiting [GENE]nuclear factor-\u03baB[\\GENE] (NF-\u03baB) activation.",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Catalpol[\\CHEMICAL] inhibits LPS plus [GENE]IFN-\u03b3[\\GENE]-induced inflammatory response in astrocytes primary cultures.",
        "label": 4,
        "major": 4,
        "len": 11
    },
    {
        "text": "Collectively, these results suggest that [CHEMICAL]catalpol[\\CHEMICAL] can exert inhibitory effects on the inflammatory reaction in astrocytes and that inactivation of [GENE]NF-\u03baB[\\GENE] could be the major determinant for its anti-inflammatory mechanism.",
        "label": 4,
        "major": 4,
        "len": 30
    },
    {
        "text": "Biochemical analyses showed that NO and ROS production and [GENE]iNOS[\\GENE] activity were significantly reduced by [CHEMICAL]catalpol[\\CHEMICAL].",
        "label": 4,
        "major": 9,
        "len": 16
    },
    {
        "text": "[GENE]Protein tyrosine phosphatase 1B[\\GENE] inhibitory effect by dammarane-type triterpenes from hydrolyzate of total Gynostemma pentaphyllum [CHEMICAL]saponins[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 16
    },
    {
        "text": "[GENE]Protein tyrosine phosphatase 1B[\\GENE] inhibitory effect by [CHEMICAL]dammarane[\\CHEMICAL]-type triterpenes from hydrolyzate of total Gynostemma pentaphyllum saponins.",
        "label": 4,
        "major": 4,
        "len": 16
    },
    {
        "text": "[GENE]Protein tyrosine phosphatase 1B[\\GENE] inhibitory effect by dammarane-type [CHEMICAL]triterpenes[\\CHEMICAL] from hydrolyzate of total Gynostemma pentaphyllum saponins.",
        "label": 4,
        "major": 4,
        "len": 16
    },
    {
        "text": "Neurodegeneration was related with decreased [(3)H]glutamate uptake and decreased Akt immunoreactivity, however [GENE]phospho-GSK-3-\u03b2[\\GENE] (Ser9) was not altered in [CHEMICAL](PhTe)(2)[\\CHEMICAL] injected rat.",
        "label": 10,
        "major": 10,
        "len": 21
    },
    {
        "text": "Neurodegeneration was related with decreased [(3)H]glutamate uptake and decreased Akt immunoreactivity, however [GENE]phospho-GSK-3-\u03b2[\\GENE] ([CHEMICAL]Ser[\\CHEMICAL]9) was not altered in (PhTe)(2) injected rat.",
        "label": 1,
        "major": 10,
        "len": 21
    },
    {
        "text": "Therefore, the present results show that the earlier cerebellar responses to [CHEMICAL](PhTe)(2)[\\CHEMICAL] include disruption of cytoskeletal homeostasis that could be related with [GENE]MAPK[\\GENE] and PKA activation and reactive astrogliosis.",
        "label": 3,
        "major": 3,
        "len": 29
    },
    {
        "text": "Therefore, the present results show that the earlier cerebellar responses to [CHEMICAL](PhTe)(2)[\\CHEMICAL] include disruption of cytoskeletal homeostasis that could be related with MAPK and [GENE]PKA[\\GENE] activation and reactive astrogliosis.",
        "label": 3,
        "major": 3,
        "len": 29
    },
    {
        "text": "Also, reactive astrogliosis takes part of the early responses to the insult with [CHEMICAL](PhTe)(2)[\\CHEMICAL], evidenced by upregulated [GENE]GFAP[\\GENE] in Western blot, PCR and immunofluorescence analysis.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "Six days after (PhTe)(2) injection we found persistent astrogliosis, increased propidium iodide (PI) positive cells in NeuN positive population evidenced by flow cytometry and reduced immunofluorescence for [GENE]NeuN[\\GENE], suggesting that the in vivo exposure to [CHEMICAL](PhTe)(2)[\\CHEMICAL] progressed to neuronal death.",
        "label": 4,
        "major": 3,
        "len": 40
    },
    {
        "text": "Neurodegeneration was related with decreased [(3)H]glutamate uptake and decreased [GENE]Akt[\\GENE] immunoreactivity, however phospho-GSK-3-\u03b2 (Ser9) was not altered in [CHEMICAL](PhTe)(2)[\\CHEMICAL] injected rat.",
        "label": 4,
        "major": 10,
        "len": 21
    },
    {
        "text": "Fluorescence of the reporter dye is turned on by rapid removal of the quinone quencher, an event that immediately occurs only after highly selective, two-electron reduction of the sterically and conformationally restricted [CHEMICAL]quinone[\\CHEMICAL] substrate by the cancer-associated [GENE]human NAD(P)H:quinone oxidoreductase isozyme 1[\\GENE] (hNQO1).",
        "label": 9,
        "major": 4,
        "len": 43
    },
    {
        "text": "Fluorescence of the reporter dye is turned on by rapid removal of the quinone quencher, an event that immediately occurs only after highly selective, two-electron reduction of the sterically and conformationally restricted [CHEMICAL]quinone[\\CHEMICAL] substrate by the cancer-associated human NAD(P)H:quinone oxidoreductase isozyme 1 ([GENE]hNQO1[\\GENE]).",
        "label": 9,
        "major": 4,
        "len": 43
    },
    {
        "text": "Synthesis, biological evaluation, and molecular modeling of [CHEMICAL]glycyrrhizin[\\CHEMICAL] derivatives as potent [GENE]high-mobility group box-1[\\GENE] inhibitors with anti-heart-failure activity in vivo.",
        "label": 4,
        "major": 4,
        "len": 20
    },
    {
        "text": "Within the [CHEMICAL]TPBP[\\CHEMICAL] scaffold, either electronic or steric perturbations to the central piperidine ring led to a loss of selective M(1) allosteric agonism and afforded pan-[GENE]mAChR[\\GENE] antagonism, which was demonstrated to be mediated via the orthosteric site.",
        "label": 6,
        "major": 5,
        "len": 37
    },
    {
        "text": "Within the TPBP scaffold, either electronic or steric perturbations to the central [CHEMICAL]piperidine[\\CHEMICAL] ring led to a loss of selective M(1) allosteric agonism and afforded pan-[GENE]mAChR[\\GENE] antagonism, which was demonstrated to be mediated via the orthosteric site.",
        "label": 6,
        "major": 6,
        "len": 37
    },
    {
        "text": "Additional SAR around a related M(1) allosteric agonist family ([CHEMICAL]VU0357017[\\CHEMICAL]) identified similar, subtle 'molecular switches' that modulated modes of pharmacology from allosteric agonism to pan-[GENE]mAChR[\\GENE] orthosteric antagonism.",
        "label": 6,
        "major": 7,
        "len": 27
    },
    {
        "text": "The objective of this article is to examine the effects of single and repeated administrations of silymarin on pharmacokinetics of a [GENE]P-gp[\\GENE] substrate, [CHEMICAL]risperidone[\\CHEMICAL], and its major metabolite, 9-hydroxyrisperidone, in rats.",
        "label": 9,
        "major": 9,
        "len": 31
    },
    {
        "text": "The objective of this article is to examine the effects of single and repeated administrations of silymarin on pharmacokinetics of a [GENE]P-gp[\\GENE] substrate, risperidone, and its major metabolite, [CHEMICAL]9-hydroxyrisperidone[\\CHEMICAL], in rats.",
        "label": 9,
        "major": 9,
        "len": 31
    },
    {
        "text": "In this study, we present the synthesis and pharmacological properties of new analogues of [GENE]arginine vasopressin[\\GENE] modified in the [CHEMICAL]N[\\CHEMICAL]-terminal part of the molecule with proline derivatives: indoline-2-carboxylic acid (Ica) and (2S,4R)-4-(naphthalene-2-ylmethyl)pyrrolidine-2-carboxylic acid.",
        "label": 1,
        "major": -1,
        "len": 33
    },
    {
        "text": "On the other hand, peptides modified with [CHEMICAL](2S,4R)-4-(naphthalene-2-ylmethyl)pyrrolidine-2-carboxylic acid[\\CHEMICAL], apart from their moderate antioxytocic activity, turned out to be weak antagonists of the pressor response to [GENE]arginine vasopressin[\\GENE].",
        "label": 6,
        "major": 6,
        "len": 28
    },
    {
        "text": "[GENE]Liver X Receptor (LXR) \u03b1[\\GENE] and LXR \u03b2 are nuclear receptors activated by [CHEMICAL]oxysterols[\\CHEMICAL], oxidized derivatives of cholesterol.",
        "label": 3,
        "major": 3,
        "len": 18
    },
    {
        "text": "Liver X Receptor (LXR) \u03b1 and [GENE]LXR \u03b2[\\GENE] are nuclear receptors activated by [CHEMICAL]oxysterols[\\CHEMICAL], oxidized derivatives of cholesterol.",
        "label": 3,
        "major": 3,
        "len": 18
    },
    {
        "text": "For example, involvement of [GENE]\u03b2-catenin[\\GENE] in LH\u03b2 induction by [CHEMICAL]GnRH[\\CHEMICAL] has been discovered.",
        "label": 2,
        "major": 3,
        "len": 13
    },
    {
        "text": "\u03b2-catenin regulates [CHEMICAL]GnRH[\\CHEMICAL]-induced [GENE]FSH\u03b2[\\GENE] gene expression.",
        "label": 3,
        "major": 3,
        "len": 6
    },
    {
        "text": "Furthermore, knockdown of Brms1L significantly attenuated [CHEMICAL]GnRH[\\CHEMICAL]-induced [GENE]FSH\u03b2[\\GENE] expression.",
        "label": 3,
        "major": 3,
        "len": 9
    },
    {
        "text": "Thus, our findings indicate that the expression of Brms1L depends on \u03b2-catenin activity and contributes to [GENE]FSH\u03b2[\\GENE] induction by [CHEMICAL]GnRH[\\CHEMICAL].",
        "label": 3,
        "major": 3,
        "len": 20
    },
    {
        "text": "[CHEMICAL]GnRH[\\CHEMICAL] caused a sustained increase in nuclear [GENE]\u03b2-catenin[\\GENE] levels, which was significantly reduced by c-Jun N-terminal kinase (JNK) inhibition.",
        "label": 3,
        "major": 4,
        "len": 19
    },
    {
        "text": "Small interfering RNA-mediated knockdown of \u03b2-catenin mRNA demonstrated that induction of [GENE]FSH\u03b2[\\GENE] mRNA by [CHEMICAL]GnRH[\\CHEMICAL] depended on \u03b2-catenin and that regulation of FSH\u03b2 by \u03b2-catenin occurred independently of the JNK-c-jun pathway.",
        "label": 3,
        "major": 3,
        "len": 31
    },
    {
        "text": "In conclusion, in this cellular model, [CHEMICAL]DOX[\\CHEMICAL] effectively protects against PQ toxicity by inducing P-gp and through the interaction with the [GENE]choline transporter[\\GENE], suggesting that compounds presenting this double feature of promoting the efflux and limiting the uptake of PQ could be used as effective antidotes to treat intoxications.",
        "label": 2,
        "major": 3,
        "len": 49
    },
    {
        "text": "In conclusion, in this cellular model, [CHEMICAL]DOX[\\CHEMICAL] effectively protects against PQ toxicity by inducing [GENE]P-gp[\\GENE] and through the interaction with the choline transporter, suggesting that compounds presenting this double feature of promoting the efflux and limiting the uptake of PQ could be used as effective antidotes to treat intoxications.",
        "label": 3,
        "major": 2,
        "len": 49
    },
    {
        "text": "The aim of the present work was to evaluate the effectiveness of such an antidote by testing whether [CHEMICAL]doxorubicin[\\CHEMICAL] (DOX), a known [GENE]P-gp[\\GENE] inducer, could efficiently protect Caco-2 cells against PQ cytotoxicity, 6 h after the incubation with the herbicide, reflecting a real-life intoxication scenario.",
        "label": 3,
        "major": 3,
        "len": 45
    },
    {
        "text": "The aim of the present work was to evaluate the effectiveness of such an antidote by testing whether doxorubicin ([CHEMICAL]DOX[\\CHEMICAL]), a known [GENE]P-gp[\\GENE] inducer, could efficiently protect Caco-2 cells against PQ cytotoxicity, 6 h after the incubation with the herbicide, reflecting a real-life intoxication scenario.",
        "label": 3,
        "major": 3,
        "len": 45
    },
    {
        "text": "The herbicide [CHEMICAL]paraquat[\\CHEMICAL] (PQ) is a [GENE]P-gp[\\GENE] substrate responsible for thousands of fatal intoxications worldwide that still lacks an effective antidote.",
        "label": 9,
        "major": 9,
        "len": 21
    },
    {
        "text": "[CHEMICAL]P505-15[\\CHEMICAL] successfully inhibited SYK-mediated [GENE]B-cell receptor[\\GENE] signaling and decreased cell viability in NHL and CLL.",
        "label": 4,
        "major": 4,
        "len": 15
    },
    {
        "text": "The selective [GENE]SYK[\\GENE] inhibitor [CHEMICAL]P505-15[\\CHEMICAL] (PRT062607) inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemia.",
        "label": 4,
        "major": 4,
        "len": 27
    },
    {
        "text": "The selective [GENE]SYK[\\GENE] inhibitor P505-15 ([CHEMICAL]PRT062607[\\CHEMICAL]) inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemia.",
        "label": 4,
        "major": 4,
        "len": 27
    },
    {
        "text": "[CHEMICAL]P505-15[\\CHEMICAL] (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule [GENE]SYK[\\GENE] inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "[CHEMICAL]P505-15[\\CHEMICAL] (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor ([GENE]SYK[\\GENE] IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "[CHEMICAL]P505-15[\\CHEMICAL] (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-[GENE]SYK[\\GENE] activity that is at least 80-fold greater than its affinity for other kinases.",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "P505-15 (also known as [CHEMICAL]PRT062607[\\CHEMICAL]) is a novel, highly selective, and orally bioavailable small molecule [GENE]SYK[\\GENE] inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "P505-15 (also known as [CHEMICAL]PRT062607[\\CHEMICAL]) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor ([GENE]SYK[\\GENE] IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.",
        "label": 4,
        "major": 2,
        "len": 37
    },
    {
        "text": "P505-15 (also known as [CHEMICAL]PRT062607[\\CHEMICAL]) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-[GENE]SYK[\\GENE] activity that is at least 80-fold greater than its affinity for other kinases.",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "[CHEMICAL]P505-15[\\CHEMICAL] successfully inhibited [GENE]SYK[\\GENE]-mediated B-cell receptor signaling and decreased cell viability in NHL and CLL.",
        "label": 4,
        "major": 4,
        "len": 15
    },
    {
        "text": "Alleles of [GENE]RPB1[\\GENE] (RPO21) with elevated slippage rates were identified among [CHEMICAL]6-azauracil[\\CHEMICAL]-sensitive mutants and were also isolated using a slippage-dependent reporter gene.",
        "label": 2,
        "major": 1,
        "len": 22
    },
    {
        "text": "Alleles of RPB1 ([GENE]RPO21[\\GENE]) with elevated slippage rates were identified among [CHEMICAL]6-azauracil[\\CHEMICAL]-sensitive mutants and were also isolated using a slippage-dependent reporter gene.",
        "label": 2,
        "major": 1,
        "len": 22
    },
    {
        "text": "We demonstrated that [GENE]AhR[\\GENE] protein not only functions as a downstream target of [CHEMICAL]17-AAG[\\CHEMICAL], but also enhances anticancer activity of 17-AAG in lung AD cells.",
        "label": 2,
        "major": 10,
        "len": 25
    },
    {
        "text": "[GENE]Aryl hydrocarbon receptor[\\GENE] is a target of [CHEMICAL]17-Allylamino-17-demethoxygeldanamycin[\\CHEMICAL] and enhances its anticancer activity in lung adenocarcinoma cells.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Although treatment with [CHEMICAL]17-AAG[\\CHEMICAL] reduced [GENE]AhR[\\GENE] levels and AhR-regulated gene expression in lung AD cells, AhR expression increased anticancer activity of 17-AAG.",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "Although treatment with [CHEMICAL]17-AAG[\\CHEMICAL] reduced AhR levels and [GENE]AhR[\\GENE]-regulated gene expression in lung AD cells, AhR expression increased anticancer activity of 17-AAG.",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "In addition, [CHEMICAL]17-AAG[\\CHEMICAL] treatment reduced cell viability, [GENE]CDK2[\\GENE], CDK4, cyclin E, cyclin D1, and phosphorylated Rb levels in AhR-expressing lung AD cells.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "In addition, [CHEMICAL]17-AAG[\\CHEMICAL] treatment reduced cell viability, CDK2, [GENE]CDK4[\\GENE], cyclin E, cyclin D1, and phosphorylated Rb levels in AhR-expressing lung AD cells.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "In addition, [CHEMICAL]17-AAG[\\CHEMICAL] treatment reduced cell viability, CDK2, CDK4, [GENE]cyclin E[\\GENE], cyclin D1, and phosphorylated Rb levels in AhR-expressing lung AD cells.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "In addition, [CHEMICAL]17-AAG[\\CHEMICAL] treatment reduced cell viability, CDK2, CDK4, cyclin E, [GENE]cyclin D1[\\GENE], and phosphorylated Rb levels in AhR-expressing lung AD cells.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "In addition, [CHEMICAL]17-AAG[\\CHEMICAL] treatment reduced cell viability, CDK2, CDK4, cyclin E, cyclin D1, and [GENE]phosphorylated Rb[\\GENE] levels in AhR-expressing lung AD cells.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "[CHEMICAL]17-Allylamino-17-demethoxygeldanamycin[\\CHEMICAL] (17-AAG), an [GENE]Hsp90[\\GENE] inhibitor, is currently under evaluation for its anticancer activity in clinical trials.",
        "label": 4,
        "major": 4,
        "len": 16
    },
    {
        "text": "17-Allylamino-17-demethoxygeldanamycin ([CHEMICAL]17-AAG[\\CHEMICAL]), an [GENE]Hsp90[\\GENE] inhibitor, is currently under evaluation for its anticancer activity in clinical trials.",
        "label": 4,
        "major": 4,
        "len": 16
    },
    {
        "text": "[GENE]DCK[\\GENE] did not significantly contribute to [CHEMICAL]dFdU[\\CHEMICAL] monophosphorylation.",
        "label": 10,
        "major": 10,
        "len": 8
    },
    {
        "text": "In conclusion, the [GENE]Lys27Gln[\\GENE] substitution does not significantly modulate CDA activity toward dFdC, and therefore would not contribute to interindividual variability in response to [CHEMICAL]gemcitabine[\\CHEMICAL].",
        "label": 10,
        "major": 10,
        "len": 25
    },
    {
        "text": "In conclusion, the Lys27Gln substitution does not significantly modulate [GENE]CDA[\\GENE] activity toward dFdC, and therefore would not contribute to interindividual variability in response to [CHEMICAL]gemcitabine[\\CHEMICAL].",
        "label": 10,
        "major": 10,
        "len": 25
    },
    {
        "text": "Wild-type enzymes and variants of [GENE]CDA[\\GENE] (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine ([CHEMICAL]Ara-C[\\CHEMICAL]), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA ([GENE]Lys27Gln[\\GENE] and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine ([CHEMICAL]Ara-C[\\CHEMICAL]), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and [GENE]Ala70Thr[\\GENE]) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine ([CHEMICAL]Ara-C[\\CHEMICAL]), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and [GENE]DCK[\\GENE] (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine ([CHEMICAL]Ara-C[\\CHEMICAL]), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK ([GENE]Ile24Val[\\GENE], Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine ([CHEMICAL]Ara-C[\\CHEMICAL]), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, [GENE]Ala119Gly[\\GENE], and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine ([CHEMICAL]Ara-C[\\CHEMICAL]), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and [GENE]Pro122Ser[\\GENE]) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine ([CHEMICAL]Ara-C[\\CHEMICAL]), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of [GENE]CDA[\\GENE] (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), [CHEMICAL]dFdC[\\CHEMICAL], and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA ([GENE]Lys27Gln[\\GENE] and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), [CHEMICAL]dFdC[\\CHEMICAL], and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and [GENE]Ala70Thr[\\GENE]) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), [CHEMICAL]dFdC[\\CHEMICAL], and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and [GENE]DCK[\\GENE] (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), [CHEMICAL]dFdC[\\CHEMICAL], and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK ([GENE]Ile24Val[\\GENE], Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), [CHEMICAL]dFdC[\\CHEMICAL], and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, [GENE]Ala119Gly[\\GENE], and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), [CHEMICAL]dFdC[\\CHEMICAL], and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and [GENE]Pro122Ser[\\GENE]) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), [CHEMICAL]dFdC[\\CHEMICAL], and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of [GENE]CDA[\\GENE] (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite [CHEMICAL]2',2'-difluorodeoxyuridine[\\CHEMICAL] (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA ([GENE]Lys27Gln[\\GENE] and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite [CHEMICAL]2',2'-difluorodeoxyuridine[\\CHEMICAL] (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and [GENE]Ala70Thr[\\GENE]) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite [CHEMICAL]2',2'-difluorodeoxyuridine[\\CHEMICAL] (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and [GENE]DCK[\\GENE] (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite [CHEMICAL]2',2'-difluorodeoxyuridine[\\CHEMICAL] (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK ([GENE]Ile24Val[\\GENE], Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite [CHEMICAL]2',2'-difluorodeoxyuridine[\\CHEMICAL] (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, [GENE]Ala119Gly[\\GENE], and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite [CHEMICAL]2',2'-difluorodeoxyuridine[\\CHEMICAL] (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and [GENE]Pro122Ser[\\GENE]) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite [CHEMICAL]2',2'-difluorodeoxyuridine[\\CHEMICAL] (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of [GENE]CDA[\\GENE] (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine ([CHEMICAL]dFdU[\\CHEMICAL]) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "All three [GENE]CDA[\\GENE] proteins showed similar K(m) and V(max) for [CHEMICAL]Ara-C[\\CHEMICAL] and dFdC deamination, except for CDA70Thr, which had a 2.5-fold lower K(m) and 6-fold lower V(max) for Ara-C deamination.",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "All three [GENE]CDA[\\GENE] proteins showed similar K(m) and V(max) for Ara-C and [CHEMICAL]dFdC[\\CHEMICAL] deamination, except for CDA70Thr, which had a 2.5-fold lower K(m) and 6-fold lower V(max) for Ara-C deamination.",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "All three CDA proteins showed similar K(m) and V(max) for Ara-C and dFdC deamination, except for [GENE]CDA[\\GENE]70Thr, which had a 2.5-fold lower K(m) and 6-fold lower V(max) for [CHEMICAL]Ara-C[\\CHEMICAL] deamination.",
        "label": 9,
        "major": -1,
        "len": 30
    },
    {
        "text": "All four [GENE]DCK[\\GENE] proteins yielded comparable metabolic activity for [CHEMICAL]Ara-C[\\CHEMICAL] and dFdC monophosphorylation, except for DCK24Val, which demonstrated an approximately 2-fold increase (P < 0.05) in the intrinsic clearance of dFdC monophosphorylation due to a 40% decrease in K(m) (P < 0.05).",
        "label": 9,
        "major": 4,
        "len": 42
    },
    {
        "text": "All four [GENE]DCK[\\GENE] proteins yielded comparable metabolic activity for Ara-C and [CHEMICAL]dFdC[\\CHEMICAL] monophosphorylation, except for DCK24Val, which demonstrated an approximately 2-fold increase (P < 0.05) in the intrinsic clearance of dFdC monophosphorylation due to a 40% decrease in K(m) (P < 0.05).",
        "label": 9,
        "major": 4,
        "len": 42
    },
    {
        "text": "[CHEMICAL]Gemcitabine[\\CHEMICAL] (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase ([GENE]DCK[\\GENE]), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "[CHEMICAL]Gemcitabine[\\CHEMICAL] (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by [GENE]cytidine deaminase[\\GENE] (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "[CHEMICAL]Gemcitabine[\\CHEMICAL] (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase ([GENE]CDA[\\GENE]) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "[CHEMICAL]Gemcitabine[\\CHEMICAL] (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and [GENE]deoxycytidine kinase[\\GENE] (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "All four DCK proteins yielded comparable metabolic activity for Ara-C and dFdC monophosphorylation, except for [GENE]DCK[\\GENE]24Val, which demonstrated an approximately 2-fold increase (P < 0.05) in the intrinsic clearance of [CHEMICAL]dFdC[\\CHEMICAL] monophosphorylation due to a 40% decrease in K(m) (P < 0.05).",
        "label": 9,
        "major": 3,
        "len": 42
    },
    {
        "text": "In conclusion, the [GENE]Lys27Gln[\\GENE] substitution does not significantly modulate CDA activity toward [CHEMICAL]dFdC[\\CHEMICAL], and therefore would not contribute to interindividual variability in response to gemcitabine.",
        "label": 9,
        "major": 10,
        "len": 25
    },
    {
        "text": "In conclusion, the Lys27Gln substitution does not significantly modulate [GENE]CDA[\\GENE] activity toward [CHEMICAL]dFdC[\\CHEMICAL], and therefore would not contribute to interindividual variability in response to gemcitabine.",
        "label": 9,
        "major": 7,
        "len": 25
    },
    {
        "text": "Gemcitabine ([CHEMICAL]dFdC[\\CHEMICAL], 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase ([GENE]DCK[\\GENE]), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "Gemcitabine ([CHEMICAL]dFdC[\\CHEMICAL], 2',2'-difluorodeoxycytidine) is metabolized by [GENE]cytidine deaminase[\\GENE] (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "Gemcitabine ([CHEMICAL]dFdC[\\CHEMICAL], 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase ([GENE]CDA[\\GENE]) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "Gemcitabine ([CHEMICAL]dFdC[\\CHEMICAL], 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and [GENE]deoxycytidine kinase[\\GENE] (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "The higher in vitro catalytic efficiency of [GENE]DCK[\\GENE]24Val toward [CHEMICAL]dFdC[\\CHEMICAL] monophosphorylation may be relevant to dFdC clinical response.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "The higher in vitro catalytic efficiency of [GENE]DCK[\\GENE]24Val toward dFdC monophosphorylation may be relevant to [CHEMICAL]dFdC[\\CHEMICAL] clinical response.",
        "label": 9,
        "major": -1,
        "len": 18
    },
    {
        "text": "Gemcitabine (dFdC, [CHEMICAL]2',2'-difluorodeoxycytidine[\\CHEMICAL]) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase ([GENE]DCK[\\GENE]), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "Gemcitabine (dFdC, [CHEMICAL]2',2'-difluorodeoxycytidine[\\CHEMICAL]) is metabolized by [GENE]cytidine deaminase[\\GENE] (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "Gemcitabine (dFdC, [CHEMICAL]2',2'-difluorodeoxycytidine[\\CHEMICAL]) is metabolized by cytidine deaminase ([GENE]CDA[\\GENE]) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "Gemcitabine (dFdC, [CHEMICAL]2',2'-difluorodeoxycytidine[\\CHEMICAL]) is metabolized by cytidine deaminase (CDA) and [GENE]deoxycytidine kinase[\\GENE] (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.",
        "label": 9,
        "major": -1,
        "len": 36
    },
    {
        "text": "Wild-type enzymes and variants of [GENE]CDA[\\GENE] (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for [CHEMICAL]cytarabine[\\CHEMICAL] (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA ([GENE]Lys27Gln[\\GENE] and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for [CHEMICAL]cytarabine[\\CHEMICAL] (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and [GENE]Ala70Thr[\\GENE]) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for [CHEMICAL]cytarabine[\\CHEMICAL] (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and [GENE]DCK[\\GENE] (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for [CHEMICAL]cytarabine[\\CHEMICAL] (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK ([GENE]Ile24Val[\\GENE], Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for [CHEMICAL]cytarabine[\\CHEMICAL] (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, [GENE]Ala119Gly[\\GENE], and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for [CHEMICAL]cytarabine[\\CHEMICAL] (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and [GENE]Pro122Ser[\\GENE]) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for [CHEMICAL]cytarabine[\\CHEMICAL] (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.",
        "label": 9,
        "major": 9,
        "len": 40
    },
    {
        "text": "A series of compounds based on a [CHEMICAL]4-phenyl-2-phenylaminopyridine[\\CHEMICAL] scaffold that are potent and selective inhibitors of [GENE]Traf2- and Nck-interacting kinase[\\GENE] (TNIK) activity are described.",
        "label": 4,
        "major": 4,
        "len": 24
    },
    {
        "text": "A series of compounds based on a [CHEMICAL]4-phenyl-2-phenylaminopyridine[\\CHEMICAL] scaffold that are potent and selective inhibitors of Traf2- and Nck-interacting kinase ([GENE]TNIK[\\GENE]) activity are described.",
        "label": 4,
        "major": 2,
        "len": 24
    },
    {
        "text": "Discovery of [CHEMICAL]4-phenyl-2-phenylaminopyridine[\\CHEMICAL] based [GENE]TNIK[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 6
    },
    {
        "text": "Here we present [CHEMICAL]boronic[\\CHEMICAL] and borinic acid derivatives as a new class of potent and nontoxic [GENE]APT[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "Here we present boronic and [CHEMICAL]borinic acid[\\CHEMICAL] derivatives as a new class of potent and nontoxic [GENE]APT[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Boron[\\CHEMICAL]-based inhibitors of [GENE]acyl protein thioesterases 1 and 2[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 9
    },
    {
        "text": "[CHEMICAL]Genistein[\\CHEMICAL] had no effect on resting intracellular [Ca(2+)] or [GENE]thrombin[\\GENE]-induced increase in Ca(2+) mobilization.",
        "label": 10,
        "major": 3,
        "len": 14
    },
    {
        "text": "Genistein also reduced the formation of stress fibers by thrombin and suppressed thrombin-induced phosphorylation of [GENE]myosin light chain[\\GENE] (MLC) on [CHEMICAL]Ser[\\CHEMICAL](19)/Thr(18) in endothelial cells (ECs).",
        "label": 1,
        "major": 4,
        "len": 25
    },
    {
        "text": "Genistein also reduced the formation of stress fibers by thrombin and suppressed thrombin-induced phosphorylation of myosin light chain ([GENE]MLC[\\GENE]) on [CHEMICAL]Ser[\\CHEMICAL](19)/Thr(18) in endothelial cells (ECs).",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "Genistein also reduced the formation of stress fibers by thrombin and suppressed thrombin-induced phosphorylation of [GENE]myosin light chain[\\GENE] (MLC) on Ser(19)/[CHEMICAL]Thr[\\CHEMICAL](18) in endothelial cells (ECs).",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "Genistein also reduced the formation of stress fibers by thrombin and suppressed thrombin-induced phosphorylation of myosin light chain ([GENE]MLC[\\GENE]) on Ser(19)/[CHEMICAL]Thr[\\CHEMICAL](18) in endothelial cells (ECs).",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "Phytoestrogen [CHEMICAL]genistein[\\CHEMICAL] protects against endothelial barrier dysfunction in vascular endothelial cells through PKA-mediated suppression of [GENE]RhoA[\\GENE] signaling.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "These findings demonstrated that [CHEMICAL]genistein[\\CHEMICAL] improves thrombin-induced endothelial barrier dysfunction in ECs through PKA-mediated suppression of [GENE]RhoA[\\GENE] signaling.",
        "label": 2,
        "major": 3,
        "len": 18
    },
    {
        "text": "Phytoestrogen [CHEMICAL]genistein[\\CHEMICAL] protects against endothelial barrier dysfunction in vascular endothelial cells through [GENE]PKA[\\GENE]-mediated suppression of RhoA signaling.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Inhibition of PKA significantly attenuated the effect of [CHEMICAL]genistein[\\CHEMICAL] on [GENE]thrombin[\\GENE]-induced EC permeability, MLC phosphorylation, and RhoA membrane translocation in ECs.",
        "label": 2,
        "major": 4,
        "len": 21
    },
    {
        "text": "Inhibition of PKA significantly attenuated the effect of [CHEMICAL]genistein[\\CHEMICAL] on thrombin-induced EC permeability, [GENE]MLC[\\GENE] phosphorylation, and RhoA membrane translocation in ECs.",
        "label": 2,
        "major": 3,
        "len": 21
    },
    {
        "text": "Inhibition of PKA significantly attenuated the effect of [CHEMICAL]genistein[\\CHEMICAL] on thrombin-induced EC permeability, MLC phosphorylation, and [GENE]RhoA[\\GENE] membrane translocation in ECs.",
        "label": 2,
        "major": 3,
        "len": 21
    },
    {
        "text": "These findings demonstrated that [CHEMICAL]genistein[\\CHEMICAL] improves [GENE]thrombin[\\GENE]-induced endothelial barrier dysfunction in ECs through PKA-mediated suppression of RhoA signaling.",
        "label": 2,
        "major": 3,
        "len": 18
    },
    {
        "text": "These findings demonstrated that [CHEMICAL]genistein[\\CHEMICAL] improves thrombin-induced endothelial barrier dysfunction in ECs through [GENE]PKA[\\GENE]-mediated suppression of RhoA signaling.",
        "label": 2,
        "major": 3,
        "len": 18
    },
    {
        "text": "Furthermore, [GENE]thrombin[\\GENE] diminished cAMP production in ECs, which were prevented by treatment with [CHEMICAL]genistein[\\CHEMICAL].",
        "label": 4,
        "major": 9,
        "len": 14
    },
    {
        "text": "Here, we report that [CHEMICAL]genistein[\\CHEMICAL] at physiologically relevant concentrations (0.1-10 \u03bcM) significantly inhibited [GENE]thrombin[\\GENE]-induced increase in endothelial monolayer permeability.",
        "label": 4,
        "major": 3,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Genistein[\\CHEMICAL] also reduced the formation of stress fibers by [GENE]thrombin[\\GENE] and suppressed thrombin-induced phosphorylation of myosin light chain (MLC) on Ser(19)/Thr(18) in endothelial cells (ECs).",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "[CHEMICAL]Genistein[\\CHEMICAL] also reduced the formation of stress fibers by thrombin and suppressed [GENE]thrombin[\\GENE]-induced phosphorylation of myosin light chain (MLC) on Ser(19)/Thr(18) in endothelial cells (ECs).",
        "label": 4,
        "major": 3,
        "len": 25
    },
    {
        "text": "[CHEMICAL]Genistein[\\CHEMICAL] also reduced the formation of stress fibers by thrombin and suppressed thrombin-induced phosphorylation of [GENE]myosin light chain[\\GENE] (MLC) on Ser(19)/Thr(18) in endothelial cells (ECs).",
        "label": 4,
        "major": 3,
        "len": 25
    },
    {
        "text": "[CHEMICAL]Genistein[\\CHEMICAL] also reduced the formation of stress fibers by thrombin and suppressed thrombin-induced phosphorylation of myosin light chain ([GENE]MLC[\\GENE]) on Ser(19)/Thr(18) in endothelial cells (ECs).",
        "label": 4,
        "major": 3,
        "len": 25
    },
    {
        "text": "In contrast, [CHEMICAL]GSK1292263[\\CHEMICAL] did not inhibit [GENE]OATP1B1[\\GENE] based on the lack of changes in simvastatin acid exposure [mean AUC(0-inf) ratio (90% CI) of 1.05 (0.91, 1.21)].",
        "label": 10,
        "major": 10,
        "len": 26
    },
    {
        "text": "In vitro, [CHEMICAL]GSK1292263[\\CHEMICAL] demonstrated little/weak inhibition (IC50 values >30 \u03bcM) towards [GENE]CYPs[\\GENE] (CYP1A2, 2C9, 2C19, 2D6, 3A4), Pgp, OATP1B3, or OCT2.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In vitro, [CHEMICAL]GSK1292263[\\CHEMICAL] demonstrated little/weak inhibition (IC50 values >30 \u03bcM) towards CYPs ([GENE]CYP1A2[\\GENE], 2C9, 2C19, 2D6, 3A4), Pgp, OATP1B3, or OCT2.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In vitro, [CHEMICAL]GSK1292263[\\CHEMICAL] demonstrated little/weak inhibition (IC50 values >30 \u03bcM) towards CYPs (CYP1A2, [GENE]2C9[\\GENE], 2C19, 2D6, 3A4), Pgp, OATP1B3, or OCT2.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In vitro, [CHEMICAL]GSK1292263[\\CHEMICAL] demonstrated little/weak inhibition (IC50 values >30 \u03bcM) towards CYPs (CYP1A2, 2C9, [GENE]2C19[\\GENE], 2D6, 3A4), Pgp, OATP1B3, or OCT2.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In vitro, [CHEMICAL]GSK1292263[\\CHEMICAL] demonstrated little/weak inhibition (IC50 values >30 \u03bcM) towards CYPs (CYP1A2, 2C9, 2C19, [GENE]2D6[\\GENE], 3A4), Pgp, OATP1B3, or OCT2.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In vitro, [CHEMICAL]GSK1292263[\\CHEMICAL] demonstrated little/weak inhibition (IC50 values >30 \u03bcM) towards CYPs (CYP1A2, 2C9, 2C19, 2D6, [GENE]3A4[\\GENE]), Pgp, OATP1B3, or OCT2.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In vitro, [CHEMICAL]GSK1292263[\\CHEMICAL] demonstrated little/weak inhibition (IC50 values >30 \u03bcM) towards CYPs (CYP1A2, 2C9, 2C19, 2D6, 3A4), [GENE]Pgp[\\GENE], OATP1B3, or OCT2.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In vitro, [CHEMICAL]GSK1292263[\\CHEMICAL] demonstrated little/weak inhibition (IC50 values >30 \u03bcM) towards CYPs (CYP1A2, 2C9, 2C19, 2D6, 3A4), Pgp, [GENE]OATP1B3[\\GENE], or OCT2.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In vitro, [CHEMICAL]GSK1292263[\\CHEMICAL] demonstrated little/weak inhibition (IC50 values >30 \u03bcM) towards CYPs (CYP1A2, 2C9, 2C19, 2D6, 3A4), Pgp, OATP1B3, or [GENE]OCT2[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "However, [CHEMICAL]GSK1292263[\\CHEMICAL] inhibited [GENE]BCRP[\\GENE] and OATP1B1, which are transporters involved in statin disposition.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "However, [CHEMICAL]GSK1292263[\\CHEMICAL] inhibited BCRP and [GENE]OATP1B1[\\GENE], which are transporters involved in statin disposition.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "In the clinical study, small increases in the AUC(0-inf) of simvastatin [mean ratio (90% CI) of 1.34 (1.22, 1.48)] and rosuvastatin [mean ratio (90% CI) of 1.39 (1.30, 1.49)] were observed when co-administered with [CHEMICAL]GSK1292263[\\CHEMICAL], which is consistent with an inhibitory effect on intestinal BCRP and [GENE]CYP3A4[\\GENE].",
        "label": 4,
        "major": 3,
        "len": 47
    },
    {
        "text": "In the clinical study, small increases in the AUC(0-inf) of simvastatin [mean ratio (90% CI) of 1.34 (1.22, 1.48)] and rosuvastatin [mean ratio (90% CI) of 1.39 (1.30, 1.49)] were observed when co-administered with [CHEMICAL]GSK1292263[\\CHEMICAL], which is consistent with an inhibitory effect on intestinal [GENE]BCRP[\\GENE] and CYP3A4.",
        "label": 4,
        "major": 4,
        "len": 47
    },
    {
        "text": "This work investigated the drug interaction potential of GSK1292263, a novel GPR119 agonist, with the [GENE]HMG-coA reductase[\\GENE] inhibitors [CHEMICAL]simvastatin[\\CHEMICAL] and rosuvastatin.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "This study provides a mechanistic understanding of the in vivo inhibition of [GENE]transporters[\\GENE] and enzymes by [CHEMICAL]GSK1292263[\\CHEMICAL].",
        "label": 4,
        "major": 9,
        "len": 17
    },
    {
        "text": "This work investigated the drug interaction potential of GSK1292263, a novel GPR119 agonist, with the [GENE]HMG-coA reductase[\\GENE] inhibitors simvastatin and [CHEMICAL]rosuvastatin[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In vitro experiments assessed the inhibition of [GENE]transporters[\\GENE] and CYP enzymes by [CHEMICAL]GSK1292263[\\CHEMICAL], and a clinical drug interaction study investigated the effect of GSK1292263 (300\u2009mg BID) on the pharmacokinetic profile of simvastatin (40\u2009mg single dose) and rosuvastatin (10\u2009mg single dose).",
        "label": 4,
        "major": 2,
        "len": 40
    },
    {
        "text": "In vitro experiments assessed the inhibition of transporters and [GENE]CYP[\\GENE] enzymes by [CHEMICAL]GSK1292263[\\CHEMICAL], and a clinical drug interaction study investigated the effect of GSK1292263 (300\u2009mg BID) on the pharmacokinetic profile of simvastatin (40\u2009mg single dose) and rosuvastatin (10\u2009mg single dose).",
        "label": 4,
        "major": 9,
        "len": 40
    },
    {
        "text": "This work investigated the drug interaction potential of [CHEMICAL]GSK1292263[\\CHEMICAL], a novel [GENE]GPR119[\\GENE] agonist, with the HMG-coA reductase inhibitors simvastatin and rosuvastatin.",
        "label": 5,
        "major": 4,
        "len": 21
    },
    {
        "text": "Evaluation of drug interactions of [CHEMICAL]GSK1292263[\\CHEMICAL] (a [GENE]GPR119[\\GENE] agonist) with statins: from in vitro data to clinical study design.",
        "label": 5,
        "major": 5,
        "len": 19
    },
    {
        "text": "Proteins [GENE]Aus1[\\GENE] and Dan1 were not found to be involved in [CHEMICAL]steroid[\\CHEMICAL] import.",
        "label": 10,
        "major": 10,
        "len": 13
    },
    {
        "text": "Proteins Aus1 and [GENE]Dan1[\\GENE] were not found to be involved in [CHEMICAL]steroid[\\CHEMICAL] import.",
        "label": 10,
        "major": 10,
        "len": 13
    },
    {
        "text": "The presence of [CHEMICAL]steroid[\\CHEMICAL] hormones most probably causes the degradation of the [GENE]Tat2[\\GENE] permease and impairment of tryptophan import.",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "Promoter replacements conferring constitutive expression of [GENE]MSH2[\\GENE] revealed that the transcriptional induction in response to [CHEMICAL]MMS[\\CHEMICAL] is required to maintain induced levels of Msh2.",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "Promoter replacements conferring constitutive expression of MSH2 revealed that the transcriptional induction in response to [CHEMICAL]MMS[\\CHEMICAL] is required to maintain induced levels of [GENE]Msh2[\\GENE].",
        "label": 2,
        "major": 1,
        "len": 24
    },
    {
        "text": "Further study showed that [CHEMICAL]icariin[\\CHEMICAL] dose-dependently inhibited the proliferation and activation of T lymphocytes, and suppressed pro-inflammatory [GENE]cytokine[\\GENE] levels of activated T cells.",
        "label": 4,
        "major": 4,
        "len": 23
    },
    {
        "text": "Inhibition of Th1/Th17 responses via suppression of [GENE]STAT1[\\GENE] and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside [CHEMICAL]icariin[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 25
    },
    {
        "text": "Inhibition of Th1/Th17 responses via suppression of STAT1 and [GENE]STAT3[\\GENE] activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside [CHEMICAL]icariin[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "Moreover, [CHEMICAL]icariin[\\CHEMICAL] treatment inhibited the phosphorylations of [GENE]STAT1[\\GENE] and STAT3 in CD4(+) T cells, which were the crucial transcription factors for Th1 and Th17 respectively.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "Moreover, [CHEMICAL]icariin[\\CHEMICAL] treatment inhibited the phosphorylations of STAT1 and [GENE]STAT3[\\GENE] in CD4(+) T cells, which were the crucial transcription factors for Th1 and Th17 respectively.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "Inhibition of Th1/Th17 responses via suppression of [GENE]STAT1[\\GENE] and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural [CHEMICAL]flavonoid[\\CHEMICAL] glucoside icariin.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "Inhibition of Th1/Th17 responses via suppression of STAT1 and [GENE]STAT3[\\GENE] activation contributes to the amelioration of murine experimental colitis by a natural [CHEMICAL]flavonoid[\\CHEMICAL] glucoside icariin.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "Pharmacological inhibition of MTORC1 with [CHEMICAL]rapamycin[\\CHEMICAL] abrogated the [GENE]insulin[\\GENE]-induced phosphorylation of EIF4EBP1, RPS6KB1 and its downstream effector, RPS6.",
        "label": 4,
        "major": 3,
        "len": 18
    },
    {
        "text": "Furthermore, [GENE]insulin[\\GENE]-stimulated T-I cell proliferation and the expression of cell cycle regulatory proteins CDK4, CCND3 and PCNA were also blocked by [CHEMICAL]rapamycin[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "Furthermore, insulin-stimulated T-I cell proliferation and the expression of [GENE]cell cycle regulatory proteins[\\GENE] CDK4, CCND3 and PCNA were also blocked by [CHEMICAL]rapamycin[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "Furthermore, insulin-stimulated T-I cell proliferation and the expression of cell cycle regulatory proteins [GENE]CDK4[\\GENE], CCND3 and PCNA were also blocked by [CHEMICAL]rapamycin[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "Furthermore, insulin-stimulated T-I cell proliferation and the expression of cell cycle regulatory proteins CDK4, [GENE]CCND3[\\GENE] and PCNA were also blocked by [CHEMICAL]rapamycin[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "Furthermore, insulin-stimulated T-I cell proliferation and the expression of cell cycle regulatory proteins CDK4, CCND3 and [GENE]PCNA[\\GENE] were also blocked by [CHEMICAL]rapamycin[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "Pharmacological inhibition of [GENE]MTORC1[\\GENE] with [CHEMICAL]rapamycin[\\CHEMICAL] abrogated the insulin-induced phosphorylation of EIF4EBP1, RPS6KB1 and its downstream effector, RPS6.",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "Pharmacological inhibition of MTORC1 with [CHEMICAL]rapamycin[\\CHEMICAL] abrogated the insulin-induced phosphorylation of [GENE]EIF4EBP1[\\GENE], RPS6KB1 and its downstream effector, RPS6.",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "Pharmacological inhibition of MTORC1 with [CHEMICAL]rapamycin[\\CHEMICAL] abrogated the insulin-induced phosphorylation of EIF4EBP1, [GENE]RPS6KB1[\\GENE] and its downstream effector, RPS6.",
        "label": 4,
        "major": 3,
        "len": 18
    },
    {
        "text": "Pharmacological inhibition of MTORC1 with [CHEMICAL]rapamycin[\\CHEMICAL] abrogated the insulin-induced phosphorylation of EIF4EBP1, RPS6KB1 and its downstream effector, [GENE]RPS6[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "AF10 has mostly been studied in the context of the leukemic MLL-AF10 fusion protein, which lacks the [CHEMICAL]N[\\CHEMICAL]-terminal PHD fingers of [GENE]AF10[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 22
    },
    {
        "text": "We demonstrate that the PHD1-PHD2 region is essential for viability and that the first PHD finger contributes to the preferred binding of [GENE]PHD1-PHD2[\\GENE] to [CHEMICAL]lysine[\\CHEMICAL] 4-methylated histone H3 tails.",
        "label": 2,
        "major": 2,
        "len": 29
    },
    {
        "text": "We report the discovery of novel series of highly potent [GENE]TLR7[\\GENE] agonists based on 8-oxoadenines, 1 and 2 by introducing and optimizing various [CHEMICAL]tertiary amines[\\CHEMICAL] onto the N(9)-position of the adenine moiety.",
        "label": 5,
        "major": 5,
        "len": 32
    },
    {
        "text": "We report the discovery of novel series of highly potent [GENE]TLR7[\\GENE] agonists based on 8-oxoadenines, 1 and 2 by introducing and optimizing various tertiary amines onto the [CHEMICAL]N[\\CHEMICAL](9)-position of the adenine moiety.",
        "label": 5,
        "major": 5,
        "len": 32
    },
    {
        "text": "We report the discovery of novel series of highly potent [GENE]TLR7[\\GENE] agonists based on 8-oxoadenines, 1 and 2 by introducing and optimizing various tertiary amines onto the N(9)-position of the [CHEMICAL]adenine[\\CHEMICAL] moiety.",
        "label": 5,
        "major": 5,
        "len": 32
    },
    {
        "text": "The introduction of the [CHEMICAL]amino[\\CHEMICAL] group resulted in not only improved water solubility but also enhanced [GENE]TLR7[\\GENE] agonistic activity.",
        "label": 5,
        "major": 10,
        "len": 19
    },
    {
        "text": "We report the discovery of novel series of highly potent [GENE]TLR7[\\GENE] agonists based on [CHEMICAL]8-oxoadenines[\\CHEMICAL], 1 and 2 by introducing and optimizing various tertiary amines onto the N(9)-position of the adenine moiety.",
        "label": 5,
        "major": 5,
        "len": 32
    },
    {
        "text": "Synthesis and evaluation of [CHEMICAL]8-oxoadenine[\\CHEMICAL] derivatives as potent [GENE]Toll-like receptor 7[\\GENE] agonists with high water solubility.",
        "label": 5,
        "major": 5,
        "len": 16
    },
    {
        "text": "Inhibitors based on a [CHEMICAL]benzo-fused spirocyclic oxazepine[\\CHEMICAL] scaffold were discovered for stearoyl-coenzyme A (CoA) desaturase 1 ([GENE]SCD1[\\GENE]) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model.",
        "label": 4,
        "major": 4,
        "len": 40
    },
    {
        "text": "Inhibitors based on a [CHEMICAL]benzo-fused spirocyclic oxazepine[\\CHEMICAL] scaffold were discovered for [GENE]stearoyl-coenzyme A (CoA) desaturase 1[\\GENE] (SCD1) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model.",
        "label": 4,
        "major": 4,
        "len": 40
    },
    {
        "text": "The porcine heart malate dehydrogenase (MDH) refolding assay revealed that compound 1l inhibited [GENE]human Hsp60[\\GENE] chaperone activity (IC(50): 6.80 \u00b1 0.25 \u03bcM) and this inhibition activity was higher than that of [CHEMICAL]ETB[\\CHEMICAL] (IC(50): 10.9 \u00b1 0.63 \u03bcM).",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "[CHEMICAL]Apocynin[\\CHEMICAL] and raisanberine alleviate intermittent hypoxia induced abnormal [GENE]StAR[\\GENE] and 3\u03b2-HSD and low testosterone by suppressing endoplasmic reticulum stress and activated p66Shc in rat testes.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "[CHEMICAL]Apocynin[\\CHEMICAL] and raisanberine alleviate intermittent hypoxia induced abnormal StAR and [GENE]3\u03b2-HSD[\\GENE] and low testosterone by suppressing endoplasmic reticulum stress and activated p66Shc in rat testes.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "Apocynin and [CHEMICAL]raisanberine[\\CHEMICAL] alleviate intermittent hypoxia induced abnormal [GENE]StAR[\\GENE] and 3\u03b2-HSD and low testosterone by suppressing endoplasmic reticulum stress and activated p66Shc in rat testes.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "[CHEMICAL]Apocynin[\\CHEMICAL] and raisanberine alleviate intermittent hypoxia induced abnormal StAR and 3\u03b2-HSD and low testosterone by suppressing endoplasmic reticulum stress and activated [GENE]p66Shc[\\GENE] in rat testes.",
        "label": 4,
        "major": 3,
        "len": 25
    },
    {
        "text": "Apocynin and [CHEMICAL]raisanberine[\\CHEMICAL] alleviate intermittent hypoxia induced abnormal StAR and 3\u03b2-HSD and low testosterone by suppressing endoplasmic reticulum stress and activated [GENE]p66Shc[\\GENE] in rat testes.",
        "label": 4,
        "major": 3,
        "len": 25
    },
    {
        "text": "We hypothesized that hypoxia induced testicular damage is mediated by an activated NADPH oxidase (NOX), therefore, [CHEMICAL]APO[\\CHEMICAL] (apocynin) an inhibitor of [GENE]NOX[\\GENE] and raisanberine (RS), a calcium influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis.",
        "label": 4,
        "major": 3,
        "len": 40
    },
    {
        "text": "We hypothesized that hypoxia induced testicular damage is mediated by an activated NADPH oxidase (NOX), therefore, APO ([CHEMICAL]apocynin[\\CHEMICAL]) an inhibitor of [GENE]NOX[\\GENE] and raisanberine (RS), a calcium influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis.",
        "label": 4,
        "major": 3,
        "len": 40
    },
    {
        "text": "[CHEMICAL]APO[\\CHEMICAL] and RS at least partially normalize hypoxia caused male hypogonadism by suppressing ER stress, and [GENE]p66Shc[\\GENE] in testes.",
        "label": 4,
        "major": -1,
        "len": 19
    },
    {
        "text": "Apocynin and [CHEMICAL]raisanberine[\\CHEMICAL] alleviate intermittent hypoxia induced abnormal StAR and [GENE]3\u03b2-HSD[\\GENE] and low testosterone by suppressing endoplasmic reticulum stress and activated p66Shc in rat testes.",
        "label": 9,
        "major": 3,
        "len": 25
    },
    {
        "text": "Here we found that [CHEMICAL]arsenic trioxide[\\CHEMICAL], a frontline agent for acute promyelocytic leukemia, inhibits \u0394Np63 but not [GENE]TAp63[\\GENE] expression in time- and dose-dependent manners.",
        "label": 10,
        "major": 4,
        "len": 24
    },
    {
        "text": "In addition, we found that [CHEMICAL]arsenic trioxide[\\CHEMICAL] decreases the stability of \u0394Np63 protein via a proteasome-dependent pathway but has little effect on the level of [GENE]\u0394Np63[\\GENE] transcript.",
        "label": 2,
        "major": 4,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Arsenic[\\CHEMICAL] suppresses cell survival via Pirh2-mediated proteasomal degradation of [GENE]\u0394Np63[\\GENE] protein.",
        "label": 2,
        "major": -1,
        "len": 11
    },
    {
        "text": "Together, these data suggest that [CHEMICAL]arsenic[\\CHEMICAL] degrades \u0394Np63 protein at least in part via [GENE]Pirh2[\\GENE]-dependent proteolysis and that inhibition of \u0394Np63 expression facilitates tumor cells to arsenic-induced death.",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, we found that [CHEMICAL]arsenic trioxide[\\CHEMICAL] decreases the stability of \u0394Np63 protein via a [GENE]proteasome[\\GENE]-dependent pathway but has little effect on the level of \u0394Np63 transcript.",
        "label": 2,
        "major": 4,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Arsenic[\\CHEMICAL] suppresses cell survival via [GENE]Pirh2[\\GENE]-mediated proteasomal degradation of \u0394Np63 protein.",
        "label": 2,
        "major": -1,
        "len": 11
    },
    {
        "text": "Furthermore, we found that [CHEMICAL]arsenic trioxide[\\CHEMICAL] activates the [GENE]Pirh2 promoter[\\GENE] and consequently induces Pirh2 expression.",
        "label": 3,
        "major": 3,
        "len": 15
    },
    {
        "text": "Furthermore, we found that [CHEMICAL]arsenic trioxide[\\CHEMICAL] activates the Pirh2 promoter and consequently induces [GENE]Pirh2[\\GENE] expression.",
        "label": 3,
        "major": 3,
        "len": 15
    },
    {
        "text": "Consistent with this, we found that knockdown of Pirh2 inhibits, whereas ectopic expression of Pirh2 enhances, [CHEMICAL]arsenic[\\CHEMICAL]-induced degradation of [GENE]\u0394Np63[\\GENE] protein.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "Together, these data suggest that [CHEMICAL]arsenic[\\CHEMICAL] degrades [GENE]\u0394Np63[\\GENE] protein at least in part via Pirh2-dependent proteolysis and that inhibition of \u0394Np63 expression facilitates tumor cells to arsenic-induced death.",
        "label": 4,
        "major": 4,
        "len": 28
    },
    {
        "text": "Together, these data suggest that [CHEMICAL]arsenic[\\CHEMICAL] degrades \u0394Np63 protein at least in part via Pirh2-dependent proteolysis and that inhibition of [GENE]\u0394Np63[\\GENE] expression facilitates tumor cells to arsenic-induced death.",
        "label": 4,
        "major": 4,
        "len": 28
    },
    {
        "text": "Here we found that [CHEMICAL]arsenic trioxide[\\CHEMICAL], a frontline agent for acute promyelocytic leukemia, inhibits [GENE]\u0394Np63[\\GENE] but not TAp63 expression in time- and dose-dependent manners.",
        "label": 4,
        "major": 10,
        "len": 24
    },
    {
        "text": "In addition, we found that [CHEMICAL]arsenic trioxide[\\CHEMICAL] decreases the stability of [GENE]\u0394Np63[\\GENE] protein via a proteasome-dependent pathway but has little effect on the level of \u0394Np63 transcript.",
        "label": 4,
        "major": 4,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Jaceosidin[\\CHEMICAL] induced G2/M phase cell cycle arrest and modulated the levels of [GENE]cyclin B[\\GENE] and p-Cdc2 in Hec1A cells.",
        "label": 2,
        "major": 3,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Jaceosidin[\\CHEMICAL] induced G2/M phase cell cycle arrest and modulated the levels of cyclin B and [GENE]p-Cdc2[\\GENE] in Hec1A cells.",
        "label": 2,
        "major": 7,
        "len": 19
    },
    {
        "text": "Moreover, [CHEMICAL]jaceosidin[\\CHEMICAL] treatment resulted in phosphorylation of [GENE]ERK[\\GENE], and pretreatment with the ERK inhibitor, PD98059, attenuated cell growth inhibition by jaceosidin.",
        "label": 2,
        "major": 4,
        "len": 21
    },
    {
        "text": "These data suggest that [CHEMICAL]jaceosidin[\\CHEMICAL], isolated from Japanese mugwort, modulates the [GENE]ERK[\\GENE]/ATM/Chk1/2 pathway, leading to inactivation of the Cdc2-cyclin B1 complex, followed by G2/M cell cycle arrest in endometrial cancer cells.",
        "label": 2,
        "major": 3,
        "len": 31
    },
    {
        "text": "These data suggest that [CHEMICAL]jaceosidin[\\CHEMICAL], isolated from Japanese mugwort, modulates the ERK/[GENE]ATM[\\GENE]/Chk1/2 pathway, leading to inactivation of the Cdc2-cyclin B1 complex, followed by G2/M cell cycle arrest in endometrial cancer cells.",
        "label": 2,
        "major": 3,
        "len": 31
    },
    {
        "text": "Additional mechanistic studies revealed that [CHEMICAL]jaceosidin[\\CHEMICAL] treatment resulted in an increase in phosphorylation of [GENE]Cdc25C[\\GENE] and ATM-Chk1/2.",
        "label": 3,
        "major": 3,
        "len": 17
    },
    {
        "text": "Additional mechanistic studies revealed that [CHEMICAL]jaceosidin[\\CHEMICAL] treatment resulted in an increase in phosphorylation of Cdc25C and [GENE]ATM[\\GENE]-Chk1/2.",
        "label": 3,
        "major": 3,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Jaceosidin[\\CHEMICAL], isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating cdc25C-cdc2 via [GENE]ATM[\\GENE]-Chk1/2 activation.",
        "label": 3,
        "major": 3,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Jaceosidin[\\CHEMICAL], isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating [GENE]cdc25C[\\GENE]-cdc2 via ATM-Chk1/2 activation.",
        "label": 4,
        "major": 3,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Jaceosidin[\\CHEMICAL], isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating cdc25C-[GENE]cdc2[\\GENE] via ATM-Chk1/2 activation.",
        "label": 4,
        "major": 3,
        "len": 18
    },
    {
        "text": "Moreover, jaceosidin treatment resulted in phosphorylation of ERK, and pretreatment with the [GENE]ERK[\\GENE] inhibitor, [CHEMICAL]PD98059[\\CHEMICAL], attenuated cell growth inhibition by jaceosidin.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "These data suggest that [CHEMICAL]jaceosidin[\\CHEMICAL], isolated from Japanese mugwort, modulates the ERK/ATM/Chk1/2 pathway, leading to inactivation of the [GENE]Cdc2[\\GENE]-cyclin B1 complex, followed by G2/M cell cycle arrest in endometrial cancer cells.",
        "label": 4,
        "major": 3,
        "len": 31
    },
    {
        "text": "These data suggest that [CHEMICAL]jaceosidin[\\CHEMICAL], isolated from Japanese mugwort, modulates the ERK/ATM/Chk1/2 pathway, leading to inactivation of the Cdc2-[GENE]cyclin B1[\\GENE] complex, followed by G2/M cell cycle arrest in endometrial cancer cells.",
        "label": 4,
        "major": 7,
        "len": 31
    },
    {
        "text": "Electrical Stimuli Release [CHEMICAL]ATP[\\CHEMICAL] to Increase [GENE]GLUT4[\\GENE] Translocation and Glucose Uptake via PI3K\u03b3-Akt-AS160 in Skeletal Muscle Cells.",
        "label": 2,
        "major": 3,
        "len": 17
    },
    {
        "text": "Electrical Stimuli Release [CHEMICAL]ATP[\\CHEMICAL] to Increase GLUT4 Translocation and Glucose Uptake via [GENE]PI3K\u03b3[\\GENE]-Akt-AS160 in Skeletal Muscle Cells.",
        "label": 2,
        "major": 3,
        "len": 17
    },
    {
        "text": "Electrical Stimuli Release [CHEMICAL]ATP[\\CHEMICAL] to Increase GLUT4 Translocation and Glucose Uptake via PI3K\u03b3-[GENE]Akt[\\GENE]-AS160 in Skeletal Muscle Cells.",
        "label": 2,
        "major": 3,
        "len": 17
    },
    {
        "text": "Electrical Stimuli Release [CHEMICAL]ATP[\\CHEMICAL] to Increase GLUT4 Translocation and Glucose Uptake via PI3K\u03b3-Akt-[GENE]AS160[\\GENE] in Skeletal Muscle Cells.",
        "label": 2,
        "major": 3,
        "len": 17
    },
    {
        "text": "[CHEMICAL]ATP[\\CHEMICAL] caused translocation of [GENE]GLUT4[\\GENE]myc-eGFP to the cell surface, mechanistically mediated by increased exocytosis involving AS160/Rab8A reduced by dominant-negative Akt or PI3K\u03b3 kinase-dead mutants, and potentiated by myristoylated PI3K\u03b3.",
        "label": 2,
        "major": 4,
        "len": 29
    },
    {
        "text": "[CHEMICAL]ATP[\\CHEMICAL] is released from skeletal muscle by contractile activity and can autocrinely signal through [GENE]purinergic receptors[\\GENE], and we hypothesized it may influence glucose uptake.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Exogenous [CHEMICAL]ATP[\\CHEMICAL] transiently activated [GENE]Akt[\\GENE] and, inhibiting phosphatidylinositol 3-kinase (PI3K) or Akt as well as dominant-negative Akt mutant, reduced ATP-dependent 2-NBDG uptake and Akt phosphorylation.",
        "label": 3,
        "major": 4,
        "len": 25
    },
    {
        "text": "Electrical stimulation, ATP, and insulin each increased fluorescent 2-NBD-Glucose (2-NBDG) uptake in primary myotubes, but only electrical stimulation and ATP-dependent 2-NBDG uptake were inhibited by [GENE]adenosine-phosphate phosphatase[\\GENE] and by purinergic receptor blockade ([CHEMICAL]suramin[\\CHEMICAL]).",
        "label": 4,
        "major": 3,
        "len": 33
    },
    {
        "text": "Electrical stimulation, ATP, and insulin each increased fluorescent 2-NBD-Glucose (2-NBDG) uptake in primary myotubes, but only electrical stimulation and ATP-dependent 2-NBDG uptake were inhibited by adenosine-phosphate phosphatase and by [GENE]purinergic receptor[\\GENE] blockade ([CHEMICAL]suramin[\\CHEMICAL]).",
        "label": 4,
        "major": 3,
        "len": 33
    },
    {
        "text": "Electrical stimulation transiently elevated extracellular ATP and caused [GENE]Akt[\\GENE] phosphorylation that was additive to insulin and inhibited by [CHEMICAL]suramin[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 19
    },
    {
        "text": "ATP-dependent 2-NBDG uptake was also inhibited by the G protein \u03b2\u03b3 subunit-interacting peptide \u03b2ark-ct and by the [GENE]phosphatidylinositol 3-kinase-\u03b3[\\GENE] (PI3K\u03b3) inhibitor [CHEMICAL]AS605240[\\CHEMICAL].",
        "label": 4,
        "major": 2,
        "len": 22
    },
    {
        "text": "ATP-dependent 2-NBDG uptake was also inhibited by the G protein \u03b2\u03b3 subunit-interacting peptide \u03b2ark-ct and by the phosphatidylinositol 3-kinase-\u03b3 ([GENE]PI3K\u03b3[\\GENE]) inhibitor [CHEMICAL]AS605240[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "Electrical Stimuli Release ATP to Increase [GENE]GLUT4[\\GENE] Translocation and [CHEMICAL]Glucose[\\CHEMICAL] Uptake via PI3K\u03b3-Akt-AS160 in Skeletal Muscle Cells.",
        "label": 9,
        "major": 3,
        "len": 17
    },
    {
        "text": "The CSN/IRF5 interaction occurred on the [CHEMICAL]carboxyl[\\CHEMICAL] and amino termini of [GENE]IRF5[\\GENE]; a single internal deletion from amino acids 455 to 466 (\u0394455-466) was found to significantly reduce IRF5 protein stability.",
        "label": 1,
        "major": 1,
        "len": 31
    },
    {
        "text": "The CSN/IRF5 interaction occurred on the carboxyl and [CHEMICAL]amino[\\CHEMICAL] termini of [GENE]IRF5[\\GENE]; a single internal deletion from amino acids 455 to 466 (\u0394455-466) was found to significantly reduce IRF5 protein stability.",
        "label": 1,
        "major": 4,
        "len": 31
    },
    {
        "text": "The CSN/IRF5 interaction occurred on the carboxyl and amino termini of IRF5; a single internal deletion from [CHEMICAL]amino acids[\\CHEMICAL] 455 to 466 (\u0394455-466) was found to significantly reduce [GENE]IRF5[\\GENE] protein stability.",
        "label": 1,
        "major": 1,
        "len": 31
    },
    {
        "text": "A series of [CHEMICAL]anthra[1,2-d]imidazole-6,11-dione[\\CHEMICAL] derivatives were synthesized and evaluated for telomerase inhibition, [GENE]hTERT[\\GENE] expression and suppression of cancer cell growth in vitro.",
        "label": 2,
        "major": 4,
        "len": 22
    },
    {
        "text": "A series of [CHEMICAL]anthra[1,2-d]imidazole-6,11-dione[\\CHEMICAL] derivatives were synthesized and evaluated for [GENE]telomerase[\\GENE] inhibition, hTERT expression and suppression of cancer cell growth in vitro.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "Structure-based design, synthesis and evaluation of novel [CHEMICAL]anthra[1,2-d]imidazole-6,11-dione[\\CHEMICAL] derivatives as [GENE]telomerase[\\GENE] inhibitors and potential for cancer polypharmacology.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "In addition, [CHEMICAL]TSA[\\CHEMICAL] induced [GENE]Nrf2[\\GENE] nuclear translocation and up-regulated the expression of Nrf2-ARE downstream antioxidant genes, whereas Nrf2 knockdown by RNA interference blocked the inhibition of TSA on myofibroblast differentiation.",
        "label": 2,
        "major": 4,
        "len": 30
    },
    {
        "text": "The present study aimed at investigating the role of reactive oxygen species (ROS) scavenging by [CHEMICAL]TSA[\\CHEMICAL] on [GENE]transforming growth factor-\u03b2[\\GENE] (TGF-\u03b2)-induced myofibroblast differentiation of corneal fibroblasts in vitro.",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "Treatment with TSA and the Nrf2-ARE activator resulted in increased inhibition of the [GENE]TGF-\u03b2[\\GENE]-induced myofibroblast differentiation as compared with treatment with [CHEMICAL]DPI[\\CHEMICAL] or NAC.",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "Treatment with TSA and the Nrf2-ARE activator resulted in increased inhibition of the [GENE]TGF-\u03b2[\\GENE]-induced myofibroblast differentiation as compared with treatment with DPI or [CHEMICAL]NAC[\\CHEMICAL].",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "Human immortalized corneal fibroblasts were treated with TGF-\u03b2 in the presence of TSA, the NAD(P)H oxidase inhibitor diphenyleneiodonium (DPI), the antioxidant N-acetyl-cysteine (NAC), the [GENE]NF-E2-related factor 2[\\GENE]-antioxidant response element (Nrf2-ARE) activator [CHEMICAL]sulforaphane[\\CHEMICAL], or small interfering RNA.",
        "label": 3,
        "major": 3,
        "len": 36
    },
    {
        "text": "Human immortalized corneal fibroblasts were treated with TGF-\u03b2 in the presence of TSA, the NAD(P)H oxidase inhibitor diphenyleneiodonium (DPI), the antioxidant N-acetyl-cysteine (NAC), the NF-E2-related factor 2-[GENE]antioxidant response element[\\GENE] (Nrf2-ARE) activator [CHEMICAL]sulforaphane[\\CHEMICAL], or small interfering RNA.",
        "label": 3,
        "major": 3,
        "len": 36
    },
    {
        "text": "Human immortalized corneal fibroblasts were treated with TGF-\u03b2 in the presence of TSA, the NAD(P)H oxidase inhibitor diphenyleneiodonium (DPI), the antioxidant N-acetyl-cysteine (NAC), the NF-E2-related factor 2-antioxidant response element ([GENE]Nrf2[\\GENE]-ARE) activator [CHEMICAL]sulforaphane[\\CHEMICAL], or small interfering RNA.",
        "label": 3,
        "major": 3,
        "len": 36
    },
    {
        "text": "Human immortalized corneal fibroblasts were treated with TGF-\u03b2 in the presence of TSA, the NAD(P)H oxidase inhibitor diphenyleneiodonium (DPI), the antioxidant N-acetyl-cysteine (NAC), the NF-E2-related factor 2-antioxidant response element (Nrf2-[GENE]ARE[\\GENE]) activator [CHEMICAL]sulforaphane[\\CHEMICAL], or small interfering RNA.",
        "label": 3,
        "major": 3,
        "len": 36
    },
    {
        "text": "In conclusion, this study provides the first evidence implicating that [CHEMICAL]TSA[\\CHEMICAL] inhibits TGF-\u03b2-induced ROS accumulation and myofibroblast differentiation via enhanced [GENE]Nrf2[\\GENE]-ARE signaling.",
        "label": 3,
        "major": 3,
        "len": 22
    },
    {
        "text": "In conclusion, this study provides the first evidence implicating that [CHEMICAL]TSA[\\CHEMICAL] inhibits TGF-\u03b2-induced ROS accumulation and myofibroblast differentiation via enhanced Nrf2-[GENE]ARE[\\GENE] signaling.",
        "label": 3,
        "major": 4,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Trichostatin A[\\CHEMICAL] inhibits transforming growth factor-\u03b2-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced [GENE]NF-E2-related factor 2[\\GENE]-antioxidant response element signaling.",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Trichostatin A[\\CHEMICAL] inhibits transforming growth factor-\u03b2-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-[GENE]antioxidant response element[\\GENE] signaling.",
        "label": 3,
        "major": 4,
        "len": 21
    },
    {
        "text": "In addition, [CHEMICAL]TSA[\\CHEMICAL] induced Nrf2 nuclear translocation and up-regulated the expression of [GENE]Nrf2[\\GENE]-ARE downstream antioxidant genes, whereas Nrf2 knockdown by RNA interference blocked the inhibition of TSA on myofibroblast differentiation.",
        "label": 3,
        "major": 3,
        "len": 30
    },
    {
        "text": "In addition, [CHEMICAL]TSA[\\CHEMICAL] induced Nrf2 nuclear translocation and up-regulated the expression of Nrf2-[GENE]ARE[\\GENE] downstream antioxidant genes, whereas Nrf2 knockdown by RNA interference blocked the inhibition of TSA on myofibroblast differentiation.",
        "label": 3,
        "major": 3,
        "len": 30
    },
    {
        "text": "In conclusion, this study provides the first evidence implicating that [CHEMICAL]TSA[\\CHEMICAL] inhibits [GENE]TGF-\u03b2[\\GENE]-induced ROS accumulation and myofibroblast differentiation via enhanced Nrf2-ARE signaling.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "Human immortalized corneal fibroblasts were treated with TGF-\u03b2 in the presence of TSA, the [GENE]NAD(P)H oxidase[\\GENE] inhibitor [CHEMICAL]diphenyleneiodonium[\\CHEMICAL] (DPI), the antioxidant N-acetyl-cysteine (NAC), the NF-E2-related factor 2-antioxidant response element (Nrf2-ARE) activator sulforaphane, or small interfering RNA.",
        "label": 4,
        "major": 3,
        "len": 36
    },
    {
        "text": "Human immortalized corneal fibroblasts were treated with TGF-\u03b2 in the presence of TSA, the [GENE]NAD(P)H oxidase[\\GENE] inhibitor diphenyleneiodonium ([CHEMICAL]DPI[\\CHEMICAL]), the antioxidant N-acetyl-cysteine (NAC), the NF-E2-related factor 2-antioxidant response element (Nrf2-ARE) activator sulforaphane, or small interfering RNA.",
        "label": 4,
        "major": 3,
        "len": 36
    },
    {
        "text": "Treatment with [CHEMICAL]TSA[\\CHEMICAL] and the Nrf2-ARE activator resulted in increased inhibition of the [GENE]TGF-\u03b2[\\GENE]-induced myofibroblast differentiation as compared with treatment with DPI or NAC.",
        "label": 4,
        "major": 3,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Trichostatin A[\\CHEMICAL] inhibits [GENE]transforming growth factor-\u03b2[\\GENE]-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "Furthermore, [CHEMICAL]TSA[\\CHEMICAL] also decreased cellular ROS and H(2)O(2) accumulation induced by [GENE]TGF-\u03b2[\\GENE], whereas it elevated intracellular GSH level and cellular total antioxidant capacity.",
        "label": 4,
        "major": 3,
        "len": 23
    },
    {
        "text": "In the present studies, the CB(1) inverse agonist SR141716A (rimonabant) and the CB(1) neutral antagonist [CHEMICAL]AM4113[\\CHEMICAL] were compared for their ability to modify [GENE]CB(1) receptor[\\GENE]-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel CB(1) full agonist AM4054.",
        "label": 2,
        "major": 5,
        "len": 40
    },
    {
        "text": "In the present studies, the CB(1) inverse agonist [CHEMICAL]SR141716A[\\CHEMICAL] (rimonabant) and the CB(1) neutral antagonist AM4113 were compared for their ability to modify [GENE]CB(1) receptor[\\GENE]-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel CB(1) full agonist AM4054.",
        "label": 2,
        "major": 5,
        "len": 40
    },
    {
        "text": "In the present studies, the CB(1) inverse agonist SR141716A ([CHEMICAL]rimonabant[\\CHEMICAL]) and the CB(1) neutral antagonist AM4113 were compared for their ability to modify [GENE]CB(1) receptor[\\GENE]-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel CB(1) full agonist AM4054.",
        "label": 2,
        "major": 5,
        "len": 40
    },
    {
        "text": "Results indicate that [CHEMICAL]AM4054[\\CHEMICAL] serves as an effective [GENE]CB(1)[\\GENE] discriminative stimulus, with an onset and time course of action comparable with that of the CB(1) agonist \u0394(9)-tetrahydrocannabinol, and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.",
        "label": 3,
        "major": 5,
        "len": 59
    },
    {
        "text": "In the present studies, the CB(1) inverse agonist SR141716A (rimonabant) and the CB(1) neutral antagonist AM4113 were compared for their ability to modify CB(1) receptor-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel [GENE]CB(1)[\\GENE] full agonist [CHEMICAL]AM4054[\\CHEMICAL].",
        "label": 5,
        "major": 6,
        "len": 40
    },
    {
        "text": "Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the [GENE]CB(1)[\\GENE] agonist [CHEMICAL]\u0394(9)-tetrahydrocannabinol[\\CHEMICAL], and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.",
        "label": 5,
        "major": 9,
        "len": 59
    },
    {
        "text": "Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the [GENE]CB(1)[\\GENE] agonist \u0394(9)-tetrahydrocannabinol, and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose-related rightward shifts in the [CHEMICAL]AM4054[\\CHEMICAL] dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.",
        "label": 5,
        "major": 6,
        "len": 59
    },
    {
        "text": "Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the [GENE]CB(1)[\\GENE] agonist \u0394(9)-tetrahydrocannabinol, and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of [CHEMICAL]AM4054[\\CHEMICAL].",
        "label": 5,
        "major": 5,
        "len": 59
    },
    {
        "text": "Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the [GENE]CB(1)[\\GENE] agonist \u0394(9)-tetrahydrocannabinol, and that the inverse agonist [CHEMICAL]rimonabant[\\CHEMICAL] and the neutral antagonist AM4113 produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.",
        "label": 5,
        "major": 9,
        "len": 59
    },
    {
        "text": "In the present studies, the [GENE]CB(1)[\\GENE] inverse agonist [CHEMICAL]SR141716A[\\CHEMICAL] (rimonabant) and the CB(1) neutral antagonist AM4113 were compared for their ability to modify CB(1) receptor-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel CB(1) full agonist AM4054.",
        "label": 5,
        "major": 5,
        "len": 40
    },
    {
        "text": "In the present studies, the [GENE]CB(1)[\\GENE] inverse agonist SR141716A ([CHEMICAL]rimonabant[\\CHEMICAL]) and the CB(1) neutral antagonist AM4113 were compared for their ability to modify CB(1) receptor-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel CB(1) full agonist AM4054.",
        "label": 5,
        "major": 5,
        "len": 40
    },
    {
        "text": "[GENE]Cannabinoid receptor 1[\\GENE] (CB(1)) inverse agonists (e.g., [CHEMICAL]rimonabant[\\CHEMICAL]) have been reported to produce adverse effects including nausea, emesis, and anhedonia that limit their clinical applications.",
        "label": 5,
        "major": 9,
        "len": 25
    },
    {
        "text": "Cannabinoid receptor 1 ([GENE]CB(1)[\\GENE]) inverse agonists (e.g., [CHEMICAL]rimonabant[\\CHEMICAL]) have been reported to produce adverse effects including nausea, emesis, and anhedonia that limit their clinical applications.",
        "label": 5,
        "major": 5,
        "len": 25
    },
    {
        "text": "In the present studies, the CB(1) inverse agonist SR141716A (rimonabant) and the [GENE]CB(1)[\\GENE] neutral antagonist [CHEMICAL]AM4113[\\CHEMICAL] were compared for their ability to modify CB(1) receptor-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel CB(1) full agonist AM4054.",
        "label": 6,
        "major": 6,
        "len": 40
    },
    {
        "text": "Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the [GENE]CB(1)[\\GENE] agonist \u0394(9)-tetrahydrocannabinol, and that the inverse agonist rimonabant and the neutral antagonist [CHEMICAL]AM4113[\\CHEMICAL] produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.",
        "label": 6,
        "major": 5,
        "len": 59
    },
    {
        "text": "In early pregnancy, there were no significant differences in [GENE]insulin[\\GENE] sensitivity (insulin sensitivity index derived from OGTT [ISOGTT] and homeostasis model assessment for insulin resistance [HOMA-IR]) and insulin secretion (a ratio of the total area-under-the-insulin-curve to the total area-under-the-[CHEMICAL]glucose[\\CHEMICAL]-curve [AUCins/glu] and insulinogenic index [IGI]) between the NGT and late-onset GDM groups.",
        "label": 2,
        "major": -1,
        "len": 51
    },
    {
        "text": "[CHEMICAL]Dabigatran[\\CHEMICAL] has an advantage over the indirect [GENE]thrombin[\\GENE] inhibitors, unfractionated heparin and low-molecular-weight heparin, in that it inhibits free and fibrin-bound thrombin.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Dabigatran[\\CHEMICAL] has an advantage over the indirect thrombin inhibitors, unfractionated heparin and low-molecular-weight heparin, in that it inhibits free and [GENE]fibrin[\\GENE]-bound thrombin.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Dabigatran[\\CHEMICAL] has an advantage over the indirect thrombin inhibitors, unfractionated heparin and low-molecular-weight heparin, in that it inhibits free and fibrin-bound [GENE]thrombin[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "The reversible binding of [CHEMICAL]dabigatran[\\CHEMICAL] may provide safer and more predictable anticoagulant treatment than seen with irreversible, non-covalent [GENE]thrombin[\\GENE] inhibitors, e.g.",
        "label": 4,
        "major": 2,
        "len": 21
    },
    {
        "text": "[GENE]FXa[\\GENE] inhibitors, e.g. [CHEMICAL]rivaroxaban[\\CHEMICAL] and apixaban, are potent, oral direct inhibitors of prothrombinase-bound, clot-associated or free FXa.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "[CHEMICAL]rivaroxaban[\\CHEMICAL] and apixaban, are potent, oral direct inhibitors of [GENE]prothrombinase[\\GENE]-bound, clot-associated or free FXa.",
        "label": 4,
        "major": 4,
        "len": 14
    },
    {
        "text": "[CHEMICAL]rivaroxaban[\\CHEMICAL] and apixaban, are potent, oral direct inhibitors of prothrombinase-bound, clot-associated or free [GENE]FXa[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 14
    },
    {
        "text": "[GENE]FXa[\\GENE] inhibitors, e.g. rivaroxaban and [CHEMICAL]apixaban[\\CHEMICAL], are potent, oral direct inhibitors of prothrombinase-bound, clot-associated or free FXa.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "rivaroxaban and [CHEMICAL]apixaban[\\CHEMICAL], are potent, oral direct inhibitors of [GENE]prothrombinase[\\GENE]-bound, clot-associated or free FXa.",
        "label": 4,
        "major": 4,
        "len": 14
    },
    {
        "text": "rivaroxaban and [CHEMICAL]apixaban[\\CHEMICAL], are potent, oral direct inhibitors of prothrombinase-bound, clot-associated or free [GENE]FXa[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 14
    },
    {
        "text": "Although parenteral oral direct [GENE]thrombin[\\GENE] inhibitors (DTIs), such as [CHEMICAL]argatroban[\\CHEMICAL] and bivalirudin, have been on the market for years, DTIs such as dabigatran are novel synthetic thrombin antagonists.",
        "label": 4,
        "major": 6,
        "len": 28
    },
    {
        "text": "Although parenteral oral direct thrombin inhibitors (DTIs), such as argatroban and bivalirudin, have been on the market for years, DTIs such as [CHEMICAL]dabigatran[\\CHEMICAL] are novel synthetic [GENE]thrombin[\\GENE] antagonists.",
        "label": 6,
        "major": 6,
        "len": 28
    },
    {
        "text": "As the Mg(2+) ion concentration was increased, there was a consistent decrease of the enzyme catalytic turnover from 0.31 s(-1) (0 \u03bcM Mg(2+)) to 0.050 s(-1) (6000 \u03bcM Mg(2+)) and a distinct shift in steady-state conformational population from one that favors the [GENE]ALDH1[\\GENE]-[CHEMICAL]NADH[\\CHEMICAL] complex with the shorter fluorescence lifetime (33% excess) in the absence of magnesium ion to one that favors the ALDH1-NADH complex with the longer fluorescence lifetime (13% excess) at 6000 \u03bcM Mg(2+).",
        "label": 2,
        "major": 3,
        "len": 75
    },
    {
        "text": "As the Mg(2+) ion concentration was increased, there was a consistent decrease of the enzyme catalytic turnover from 0.31 s(-1) (0 \u03bcM Mg(2+)) to 0.050 s(-1) (6000 \u03bcM Mg(2+)) and a distinct shift in steady-state conformational population from one that favors the ALDH1-NADH complex with the shorter fluorescence lifetime (33% excess) in the absence of magnesium ion to one that favors the [GENE]ALDH1[\\GENE]-[CHEMICAL]NADH[\\CHEMICAL] complex with the longer fluorescence lifetime (13% excess) at 6000 \u03bcM Mg(2+).",
        "label": 2,
        "major": 4,
        "len": 75
    },
    {
        "text": "Physiologic levels of Mg(2+) ions decrease [GENE]ALDH1[\\GENE] activity in part by increasing [CHEMICAL]NADH[\\CHEMICAL] binding affinity to the enzyme.",
        "label": 2,
        "major": 2,
        "len": 18
    },
    {
        "text": "This shift in conformational population at higher Mg(2+) ion concentrations and to lower enzyme activity may be due to longer residence time of the [CHEMICAL]NADH[\\CHEMICAL] in the [GENE]ALDH1[\\GENE] pocket.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "The results from monitoring enzyme catalysis in the absence of magnesium suggests that the [GENE]ALDH1[\\GENE]-[CHEMICAL]NADH[\\CHEMICAL] complex with the shorter fluorescence lifetime is the form initially produced, and the complex with the longer fluorescence lifetime is produced through isomerization.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "From the resolved free and bound NADH fluorescence signatures, the KD values for both [CHEMICAL]NADH[\\CHEMICAL] conformations in [GENE]ALDH1A1[\\GENE] ranged from about 24 \u03bcM to 1 \u03bcM for Mg(2+) ion concentrations of 0-6000 \u03bcM, respectively.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Fluorescence lifetime analysis and effect of magnesium ions on binding of [CHEMICAL]NADH[\\CHEMICAL] to [GENE]human aldehyde dehydrogenase 1[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 17
    },
    {
        "text": "From the resolved free and bound NADH fluorescence signatures, the KD values for both NADH conformations in [GENE]ALDH1A1[\\GENE] ranged from about 24 \u03bcM to 1 \u03bcM for [CHEMICAL]Mg(2+)[\\CHEMICAL] ion concentrations of 0-6000 \u03bcM, respectively.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "This shift in conformational population at higher [CHEMICAL]Mg(2+)[\\CHEMICAL] ion concentrations and to lower enzyme activity may be due to longer residence time of the NADH in the [GENE]ALDH1[\\GENE] pocket.",
        "label": 4,
        "major": -1,
        "len": 29
    },
    {
        "text": "As the [CHEMICAL]Mg(2+)[\\CHEMICAL] ion concentration was increased, there was a consistent decrease of the enzyme catalytic turnover from 0.31 s(-1) (0 \u03bcM Mg(2+)) to 0.050 s(-1) (6000 \u03bcM Mg(2+)) and a distinct shift in steady-state conformational population from one that favors the [GENE]ALDH1[\\GENE]-NADH complex with the shorter fluorescence lifetime (33% excess) in the absence of magnesium ion to one that favors the ALDH1-NADH complex with the longer fluorescence lifetime (13% excess) at 6000 \u03bcM Mg(2+).",
        "label": 4,
        "major": 4,
        "len": 75
    },
    {
        "text": "Physiologic levels of [CHEMICAL]Mg(2+)[\\CHEMICAL] ions decrease [GENE]ALDH1[\\GENE] activity in part by increasing NADH binding affinity to the enzyme.",
        "label": 4,
        "major": 2,
        "len": 18
    },
    {
        "text": "[GENE]Aldehyde dehydrogenase 1[\\GENE] (ALDH1A1) catalyzes the oxidation of toxic aldehydes to [CHEMICAL]carboxylic acids[\\CHEMICAL].",
        "label": 9,
        "major": 9,
        "len": 13
    },
    {
        "text": "Aldehyde dehydrogenase 1 ([GENE]ALDH1A1[\\GENE]) catalyzes the oxidation of toxic aldehydes to [CHEMICAL]carboxylic acids[\\CHEMICAL].",
        "label": 9,
        "major": 9,
        "len": 13
    },
    {
        "text": "[GENE]Aldehyde dehydrogenase 1[\\GENE] (ALDH1A1) catalyzes the oxidation of toxic [CHEMICAL]aldehydes[\\CHEMICAL] to carboxylic acids.",
        "label": 9,
        "major": 9,
        "len": 13
    },
    {
        "text": "Aldehyde dehydrogenase 1 ([GENE]ALDH1A1[\\GENE]) catalyzes the oxidation of toxic [CHEMICAL]aldehydes[\\CHEMICAL] to carboxylic acids.",
        "label": 9,
        "major": 9,
        "len": 13
    },
    {
        "text": "Interestingly, [CHEMICAL]Acrolein[\\CHEMICAL] increased proteins' levels of amyloid precursor protein ([GENE]APP[\\GENE]), \u03b2-secretase (BACE-1) and the amyloid \u03b2-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.",
        "label": 2,
        "major": 9,
        "len": 31
    },
    {
        "text": "Moreover, [CHEMICAL]Acrolein[\\CHEMICAL] resulted in activation of astrocytes, up-regulation of [GENE]BACE-1[\\GENE] in cortex and down-regulation of ADAM-10 in hippocampus and cortex.",
        "label": 3,
        "major": 3,
        "len": 20
    },
    {
        "text": "Interestingly, [CHEMICAL]Acrolein[\\CHEMICAL] increased proteins' levels of [GENE]amyloid precursor protein[\\GENE] (APP), \u03b2-secretase (BACE-1) and the amyloid \u03b2-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.",
        "label": 3,
        "major": 9,
        "len": 31
    },
    {
        "text": "Interestingly, [CHEMICAL]Acrolein[\\CHEMICAL] increased proteins' levels of amyloid precursor protein (APP), [GENE]\u03b2-secretase[\\GENE] (BACE-1) and the amyloid \u03b2-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.",
        "label": 3,
        "major": 9,
        "len": 31
    },
    {
        "text": "Interestingly, [CHEMICAL]Acrolein[\\CHEMICAL] increased proteins' levels of amyloid precursor protein (APP), \u03b2-secretase ([GENE]BACE-1[\\GENE]) and the amyloid \u03b2-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.",
        "label": 3,
        "major": 9,
        "len": 31
    },
    {
        "text": "Interestingly, [CHEMICAL]Acrolein[\\CHEMICAL] increased proteins' levels of amyloid precursor protein (APP), \u03b2-secretase (BACE-1) and the [GENE]amyloid \u03b2-peptide transporter[\\GENE] receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.",
        "label": 3,
        "major": 9,
        "len": 31
    },
    {
        "text": "Interestingly, [CHEMICAL]Acrolein[\\CHEMICAL] increased proteins' levels of amyloid precursor protein (APP), \u03b2-secretase (BACE-1) and the amyloid \u03b2-peptide transporter [GENE]receptor for advanced glycation end products[\\GENE], and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.",
        "label": 3,
        "major": 9,
        "len": 31
    },
    {
        "text": "Moreover, [CHEMICAL]Acrolein[\\CHEMICAL] resulted in activation of astrocytes, up-regulation of BACE-1 in cortex and down-regulation of [GENE]ADAM-10[\\GENE] in hippocampus and cortex.",
        "label": 4,
        "major": 4,
        "len": 20
    },
    {
        "text": "Interestingly, [CHEMICAL]Acrolein[\\CHEMICAL] increased proteins' levels of amyloid precursor protein (APP), \u03b2-secretase (BACE-1) and the amyloid \u03b2-peptide transporter receptor for advanced glycation end products, and decreased [GENE]A-disintegrin and metalloprotease (ADAM) 10[\\GENE] levels.",
        "label": 4,
        "major": 9,
        "len": 31
    },
    {
        "text": "Regulation of sexual reproduction by [CHEMICAL]estradiol[\\CHEMICAL] involves the activation of [GENE]estrogen receptors[\\GENE] (ERs) in the hypothalamus.",
        "label": 3,
        "major": 3,
        "len": 16
    },
    {
        "text": "Regulation of sexual reproduction by [CHEMICAL]estradiol[\\CHEMICAL] involves the activation of estrogen receptors ([GENE]ERs[\\GENE]) in the hypothalamus.",
        "label": 3,
        "major": 3,
        "len": 16
    },
    {
        "text": "Using surface biotinylation, we observed that treatment of N-38 neurons with estradiol or with a membrane impermeant [CHEMICAL]estradiol[\\CHEMICAL] elevated plasma membrane [GENE]ER\u03b1[\\GENE] protein levels, indicating that membrane signaling increased receptor insertion into the cell membrane.",
        "label": 3,
        "major": 3,
        "len": 35
    },
    {
        "text": "These results indicate that membrane [GENE]ER\u03b1[\\GENE] levels in N-38 neurons are dynamically autoregulated by [CHEMICAL]estradiol[\\CHEMICAL].",
        "label": 3,
        "major": -1,
        "len": 15
    },
    {
        "text": "Using surface biotinylation, we observed that treatment of N-38 neurons with [CHEMICAL]estradiol[\\CHEMICAL] or with a membrane impermeant estradiol elevated plasma membrane [GENE]ER\u03b1[\\GENE] protein levels, indicating that membrane signaling increased receptor insertion into the cell membrane.",
        "label": 3,
        "major": 3,
        "len": 35
    },
    {
        "text": "Insertion of [GENE]ER\u03b1[\\GENE] was blocked by the ER antagonist [CHEMICAL]ICI 182,780[\\CHEMICAL] or with the protein kinase C (PKC) pathway inhibitor bisindolylmaleimide (BIS).",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "Insertion of [GENE]ER\u03b1[\\GENE] was blocked by the ER antagonist ICI 182,780 or with the protein kinase C (PKC) pathway inhibitor [CHEMICAL]bisindolylmaleimide[\\CHEMICAL] (BIS).",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "Insertion of ER\u03b1 was blocked by the ER antagonist ICI 182,780 or with the [GENE]protein kinase C[\\GENE] (PKC) pathway inhibitor [CHEMICAL]bisindolylmaleimide[\\CHEMICAL] (BIS).",
        "label": 4,
        "major": 6,
        "len": 22
    },
    {
        "text": "Insertion of ER\u03b1 was blocked by the ER antagonist ICI 182,780 or with the protein kinase C ([GENE]PKC[\\GENE]) pathway inhibitor [CHEMICAL]bisindolylmaleimide[\\CHEMICAL] (BIS).",
        "label": 4,
        "major": 6,
        "len": 22
    },
    {
        "text": "Insertion of [GENE]ER\u03b1[\\GENE] was blocked by the ER antagonist ICI 182,780 or with the protein kinase C (PKC) pathway inhibitor bisindolylmaleimide ([CHEMICAL]BIS[\\CHEMICAL]).",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "Insertion of ER\u03b1 was blocked by the ER antagonist ICI 182,780 or with the [GENE]protein kinase C[\\GENE] (PKC) pathway inhibitor bisindolylmaleimide ([CHEMICAL]BIS[\\CHEMICAL]).",
        "label": 4,
        "major": 6,
        "len": 22
    },
    {
        "text": "Insertion of ER\u03b1 was blocked by the ER antagonist ICI 182,780 or with the protein kinase C ([GENE]PKC[\\GENE]) pathway inhibitor bisindolylmaleimide ([CHEMICAL]BIS[\\CHEMICAL]).",
        "label": 4,
        "major": 6,
        "len": 22
    },
    {
        "text": "Insertion of ER\u03b1 was blocked by the [GENE]ER[\\GENE] antagonist [CHEMICAL]ICI 182,780[\\CHEMICAL] or with the protein kinase C (PKC) pathway inhibitor bisindolylmaleimide (BIS).",
        "label": 6,
        "major": 6,
        "len": 22
    },
    {
        "text": "These findings indicate that the neuroprotective effect of [CHEMICAL]EHT[\\CHEMICAL] against MPTP is through several mechanisms including its anti-inflammatory and antioxidant activities as well as its ability to modulate the methylation and hence activity of [GENE]PP2A[\\GENE].",
        "label": 2,
        "major": 7,
        "len": 35
    },
    {
        "text": "These findings indicate that the neuroprotective effect of EHT against [CHEMICAL]MPTP[\\CHEMICAL] is through several mechanisms including its anti-inflammatory and antioxidant activities as well as its ability to modulate the methylation and hence activity of [GENE]PP2A[\\GENE].",
        "label": 2,
        "major": 7,
        "len": 35
    },
    {
        "text": "One of these compounds is [CHEMICAL]eicosanoyl-5-hydroxytryptamide[\\CHEMICAL] (EHT), which ameliorates the phenotype of [GENE]\u03b1-synuclein[\\GENE] transgenic mice associated with decreased protein aggregation and phosphorylation, improved neuronal integrity and reduced neuroinflammation.",
        "label": 2,
        "major": 4,
        "len": 28
    },
    {
        "text": "One of these compounds is eicosanoyl-5-hydroxytryptamide ([CHEMICAL]EHT[\\CHEMICAL]), which ameliorates the phenotype of [GENE]\u03b1-synuclein[\\GENE] transgenic mice associated with decreased protein aggregation and phosphorylation, improved neuronal integrity and reduced neuroinflammation.",
        "label": 2,
        "major": 4,
        "len": 28
    },
    {
        "text": "Reductions in striatal dopamine and [GENE]tyrosine hydroxylase[\\GENE] content were also less pronounced with [CHEMICAL]EHT[\\CHEMICAL] treatment.",
        "label": 3,
        "major": 4,
        "len": 15
    },
    {
        "text": "Additionally, in SH-SY5Y cells, MPP(+)-induced demethylation of [GENE]phosphoprotein phosphatase 2A[\\GENE] (PP2A), the master regulator of the cellular phosphoregulatory network, and cytotoxicity were ameliorated by [CHEMICAL]EHT[\\CHEMICAL].",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "Additionally, in SH-SY5Y cells, MPP(+)-induced demethylation of phosphoprotein phosphatase 2A ([GENE]PP2A[\\GENE]), the master regulator of the cellular phosphoregulatory network, and cytotoxicity were ameliorated by [CHEMICAL]EHT[\\CHEMICAL].",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "Additionally, in SH-SY5Y cells, [CHEMICAL]MPP(+)[\\CHEMICAL]-induced demethylation of [GENE]phosphoprotein phosphatase 2A[\\GENE] (PP2A), the master regulator of the cellular phosphoregulatory network, and cytotoxicity were ameliorated by EHT.",
        "label": 4,
        "major": 3,
        "len": 25
    },
    {
        "text": "Additionally, in SH-SY5Y cells, [CHEMICAL]MPP(+)[\\CHEMICAL]-induced demethylation of phosphoprotein phosphatase 2A ([GENE]PP2A[\\GENE]), the master regulator of the cellular phosphoregulatory network, and cytotoxicity were ameliorated by EHT.",
        "label": 4,
        "major": 3,
        "len": 25
    },
    {
        "text": "The neuroinflammatory response to MPTP was markedly attenuated, and indices of oxidative stress and [GENE]JNK[\\GENE] activation were significantly prevented with [CHEMICAL]EHT[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 21
    },
    {
        "text": "In cultured primary microglia and astrocytes, [CHEMICAL]EHT[\\CHEMICAL] had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced [GENE]NF\u03baB[\\GENE] activation, iNOS induction, and nitric oxide production.",
        "label": 4,
        "major": 3,
        "len": 25
    },
    {
        "text": "In cultured primary microglia and astrocytes, [CHEMICAL]EHT[\\CHEMICAL] had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced NF\u03baB activation, [GENE]iNOS[\\GENE] induction, and nitric oxide production.",
        "label": 4,
        "major": 3,
        "len": 25
    },
    {
        "text": "Substantial evidence shows that [CHEMICAL]H(2)S[\\CHEMICAL] is involved in aging by inhibiting free-radical reactions, activating SIRT1, and probably interacting with the age-related gene [GENE]Klotho[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 23
    },
    {
        "text": "Substantial evidence shows that [CHEMICAL]H(2)S[\\CHEMICAL] is involved in aging by inhibiting free-radical reactions, activating [GENE]SIRT1[\\GENE], and probably interacting with the age-related gene Klotho.",
        "label": 3,
        "major": 4,
        "len": 23
    },
    {
        "text": "The induction of [GENE]HO-1[\\GENE] by EIH was inhibited by SB203580 but not by [CHEMICAL]SP600125[\\CHEMICAL], PD98059, nor LY294002.",
        "label": 10,
        "major": 4,
        "len": 17
    },
    {
        "text": "The induction of [GENE]HO-1[\\GENE] by EIH was inhibited by SB203580 but not by SP600125, [CHEMICAL]PD98059[\\CHEMICAL], nor LY294002.",
        "label": 10,
        "major": 10,
        "len": 17
    },
    {
        "text": "The induction of [GENE]HO-1[\\GENE] by EIH was inhibited by SB203580 but not by SP600125, PD98059, nor [CHEMICAL]LY294002[\\CHEMICAL].",
        "label": 10,
        "major": 3,
        "len": 17
    },
    {
        "text": "Induction of [GENE]HO-1[\\GENE] through p38 MAPK/Nrf2 signaling pathway by [CHEMICAL]ethanol[\\CHEMICAL] extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice.",
        "label": 3,
        "major": 3,
        "len": 26
    },
    {
        "text": "Induction of HO-1 through [GENE]p38[\\GENE] MAPK/Nrf2 signaling pathway by [CHEMICAL]ethanol[\\CHEMICAL] extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice.",
        "label": 3,
        "major": 3,
        "len": 26
    },
    {
        "text": "Induction of HO-1 through p38 [GENE]MAPK[\\GENE]/Nrf2 signaling pathway by [CHEMICAL]ethanol[\\CHEMICAL] extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice.",
        "label": 3,
        "major": 3,
        "len": 26
    },
    {
        "text": "The induction of [GENE]HO-1[\\GENE] by EIH was inhibited by [CHEMICAL]SB203580[\\CHEMICAL] but not by SP600125, PD98059, nor LY294002.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "FMO3 expression is induced by dietary [CHEMICAL]bile acids[\\CHEMICAL] by a mechanism that involves the [GENE]farnesoid X receptor[\\GENE] (FXR), a bile acid-activated nuclear receptor.",
        "label": 2,
        "major": 3,
        "len": 23
    },
    {
        "text": "FMO3 expression is induced by dietary [CHEMICAL]bile acids[\\CHEMICAL] by a mechanism that involves the farnesoid X receptor ([GENE]FXR[\\GENE]), a bile acid-activated nuclear receptor.",
        "label": 2,
        "major": 3,
        "len": 23
    },
    {
        "text": "FMO3 expression is induced by dietary bile acids by a mechanism that involves the [GENE]farnesoid X receptor[\\GENE] (FXR), a [CHEMICAL]bile acid[\\CHEMICAL]-activated nuclear receptor.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "FMO3 expression is induced by dietary bile acids by a mechanism that involves the farnesoid X receptor ([GENE]FXR[\\GENE]), a [CHEMICAL]bile acid[\\CHEMICAL]-activated nuclear receptor.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "[GENE]FMO3[\\GENE] expression is induced by dietary [CHEMICAL]bile acids[\\CHEMICAL] by a mechanism that involves the farnesoid X receptor (FXR), a bile acid-activated nuclear receptor.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "In mice, this reduction in [GENE]FMO3[\\GENE] expression is due primarily to downregulation by [CHEMICAL]androgens[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 14
    },
    {
        "text": "Analysis of natural genetic variation among inbred strains of mice indicates that [GENE]FMO3[\\GENE] and [CHEMICAL]TMAO[\\CHEMICAL] are significantly correlated, and TMAO levels explain 11% of the variation in atherosclerosis.",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "We demonstrate that two [GENE]flavin mono-oxygenase[\\GENE] family members, FMO1 and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of choline, to [CHEMICAL]TMAO[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "We demonstrate that two flavin mono-oxygenase family members, [GENE]FMO1[\\GENE] and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of choline, to [CHEMICAL]TMAO[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "We demonstrate that two flavin mono-oxygenase family members, FMO1 and [GENE]FMO3[\\GENE], oxidize trimethylamine (TMA), derived from gut flora metabolism of choline, to [CHEMICAL]TMAO[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "FMO3 overexpression in mice significantly increases plasma TMAO levels while silencing [GENE]FMO3[\\GENE] decreases [CHEMICAL]TMAO[\\CHEMICAL] levels.",
        "label": 9,
        "major": 3,
        "len": 15
    },
    {
        "text": "We demonstrate that two [GENE]flavin mono-oxygenase[\\GENE] family members, FMO1 and FMO3, oxidize [CHEMICAL]trimethylamine[\\CHEMICAL] (TMA), derived from gut flora metabolism of choline, to TMAO.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "We demonstrate that two flavin mono-oxygenase family members, [GENE]FMO1[\\GENE] and FMO3, oxidize [CHEMICAL]trimethylamine[\\CHEMICAL] (TMA), derived from gut flora metabolism of choline, to TMAO.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "We demonstrate that two flavin mono-oxygenase family members, FMO1 and [GENE]FMO3[\\GENE], oxidize [CHEMICAL]trimethylamine[\\CHEMICAL] (TMA), derived from gut flora metabolism of choline, to TMAO.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "We demonstrate that two [GENE]flavin mono-oxygenase[\\GENE] family members, FMO1 and FMO3, oxidize trimethylamine ([CHEMICAL]TMA[\\CHEMICAL]), derived from gut flora metabolism of choline, to TMAO.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "We demonstrate that two flavin mono-oxygenase family members, [GENE]FMO1[\\GENE] and FMO3, oxidize trimethylamine ([CHEMICAL]TMA[\\CHEMICAL]), derived from gut flora metabolism of choline, to TMAO.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "We demonstrate that two flavin mono-oxygenase family members, FMO1 and [GENE]FMO3[\\GENE], oxidize trimethylamine ([CHEMICAL]TMA[\\CHEMICAL]), derived from gut flora metabolism of choline, to TMAO.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "We demonstrate that two [GENE]flavin mono-oxygenase[\\GENE] family members, FMO1 and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of [CHEMICAL]choline[\\CHEMICAL], to TMAO.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "We demonstrate that two flavin mono-oxygenase family members, [GENE]FMO1[\\GENE] and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of [CHEMICAL]choline[\\CHEMICAL], to TMAO.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "We demonstrate that two flavin mono-oxygenase family members, FMO1 and [GENE]FMO3[\\GENE], oxidize trimethylamine (TMA), derived from gut flora metabolism of [CHEMICAL]choline[\\CHEMICAL], to TMAO.",
        "label": 9,
        "major": -1,
        "len": 23
    },
    {
        "text": "[GENE]FMO3[\\GENE] overexpression in mice significantly increases plasma [CHEMICAL]TMAO[\\CHEMICAL] levels while silencing FMO3 decreases TMAO levels.",
        "label": 9,
        "major": 3,
        "len": 15
    },
    {
        "text": "However, other [CHEMICAL]steroids[\\CHEMICAL], including \u0394(5)-androstenediol, 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to [GENE]estrogen receptor-\u03b1[\\GENE] (ER\u03b1) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other [CHEMICAL]steroids[\\CHEMICAL], including \u0394(5)-androstenediol, 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-\u03b1 ([GENE]ER\u03b1[\\GENE]) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other [CHEMICAL]steroids[\\CHEMICAL], including \u0394(5)-androstenediol, 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-\u03b1 (ER\u03b1) and [GENE]ER\u03b2[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including [CHEMICAL]\u0394(5)-androstenediol[\\CHEMICAL], 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to [GENE]estrogen receptor-\u03b1[\\GENE] (ER\u03b1) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including [CHEMICAL]\u0394(5)-androstenediol[\\CHEMICAL], 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-\u03b1 ([GENE]ER\u03b1[\\GENE]) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including [CHEMICAL]\u0394(5)-androstenediol[\\CHEMICAL], 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-\u03b1 (ER\u03b1) and [GENE]ER\u03b2[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, [CHEMICAL]5\u03b1-androstanediol[\\CHEMICAL] and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to [GENE]estrogen receptor-\u03b1[\\GENE] (ER\u03b1) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, [CHEMICAL]5\u03b1-androstanediol[\\CHEMICAL] and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-\u03b1 ([GENE]ER\u03b1[\\GENE]) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, [CHEMICAL]5\u03b1-androstanediol[\\CHEMICAL] and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-\u03b1 (ER\u03b1) and [GENE]ER\u03b2[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, 5\u03b1-androstanediol and [CHEMICAL]27-hydroxycholesterol[\\CHEMICAL], which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to [GENE]estrogen receptor-\u03b1[\\GENE] (ER\u03b1) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, 5\u03b1-androstanediol and [CHEMICAL]27-hydroxycholesterol[\\CHEMICAL], which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-\u03b1 ([GENE]ER\u03b1[\\GENE]) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, 5\u03b1-androstanediol and [CHEMICAL]27-hydroxycholesterol[\\CHEMICAL], which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-\u03b1 (ER\u03b1) and [GENE]ER\u03b2[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a [CHEMICAL]3\u03b2-hydroxyl[\\CHEMICAL] and a C19 methyl group, also mediate physiological responses through binding to [GENE]estrogen receptor-\u03b1[\\GENE] (ER\u03b1) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a [CHEMICAL]3\u03b2-hydroxyl[\\CHEMICAL] and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-\u03b1 ([GENE]ER\u03b1[\\GENE]) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a [CHEMICAL]3\u03b2-hydroxyl[\\CHEMICAL] and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-\u03b1 (ER\u03b1) and [GENE]ER\u03b2[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 [CHEMICAL]methyl[\\CHEMICAL] group, also mediate physiological responses through binding to [GENE]estrogen receptor-\u03b1[\\GENE] (ER\u03b1) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 [CHEMICAL]methyl[\\CHEMICAL] group, also mediate physiological responses through binding to estrogen receptor-\u03b1 ([GENE]ER\u03b1[\\GENE]) and ER\u03b2.",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "However, other steroids, including \u0394(5)-androstenediol, 5\u03b1-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3\u03b2-hydroxyl and a C19 [CHEMICAL]methyl[\\CHEMICAL] group, also mediate physiological responses through binding to estrogen receptor-\u03b1 (ER\u03b1) and [GENE]ER\u03b2[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 34
    },
    {
        "text": "Moreover, selective [CHEMICAL]estrogen[\\CHEMICAL] response modulators (SERMs) with diverse structures also regulate transcription of [GENE]ER\u03b1[\\GENE] and ER\u03b2.",
        "label": 2,
        "major": 7,
        "len": 16
    },
    {
        "text": "Moreover, selective [CHEMICAL]estrogen[\\CHEMICAL] response modulators (SERMs) with diverse structures also regulate transcription of ER\u03b1 and [GENE]ER\u03b2[\\GENE].",
        "label": 2,
        "major": 7,
        "len": 16
    },
    {
        "text": "Further studies of the role of these [CHEMICAL]steroids[\\CHEMICAL] and SERMs in regulating responses mediated by [GENE]ER\u03b1[\\GENE] and ER\u03b2 a variety of tissues, during different stages of development, are likely to uncover additional estrogenic activities.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Further studies of the role of these [CHEMICAL]steroids[\\CHEMICAL] and SERMs in regulating responses mediated by ER\u03b1 and [GENE]ER\u03b2[\\GENE] a variety of tissues, during different stages of development, are likely to uncover additional estrogenic activities.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "Synthesis of [CHEMICAL]quinoline[\\CHEMICAL] derivatives: discovery of a potent and selective [GENE]phosphodiesterase 5[\\GENE] inhibitor for the treatment of Alzheimer's disease.",
        "label": 4,
        "major": 4,
        "len": 19
    },
    {
        "text": "Phosphodiesterase type 5 ([GENE]PDE5[\\GENE]) mediates the degradation of [CHEMICAL]cGMP[\\CHEMICAL] in a variety of tissues including brain.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "[GENE]Phosphodiesterase type 5[\\GENE] (PDE5) mediates the degradation of [CHEMICAL]cGMP[\\CHEMICAL] in a variety of tissues including brain.",
        "label": 9,
        "major": -1,
        "len": 16
    },
    {
        "text": "A novel potent compound, [CHEMICAL]N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide[\\CHEMICAL] (12c), which binds [GENE]Mcl-1[\\GENE] with an IC(50) value of 54 nM was obtained.",
        "label": 2,
        "major": 2,
        "len": 19
    },
    {
        "text": "A novel potent compound, [CHEMICAL]N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide[\\CHEMICAL] (12c), which binds [GENE]Mcl-1[\\GENE] with an IC(50) value of 54 nM was obtained.",
        "label": 4,
        "major": 2,
        "len": 19
    },
    {
        "text": "We have previously reported a nanomolar inhibitor of antiapoptotic [GENE]Mcl-1[\\GENE] protein, [CHEMICAL]3-thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile[\\CHEMICAL] (S1).",
        "label": 4,
        "major": 4,
        "len": 15
    },
    {
        "text": "Fragment-based design, synthesis, and biological evaluation of [CHEMICAL]N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide[\\CHEMICAL] derivatives as novel [GENE]Mcl-1[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "[CHEMICAL]Peginesatide[\\CHEMICAL], a polyethylene glycol (PEG)ylated peptide-based erythropoiesis-stimulating agent, stimulates the [GENE]erythropoietin receptor[\\GENE] dimer that governs erythropoiesis.",
        "label": 3,
        "major": 3,
        "len": 16
    },
    {
        "text": "Peginesatide, a [CHEMICAL]polyethylene glycol[\\CHEMICAL] (PEG)ylated peptide-based erythropoiesis-stimulating agent, stimulates the [GENE]erythropoietin receptor[\\GENE] dimer that governs erythropoiesis.",
        "label": 3,
        "major": 3,
        "len": 16
    },
    {
        "text": "Peginesatide, a polyethylene glycol ([CHEMICAL]PEG[\\CHEMICAL])ylated peptide-based erythropoiesis-stimulating agent, stimulates the [GENE]erythropoietin receptor[\\GENE] dimer that governs erythropoiesis.",
        "label": 3,
        "major": 3,
        "len": 16
    },
    {
        "text": "Electron paramagnetic resonance (EPR) studies using [CHEMICAL]nucleotide[\\CHEMICAL] analog spin label probes showed that dephosphorylated myosin heads are highly ordered in the relaxed fibers and have very low [GENE]ATPase[\\GENE] activity.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "Electron paramagnetic resonance (EPR) studies using [CHEMICAL]nucleotide[\\CHEMICAL] analog spin label probes showed that [GENE]dephosphorylated myosin[\\GENE] heads are highly ordered in the relaxed fibers and have very low ATPase activity.",
        "label": 2,
        "major": -1,
        "len": 29
    },
    {
        "text": "LPA1-induced cytoskeleton reorganization therefore makes a previously unrecognized but critically important contribution to the profibrotic activities of [CHEMICAL]LPA[\\CHEMICAL] by driving [GENE]MRTF[\\GENE]-dependent CTGF expression, which, in turn, drives fibroblast proliferation.-Sakai, N., Chun, J., Duffield, J. S., Wada, T., Luster, A. D., Tager, A. M. LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.",
        "label": 2,
        "major": 3,
        "len": 52
    },
    {
        "text": "There has been much recent interest in lysophosphatidic acid (LPA) signaling through one of its receptors, LPA1, in fibrotic diseases, but the mechanisms by which [CHEMICAL]LPA[\\CHEMICAL]-[GENE]LPA1[\\GENE] signaling promotes pathological fibrosis remain to be fully elucidated.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "There has been much recent interest in [CHEMICAL]lysophosphatidic acid[\\CHEMICAL] (LPA) signaling through one of its receptors, [GENE]LPA1[\\GENE], in fibrotic diseases, but the mechanisms by which LPA-LPA1 signaling promotes pathological fibrosis remain to be fully elucidated.",
        "label": 2,
        "major": -1,
        "len": 35
    },
    {
        "text": "LPA1-induced cytoskeleton reorganization therefore makes a previously unrecognized but critically important contribution to the profibrotic activities of [CHEMICAL]LPA[\\CHEMICAL] by driving MRTF-dependent [GENE]CTGF[\\GENE] expression, which, in turn, drives fibroblast proliferation.-Sakai, N., Chun, J., Duffield, J. S., Wada, T., Luster, A. D., Tager, A. M. LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.",
        "label": 3,
        "major": 3,
        "len": 52
    },
    {
        "text": "Styrene oxide and [CHEMICAL]4-vinylphenol[\\CHEMICAL] possessed similar affinity for [GENE]CYP2E1[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 9
    },
    {
        "text": "We hypothesized that [CHEMICAL]styrene[\\CHEMICAL] metabolites have lower affinity than styrene toward [GENE]CYP2E1[\\GENE] and limited ability to induce cooperative effects during metabolism.",
        "label": 2,
        "major": 2,
        "len": 21
    },
    {
        "text": "We hypothesized that styrene metabolites have lower affinity than [CHEMICAL]styrene[\\CHEMICAL] toward [GENE]CYP2E1[\\GENE] and limited ability to induce cooperative effects during metabolism.",
        "label": 2,
        "major": 2,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Styrene oxide[\\CHEMICAL] and 4-vinylphenol possessed similar affinity for [GENE]CYP2E1[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 9
    },
    {
        "text": "Cooperative effects for [GENE]CYP2E1[\\GENE] differ between [CHEMICAL]styrene[\\CHEMICAL] and its metabolites.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "[CHEMICAL]Bile acids[\\CHEMICAL] are signaling molecules that activate nuclear receptors, such as farnesoid X receptor, pregnane X receptor, [GENE]constitutive androstane receptor[\\GENE], and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.",
        "label": 3,
        "major": 3,
        "len": 39
    },
    {
        "text": "[CHEMICAL]Bile acids[\\CHEMICAL] are signaling molecules that activate nuclear receptors, such as farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, and [GENE]vitamin D receptor[\\GENE], and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.",
        "label": 3,
        "major": 3,
        "len": 39
    },
    {
        "text": "[CHEMICAL]Bile acids[\\CHEMICAL] are signaling molecules that activate [GENE]nuclear receptors[\\GENE], such as farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.",
        "label": 3,
        "major": 3,
        "len": 39
    },
    {
        "text": "[CHEMICAL]Bile acids[\\CHEMICAL] are signaling molecules that activate nuclear receptors, such as [GENE]farnesoid X receptor[\\GENE], pregnane X receptor, constitutive androstane receptor, and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.",
        "label": 3,
        "major": 3,
        "len": 39
    },
    {
        "text": "[CHEMICAL]Bile acids[\\CHEMICAL] are signaling molecules that activate nuclear receptors, such as farnesoid X receptor, [GENE]pregnane X receptor[\\GENE], constitutive androstane receptor, and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.",
        "label": 3,
        "major": 3,
        "len": 39
    },
    {
        "text": "The peptide [CHEMICAL]YR-11[\\CHEMICAL] (YLEIEFSLKHR), obtained by direct substitution of cysteine with a serine residue in the template sequence, significantly (p<0.05) inhibited [GENE]RANK[\\GENE]-RANKL binding, and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 2,
        "major": 3,
        "len": 36
    },
    {
        "text": "The peptide [CHEMICAL]YR-11[\\CHEMICAL] (YLEIEFSLKHR), obtained by direct substitution of cysteine with a serine residue in the template sequence, significantly (p<0.05) inhibited RANK-[GENE]RANKL[\\GENE] binding, and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 2,
        "major": 4,
        "len": 36
    },
    {
        "text": "The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of [CHEMICAL]cysteine[\\CHEMICAL] with a serine residue in the template sequence, significantly (p<0.05) inhibited [GENE]RANK[\\GENE]-RANKL binding, and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 2,
        "major": 4,
        "len": 36
    },
    {
        "text": "The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of [CHEMICAL]cysteine[\\CHEMICAL] with a serine residue in the template sequence, significantly (p<0.05) inhibited RANK-[GENE]RANKL[\\GENE] binding, and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 2,
        "major": 2,
        "len": 36
    },
    {
        "text": "The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of cysteine with a [CHEMICAL]serine[\\CHEMICAL] residue in the template sequence, significantly (p<0.05) inhibited [GENE]RANK[\\GENE]-RANKL binding, and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 2,
        "major": 3,
        "len": 36
    },
    {
        "text": "The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of cysteine with a [CHEMICAL]serine[\\CHEMICAL] residue in the template sequence, significantly (p<0.05) inhibited RANK-[GENE]RANKL[\\GENE] binding, and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 2,
        "major": 2,
        "len": 36
    },
    {
        "text": "Results confirmed that [CHEMICAL]YR-11[\\CHEMICAL] peptide inhibited pro-inflammatory cytokines in the sera and hind paw tissues of AIA rats through its suppressive effect on RANKL induced nuclear translocation of [GENE]NF-\u03baB[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 29
    },
    {
        "text": "The peptide [CHEMICAL]YR-11[\\CHEMICAL] (YLEIEFSLKHR), obtained by direct substitution of cysteine with a serine residue in the template sequence, significantly (p<0.05) inhibited RANK-RANKL binding, and [GENE]RANKL[\\GENE] induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 4,
        "major": 4,
        "len": 36
    },
    {
        "text": "The peptide [CHEMICAL]YR-11[\\CHEMICAL] (YLEIEFSLKHR), obtained by direct substitution of cysteine with a serine residue in the template sequence, significantly (p<0.05) inhibited RANK-RANKL binding, and RANKL induced [GENE]TRAP[\\GENE] activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 4,
        "major": 3,
        "len": 36
    },
    {
        "text": "The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of [CHEMICAL]cysteine[\\CHEMICAL] with a serine residue in the template sequence, significantly (p<0.05) inhibited RANK-RANKL binding, and [GENE]RANKL[\\GENE] induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 4,
        "major": 2,
        "len": 36
    },
    {
        "text": "The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of [CHEMICAL]cysteine[\\CHEMICAL] with a serine residue in the template sequence, significantly (p<0.05) inhibited RANK-RANKL binding, and RANKL induced [GENE]TRAP[\\GENE] activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 4,
        "major": 2,
        "len": 36
    },
    {
        "text": "The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of cysteine with a [CHEMICAL]serine[\\CHEMICAL] residue in the template sequence, significantly (p<0.05) inhibited RANK-RANKL binding, and [GENE]RANKL[\\GENE] induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 4,
        "major": 4,
        "len": 36
    },
    {
        "text": "The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of cysteine with a [CHEMICAL]serine[\\CHEMICAL] residue in the template sequence, significantly (p<0.05) inhibited RANK-RANKL binding, and RANKL induced [GENE]TRAP[\\GENE] activity and formation of multinucleated osteoclasts without any cytotoxicity.",
        "label": 4,
        "major": 2,
        "len": 36
    },
    {
        "text": "Results confirmed that [CHEMICAL]YR-11[\\CHEMICAL] peptide inhibited pro-inflammatory [GENE]cytokines[\\GENE] in the sera and hind paw tissues of AIA rats through its suppressive effect on RANKL induced nuclear translocation of NF-\u03baB.",
        "label": 4,
        "major": 4,
        "len": 29
    },
    {
        "text": "Results confirmed that [CHEMICAL]YR-11[\\CHEMICAL] peptide inhibited pro-inflammatory cytokines in the sera and hind paw tissues of AIA rats through its suppressive effect on [GENE]RANKL[\\GENE] induced nuclear translocation of NF-\u03baB.",
        "label": 4,
        "major": 4,
        "len": 29
    },
    {
        "text": "RESULTS: In contrast to immune stimulatory sequence ISS 1018, BCG DNA spontaneously formed nanoparticulate structures and induced [GENE]actin[\\GENE] polymerization as did synthetic [CHEMICAL]silica[\\CHEMICAL] nanoparticles.",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "The activation of [GENE]Rac1[\\GENE] was induced by [CHEMICAL]silica[\\CHEMICAL] nanoparticles as well as BCG DNA and is suggested as the critical signaling event inducing both cytoskeleton changes as well as inflammatory cell activation.",
        "label": 3,
        "major": 3,
        "len": 32
    },
    {
        "text": "In this small library of novel bioactive macrocyclic [CHEMICAL]lathyrane diterpene[\\CHEMICAL] derivatives, designed to evaluate structure-activity relationships essential in overcoming multidrug resistance (MDR), some correlations between MDR reversal and molecular weight, accessible solvent areas, and octanol/water partition coefficient were identified that can contribute to the development of new selective [GENE]P-gp[\\GENE] reversal agents.",
        "label": 2,
        "major": -1,
        "len": 51
    },
    {
        "text": "Additionally, these effects of [CHEMICAL]ATO[\\CHEMICAL] on \u03b3-H2AX, Chk1, Chk2, p53, and p21(waf1/cip1) were reduced by an [GENE]ATM[\\GENE] inhibitor.",
        "label": 3,
        "major": 4,
        "len": 18
    },
    {
        "text": "Osteoblasts survive the [CHEMICAL]arsenic trioxide[\\CHEMICAL] treatment by activation of [GENE]ATM[\\GENE]-mediated pathway.",
        "label": 3,
        "major": 3,
        "len": 11
    },
    {
        "text": "Additionally, these effects of [CHEMICAL]ATO[\\CHEMICAL] on \u03b3-H2AX, [GENE]Chk1[\\GENE], Chk2, p53, and p21(waf1/cip1) were reduced by an ATM inhibitor.",
        "label": 3,
        "major": 4,
        "len": 18
    },
    {
        "text": "Additionally, these effects of [CHEMICAL]ATO[\\CHEMICAL] on \u03b3-H2AX, Chk1, [GENE]Chk2[\\GENE], p53, and p21(waf1/cip1) were reduced by an ATM inhibitor.",
        "label": 3,
        "major": 4,
        "len": 18
    },
    {
        "text": "Additionally, these effects of [CHEMICAL]ATO[\\CHEMICAL] on \u03b3-H2AX, Chk1, Chk2, [GENE]p53[\\GENE], and p21(waf1/cip1) were reduced by an ATM inhibitor.",
        "label": 3,
        "major": 4,
        "len": 18
    },
    {
        "text": "Additionally, these effects of [CHEMICAL]ATO[\\CHEMICAL] on \u03b3-H2AX, Chk1, Chk2, p53, and [GENE]p21[\\GENE](waf1/cip1) were reduced by an ATM inhibitor.",
        "label": 3,
        "major": 4,
        "len": 18
    },
    {
        "text": "Additionally, these effects of [CHEMICAL]ATO[\\CHEMICAL] on \u03b3-H2AX, Chk1, Chk2, p53, and p21([GENE]waf1[\\GENE]/cip1) were reduced by an ATM inhibitor.",
        "label": 3,
        "major": 4,
        "len": 18
    },
    {
        "text": "Additionally, these effects of [CHEMICAL]ATO[\\CHEMICAL] on \u03b3-H2AX, Chk1, Chk2, p53, and p21(waf1/[GENE]cip1[\\GENE]) were reduced by an ATM inhibitor.",
        "label": 3,
        "major": 4,
        "len": 18
    },
    {
        "text": "Additionally, these effects of [CHEMICAL]ATO[\\CHEMICAL] on \u03b3-[GENE]H2AX[\\GENE], Chk1, Chk2, p53, and p21(waf1/cip1) were reduced by an ATM inhibitor.",
        "label": 3,
        "major": 4,
        "len": 18
    },
    {
        "text": "Furthermore, a mixture of [CHEMICAL]isoflavonoid[\\CHEMICAL] parent compounds, and a mixture of isoflavonoid metabolites were found to have [GENE]PPAR\u03b3[\\GENE] activating abilities.",
        "label": 3,
        "major": 3,
        "len": 20
    },
    {
        "text": "Furthermore, a mixture of isoflavonoid parent compounds, and a mixture of [CHEMICAL]isoflavonoid[\\CHEMICAL] metabolites were found to have [GENE]PPAR\u03b3[\\GENE] activating abilities.",
        "label": 3,
        "major": 3,
        "len": 20
    },
    {
        "text": "Both [CHEMICAL]fatty acids[\\CHEMICAL], but DHA to a lesser extent compared with EPA, selectively and dose-dependently reduced the percentage of cytokine-expressing Th cells in a peroxisome proliferator-activated receptor (PPAR)\u03b3-dependent fashion, whereas the expression of the cell surface marker [GENE]CD69[\\GENE] was unaltered on activated T cells.",
        "label": 10,
        "major": 3,
        "len": 44
    },
    {
        "text": "Both fatty acids, but [CHEMICAL]DHA[\\CHEMICAL] to a lesser extent compared with EPA, selectively and dose-dependently reduced the percentage of cytokine-expressing Th cells in a peroxisome proliferator-activated receptor (PPAR)\u03b3-dependent fashion, whereas the expression of the cell surface marker [GENE]CD69[\\GENE] was unaltered on activated T cells.",
        "label": 10,
        "major": 4,
        "len": 44
    },
    {
        "text": "Both fatty acids, but DHA to a lesser extent compared with [CHEMICAL]EPA[\\CHEMICAL], selectively and dose-dependently reduced the percentage of cytokine-expressing Th cells in a peroxisome proliferator-activated receptor (PPAR)\u03b3-dependent fashion, whereas the expression of the cell surface marker [GENE]CD69[\\GENE] was unaltered on activated T cells.",
        "label": 10,
        "major": 4,
        "len": 44
    },
    {
        "text": "In monocytes, both [CHEMICAL]EPA[\\CHEMICAL] and DHA increased interleukin (IL)-10 without affecting [GENE]tumor necrosis factor (TNF)-\u03b1[\\GENE] and IL-6.",
        "label": 10,
        "major": 3,
        "len": 17
    },
    {
        "text": "In monocytes, both [CHEMICAL]EPA[\\CHEMICAL] and DHA increased interleukin (IL)-10 without affecting tumor necrosis factor (TNF)-\u03b1 and [GENE]IL-6[\\GENE].",
        "label": 10,
        "major": 3,
        "len": 17
    },
    {
        "text": "In monocytes, both EPA and [CHEMICAL]DHA[\\CHEMICAL] increased interleukin (IL)-10 without affecting [GENE]tumor necrosis factor (TNF)-\u03b1[\\GENE] and IL-6.",
        "label": 10,
        "major": 3,
        "len": 17
    },
    {
        "text": "In monocytes, both EPA and [CHEMICAL]DHA[\\CHEMICAL] increased interleukin (IL)-10 without affecting tumor necrosis factor (TNF)-\u03b1 and [GENE]IL-6[\\GENE].",
        "label": 10,
        "major": 3,
        "len": 17
    },
    {
        "text": "Both [CHEMICAL]fatty acids[\\CHEMICAL], but DHA to a lesser extent compared with EPA, selectively and dose-dependently reduced the percentage of cytokine-expressing Th cells in a [GENE]peroxisome proliferator-activated receptor (PPAR)\u03b3[\\GENE]-dependent fashion, whereas the expression of the cell surface marker CD69 was unaltered on activated T cells.",
        "label": 2,
        "major": 3,
        "len": 44
    },
    {
        "text": "Both fatty acids, but [CHEMICAL]DHA[\\CHEMICAL] to a lesser extent compared with EPA, selectively and dose-dependently reduced the percentage of cytokine-expressing Th cells in a [GENE]peroxisome proliferator-activated receptor (PPAR)\u03b3[\\GENE]-dependent fashion, whereas the expression of the cell surface marker CD69 was unaltered on activated T cells.",
        "label": 2,
        "major": 4,
        "len": 44
    },
    {
        "text": "Both fatty acids, but DHA to a lesser extent compared with [CHEMICAL]EPA[\\CHEMICAL], selectively and dose-dependently reduced the percentage of cytokine-expressing Th cells in a [GENE]peroxisome proliferator-activated receptor (PPAR)\u03b3[\\GENE]-dependent fashion, whereas the expression of the cell surface marker CD69 was unaltered on activated T cells.",
        "label": 2,
        "major": 3,
        "len": 44
    },
    {
        "text": "In monocytes, both [CHEMICAL]EPA[\\CHEMICAL] and DHA increased [GENE]interleukin (IL)-10[\\GENE] without affecting tumor necrosis factor (TNF)-\u03b1 and IL-6.",
        "label": 3,
        "major": 3,
        "len": 17
    },
    {
        "text": "In monocytes, both EPA and [CHEMICAL]DHA[\\CHEMICAL] increased [GENE]interleukin (IL)-10[\\GENE] without affecting tumor necrosis factor (TNF)-\u03b1 and IL-6.",
        "label": 3,
        "major": 3,
        "len": 17
    },
    {
        "text": "Both [CHEMICAL]fatty acids[\\CHEMICAL], but DHA to a lesser extent compared with EPA, selectively and dose-dependently reduced the percentage of [GENE]cytokine[\\GENE]-expressing Th cells in a peroxisome proliferator-activated receptor (PPAR)\u03b3-dependent fashion, whereas the expression of the cell surface marker CD69 was unaltered on activated T cells.",
        "label": 4,
        "major": 3,
        "len": 44
    },
    {
        "text": "Both fatty acids, but [CHEMICAL]DHA[\\CHEMICAL] to a lesser extent compared with EPA, selectively and dose-dependently reduced the percentage of [GENE]cytokine[\\GENE]-expressing Th cells in a peroxisome proliferator-activated receptor (PPAR)\u03b3-dependent fashion, whereas the expression of the cell surface marker CD69 was unaltered on activated T cells.",
        "label": 4,
        "major": 3,
        "len": 44
    },
    {
        "text": "Both fatty acids, but DHA to a lesser extent compared with [CHEMICAL]EPA[\\CHEMICAL], selectively and dose-dependently reduced the percentage of [GENE]cytokine[\\GENE]-expressing Th cells in a peroxisome proliferator-activated receptor (PPAR)\u03b3-dependent fashion, whereas the expression of the cell surface marker CD69 was unaltered on activated T cells.",
        "label": 4,
        "major": 3,
        "len": 44
    },
    {
        "text": "In the in vitro model we observed high permeability of [CHEMICAL]imperatorin[\\CHEMICAL] and isoimperatorin with the [GENE]P-gp[\\GENE]-mediated efflux ratios of 0.53 and 0.06, as well as medium permeability of cnidilin with 0.82.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "In the in vitro model we observed high permeability of imperatorin and [CHEMICAL]isoimperatorin[\\CHEMICAL] with the [GENE]P-gp[\\GENE]-mediated efflux ratios of 0.53 and 0.06, as well as medium permeability of cnidilin with 0.82.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "In the in vitro model we observed high permeability of imperatorin and isoimperatorin with the [GENE]P-gp[\\GENE]-mediated efflux ratios of 0.53 and 0.06, as well as medium permeability of [CHEMICAL]cnidilin[\\CHEMICAL] with 0.82.",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "In agreement with these data, the exogenous treatment of [CHEMICAL]SAH[\\CHEMICAL] or inhibition of SAHH by specific siRNA or another type of inhibitor, 3-deazaadenosine (DAZA), similarly resulted in antitumorigenic responses, suppressive activity on Src, the alteration of [GENE]actin[\\GENE] cytoskeleton, and a change of the colocalization pattern between actin and Src.",
        "label": 2,
        "major": 10,
        "len": 49
    },
    {
        "text": "In agreement with these data, the exogenous treatment of [CHEMICAL]SAH[\\CHEMICAL] or inhibition of SAHH by specific siRNA or another type of inhibitor, 3-deazaadenosine (DAZA), similarly resulted in antitumorigenic responses, suppressive activity on Src, the alteration of actin cytoskeleton, and a change of the colocalization pattern between [GENE]actin[\\GENE] and Src.",
        "label": 2,
        "major": 10,
        "len": 49
    },
    {
        "text": "In agreement with these data, the exogenous treatment of [CHEMICAL]SAH[\\CHEMICAL] or inhibition of SAHH by specific siRNA or another type of inhibitor, 3-deazaadenosine (DAZA), similarly resulted in antitumorigenic responses, suppressive activity on Src, the alteration of actin cytoskeleton, and a change of the colocalization pattern between actin and [GENE]Src[\\GENE].",
        "label": 2,
        "major": 10,
        "len": 49
    },
    {
        "text": "Involvement of [GENE]Src[\\GENE] and the actin cytoskeleton in the antitumorigenic action of [CHEMICAL]adenosine dialdehyde[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "Involvement of Src and the [GENE]actin[\\GENE] cytoskeleton in the antitumorigenic action of [CHEMICAL]adenosine dialdehyde[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 14
    },
    {
        "text": "Taken together, these results suggest that [CHEMICAL]SAH[\\CHEMICAL]/SAHH-mediated transmethylation could be linked to the tumorigenic processes through cross-regulation between the [GENE]actin[\\GENE] cytoskeleton and Src kinase activity.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Taken together, these results suggest that [CHEMICAL]SAH[\\CHEMICAL]/SAHH-mediated transmethylation could be linked to the tumorigenic processes through cross-regulation between the actin cytoskeleton and [GENE]Src[\\GENE] kinase activity.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Taken together, these results suggest that [CHEMICAL]SAH[\\CHEMICAL]/SAHH-mediated transmethylation could be linked to the tumorigenic processes through cross-regulation between the actin cytoskeleton and Src [GENE]kinase[\\GENE] activity.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "In agreement with these data, the exogenous treatment of [CHEMICAL]SAH[\\CHEMICAL] or inhibition of SAHH by specific siRNA or another type of inhibitor, 3-deazaadenosine (DAZA), similarly resulted in antitumorigenic responses, suppressive activity on [GENE]Src[\\GENE], the alteration of actin cytoskeleton, and a change of the colocalization pattern between actin and Src.",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "Through immunoblotting analysis, it was found that [CHEMICAL]AdOx[\\CHEMICAL] was capable of indirectly diminishing the phosphorylation of oncogenic [GENE]Src[\\GENE] and its kinase activity.",
        "label": 4,
        "major": -1,
        "len": 22
    },
    {
        "text": "Interestingly, [CHEMICAL]AdOx[\\CHEMICAL] disrupted actin cytoskeleton structures, leading to morphological changes, and suppressed the formation of a signaling complex composed of [GENE]Src[\\GENE] and p85/PI3K, which is linked to various tumorigenic responses.",
        "label": 4,
        "major": -1,
        "len": 30
    },
    {
        "text": "Interestingly, [CHEMICAL]AdOx[\\CHEMICAL] disrupted actin cytoskeleton structures, leading to morphological changes, and suppressed the formation of a signaling complex composed of Src and [GENE]p85[\\GENE]/PI3K, which is linked to various tumorigenic responses.",
        "label": 4,
        "major": -1,
        "len": 30
    },
    {
        "text": "Interestingly, [CHEMICAL]AdOx[\\CHEMICAL] disrupted actin cytoskeleton structures, leading to morphological changes, and suppressed the formation of a signaling complex composed of Src and p85/[GENE]PI3K[\\GENE], which is linked to various tumorigenic responses.",
        "label": 4,
        "major": -1,
        "len": 30
    },
    {
        "text": "Through immunoblotting analysis, it was found that [CHEMICAL]AdOx[\\CHEMICAL] was capable of indirectly diminishing the phosphorylation of oncogenic Src and its [GENE]kinase[\\GENE] activity.",
        "label": 4,
        "major": -1,
        "len": 22
    },
    {
        "text": "Interestingly, [CHEMICAL]AdOx[\\CHEMICAL] disrupted [GENE]actin[\\GENE] cytoskeleton structures, leading to morphological changes, and suppressed the formation of a signaling complex composed of Src and p85/PI3K, which is linked to various tumorigenic responses.",
        "label": 4,
        "major": -1,
        "len": 30
    },
    {
        "text": "In agreement with these data, the exogenous treatment of SAH or inhibition of [GENE]SAHH[\\GENE] by specific siRNA or another type of inhibitor, [CHEMICAL]3-deazaadenosine[\\CHEMICAL] (DAZA), similarly resulted in antitumorigenic responses, suppressive activity on Src, the alteration of actin cytoskeleton, and a change of the colocalization pattern between actin and Src.",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In agreement with these data, the exogenous treatment of SAH or inhibition of [GENE]SAHH[\\GENE] by specific siRNA or another type of inhibitor, 3-deazaadenosine ([CHEMICAL]DAZA[\\CHEMICAL]), similarly resulted in antitumorigenic responses, suppressive activity on Src, the alteration of actin cytoskeleton, and a change of the colocalization pattern between actin and Src.",
        "label": 4,
        "major": 10,
        "len": 49
    },
    {
        "text": "Treatment with [CHEMICAL]adenosine dialdehyde[\\CHEMICAL] (AdOx), an inhibitor of transmethylation-suppressive [GENE]adenosylhomocysteine (SAH) hydrolase[\\GENE] (SAHH), enhanced the level of SAH and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner.",
        "label": 4,
        "major": 4,
        "len": 50
    },
    {
        "text": "Treatment with [CHEMICAL]adenosine dialdehyde[\\CHEMICAL] (AdOx), an inhibitor of transmethylation-suppressive adenosylhomocysteine (SAH) hydrolase ([GENE]SAHH[\\GENE]), enhanced the level of SAH and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner.",
        "label": 4,
        "major": 3,
        "len": 50
    },
    {
        "text": "Treatment with adenosine dialdehyde ([CHEMICAL]AdOx[\\CHEMICAL]), an inhibitor of transmethylation-suppressive [GENE]adenosylhomocysteine (SAH) hydrolase[\\GENE] (SAHH), enhanced the level of SAH and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner.",
        "label": 4,
        "major": 4,
        "len": 50
    },
    {
        "text": "Treatment with adenosine dialdehyde ([CHEMICAL]AdOx[\\CHEMICAL]), an inhibitor of transmethylation-suppressive adenosylhomocysteine (SAH) hydrolase ([GENE]SAHH[\\GENE]), enhanced the level of SAH and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner.",
        "label": 4,
        "major": 3,
        "len": 50
    },
    {
        "text": "Treatment with adenosine dialdehyde (AdOx), an inhibitor of transmethylation-suppressive [GENE]adenosylhomocysteine (SAH) hydrolase[\\GENE] (SAHH), enhanced the level of [CHEMICAL]SAH[\\CHEMICAL] and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner.",
        "label": 9,
        "major": 4,
        "len": 50
    },
    {
        "text": "Treatment with adenosine dialdehyde (AdOx), an inhibitor of transmethylation-suppressive adenosylhomocysteine (SAH) hydrolase ([GENE]SAHH[\\GENE]), enhanced the level of [CHEMICAL]SAH[\\CHEMICAL] and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner.",
        "label": 9,
        "major": 4,
        "len": 50
    },
    {
        "text": "A series of [GENE]MMP-1[\\GENE] inhibitors have been identified based upon a [CHEMICAL]methyl rosmarinate[\\CHEMICAL] scaffold using structure-based drug design methods.",
        "label": 4,
        "major": 4,
        "len": 19
    },
    {
        "text": "Synthesis of derivatives of [CHEMICAL]methyl rosmarinate[\\CHEMICAL] and their inhibitory activities against matrix metalloproteinase-1 ([GENE]MMP-1[\\GENE]).",
        "label": 4,
        "major": 4,
        "len": 14
    },
    {
        "text": "Synthesis of derivatives of [CHEMICAL]methyl rosmarinate[\\CHEMICAL] and their inhibitory activities against [GENE]matrix metalloproteinase-1[\\GENE] (MMP-1).",
        "label": 4,
        "major": 4,
        "len": 14
    },
    {
        "text": "All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as [GENE]cyclooxygenase-2[\\GENE] (COX-2)-derived [CHEMICAL]prostaglandin E2[\\CHEMICAL] (PGE2) inhibitory activity of murine macrophage RAW 264.7 cell line.",
        "label": 9,
        "major": 4,
        "len": 34
    },
    {
        "text": "All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as cyclooxygenase-2 ([GENE]COX-2[\\GENE])-derived [CHEMICAL]prostaglandin E2[\\CHEMICAL] (PGE2) inhibitory activity of murine macrophage RAW 264.7 cell line.",
        "label": 9,
        "major": 4,
        "len": 34
    },
    {
        "text": "All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as [GENE]cyclooxygenase-2[\\GENE] (COX-2)-derived prostaglandin E2 ([CHEMICAL]PGE2[\\CHEMICAL]) inhibitory activity of murine macrophage RAW 264.7 cell line.",
        "label": 9,
        "major": 4,
        "len": 34
    },
    {
        "text": "All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as cyclooxygenase-2 ([GENE]COX-2[\\GENE])-derived prostaglandin E2 ([CHEMICAL]PGE2[\\CHEMICAL]) inhibitory activity of murine macrophage RAW 264.7 cell line.",
        "label": 9,
        "major": 4,
        "len": 34
    },
    {
        "text": "It had higher levels of [CHEMICAL]oleocanthal[\\CHEMICAL] (p-HPEA-EDA), a nutraceutical compound exerting actions against [GENE]COX1[\\GENE] and COX2 (cycloxygenases).",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "It had higher levels of [CHEMICAL]oleocanthal[\\CHEMICAL] (p-HPEA-EDA), a nutraceutical compound exerting actions against COX1 and [GENE]COX2[\\GENE] (cycloxygenases).",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "It had higher levels of [CHEMICAL]oleocanthal[\\CHEMICAL] (p-HPEA-EDA), a nutraceutical compound exerting actions against COX1 and COX2 ([GENE]cycloxygenases[\\GENE]).",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "It had higher levels of oleocanthal ([CHEMICAL]p-HPEA-EDA[\\CHEMICAL]), a nutraceutical compound exerting actions against [GENE]COX1[\\GENE] and COX2 (cycloxygenases).",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "It had higher levels of oleocanthal ([CHEMICAL]p-HPEA-EDA[\\CHEMICAL]), a nutraceutical compound exerting actions against COX1 and [GENE]COX2[\\GENE] (cycloxygenases).",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "It had higher levels of oleocanthal ([CHEMICAL]p-HPEA-EDA[\\CHEMICAL]), a nutraceutical compound exerting actions against COX1 and COX2 ([GENE]cycloxygenases[\\GENE]).",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the [GENE]lipoxygenase[\\GENE] (LOX)-pathway (one having as precursors the [CHEMICAL]polyunsaturated fatty acids[\\CHEMICAL] containing a cis-cis-1,4-pentadiene system).",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the lipoxygenase ([GENE]LOX[\\GENE])-pathway (one having as precursors the [CHEMICAL]polyunsaturated fatty acids[\\CHEMICAL] containing a cis-cis-1,4-pentadiene system).",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the [GENE]lipoxygenase[\\GENE] (LOX)-pathway (one having as precursors the polyunsaturated fatty acids containing a [CHEMICAL]cis-cis-1,4-pentadiene[\\CHEMICAL] system).",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the lipoxygenase ([GENE]LOX[\\GENE])-pathway (one having as precursors the polyunsaturated fatty acids containing a [CHEMICAL]cis-cis-1,4-pentadiene[\\CHEMICAL] system).",
        "label": 9,
        "major": -1,
        "len": 31
    },
    {
        "text": "The contrasting activity of [CHEMICAL]iodido[\\CHEMICAL] versus chlorido ruthenium and osmium arene azo- and imino-pyridine anticancer complexes: control of cell selectivity, cross-resistance, [GENE]p53[\\GENE] dependence, and apoptosis pathway.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "The contrasting activity of iodido versus [CHEMICAL]chlorido ruthenium[\\CHEMICAL] and osmium arene azo- and imino-pyridine anticancer complexes: control of cell selectivity, cross-resistance, [GENE]p53[\\GENE] dependence, and apoptosis pathway.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "The contrasting activity of iodido versus chlorido ruthenium and [CHEMICAL]osmium arene azo- and imino-pyridine[\\CHEMICAL] anticancer complexes: control of cell selectivity, cross-resistance, [GENE]p53[\\GENE] dependence, and apoptosis pathway.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "The [CHEMICAL]iodido[\\CHEMICAL] complexes retain potency in [GENE]p53[\\GENE] mutant colon cells.",
        "label": 2,
        "major": 1,
        "len": 10
    },
    {
        "text": "In general, antiproliferative activity is greatly enhanced by low levels of the [GENE]glutathione synthase[\\GENE] inhibitor [CHEMICAL]l-buthionine sulfoxime[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "The recent identification of [CHEMICAL]zinc[\\CHEMICAL] permeability of the lysosomal ion channel [GENE]TRPML1[\\GENE] (transient receptor potential mucolipin 1), and the evidence of abnormal zinc levels in cells deficient in TRPML1, suggested a role for TRPML1\u00a0in zinc transport.",
        "label": 9,
        "major": 9,
        "len": 36
    },
    {
        "text": "The recent identification of [CHEMICAL]zinc[\\CHEMICAL] permeability of the lysosomal ion channel TRPML1 ([GENE]transient receptor potential mucolipin 1[\\GENE]), and the evidence of abnormal zinc levels in cells deficient in TRPML1, suggested a role for TRPML1\u00a0in zinc transport.",
        "label": 9,
        "major": 9,
        "len": 36
    },
    {
        "text": "The recent identification of zinc permeability of the lysosomal ion channel TRPML1 (transient receptor potential mucolipin 1), and the evidence of abnormal zinc levels in cells deficient in TRPML1, suggested a role for [GENE]TRPML1[\\GENE]\u00a0in [CHEMICAL]zinc[\\CHEMICAL] transport.",
        "label": 9,
        "major": 9,
        "len": 36
    },
    {
        "text": "Cellular [CHEMICAL]zinc[\\CHEMICAL] is controlled by [GENE]zinc-chelating proteins[\\GENE] and by zinc transporters.",
        "label": 9,
        "major": 9,
        "len": 11
    },
    {
        "text": "Cellular [CHEMICAL]zinc[\\CHEMICAL] is controlled by zinc-chelating proteins and by [GENE]zinc transporters[\\GENE].",
        "label": 9,
        "major": 9,
        "len": 11
    },
    {
        "text": "These results underscore a role for [GENE]TRPML1[\\GENE]\u00a0in [CHEMICAL]zinc[\\CHEMICAL] metabolism.",
        "label": 9,
        "major": -1,
        "len": 9
    },
    {
        "text": "Furthermore, they suggest that [GENE]TRPML1[\\GENE] works in concert with ZnT4 to regulate [CHEMICAL]zinc[\\CHEMICAL] translocation between the cytoplasm and lysosomes.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "Furthermore, they suggest that TRPML1 works in concert with [GENE]ZnT4[\\GENE] to regulate [CHEMICAL]zinc[\\CHEMICAL] translocation between the cytoplasm and lysosomes.",
        "label": 9,
        "major": -1,
        "len": 19
    },
    {
        "text": "Similarly, intraperitoneal administration of [CHEMICAL]\u03b1-santalol[\\CHEMICAL] (100mg/kg BW) and sandalwood oil (1g/kg BW) for two weeks modulated parameters such as serum aminotransferases, alkaline phosphatase, bilirubin, superoxide dismutase, [GENE]catalase[\\GENE], free sulfhydryl, protein carbonyl, nitric oxide, liver lipid peroxide contents, and antioxidant capacity in d-galactose mediated oxidative stress induced mice.",
        "label": 2,
        "major": 7,
        "len": 47
    },
    {
        "text": "Similarly, intraperitoneal administration of [CHEMICAL]\u03b1-santalol[\\CHEMICAL] (100mg/kg BW) and sandalwood oil (1g/kg BW) for two weeks modulated parameters such as serum [GENE]aminotransferases[\\GENE], alkaline phosphatase, bilirubin, superoxide dismutase, catalase, free sulfhydryl, protein carbonyl, nitric oxide, liver lipid peroxide contents, and antioxidant capacity in d-galactose mediated oxidative stress induced mice.",
        "label": 2,
        "major": 10,
        "len": 47
    },
    {
        "text": "Similarly, intraperitoneal administration of [CHEMICAL]\u03b1-santalol[\\CHEMICAL] (100mg/kg BW) and sandalwood oil (1g/kg BW) for two weeks modulated parameters such as serum aminotransferases, [GENE]alkaline phosphatase[\\GENE], bilirubin, superoxide dismutase, catalase, free sulfhydryl, protein carbonyl, nitric oxide, liver lipid peroxide contents, and antioxidant capacity in d-galactose mediated oxidative stress induced mice.",
        "label": 2,
        "major": 7,
        "len": 47
    },
    {
        "text": "Similarly, intraperitoneal administration of [CHEMICAL]\u03b1-santalol[\\CHEMICAL] (100mg/kg BW) and sandalwood oil (1g/kg BW) for two weeks modulated parameters such as serum aminotransferases, alkaline phosphatase, bilirubin, [GENE]superoxide dismutase[\\GENE], catalase, free sulfhydryl, protein carbonyl, nitric oxide, liver lipid peroxide contents, and antioxidant capacity in d-galactose mediated oxidative stress induced mice.",
        "label": 2,
        "major": 7,
        "len": 47
    },
    {
        "text": "The increase in SAA expression is specific to ritodrine-induced liver damage, because [GENE]SAA[\\GENE] expression was not induced by other hepatotoxic drugs such as [CHEMICAL]acetaminophen[\\CHEMICAL], valproic acid, or metformin.",
        "label": 10,
        "major": 3,
        "len": 28
    },
    {
        "text": "The increase in SAA expression is specific to ritodrine-induced liver damage, because [GENE]SAA[\\GENE] expression was not induced by other hepatotoxic drugs such as acetaminophen, [CHEMICAL]valproic acid[\\CHEMICAL], or metformin.",
        "label": 10,
        "major": 3,
        "len": 28
    },
    {
        "text": "The increase in SAA expression is specific to ritodrine-induced liver damage, because [GENE]SAA[\\GENE] expression was not induced by other hepatotoxic drugs such as acetaminophen, valproic acid, or [CHEMICAL]metformin[\\CHEMICAL].",
        "label": 10,
        "major": 3,
        "len": 28
    },
    {
        "text": "Our in vitro studies showed that [CHEMICAL]cyclic adenosine 3',5'-monophosphate[\\CHEMICAL] (cAMP) accumulation was not a primary cause of the ritodrine-induced [GENE]SAA[\\GENE] increase.",
        "label": 10,
        "major": 3,
        "len": 21
    },
    {
        "text": "Our in vitro studies showed that cyclic adenosine 3',5'-monophosphate ([CHEMICAL]cAMP[\\CHEMICAL]) accumulation was not a primary cause of the ritodrine-induced [GENE]SAA[\\GENE] increase.",
        "label": 10,
        "major": 3,
        "len": 21
    },
    {
        "text": "The tocolytic agent [CHEMICAL]ritodrine[\\CHEMICAL] acts on the [GENE]\u03b22-adrenoceptor[\\GENE] and is an effective treatment option for preterm labor.",
        "label": 2,
        "major": -1,
        "len": 17
    },
    {
        "text": "Importantly, expression of the acute-phase reactant [GENE]serum amyloid A[\\GENE] (SAA) significantly increased after [CHEMICAL]ritodrine[\\CHEMICAL] injection, with values indicating the largest fold-change.",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "Importantly, expression of the acute-phase reactant serum amyloid A ([GENE]SAA[\\GENE]) significantly increased after [CHEMICAL]ritodrine[\\CHEMICAL] injection, with values indicating the largest fold-change.",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "[GENE]Serum amyloid A[\\GENE] upsurge precedes standard biomarkers of hepatotoxicity in [CHEMICAL]ritodrine[\\CHEMICAL]-injected mice.",
        "label": 3,
        "major": -1,
        "len": 12
    },
    {
        "text": "The increase in [GENE]SAA[\\GENE] expression is specific to [CHEMICAL]ritodrine[\\CHEMICAL]-induced liver damage, because SAA expression was not induced by other hepatotoxic drugs such as acetaminophen, valproic acid, or metformin.",
        "label": 3,
        "major": 3,
        "len": 28
    },
    {
        "text": "Our in vitro studies showed that cyclic adenosine 3',5'-monophosphate (cAMP) accumulation was not a primary cause of the [CHEMICAL]ritodrine[\\CHEMICAL]-induced [GENE]SAA[\\GENE] increase.",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "Pharmacodynamic data suggest that ceftazidime-avibactam is rapidly bactericidal versus [GENE]\u03b2-lactamase[\\GENE]-producing Gram-negative bacilli that are not inhibited by [CHEMICAL]ceftazidime[\\CHEMICAL] alone.Clinical trials to date have reported that ceftazidime-avibactam is as effective as standard carbapenem therapy in complicated intra-abdominal infection and complicated urinary tract infection, including infection caused by cephalosporin-resistant Gram-negative isolates.",
        "label": 10,
        "major": 4,
        "len": 49
    },
    {
        "text": "Although not a \u03b2-lactam, the chemical structure of avibactam closely resembles portions of the [CHEMICAL]cephem[\\CHEMICAL] bicyclic ring system, and avibactam has been shown to bond covalently to [GENE]\u03b2-lactamases[\\GENE].",
        "label": 2,
        "major": 10,
        "len": 28
    },
    {
        "text": "Although not a \u03b2-lactam, the chemical structure of avibactam closely resembles portions of the cephem bicyclic ring system, and [CHEMICAL]avibactam[\\CHEMICAL] has been shown to bond covalently to [GENE]\u03b2-lactamases[\\GENE].",
        "label": 2,
        "major": 10,
        "len": 28
    },
    {
        "text": "Potential future roles for [CHEMICAL]ceftazidime[\\CHEMICAL]-avibactam include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing [GENE]extended-spectrum \u00df-lactamase[\\GENE] (ESBL), Klebsiella pneumoniae carbapenemases (KPCs) and/or AmpC \u00df-lactamases.",
        "label": 2,
        "major": 9,
        "len": 28
    },
    {
        "text": "Potential future roles for [CHEMICAL]ceftazidime[\\CHEMICAL]-avibactam include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing extended-spectrum \u00df-lactamase ([GENE]ESBL[\\GENE]), Klebsiella pneumoniae carbapenemases (KPCs) and/or AmpC \u00df-lactamases.",
        "label": 2,
        "major": 9,
        "len": 28
    },
    {
        "text": "Potential future roles for [CHEMICAL]ceftazidime[\\CHEMICAL]-avibactam include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing extended-spectrum \u00df-lactamase (ESBL), [GENE]Klebsiella pneumoniae carbapenemases[\\GENE] (KPCs) and/or AmpC \u00df-lactamases.",
        "label": 2,
        "major": 9,
        "len": 28
    },
    {
        "text": "Potential future roles for [CHEMICAL]ceftazidime[\\CHEMICAL]-avibactam include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing extended-spectrum \u00df-lactamase (ESBL), Klebsiella pneumoniae carbapenemases ([GENE]KPCs[\\GENE]) and/or AmpC \u00df-lactamases.",
        "label": 2,
        "major": 9,
        "len": 28
    },
    {
        "text": "Potential future roles for [CHEMICAL]ceftazidime[\\CHEMICAL]-avibactam include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing extended-spectrum \u00df-lactamase (ESBL), Klebsiella pneumoniae carbapenemases (KPCs) and/or [GENE]AmpC \u00df-lactamases[\\GENE].",
        "label": 2,
        "major": 9,
        "len": 28
    },
    {
        "text": "Potential future roles for ceftazidime-[CHEMICAL]avibactam[\\CHEMICAL] include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing [GENE]extended-spectrum \u00df-lactamase[\\GENE] (ESBL), Klebsiella pneumoniae carbapenemases (KPCs) and/or AmpC \u00df-lactamases.",
        "label": 2,
        "major": 9,
        "len": 28
    },
    {
        "text": "Potential future roles for ceftazidime-[CHEMICAL]avibactam[\\CHEMICAL] include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing extended-spectrum \u00df-lactamase ([GENE]ESBL[\\GENE]), Klebsiella pneumoniae carbapenemases (KPCs) and/or AmpC \u00df-lactamases.",
        "label": 2,
        "major": 9,
        "len": 28
    },
    {
        "text": "Potential future roles for ceftazidime-[CHEMICAL]avibactam[\\CHEMICAL] include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing extended-spectrum \u00df-lactamase (ESBL), [GENE]Klebsiella pneumoniae carbapenemases[\\GENE] (KPCs) and/or AmpC \u00df-lactamases.",
        "label": 2,
        "major": 9,
        "len": 28
    },
    {
        "text": "Potential future roles for ceftazidime-[CHEMICAL]avibactam[\\CHEMICAL] include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing extended-spectrum \u00df-lactamase (ESBL), Klebsiella pneumoniae carbapenemases ([GENE]KPCs[\\GENE]) and/or AmpC \u00df-lactamases.",
        "label": 2,
        "major": 9,
        "len": 28
    },
    {
        "text": "Potential future roles for ceftazidime-[CHEMICAL]avibactam[\\CHEMICAL] include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing extended-spectrum \u00df-lactamase (ESBL), Klebsiella pneumoniae carbapenemases (KPCs) and/or [GENE]AmpC \u00df-lactamases[\\GENE].",
        "label": 2,
        "major": 9,
        "len": 28
    },
    {
        "text": "Pharmacodynamic data suggest that [CHEMICAL]ceftazidime[\\CHEMICAL]-avibactam is rapidly bactericidal versus [GENE]\u03b2-lactamase[\\GENE]-producing Gram-negative bacilli that are not inhibited by ceftazidime alone.Clinical trials to date have reported that ceftazidime-avibactam is as effective as standard carbapenem therapy in complicated intra-abdominal infection and complicated urinary tract infection, including infection caused by cephalosporin-resistant Gram-negative isolates.",
        "label": 4,
        "major": 10,
        "len": 49
    },
    {
        "text": "Pharmacodynamic data suggest that ceftazidime-[CHEMICAL]avibactam[\\CHEMICAL] is rapidly bactericidal versus [GENE]\u03b2-lactamase[\\GENE]-producing Gram-negative bacilli that are not inhibited by ceftazidime alone.Clinical trials to date have reported that ceftazidime-avibactam is as effective as standard carbapenem therapy in complicated intra-abdominal infection and complicated urinary tract infection, including infection caused by cephalosporin-resistant Gram-negative isolates.",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "Avibactam (formerly [CHEMICAL]NXL104[\\CHEMICAL], AVE1330A) is a synthetic non-\u03b2-lactam, \u03b2-lactamase inhibitor that inhibits the activities of Ambler class A and C \u03b2-lactamases and some [GENE]Ambler class D[\\GENE] enzymes.",
        "label": 4,
        "major": 4,
        "len": 27
    },
    {
        "text": "Avibactam (formerly [CHEMICAL]NXL104[\\CHEMICAL], AVE1330A) is a synthetic non-\u03b2-lactam, [GENE]\u03b2-lactamase[\\GENE] inhibitor that inhibits the activities of Ambler class A and C \u03b2-lactamases and some Ambler class D enzymes.",
        "label": 4,
        "major": 4,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Avibactam[\\CHEMICAL] (formerly NXL104, AVE1330A) is a synthetic non-\u03b2-lactam, \u03b2-lactamase inhibitor that inhibits the activities of Ambler class A and C \u03b2-lactamases and some [GENE]Ambler class D[\\GENE] enzymes.",
        "label": 4,
        "major": 4,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Avibactam[\\CHEMICAL] (formerly NXL104, AVE1330A) is a synthetic non-\u03b2-lactam, [GENE]\u03b2-lactamase[\\GENE] inhibitor that inhibits the activities of Ambler class A and C \u03b2-lactamases and some Ambler class D enzymes.",
        "label": 4,
        "major": 4,
        "len": 27
    },
    {
        "text": "Ceftazidime-avibactam appears to be well tolerated in healthy subjects and hospitalized patients, with few serious drug-related treatment-emergent adverse events reported to date.In conclusion, [CHEMICAL]avibactam[\\CHEMICAL] serves to broaden the spectrum of ceftazidime versus [GENE]\u00df-lactamase[\\GENE]-producing Gram-negative bacilli.",
        "label": 4,
        "major": 9,
        "len": 35
    },
    {
        "text": "Ceftazidime-avibactam appears to be well tolerated in healthy subjects and hospitalized patients, with few serious drug-related treatment-emergent adverse events reported to date.In conclusion, avibactam serves to broaden the spectrum of [CHEMICAL]ceftazidime[\\CHEMICAL] versus [GENE]\u00df-lactamase[\\GENE]-producing Gram-negative bacilli.",
        "label": 4,
        "major": 9,
        "len": 35
    },
    {
        "text": "Avibactam (formerly NXL104, [CHEMICAL]AVE1330A[\\CHEMICAL]) is a synthetic non-\u03b2-lactam, \u03b2-lactamase inhibitor that inhibits the activities of Ambler class A and C \u03b2-lactamases and some [GENE]Ambler class D[\\GENE] enzymes.",
        "label": 4,
        "major": 4,
        "len": 27
    },
    {
        "text": "Avibactam (formerly NXL104, [CHEMICAL]AVE1330A[\\CHEMICAL]) is a synthetic non-\u03b2-lactam, [GENE]\u03b2-lactamase[\\GENE] inhibitor that inhibits the activities of Ambler class A and C \u03b2-lactamases and some Ambler class D enzymes.",
        "label": 4,
        "major": 4,
        "len": 27
    },
    {
        "text": "The addition of [CHEMICAL]avibactam[\\CHEMICAL] greatly (4-1024-fold minimum inhibitory concentration [MIC] reduction) improves the activity of ceftazidime versus most species of Enterobacteriaceae depending on the presence or absence of [GENE]\u03b2-lactamase[\\GENE] enzyme(s).",
        "label": 4,
        "major": 4,
        "len": 30
    },
    {
        "text": "The addition of avibactam greatly (4-1024-fold minimum inhibitory concentration [MIC] reduction) improves the activity of [CHEMICAL]ceftazidime[\\CHEMICAL] versus most species of Enterobacteriaceae depending on the presence or absence of [GENE]\u03b2-lactamase[\\GENE] enzyme(s).",
        "label": 4,
        "major": 4,
        "len": 30
    },
    {
        "text": "[CHEMICAL]Ceftazidime[\\CHEMICAL]-avibactam: a novel cephalosporin/[GENE]\u03b2-lactamase[\\GENE] inhibitor combination.",
        "label": 4,
        "major": 4,
        "len": 6
    },
    {
        "text": "Ceftazidime-[CHEMICAL]avibactam[\\CHEMICAL]: a novel cephalosporin/[GENE]\u03b2-lactamase[\\GENE] inhibitor combination.",
        "label": 4,
        "major": 4,
        "len": 6
    },
    {
        "text": "Moreover, treatment of high-fat-diet-fed apelin-knockout mice with a selective [GENE]cyclooxygenase-2[\\GENE] inhibitor, [CHEMICAL]celecoxib[\\CHEMICAL], improved vascular function, and also attenuated obesity.",
        "label": 4,
        "major": 4,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Upamostat[\\CHEMICAL] (Mesupron\u00ae) is a new small molecule [GENE]serine protease[\\GENE] inhibitor.",
        "label": 4,
        "major": 4,
        "len": 10
    },
    {
        "text": "Upamostat ([CHEMICAL]Mesupron[\\CHEMICAL]\u00ae) is a new small molecule [GENE]serine protease[\\GENE] inhibitor.",
        "label": 4,
        "major": 4,
        "len": 10
    },
    {
        "text": "Moreover, we show that [GENE]USP22[\\GENE] is acetylated on multiple [CHEMICAL]lysine[\\CHEMICAL] residues and that alteration of a single lysine (K129) within the ZnF-UBP domain is sufficient to alter interaction of the DUBm with the core SAGA complex.",
        "label": 1,
        "major": 2,
        "len": 36
    },
    {
        "text": "Moreover, we show that USP22 is acetylated on multiple lysine residues and that alteration of a single [CHEMICAL]lysine[\\CHEMICAL] (K129) within the [GENE]ZnF-UBP domain[\\GENE] is sufficient to alter interaction of the DUBm with the core SAGA complex.",
        "label": 1,
        "major": 2,
        "len": 36
    },
    {
        "text": "Transcripts of GPx4 genes were more highly expressed in most tissues examined in vivo (except blood, head kidney and spleen), whereas those of the [GENE]GPx1[\\GENE] genes were more responsive to [CHEMICAL]selenium[\\CHEMICAL] exposure in vitro, especially to the organic form.",
        "label": 2,
        "major": -1,
        "len": 39
    },
    {
        "text": "Interestingly, [GENE]GPx1a[\\GENE] was the most sensitive to [CHEMICAL]selenium[\\CHEMICAL] availability in non stressful conditions, whereas GPx1b1 and GPx1b2 were highly induced by exposure to selenium levels that had some toxic effects on the cells.",
        "label": 2,
        "major": 3,
        "len": 33
    },
    {
        "text": "Our results lead us to conclude that trout [GENE]GPx1[\\GENE] transcripts expression level may represent a sensitive biomarker for [CHEMICAL]selenium[\\CHEMICAL] intake, helping to evaluate if selenium concentration and chemical speciation impact on cell homeostasis.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "Characterization of [GENE]cytosolic glutathione peroxidase[\\GENE] and phospholipid-hydroperoxide glutathione peroxidase genes in rainbow trout (Oncorhynchus mykiss) and their modulation by in vitro [CHEMICAL]selenium[\\CHEMICAL] exposure.",
        "label": 2,
        "major": 7,
        "len": 23
    },
    {
        "text": "Characterization of cytosolic glutathione peroxidase and [GENE]phospholipid-hydroperoxide glutathione peroxidase[\\GENE] genes in rainbow trout (Oncorhynchus mykiss) and their modulation by in vitro [CHEMICAL]selenium[\\CHEMICAL] exposure.",
        "label": 2,
        "major": 7,
        "len": 23
    },
    {
        "text": "Interestingly, GPx1a was the most sensitive to selenium availability in non stressful conditions, whereas [GENE]GPx1b1[\\GENE] and GPx1b2 were highly induced by exposure to [CHEMICAL]selenium[\\CHEMICAL] levels that had some toxic effects on the cells.",
        "label": 3,
        "major": 3,
        "len": 33
    },
    {
        "text": "Interestingly, GPx1a was the most sensitive to selenium availability in non stressful conditions, whereas GPx1b1 and [GENE]GPx1b2[\\GENE] were highly induced by exposure to [CHEMICAL]selenium[\\CHEMICAL] levels that had some toxic effects on the cells.",
        "label": 3,
        "major": 3,
        "len": 33
    },
    {
        "text": "These findings are the first to show that long-term exposure to [CHEMICAL]Mn[\\CHEMICAL] during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers, [GENE]p38[\\GENE](MAPK) phosphorylation and caspase activity in the striatum.",
        "label": 3,
        "major": -1,
        "len": 37
    },
    {
        "text": "These findings are the first to show that long-term exposure to [CHEMICAL]Mn[\\CHEMICAL] during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers, p38([GENE]MAPK[\\GENE]) phosphorylation and caspase activity in the striatum.",
        "label": 3,
        "major": -1,
        "len": 37
    },
    {
        "text": "These findings are the first to show that long-term exposure to [CHEMICAL]Mn[\\CHEMICAL] during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers, p38(MAPK) phosphorylation and [GENE]caspase[\\GENE] activity in the striatum.",
        "label": 3,
        "major": -1,
        "len": 37
    },
    {
        "text": "[CHEMICAL]Mn[\\CHEMICAL] exposure (20\u00a0mg/kg) increased [GENE]p38[\\GENE](MAPK) and Akt phosphorylation, but decreased DARPP-32-Thr-34 phosphorylation.",
        "label": 3,
        "major": 4,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Mn[\\CHEMICAL] exposure (20\u00a0mg/kg) increased p38([GENE]MAPK[\\GENE]) and Akt phosphorylation, but decreased DARPP-32-Thr-34 phosphorylation.",
        "label": 3,
        "major": 3,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Mn[\\CHEMICAL] exposure (20\u00a0mg/kg) increased p38(MAPK) and [GENE]Akt[\\GENE] phosphorylation, but decreased DARPP-32-Thr-34 phosphorylation.",
        "label": 3,
        "major": 3,
        "len": 12
    },
    {
        "text": "[CHEMICAL]Mn[\\CHEMICAL] (10 and 20\u00a0mg/kg) increased [GENE]caspase[\\GENE] activity and F(2)-isoprostane production (a biological marker of lipid peroxidation).",
        "label": 3,
        "major": 9,
        "len": 16
    },
    {
        "text": "Notably, the antioxidant Trolox\u2122 reversed the [CHEMICAL]Mn[\\CHEMICAL] (20\u00a0mg/kg)-dependent augmentation in [GENE]p38[\\GENE](MAPK) phosphorylation and reduced the Mn (20\u00a0mg/kg)-induced caspase activity and F(2)-isoprostane production.",
        "label": 3,
        "major": 10,
        "len": 22
    },
    {
        "text": "Notably, the antioxidant Trolox\u2122 reversed the [CHEMICAL]Mn[\\CHEMICAL] (20\u00a0mg/kg)-dependent augmentation in p38([GENE]MAPK[\\GENE]) phosphorylation and reduced the Mn (20\u00a0mg/kg)-induced caspase activity and F(2)-isoprostane production.",
        "label": 3,
        "major": 9,
        "len": 22
    },
    {
        "text": "Notably, the antioxidant Trolox\u2122 reversed the Mn (20\u00a0mg/kg)-dependent augmentation in p38(MAPK) phosphorylation and reduced the [CHEMICAL]Mn[\\CHEMICAL] (20\u00a0mg/kg)-induced [GENE]caspase[\\GENE] activity and F(2)-isoprostane production.",
        "label": 3,
        "major": 4,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Mn[\\CHEMICAL] exposure (20\u00a0mg/kg) increased p38(MAPK) and Akt phosphorylation, but decreased [GENE]DARPP-32[\\GENE]-Thr-34 phosphorylation.",
        "label": 4,
        "major": 3,
        "len": 12
    },
    {
        "text": "Notably, the antioxidant [CHEMICAL]Trolox[\\CHEMICAL]\u2122 reversed the Mn (20\u00a0mg/kg)-dependent augmentation in [GENE]p38[\\GENE](MAPK) phosphorylation and reduced the Mn (20\u00a0mg/kg)-induced caspase activity and F(2)-isoprostane production.",
        "label": 4,
        "major": 9,
        "len": 22
    },
    {
        "text": "Notably, the antioxidant [CHEMICAL]Trolox[\\CHEMICAL]\u2122 reversed the Mn (20\u00a0mg/kg)-dependent augmentation in p38([GENE]MAPK[\\GENE]) phosphorylation and reduced the Mn (20\u00a0mg/kg)-induced caspase activity and F(2)-isoprostane production.",
        "label": 4,
        "major": 9,
        "len": 22
    },
    {
        "text": "Notably, the antioxidant [CHEMICAL]Trolox[\\CHEMICAL]\u2122 reversed the Mn (20\u00a0mg/kg)-dependent augmentation in p38(MAPK) phosphorylation and reduced the Mn (20\u00a0mg/kg)-induced [GENE]caspase[\\GENE] activity and F(2)-isoprostane production.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Nocapyrone H[\\CHEMICAL] (1) reduced the pro-inflammatory factor such as nitric oxide (NO), prostaglandin E2 (PGE2) and [GENE]interleukin-1\u03b2[\\GENE] (IL-1\u03b2).",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Nocapyrone H[\\CHEMICAL] (1) reduced the pro-inflammatory factor such as nitric oxide (NO), prostaglandin E2 (PGE2) and interleukin-1\u03b2 ([GENE]IL-1\u03b2[\\GENE]).",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "Investigating the enteroenteric recirculation of [CHEMICAL]apixaban[\\CHEMICAL], a [GENE]factor Xa[\\GENE] inhibitor: administration of activated charcoal to bile duct-cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats.",
        "label": 4,
        "major": 9,
        "len": 31
    },
    {
        "text": "The fecal elimination, IC, and systemic clearance of apixaban were increased upon AC administration in both BDC rats and dogs and were decreased in BDC rats dosed with [CHEMICAL]GF-120918[\\CHEMICAL], a dual [GENE]BCRP[\\GENE] and P-gp inhibitor).",
        "label": 4,
        "major": 4,
        "len": 35
    },
    {
        "text": "The fecal elimination, IC, and systemic clearance of apixaban were increased upon AC administration in both BDC rats and dogs and were decreased in BDC rats dosed with [CHEMICAL]GF-120918[\\CHEMICAL], a dual BCRP and [GENE]P-gp[\\GENE] inhibitor).",
        "label": 4,
        "major": 4,
        "len": 35
    },
    {
        "text": "[GENE]BCRP[\\GENE] appeared to play a more important role for absorption and intestinal and renal elimination of [CHEMICAL]apixaban[\\CHEMICAL] than P-gp in transporter-KO rats after oral and i.v.",
        "label": 9,
        "major": 9,
        "len": 26
    },
    {
        "text": "BCRP appeared to play a more important role for absorption and intestinal and renal elimination of [CHEMICAL]apixaban[\\CHEMICAL] than [GENE]P-gp[\\GENE] in transporter-KO rats after oral and i.v.",
        "label": 9,
        "major": 9,
        "len": 26
    },
    {
        "text": "The enzyme (TcCA) has a very high catalytic activity for the CO(2) hydration reaction, being similar kinetically to the human (h) isoform [GENE]hCA II[\\GENE], although it is devoid of the [CHEMICAL]His[\\CHEMICAL]64 proton shuttle.",
        "label": 1,
        "major": -1,
        "len": 33
    },
    {
        "text": "A large number of [CHEMICAL]aromatic/heterocyclic sulfonamides[\\CHEMICAL] and some 5-mercapto-1,3,4-thiadiazoles were investigated as [GENE]TcCA[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 14
    },
    {
        "text": "A large number of aromatic/heterocyclic sulfonamides and some [CHEMICAL]5-mercapto-1,3,4-thiadiazoles[\\CHEMICAL] were investigated as [GENE]TcCA[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 14
    },
    {
        "text": "Cloning, Characterization, and [CHEMICAL]Sulfonamide[\\CHEMICAL] and Thiol Inhibition Studies of an [GENE]\u03b1-Carbonic Anhydrase[\\GENE] from Trypanosoma cruzi, the Causative Agent of Chagas Disease.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "Cloning, Characterization, and Sulfonamide and [CHEMICAL]Thiol[\\CHEMICAL] Inhibition Studies of an [GENE]\u03b1-Carbonic Anhydrase[\\GENE] from Trypanosoma cruzi, the Causative Agent of Chagas Disease.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "The enzyme (TcCA) has a very high catalytic activity for the [CHEMICAL]CO(2)[\\CHEMICAL] hydration reaction, being similar kinetically to the human (h) isoform [GENE]hCA II[\\GENE], although it is devoid of the His64 proton shuttle.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "The enzyme ([GENE]TcCA[\\GENE]) has a very high catalytic activity for the [CHEMICAL]CO(2)[\\CHEMICAL] hydration reaction, being similar kinetically to the human (h) isoform hCA II, although it is devoid of the His64 proton shuttle.",
        "label": 9,
        "major": -1,
        "len": 33
    },
    {
        "text": "However, there were detectable concentrations of Lhcgr, Cyp11a1 and Cyp17a1 mRNAs but undetectable concentrations of [GENE]Insl3[\\GENE], Hsd17b3 and Hsd11b1 in the [CHEMICAL]DEHP[\\CHEMICAL]-treated testes, indicating that these 3\u03b2-HSD(pos) cells were newly formed progenitor Leydig cells.",
        "label": 10,
        "major": -1,
        "len": 34
    },
    {
        "text": "However, there were detectable concentrations of Lhcgr, Cyp11a1 and Cyp17a1 mRNAs but undetectable concentrations of Insl3, [GENE]Hsd17b3[\\GENE] and Hsd11b1 in the [CHEMICAL]DEHP[\\CHEMICAL]-treated testes, indicating that these 3\u03b2-HSD(pos) cells were newly formed progenitor Leydig cells.",
        "label": 10,
        "major": -1,
        "len": 34
    },
    {
        "text": "However, there were detectable concentrations of Lhcgr, Cyp11a1 and Cyp17a1 mRNAs but undetectable concentrations of Insl3, Hsd17b3 and [GENE]Hsd11b1[\\GENE] in the [CHEMICAL]DEHP[\\CHEMICAL]-treated testes, indicating that these 3\u03b2-HSD(pos) cells were newly formed progenitor Leydig cells.",
        "label": 10,
        "major": -1,
        "len": 34
    },
    {
        "text": "The mRNA level for [GENE]nestin[\\GENE] (Nes, biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post-EDS, but not in the [CHEMICAL]DEHP[\\CHEMICAL] treated testes, suggesting that these nestin positive stem cells were differentiated into progenitor Leydig cells in the DEHP-treated testes.",
        "label": 10,
        "major": 3,
        "len": 46
    },
    {
        "text": "The mRNA level for nestin ([GENE]Nes[\\GENE], biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post-EDS, but not in the [CHEMICAL]DEHP[\\CHEMICAL] treated testes, suggesting that these nestin positive stem cells were differentiated into progenitor Leydig cells in the DEHP-treated testes.",
        "label": 10,
        "major": 10,
        "len": 46
    },
    {
        "text": "However, there were detectable concentrations of [GENE]Lhcgr[\\GENE], Cyp11a1 and Cyp17a1 mRNAs but undetectable concentrations of Insl3, Hsd17b3 and Hsd11b1 in the [CHEMICAL]DEHP[\\CHEMICAL]-treated testes, indicating that these 3\u03b2-HSD(pos) cells were newly formed progenitor Leydig cells.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "However, there were detectable concentrations of Lhcgr, [GENE]Cyp11a1[\\GENE] and Cyp17a1 mRNAs but undetectable concentrations of Insl3, Hsd17b3 and Hsd11b1 in the [CHEMICAL]DEHP[\\CHEMICAL]-treated testes, indicating that these 3\u03b2-HSD(pos) cells were newly formed progenitor Leydig cells.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "However, there were detectable concentrations of Lhcgr, Cyp11a1 and [GENE]Cyp17a1[\\GENE] mRNAs but undetectable concentrations of Insl3, Hsd17b3 and Hsd11b1 in the [CHEMICAL]DEHP[\\CHEMICAL]-treated testes, indicating that these 3\u03b2-HSD(pos) cells were newly formed progenitor Leydig cells.",
        "label": 2,
        "major": -1,
        "len": 34
    },
    {
        "text": "The mRNA level for [GENE]nestin[\\GENE] (Nes, biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post-[CHEMICAL]EDS[\\CHEMICAL], but not in the DEHP treated testes, suggesting that these nestin positive stem cells were differentiated into progenitor Leydig cells in the DEHP-treated testes.",
        "label": 3,
        "major": 3,
        "len": 46
    },
    {
        "text": "The mRNA level for nestin ([GENE]Nes[\\GENE], biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post-[CHEMICAL]EDS[\\CHEMICAL], but not in the DEHP treated testes, suggesting that these nestin positive stem cells were differentiated into progenitor Leydig cells in the DEHP-treated testes.",
        "label": 3,
        "major": 3,
        "len": 46
    },
    {
        "text": "Expression of pituitary [GENE]FSH[\\GENE] and LH, under the control of pulsatile [CHEMICAL]GnRH[\\CHEMICAL], is essential for fertility.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "Expression of pituitary FSH and [GENE]LH[\\GENE], under the control of pulsatile [CHEMICAL]GnRH[\\CHEMICAL], is essential for fertility.",
        "label": 2,
        "major": -1,
        "len": 16
    },
    {
        "text": "We hypothesized that CREB is activated by a distinct signaling pathway in response to pulsatile [CHEMICAL]GnRH[\\CHEMICAL] in a frequency-dependent manner to dictate the [GENE]FSH\u03b2[\\GENE] transcriptional response.",
        "label": 2,
        "major": 3,
        "len": 26
    },
    {
        "text": "A dominant negative PKA (DNPKA) reduced GnRH-stimulated pCREB and markedly decreased [CHEMICAL]GnRH[\\CHEMICAL] stimulation of FSH\u03b2 mRNA and FSH\u03b2LUC activity, but had little effect on [GENE]LH\u03b2[\\GENE]LUC activity, indicating relative specificity of this pathway.",
        "label": 2,
        "major": 4,
        "len": 32
    },
    {
        "text": "A dominant negative PKA (DNPKA) reduced [CHEMICAL]GnRH[\\CHEMICAL]-stimulated [GENE]pCREB[\\GENE] and markedly decreased GnRH stimulation of FSH\u03b2 mRNA and FSH\u03b2LUC activity, but had little effect on LH\u03b2LUC activity, indicating relative specificity of this pathway.",
        "label": 3,
        "major": 4,
        "len": 32
    },
    {
        "text": "A dominant negative PKA (DNPKA) reduced GnRH-stimulated pCREB and markedly decreased [CHEMICAL]GnRH[\\CHEMICAL] stimulation of FSH\u03b2 mRNA and [GENE]FSH\u03b2[\\GENE]LUC activity, but had little effect on LH\u03b2LUC activity, indicating relative specificity of this pathway.",
        "label": 3,
        "major": 4,
        "len": 32
    },
    {
        "text": "In perifusion studies, FSH\u03b2 mRNA levels and [GENE]FSH\u03b2[\\GENE]LUC activities were increased by pulsatile [CHEMICAL]GnRH[\\CHEMICAL], with significantly greater increases at low compared with high pulse frequencies.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "[CHEMICAL]GnRH[\\CHEMICAL] pulse frequency-dependent stimulation of FSH\u03b2 transcription is mediated via activation of PKA and [GENE]CREB[\\GENE].",
        "label": 3,
        "major": 3,
        "len": 15
    },
    {
        "text": "[CHEMICAL]GnRH[\\CHEMICAL] pulse frequency-dependent stimulation of FSH\u03b2 transcription is mediated via activation of [GENE]PKA[\\GENE] and CREB.",
        "label": 3,
        "major": 3,
        "len": 15
    },
    {
        "text": "Correlating with [GENE]FSH\u03b2[\\GENE] activation, both PKA activity and levels of pCREB were increased to a greater extent by low compared with high [CHEMICAL]GnRH[\\CHEMICAL] pulse frequencies, and the induction of pCREB was also attenuated by overexpression of DNPKA at both low and high pulse frequencies.",
        "label": 3,
        "major": 3,
        "len": 44
    },
    {
        "text": "Correlating with FSH\u03b2 activation, both [GENE]PKA[\\GENE] activity and levels of pCREB were increased to a greater extent by low compared with high [CHEMICAL]GnRH[\\CHEMICAL] pulse frequencies, and the induction of pCREB was also attenuated by overexpression of DNPKA at both low and high pulse frequencies.",
        "label": 3,
        "major": 3,
        "len": 44
    },
    {
        "text": "Correlating with FSH\u03b2 activation, both PKA activity and levels of pCREB were increased to a greater extent by low compared with high [CHEMICAL]GnRH[\\CHEMICAL] pulse frequencies, and the induction of [GENE]pCREB[\\GENE] was also attenuated by overexpression of DNPKA at both low and high pulse frequencies.",
        "label": 3,
        "major": 3,
        "len": 44
    },
    {
        "text": "Taken together, these data indicate that a PKA-mediated signaling pathway mediates [CHEMICAL]GnRH[\\CHEMICAL] activation of [GENE]CREB[\\GENE] at low-pulse frequencies, playing a significant role in the decoding of the hypothalamic GnRH signal to result in frequency-dependent FSH\u03b2 activation.",
        "label": 3,
        "major": 3,
        "len": 36
    },
    {
        "text": "Taken together, these data indicate that a PKA-mediated signaling pathway mediates GnRH activation of CREB at low-pulse frequencies, playing a significant role in the decoding of the hypothalamic [CHEMICAL]GnRH[\\CHEMICAL] signal to result in frequency-dependent [GENE]FSH\u03b2[\\GENE] activation.",
        "label": 3,
        "major": 3,
        "len": 36
    },
    {
        "text": "cAMP response element-binding protein (CREB) has been implicated in the regulation of FSH\u03b2 gene expression, but the molecular mechanisms by which pulsatile [CHEMICAL]GnRH[\\CHEMICAL] regulates [GENE]CREB[\\GENE] activation remain poorly understood.",
        "label": 3,
        "major": 2,
        "len": 29
    },
    {
        "text": "We hypothesized that [GENE]CREB[\\GENE] is activated by a distinct signaling pathway in response to pulsatile [CHEMICAL]GnRH[\\CHEMICAL] in a frequency-dependent manner to dictate the FSH\u03b2 transcriptional response.",
        "label": 3,
        "major": 3,
        "len": 26
    },
    {
        "text": "[CHEMICAL]GnRH[\\CHEMICAL] stimulation of [GENE]CREB[\\GENE] phosphorylation (pCREB) in the gonadotrope-derived L\u03b2T2 cell line was attenuated by a protein kinase A (PKA) inhibitor, H89.",
        "label": 3,
        "major": 4,
        "len": 22
    },
    {
        "text": "[CHEMICAL]GnRH[\\CHEMICAL] stimulation of CREB phosphorylation ([GENE]pCREB[\\GENE]) in the gonadotrope-derived L\u03b2T2 cell line was attenuated by a protein kinase A (PKA) inhibitor, H89.",
        "label": 3,
        "major": 4,
        "len": 22
    },
    {
        "text": "A dominant negative PKA (DNPKA) reduced GnRH-stimulated pCREB and markedly decreased [CHEMICAL]GnRH[\\CHEMICAL] stimulation of [GENE]FSH\u03b2[\\GENE] mRNA and FSH\u03b2LUC activity, but had little effect on LH\u03b2LUC activity, indicating relative specificity of this pathway.",
        "label": 3,
        "major": 4,
        "len": 32
    },
    {
        "text": "In perifusion studies, [GENE]FSH\u03b2[\\GENE] mRNA levels and FSH\u03b2LUC activities were increased by pulsatile [CHEMICAL]GnRH[\\CHEMICAL], with significantly greater increases at low compared with high pulse frequencies.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "[CHEMICAL]GnRH[\\CHEMICAL] pulse frequency-dependent stimulation of [GENE]FSH\u03b2[\\GENE] transcription is mediated via activation of PKA and CREB.",
        "label": 3,
        "major": 3,
        "len": 15
    },
    {
        "text": "DNPKA markedly reduced these [CHEMICAL]GnRH[\\CHEMICAL]-stimulated [GENE]FSH\u03b2[\\GENE] responses at both low and high pulse frequencies.",
        "label": 3,
        "major": 4,
        "len": 14
    },
    {
        "text": "Correlating with FSH\u03b2 activation, both PKA activity and levels of [GENE]pCREB[\\GENE] were increased to a greater extent by low compared with high [CHEMICAL]GnRH[\\CHEMICAL] pulse frequencies, and the induction of pCREB was also attenuated by overexpression of DNPKA at both low and high pulse frequencies.",
        "label": 3,
        "major": 3,
        "len": 44
    },
    {
        "text": "GnRH stimulation of [GENE]CREB[\\GENE] phosphorylation (pCREB) in the gonadotrope-derived L\u03b2T2 cell line was attenuated by a protein kinase A (PKA) inhibitor, [CHEMICAL]H89[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "GnRH stimulation of CREB phosphorylation ([GENE]pCREB[\\GENE]) in the gonadotrope-derived L\u03b2T2 cell line was attenuated by a protein kinase A (PKA) inhibitor, [CHEMICAL]H89[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "GnRH stimulation of CREB phosphorylation (pCREB) in the gonadotrope-derived L\u03b2T2 cell line was attenuated by a [GENE]protein kinase A[\\GENE] (PKA) inhibitor, [CHEMICAL]H89[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "GnRH stimulation of CREB phosphorylation (pCREB) in the gonadotrope-derived L\u03b2T2 cell line was attenuated by a protein kinase A ([GENE]PKA[\\GENE]) inhibitor, [CHEMICAL]H89[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Sophocarpine[\\CHEMICAL], an effective compound derived from foxtail-like sophora herb and seed, has been reported that it can alleviate non-alcoholic steatohepatitis (NASH) in rats and affect [GENE]adipocytokine[\\GENE] synthesis.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "We concluded that [CHEMICAL]sophocarpine[\\CHEMICAL] could alleviate hepatocyte steatosis and the potential mechanism might be the activated signaling pathway of [GENE]AMPK[\\GENE].",
        "label": 3,
        "major": 3,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Sophocarpine[\\CHEMICAL] alleviates hepatocyte steatosis through activating [GENE]AMPK[\\GENE] signaling pathway.",
        "label": 3,
        "major": 3,
        "len": 9
    },
    {
        "text": "Moreover, compared with the model group, [CHEMICAL]sophocarpine[\\CHEMICAL] could significantly increase P-AMPK\u03b1 (>5.82-fold), AMPK\u03b1 (>1.29-fold) and [GENE]ACC[\\GENE] (>3.27-fold) protein expressions, and reduce P-ACC (<0.30-fold) and HNF-4\u03b1 (<0.20-fold) protein expression.",
        "label": 3,
        "major": 3,
        "len": 28
    },
    {
        "text": "Moreover, compared with the model group, [CHEMICAL]sophocarpine[\\CHEMICAL] could significantly increase [GENE]P-AMPK\u03b1[\\GENE] (>5.82-fold), AMPK\u03b1 (>1.29-fold) and ACC (>3.27-fold) protein expressions, and reduce P-ACC (<0.30-fold) and HNF-4\u03b1 (<0.20-fold) protein expression.",
        "label": 3,
        "major": 3,
        "len": 28
    },
    {
        "text": "Moreover, compared with the model group, [CHEMICAL]sophocarpine[\\CHEMICAL] could significantly increase P-AMPK\u03b1 (>5.82-fold), [GENE]AMPK\u03b1[\\GENE] (>1.29-fold) and ACC (>3.27-fold) protein expressions, and reduce P-ACC (<0.30-fold) and HNF-4\u03b1 (<0.20-fold) protein expression.",
        "label": 3,
        "major": 3,
        "len": 28
    },
    {
        "text": "While [CHEMICAL]sophocarpine[\\CHEMICAL] treatment resulted in: significant improvement of steatosis (>50% decrease), decrease of leptin expression (<0.57-fold) and increase of [GENE]adiponectin[\\GENE] expression (>1.48-fold).",
        "label": 3,
        "major": 4,
        "len": 22
    },
    {
        "text": "Moreover, compared with the model group, [CHEMICAL]sophocarpine[\\CHEMICAL] could significantly increase P-AMPK\u03b1 (>5.82-fold), AMPK\u03b1 (>1.29-fold) and ACC (>3.27-fold) protein expressions, and reduce [GENE]P-ACC[\\GENE] (<0.30-fold) and HNF-4\u03b1 (<0.20-fold) protein expression.",
        "label": 4,
        "major": 3,
        "len": 28
    },
    {
        "text": "Moreover, compared with the model group, [CHEMICAL]sophocarpine[\\CHEMICAL] could significantly increase P-AMPK\u03b1 (>5.82-fold), AMPK\u03b1 (>1.29-fold) and ACC (>3.27-fold) protein expressions, and reduce P-ACC (<0.30-fold) and [GENE]HNF-4\u03b1[\\GENE] (<0.20-fold) protein expression.",
        "label": 4,
        "major": 3,
        "len": 28
    },
    {
        "text": "While [CHEMICAL]sophocarpine[\\CHEMICAL] treatment resulted in: significant improvement of steatosis (>50% decrease), decrease of [GENE]leptin[\\GENE] expression (<0.57-fold) and increase of adiponectin expression (>1.48-fold).",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "The involvement of P-gp in the absorption of darunavir was clearly shown by coperfusion of darunavir with the [GENE]P-gp[\\GENE] inhibitor [CHEMICAL]zosuquidar[\\CHEMICAL].",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "Upon studying the drug-drug interaction of darunavir with ketoconazole, data were indicative for an inhibitory effect of [CHEMICAL]ketoconazole[\\CHEMICAL] on [GENE]P-gp[\\GENE] as the main mechanism for the increased transport of darunavir across the small intestine.",
        "label": 4,
        "major": 4,
        "len": 34
    },
    {
        "text": "The involvement of [GENE]P-gp[\\GENE] in the absorption of [CHEMICAL]darunavir[\\CHEMICAL] was clearly shown by coperfusion of darunavir with the P-gp inhibitor zosuquidar.",
        "label": 9,
        "major": 4,
        "len": 21
    },
    {
        "text": "Involvement of [GENE]P450[\\GENE] mediated metabolism in the absorption of [CHEMICAL]darunavir[\\CHEMICAL] could not be demonstrated in this rat model.",
        "label": 9,
        "major": 10,
        "len": 18
    },
    {
        "text": "Upon studying the drug-drug interaction of darunavir with ketoconazole, data were indicative for an inhibitory effect of ketoconazole on [GENE]P-gp[\\GENE] as the main mechanism for the increased transport of [CHEMICAL]darunavir[\\CHEMICAL] across the small intestine.",
        "label": 9,
        "major": 4,
        "len": 34
    },
    {
        "text": "To evaluate to what extent the regional differences in expression of [GENE]P-gp[\\GENE] and P450 enzymes affect the absorption of a dual substrate, we investigated the transport of [CHEMICAL]darunavir[\\CHEMICAL] across different small intestinal segments (duodenum, proximal jejunum and ileum).",
        "label": 9,
        "major": 9,
        "len": 38
    },
    {
        "text": "To evaluate to what extent the regional differences in expression of P-gp and [GENE]P450 enzymes[\\GENE] affect the absorption of a dual substrate, we investigated the transport of [CHEMICAL]darunavir[\\CHEMICAL] across different small intestinal segments (duodenum, proximal jejunum and ileum).",
        "label": 9,
        "major": 9,
        "len": 38
    },
    {
        "text": "In another experiment, topical application of CFB, CFE or [CHEMICAL]CLS[\\CHEMICAL] prior to UVB irradiation (200mJ/cm(2)) on BALB/c mice, inhibited the UVB-elevated protein levels of [GENE]COX-2[\\GENE], iNOS, and TNF-\u03b1.",
        "label": 4,
        "major": 4,
        "len": 28
    },
    {
        "text": "In another experiment, topical application of CFB, CFE or [CHEMICAL]CLS[\\CHEMICAL] prior to UVB irradiation (200mJ/cm(2)) on BALB/c mice, inhibited the UVB-elevated protein levels of COX-2, [GENE]iNOS[\\GENE], and TNF-\u03b1.",
        "label": 4,
        "major": 10,
        "len": 28
    },
    {
        "text": "In another experiment, topical application of CFB, CFE or [CHEMICAL]CLS[\\CHEMICAL] prior to UVB irradiation (200mJ/cm(2)) on BALB/c mice, inhibited the UVB-elevated protein levels of COX-2, iNOS, and [GENE]TNF-\u03b1[\\GENE].",
        "label": 4,
        "major": 10,
        "len": 28
    },
    {
        "text": "In HaCaT cells, [CHEMICAL]buthanol[\\CHEMICAL] and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including [GENE]cyclooxygenase-2[\\GENE] (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, [CHEMICAL]buthanol[\\CHEMICAL] and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 ([GENE]COX-2[\\GENE]), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, [CHEMICAL]buthanol[\\CHEMICAL] and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), [GENE]inducible nitric oxide synthase[\\GENE] (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, [CHEMICAL]buthanol[\\CHEMICAL] and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase ([GENE]iNOS[\\GENE]), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, [CHEMICAL]buthanol[\\CHEMICAL] and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and [GENE]tumor necrosis factor-\u03b1[\\GENE] (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, [CHEMICAL]buthanol[\\CHEMICAL] and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 ([GENE]TNF- \u03b1[\\GENE]).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and [CHEMICAL]ethylacetate[\\CHEMICAL] fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including [GENE]cyclooxygenase-2[\\GENE] (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and [CHEMICAL]ethylacetate[\\CHEMICAL] fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 ([GENE]COX-2[\\GENE]), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and [CHEMICAL]ethylacetate[\\CHEMICAL] fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), [GENE]inducible nitric oxide synthase[\\GENE] (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and [CHEMICAL]ethylacetate[\\CHEMICAL] fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase ([GENE]iNOS[\\GENE]), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and [CHEMICAL]ethylacetate[\\CHEMICAL] fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and [GENE]tumor necrosis factor-\u03b1[\\GENE] (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and [CHEMICAL]ethylacetate[\\CHEMICAL] fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 ([GENE]TNF- \u03b1[\\GENE]).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% [CHEMICAL]methanol[\\CHEMICAL] C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including [GENE]cyclooxygenase-2[\\GENE] (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% [CHEMICAL]methanol[\\CHEMICAL] C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 ([GENE]COX-2[\\GENE]), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% [CHEMICAL]methanol[\\CHEMICAL] C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), [GENE]inducible nitric oxide synthase[\\GENE] (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% [CHEMICAL]methanol[\\CHEMICAL] C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase ([GENE]iNOS[\\GENE]), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% [CHEMICAL]methanol[\\CHEMICAL] C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and [GENE]tumor necrosis factor-\u03b1[\\GENE] (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% [CHEMICAL]methanol[\\CHEMICAL] C. fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 ([GENE]TNF- \u03b1[\\GENE]).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, [CHEMICAL]clerosterol[\\CHEMICAL] (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including [GENE]cyclooxygenase-2[\\GENE] (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, [CHEMICAL]clerosterol[\\CHEMICAL] (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 ([GENE]COX-2[\\GENE]), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, [CHEMICAL]clerosterol[\\CHEMICAL] (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), [GENE]inducible nitric oxide synthase[\\GENE] (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, [CHEMICAL]clerosterol[\\CHEMICAL] (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase ([GENE]iNOS[\\GENE]), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, [CHEMICAL]clerosterol[\\CHEMICAL] (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and [GENE]tumor necrosis factor-\u03b1[\\GENE] (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, [CHEMICAL]clerosterol[\\CHEMICAL] (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 ([GENE]TNF- \u03b1[\\GENE]).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol ([CHEMICAL]CLS[\\CHEMICAL]) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including [GENE]cyclooxygenase-2[\\GENE] (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol ([CHEMICAL]CLS[\\CHEMICAL]) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 ([GENE]COX-2[\\GENE]), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol ([CHEMICAL]CLS[\\CHEMICAL]) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), [GENE]inducible nitric oxide synthase[\\GENE] (iNOS), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol ([CHEMICAL]CLS[\\CHEMICAL]) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase ([GENE]iNOS[\\GENE]), and tumor necrosis factor-\u03b1 (TNF- \u03b1).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol ([CHEMICAL]CLS[\\CHEMICAL]) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and [GENE]tumor necrosis factor-\u03b1[\\GENE] (TNF- \u03b1).",
        "label": 4,
        "major": 3,
        "len": 49
    },
    {
        "text": "In HaCaT cells, buthanol and ethylacetate fractions of 80% methanol C. fragile extract (CFB or CFE) and a single compound, clerosterol ([CHEMICAL]CLS[\\CHEMICAL]) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-\u03b1 ([GENE]TNF- \u03b1[\\GENE]).",
        "label": 4,
        "major": 4,
        "len": 49
    },
    {
        "text": "Interaction of silymarin [CHEMICAL]flavonolignans[\\CHEMICAL] with [GENE]organic anion-transporting polypeptides[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 8
    },
    {
        "text": "The extent of silymarin-drug interactions depends on [GENE]OATP[\\GENE] isoform specificity and concentrations of [CHEMICAL]flavonolignans[\\CHEMICAL] at the site of drug transport.",
        "label": 2,
        "major": 9,
        "len": 20
    },
    {
        "text": "In overexpressing cell lines, [GENE]OATP1B1[\\GENE]- and OATP1B3-mediated estradiol-17\u03b2-glucuronide uptake and OATP2B1-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin [CHEMICAL]flavonolignans[\\CHEMICAL] investigated.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "In overexpressing cell lines, OATP1B1- and [GENE]OATP1B3[\\GENE]-mediated estradiol-17\u03b2-glucuronide uptake and OATP2B1-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin [CHEMICAL]flavonolignans[\\CHEMICAL] investigated.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "In overexpressing cell lines, OATP1B1- and OATP1B3-mediated estradiol-17\u03b2-glucuronide uptake and [GENE]OATP2B1[\\GENE]-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin [CHEMICAL]flavonolignans[\\CHEMICAL] investigated.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "[GENE]OATP1B1[\\GENE]-, OATP1B3-, and OATP2B1-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 \u00b5M, respectively), [CHEMICAL]silybin A[\\CHEMICAL] (IC50 values of 9.7, 2.7 and 4.5 \u00b5M, respectively), silybin B (IC50 values of 8.5, 5.0 and 0.8 \u00b5M, respectively), and silychristin (IC50 values of 9.0, 36.4, and 3.6 \u00b5M, respectively).",
        "label": 4,
        "major": 9,
        "len": 53
    },
    {
        "text": "OATP1B1-, [GENE]OATP1B3[\\GENE]-, and OATP2B1-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 \u00b5M, respectively), [CHEMICAL]silybin A[\\CHEMICAL] (IC50 values of 9.7, 2.7 and 4.5 \u00b5M, respectively), silybin B (IC50 values of 8.5, 5.0 and 0.8 \u00b5M, respectively), and silychristin (IC50 values of 9.0, 36.4, and 3.6 \u00b5M, respectively).",
        "label": 4,
        "major": 9,
        "len": 53
    },
    {
        "text": "OATP1B1-, OATP1B3-, and [GENE]OATP2B1[\\GENE]-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 \u00b5M, respectively), [CHEMICAL]silybin A[\\CHEMICAL] (IC50 values of 9.7, 2.7 and 4.5 \u00b5M, respectively), silybin B (IC50 values of 8.5, 5.0 and 0.8 \u00b5M, respectively), and silychristin (IC50 values of 9.0, 36.4, and 3.6 \u00b5M, respectively).",
        "label": 4,
        "major": 9,
        "len": 53
    },
    {
        "text": "[GENE]OATP1B1[\\GENE]-, OATP1B3-, and OATP2B1-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 \u00b5M, respectively), silybin A (IC50 values of 9.7, 2.7 and 4.5 \u00b5M, respectively), [CHEMICAL]silybin B[\\CHEMICAL] (IC50 values of 8.5, 5.0 and 0.8 \u00b5M, respectively), and silychristin (IC50 values of 9.0, 36.4, and 3.6 \u00b5M, respectively).",
        "label": 4,
        "major": 9,
        "len": 53
    },
    {
        "text": "OATP1B1-, [GENE]OATP1B3[\\GENE]-, and OATP2B1-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 \u00b5M, respectively), silybin A (IC50 values of 9.7, 2.7 and 4.5 \u00b5M, respectively), [CHEMICAL]silybin B[\\CHEMICAL] (IC50 values of 8.5, 5.0 and 0.8 \u00b5M, respectively), and silychristin (IC50 values of 9.0, 36.4, and 3.6 \u00b5M, respectively).",
        "label": 4,
        "major": 9,
        "len": 53
    },
    {
        "text": "OATP1B1-, OATP1B3-, and [GENE]OATP2B1[\\GENE]-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 \u00b5M, respectively), silybin A (IC50 values of 9.7, 2.7 and 4.5 \u00b5M, respectively), [CHEMICAL]silybin B[\\CHEMICAL] (IC50 values of 8.5, 5.0 and 0.8 \u00b5M, respectively), and silychristin (IC50 values of 9.0, 36.4, and 3.6 \u00b5M, respectively).",
        "label": 4,
        "major": 9,
        "len": 53
    },
    {
        "text": "[GENE]OATP1B1[\\GENE]-, OATP1B3-, and OATP2B1-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 \u00b5M, respectively), silybin A (IC50 values of 9.7, 2.7 and 4.5 \u00b5M, respectively), silybin B (IC50 values of 8.5, 5.0 and 0.8 \u00b5M, respectively), and [CHEMICAL]silychristin[\\CHEMICAL] (IC50 values of 9.0, 36.4, and 3.6 \u00b5M, respectively).",
        "label": 4,
        "major": 9,
        "len": 53
    },
    {
        "text": "OATP1B1-, [GENE]OATP1B3[\\GENE]-, and OATP2B1-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 \u00b5M, respectively), silybin A (IC50 values of 9.7, 2.7 and 4.5 \u00b5M, respectively), silybin B (IC50 values of 8.5, 5.0 and 0.8 \u00b5M, respectively), and [CHEMICAL]silychristin[\\CHEMICAL] (IC50 values of 9.0, 36.4, and 3.6 \u00b5M, respectively).",
        "label": 4,
        "major": 9,
        "len": 53
    },
    {
        "text": "OATP1B1-, OATP1B3-, and [GENE]OATP2B1[\\GENE]-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 \u00b5M, respectively), silybin A (IC50 values of 9.7, 2.7 and 4.5 \u00b5M, respectively), silybin B (IC50 values of 8.5, 5.0 and 0.8 \u00b5M, respectively), and [CHEMICAL]silychristin[\\CHEMICAL] (IC50 values of 9.0, 36.4, and 3.6 \u00b5M, respectively).",
        "label": 4,
        "major": 9,
        "len": 53
    },
    {
        "text": "Furthermore, silymarin, [CHEMICAL]silybin A[\\CHEMICAL], and silybin B (100 \u00b5M) significantly inhibited [GENE]OATP[\\GENE]-mediated estradiol-17\u03b2-glucuronide and rosuvastatin uptake into human hepatocytes.",
        "label": 4,
        "major": 4,
        "len": 19
    },
    {
        "text": "Furthermore, silymarin, silybin A, and [CHEMICAL]silybin B[\\CHEMICAL] (100 \u00b5M) significantly inhibited [GENE]OATP[\\GENE]-mediated estradiol-17\u03b2-glucuronide and rosuvastatin uptake into human hepatocytes.",
        "label": 4,
        "major": 4,
        "len": 19
    },
    {
        "text": "In overexpressing cell lines, [GENE]OATP1B1[\\GENE]- and OATP1B3-mediated [CHEMICAL]estradiol-17\u03b2-glucuronide[\\CHEMICAL] uptake and OATP2B1-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin flavonolignans investigated.",
        "label": 9,
        "major": 4,
        "len": 22
    },
    {
        "text": "In overexpressing cell lines, OATP1B1- and [GENE]OATP1B3[\\GENE]-mediated [CHEMICAL]estradiol-17\u03b2-glucuronide[\\CHEMICAL] uptake and OATP2B1-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin flavonolignans investigated.",
        "label": 9,
        "major": 4,
        "len": 22
    },
    {
        "text": "In overexpressing cell lines, OATP1B1- and OATP1B3-mediated estradiol-17\u03b2-glucuronide uptake and [GENE]OATP2B1[\\GENE]-mediated [CHEMICAL]estrone-3-sulfate[\\CHEMICAL] uptake were inhibited by most of the silymarin flavonolignans investigated.",
        "label": 9,
        "major": 4,
        "len": 22
    },
    {
        "text": "Furthermore, silymarin, silybin A, and silybin B (100 \u00b5M) significantly inhibited [GENE]OATP[\\GENE]-mediated [CHEMICAL]estradiol-17\u03b2-glucuronide[\\CHEMICAL] and rosuvastatin uptake into human hepatocytes.",
        "label": 9,
        "major": 4,
        "len": 19
    },
    {
        "text": "Furthermore, silymarin, silybin A, and silybin B (100 \u00b5M) significantly inhibited [GENE]OATP[\\GENE]-mediated estradiol-17\u03b2-glucuronide and [CHEMICAL]rosuvastatin[\\CHEMICAL] uptake into human hepatocytes.",
        "label": 9,
        "major": 4,
        "len": 19
    },
    {
        "text": "Selective oxidation of \u03c9-tertiary amine self-assembled thiol monolayers to [CHEMICAL]tertiary amine N-oxides[\\CHEMICAL] is shown to transform the adhesion of model proteins [GENE]lysozyme[\\GENE] and fibrinogen upon them.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Selective oxidation of \u03c9-tertiary amine self-assembled thiol monolayers to [CHEMICAL]tertiary amine N-oxides[\\CHEMICAL] is shown to transform the adhesion of model proteins lysozyme and [GENE]fibrinogen[\\GENE] upon them.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Tertiary amine-functionalized sensors adsorbed multilayers of aggregated [GENE]lysozyme[\\GENE], whereas [CHEMICAL]tertiary amine N-oxides[\\CHEMICAL] and triethylene glycol-terminated monolayers are consistent with small protein aggregates.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Tertiary amine-functionalized sensors adsorbed multilayers of aggregated [GENE]lysozyme[\\GENE], whereas tertiary amine N-oxides and [CHEMICAL]triethylene glycol[\\CHEMICAL]-terminated monolayers are consistent with small protein aggregates.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Selective oxidation of [CHEMICAL]\u03c9-tertiary amine[\\CHEMICAL] self-assembled thiol monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins [GENE]lysozyme[\\GENE] and fibrinogen upon them.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Selective oxidation of [CHEMICAL]\u03c9-tertiary amine[\\CHEMICAL] self-assembled thiol monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins lysozyme and [GENE]fibrinogen[\\GENE] upon them.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Selective oxidation of \u03c9-tertiary amine self-assembled [CHEMICAL]thiol[\\CHEMICAL] monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins [GENE]lysozyme[\\GENE] and fibrinogen upon them.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Selective oxidation of \u03c9-tertiary amine self-assembled [CHEMICAL]thiol[\\CHEMICAL] monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins lysozyme and [GENE]fibrinogen[\\GENE] upon them.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Oxidation with [CHEMICAL]hydrogen peroxide[\\CHEMICAL] was similarly assessed, and adhesion of [GENE]lysozyme[\\GENE] and fibrinogen from phosphate buffered saline was then assayed by QCM and imaged by AFM.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Oxidation with [CHEMICAL]hydrogen peroxide[\\CHEMICAL] was similarly assessed, and adhesion of lysozyme and [GENE]fibrinogen[\\GENE] from phosphate buffered saline was then assayed by QCM and imaged by AFM.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Further investigation demonstrated that 8k reduced [CHEMICAL]H2O2[\\CHEMICAL]-induced activation of mitochondrial apoptosis by inhibiting the expression of [GENE]Bax[\\GENE] and elevating the expression of Bcl-2.",
        "label": 3,
        "major": 4,
        "len": 23
    },
    {
        "text": "Further investigation demonstrated that 8k reduced [CHEMICAL]H2O2[\\CHEMICAL]-induced activation of mitochondrial apoptosis by inhibiting the expression of Bax and elevating the expression of [GENE]Bcl-2[\\GENE].",
        "label": 4,
        "major": 3,
        "len": 23
    },
    {
        "text": "[GENE]Insulin[\\GENE] levels were negatively correlated with variables of vagal control, reaching significance for rMSSD and log(10)HF, but not for pvRSA, during the last four phases of the hyperglycaemic clamp (hyperglycaemic second phase, GLP-1 first and second phases, and [CHEMICAL]arginine[\\CHEMICAL]).",
        "label": 2,
        "major": 10,
        "len": 39
    },
    {
        "text": "Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of [GENE]insulin[\\GENE] (achieved by administering insulin plus [CHEMICAL]glucose[\\CHEMICAL], glucose only, glucose and GLP-1, and glucose and GLP-1 combined with arginine).",
        "label": 3,
        "major": 3,
        "len": 74
    },
    {
        "text": "Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of [GENE]insulin[\\GENE] (achieved by administering insulin plus glucose, [CHEMICAL]glucose[\\CHEMICAL] only, glucose and GLP-1, and glucose and GLP-1 combined with arginine).",
        "label": 3,
        "major": 3,
        "len": 74
    },
    {
        "text": "Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of [GENE]insulin[\\GENE] (achieved by administering insulin plus glucose, glucose only, [CHEMICAL]glucose[\\CHEMICAL] and GLP-1, and glucose and GLP-1 combined with arginine).",
        "label": 3,
        "major": 3,
        "len": 74
    },
    {
        "text": "Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of [GENE]insulin[\\GENE] (achieved by administering insulin plus glucose, glucose only, glucose and GLP-1, and [CHEMICAL]glucose[\\CHEMICAL] and GLP-1 combined with arginine).",
        "label": 3,
        "major": 3,
        "len": 74
    },
    {
        "text": "Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of [GENE]insulin[\\GENE] (achieved by administering insulin plus glucose, glucose only, glucose and GLP-1, and glucose and GLP-1 combined with [CHEMICAL]arginine[\\CHEMICAL]).",
        "label": 3,
        "major": 3,
        "len": 74
    },
    {
        "text": "In a mouse tumor model, removal of only the [CHEMICAL]C[\\CHEMICAL]-terminal propeptide from full-length [GENE]VEGF-D[\\GENE] was sufficient to enhance angiogenesis and tumor growth.",
        "label": 1,
        "major": -1,
        "len": 22
    },
    {
        "text": "We report for the first time that VEGF-D binds heparin, and that the [CHEMICAL]C[\\CHEMICAL]-terminal propeptide significantly enhances this interaction (removal of this propeptide from full-length [GENE]VEGF-D[\\GENE] completely prevents heparin binding).",
        "label": 1,
        "major": 2,
        "len": 30
    },
    {
        "text": "We also show that removal of either the [CHEMICAL]N[\\CHEMICAL]- or C-terminal propeptide is required for [GENE]VEGF-D[\\GENE] to drive formation of VEGFR-2/VEGFR-3 heterodimers which have recently been shown to positively regulate angiogenic sprouting.",
        "label": 1,
        "major": -1,
        "len": 32
    },
    {
        "text": "We also show that removal of either the N- or [CHEMICAL]C[\\CHEMICAL]-terminal propeptide is required for [GENE]VEGF-D[\\GENE] to drive formation of VEGFR-2/VEGFR-3 heterodimers which have recently been shown to positively regulate angiogenic sprouting.",
        "label": 1,
        "major": -1,
        "len": 32
    },
    {
        "text": "The [GENE]CRF(1) receptor[\\GENE] antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with [CHEMICAL]paroxetine[\\CHEMICAL] and D-cycloserine.",
        "label": 2,
        "major": 6,
        "len": 18
    },
    {
        "text": "The [GENE]CRF(1) receptor[\\GENE] antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with paroxetine and [CHEMICAL]D-cycloserine[\\CHEMICAL].",
        "label": 2,
        "major": 3,
        "len": 18
    },
    {
        "text": "Effects of SSR125543 were compared to those of the 5-HT reuptake inhibitor, paroxetine (10\u00a0mg/kg/day), and the partial [GENE]N-methyl-D-aspartate (NMDA) receptor[\\GENE] agonist, [CHEMICAL]D-cycloserine[\\CHEMICAL] (10\u00a0mg/kg/day), two compounds which have demonstrated clinical efficacy against PTSD.",
        "label": 5,
        "major": 5,
        "len": 32
    },
    {
        "text": "RATIONALE: The selective [GENE]CRF(1) (corticotropin releasing factor type 1) receptor[\\GENE] antagonist [CHEMICAL]SSR125543[\\CHEMICAL] has been previously shown to attenuate the long-term cognitive deficit produced by traumatic stress exposure.",
        "label": 6,
        "major": 6,
        "len": 27
    },
    {
        "text": "The [GENE]CRF(1) receptor[\\GENE] antagonist [CHEMICAL]SSR125543[\\CHEMICAL] prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with paroxetine and D-cycloserine.",
        "label": 6,
        "major": 6,
        "len": 18
    },
    {
        "text": "CONCLUSIONS: These findings confirm that the [GENE]CRF(1) receptor[\\GENE] antagonist [CHEMICAL]SSR125543[\\CHEMICAL] is able to attenuate the behavioral effects of traumatic stress exposure and indicate that these effects are associated with a normalization of hippocampal neuronal excitability impaired by stress.",
        "label": 6,
        "major": 6,
        "len": 38
    },
    {
        "text": "[CHEMICAL]Aryl sulfonamide[\\CHEMICAL] antagonists bind to [GENE]CCR4[\\GENE] at an intracellular allosteric site denoted site II.",
        "label": 2,
        "major": 10,
        "len": 14
    },
    {
        "text": "A series of [CHEMICAL]indazole arylsulfonamides[\\CHEMICAL] were synthesized and examined as [GENE]human CCR4[\\GENE] antagonists.",
        "label": 6,
        "major": 6,
        "len": 13
    },
    {
        "text": "Synthesis and structure-activity relationships of [CHEMICAL]indazole arylsulfonamides[\\CHEMICAL] as allosteric CC-chemokine receptor 4 ([GENE]CCR4[\\GENE]) antagonists.",
        "label": 7,
        "major": 7,
        "len": 14
    },
    {
        "text": "Synthesis and structure-activity relationships of [CHEMICAL]indazole arylsulfonamides[\\CHEMICAL] as allosteric [GENE]CC-chemokine receptor 4[\\GENE] (CCR4) antagonists.",
        "label": 7,
        "major": 6,
        "len": 14
    },
    {
        "text": "Mice given daily injections of high dose JZL184 (\u226516 mg/kg) for six days displayed decreased [GENE]CB(1)[\\GENE] receptor density and function in brain, as assessed in [CHEMICAL][(3)H]SR141716A[\\CHEMICAL] binding and CP55,940-stimulated [(35)S]GTP\u03b3S binding assays, respectively.",
        "label": 2,
        "major": 4,
        "len": 33
    },
    {
        "text": "Mice given daily injections of high dose JZL184 (\u226516 mg/kg) for six days displayed decreased [GENE]CB(1)[\\GENE] receptor density and function in brain, as assessed in [(3)H]SR141716A binding and [CHEMICAL]CP55,940[\\CHEMICAL]-stimulated [(35)S]GTP\u03b3S binding assays, respectively.",
        "label": 2,
        "major": 3,
        "len": 33
    },
    {
        "text": "Mice given daily injections of high dose JZL184 (\u226516 mg/kg) for six days displayed decreased [GENE]CB(1)[\\GENE] receptor density and function in brain, as assessed in [(3)H]SR141716A binding and CP55,940-stimulated [[CHEMICAL](35)S[\\CHEMICAL]]GTP\u03b3S binding assays, respectively.",
        "label": 2,
        "major": 4,
        "len": 33
    },
    {
        "text": "In contrast, normal [GENE]CB(1)[\\GENE] receptor expression and function were maintained following repeated administration of low dose [CHEMICAL]JZL184[\\CHEMICAL] (\u22648 mg/kg).",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor [CHEMICAL]JZL184[\\CHEMICAL] Retains [GENE]CB1[\\GENE] Receptor Mediated Antinociceptive and Gastroprotective Effects.",
        "label": 2,
        "major": 4,
        "len": 18
    },
    {
        "text": "In contrast, normal [GENE]CB(1)[\\GENE] receptor expression and function were maintained following repeated administration of low dose [CHEMICAL]JZL184[\\CHEMICAL] (\u22648 mg/kg).",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "Mice given daily injections of high dose [CHEMICAL]JZL184[\\CHEMICAL] (\u226516 mg/kg) for six days displayed decreased [GENE]CB(1)[\\GENE] receptor density and function in brain, as assessed in [(3)H]SR141716A binding and CP55,940-stimulated [(35)S]GTP\u03b3S binding assays, respectively.",
        "label": 4,
        "major": 2,
        "len": 33
    },
    {
        "text": "The monoacylglycerol lipase ([GENE]MAGL[\\GENE]) inhibitor [CHEMICAL]JZL184[\\CHEMICAL] produces antinociceptive and anti-inflammatory effects.",
        "label": 4,
        "major": 4,
        "len": 11
    },
    {
        "text": "The [GENE]monoacylglycerol lipase[\\GENE] (MAGL) inhibitor [CHEMICAL]JZL184[\\CHEMICAL] produces antinociceptive and anti-inflammatory effects.",
        "label": 4,
        "major": 4,
        "len": 11
    },
    {
        "text": "Repeated Low Dose Administration of the [GENE]Monoacylglycerol Lipase[\\GENE] Inhibitor [CHEMICAL]JZL184[\\CHEMICAL] Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects.",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Bicyclic pyrazinone and pyrimidinone amides[\\CHEMICAL] were designed and synthesized as potent TF-[GENE]FVIIa[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "[CHEMICAL]Bicyclic pyrazinone and pyrimidinone amides[\\CHEMICAL] were designed and synthesized as potent [GENE]TF[\\GENE]-FVIIa inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Design and synthesis of [CHEMICAL]bicyclic pyrazinone and pyrimidinone amides[\\CHEMICAL] as potent [GENE]TF[\\GENE]-FVIIa inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Design and synthesis of [CHEMICAL]bicyclic pyrazinone and pyrimidinone amides[\\CHEMICAL] as potent TF-[GENE]FVIIa[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "While HIF-1\u03b1 in hypoxia translocates to the nucleus where it transcribes the target genes including vascular endothelial growth factor (VEGF) mRNA, [GENE]HIF-1\u03b1[\\GENE] is degraded under normoxia, which involves its [CHEMICAL]proline[\\CHEMICAL] hydroxylation and subsequent binding to the von Hippel-Lindau protein-Elongin B-Elogin C (VBC) complex.",
        "label": 1,
        "major": 2,
        "len": 43
    },
    {
        "text": "The most potent compound 5 ([CHEMICAL]HJC0123[\\CHEMICAL]) has demonstrated to inhibit STAT3 promoter activity, downregulate phosphorylation of STAT3, increase the expression of cleaved [GENE]caspase-3[\\GENE], inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values.",
        "label": 3,
        "major": 4,
        "len": 43
    },
    {
        "text": "The most potent compound 5 ([CHEMICAL]HJC0123[\\CHEMICAL]) has demonstrated to inhibit [GENE]STAT3 promoter[\\GENE] activity, downregulate phosphorylation of STAT3, increase the expression of cleaved caspase-3, inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values.",
        "label": 4,
        "major": 4,
        "len": 43
    },
    {
        "text": "The most potent compound 5 ([CHEMICAL]HJC0123[\\CHEMICAL]) has demonstrated to inhibit STAT3 promoter activity, downregulate phosphorylation of [GENE]STAT3[\\GENE], increase the expression of cleaved caspase-3, inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values.",
        "label": 4,
        "major": 4,
        "len": 43
    },
    {
        "text": "Fragment-based drug design and identification of [CHEMICAL]HJC0123[\\CHEMICAL], a novel orally bioavailable [GENE]STAT3[\\GENE] inhibitor for cancer therapy.",
        "label": 4,
        "major": 4,
        "len": 16
    },
    {
        "text": "To map supercoiling, we used [CHEMICAL]biotinylated trimethylpsoralen[\\CHEMICAL] as a DNA structure probe to show that the human genome is organized into [GENE]supercoiling domains[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "Therefore, we examined whether the [GENE]PDE5[\\GENE]-I [CHEMICAL]vardenafil[\\CHEMICAL] improves memory and executive functioning and affect electroencephalography (EEG) in healthy young adults.",
        "label": 4,
        "major": -1,
        "len": 20
    },
    {
        "text": "The effects of the [GENE]phosphodiesterase type 5[\\GENE] inhibitor [CHEMICAL]vardenafil[\\CHEMICAL] on cognitive performance in healthy adults: a behavioral- electroencephalography study.",
        "label": 4,
        "major": 4,
        "len": 19
    },
    {
        "text": "[GENE]Catalase[\\GENE], glutathione-S-transferase and xanthine oxidase activities were not altered by [CHEMICAL]atorvastatin[\\CHEMICAL] treatment or withdrawal, as well as protein carbonyl and 4-hydroxy-2-nonenal immunoreactivity.",
        "label": 10,
        "major": 10,
        "len": 22
    },
    {
        "text": "Catalase, [GENE]glutathione-S-transferase[\\GENE] and xanthine oxidase activities were not altered by [CHEMICAL]atorvastatin[\\CHEMICAL] treatment or withdrawal, as well as protein carbonyl and 4-hydroxy-2-nonenal immunoreactivity.",
        "label": 10,
        "major": 10,
        "len": 22
    },
    {
        "text": "Catalase, glutathione-S-transferase and [GENE]xanthine oxidase[\\GENE] activities were not altered by [CHEMICAL]atorvastatin[\\CHEMICAL] treatment or withdrawal, as well as protein carbonyl and 4-hydroxy-2-nonenal immunoreactivity.",
        "label": 10,
        "major": 10,
        "len": 22
    },
    {
        "text": "We found that atorvastatin withdrawal decreased levels of nitric oxide and mitochondrial superoxide dismutase activity, whereas increased [GENE]NADPH oxidase[\\GENE] activity and immunoreactivity for the protein nitration marker [CHEMICAL]3-nitrotyrosine[\\CHEMICAL] in the cerebral cortex.",
        "label": 3,
        "major": 4,
        "len": 32
    },
    {
        "text": "Statins are inhibitors of the enzyme [GENE]3-hydroxy-3-methylglutaryl coenzyme A reductase[\\GENE], the rate-limiting step in [CHEMICAL]cholesterol[\\CHEMICAL] biosynthesis.",
        "label": 9,
        "major": 4,
        "len": 16
    },
    {
        "text": "Hyperthyroidism-induced oxidative stress, reduction in [GENE]cytochrome c oxidase[\\GENE] activity, and myocardial ATP concentration were also significantly checked by [CHEMICAL]Bzf[\\CHEMICAL].",
        "label": 2,
        "major": 4,
        "len": 19
    },
    {
        "text": "for 15 days or along with a [GENE]peroxisome proliferator-activated receptor alpha[\\GENE] agonist [CHEMICAL]bezafibrate[\\CHEMICAL] (Bzf; 30\u200a\u03bcg/100\u200ag BW, oral) and were found to improve in the Bzf co-treated condition.",
        "label": 5,
        "major": 3,
        "len": 27
    },
    {
        "text": "for 15 days or along with a [GENE]peroxisome proliferator-activated receptor alpha[\\GENE] agonist bezafibrate ([CHEMICAL]Bzf[\\CHEMICAL]; 30\u200a\u03bcg/100\u200ag BW, oral) and were found to improve in the Bzf co-treated condition.",
        "label": 5,
        "major": 5,
        "len": 27
    },
    {
        "text": "The serum or [CHEMICAL]dexamethasone[\\CHEMICAL]-induced oscillation in the expression of [GENE]DRD3[\\GENE] in cells was abrogated by the downregulation or overexpression of REV-ERB\u03b1, suggesting that REV-ERB\u03b1 functions as a regulator of DRD3 oscillations in the cellular autonomous clock.",
        "label": 2,
        "major": 3,
        "len": 36
    },
    {
        "text": "The serum or [CHEMICAL]dexamethasone[\\CHEMICAL]-induced oscillation in the expression of DRD3 in cells was abrogated by the downregulation or overexpression of [GENE]REV-ERB\u03b1[\\GENE], suggesting that REV-ERB\u03b1 functions as a regulator of DRD3 oscillations in the cellular autonomous clock.",
        "label": 2,
        "major": 3,
        "len": 36
    },
    {
        "text": "Moreover, the effects of the [GENE]DRD3[\\GENE] agonist [CHEMICAL]7-hydroxy-N,N-dipropyl-2-aminotetralin[\\CHEMICAL] (7-OH-DPAT)-induced locomotor hypoactivity were significantly increased when DRD3 proteins were abundant.",
        "label": 5,
        "major": 3,
        "len": 19
    },
    {
        "text": "Moreover, the effects of the DRD3 agonist [CHEMICAL]7-hydroxy-N,N-dipropyl-2-aminotetralin[\\CHEMICAL] (7-OH-DPAT)-induced locomotor hypoactivity were significantly increased when [GENE]DRD3[\\GENE] proteins were abundant.",
        "label": 5,
        "major": 3,
        "len": 19
    },
    {
        "text": "Moreover, the effects of the [GENE]DRD3[\\GENE] agonist 7-hydroxy-N,N-dipropyl-2-aminotetralin ([CHEMICAL]7-OH-DPAT[\\CHEMICAL])-induced locomotor hypoactivity were significantly increased when DRD3 proteins were abundant.",
        "label": 5,
        "major": 3,
        "len": 19
    },
    {
        "text": "Moreover, the effects of the DRD3 agonist 7-hydroxy-N,N-dipropyl-2-aminotetralin ([CHEMICAL]7-OH-DPAT[\\CHEMICAL])-induced locomotor hypoactivity were significantly increased when [GENE]DRD3[\\GENE] proteins were abundant.",
        "label": 5,
        "major": 3,
        "len": 19
    },
    {
        "text": "Racemic IKM-159 was crystallized with the ligand-binding domain of [GENE]GluA2[\\GENE], and the structure revealed a complex containing [CHEMICAL](2R)-IKM-159[\\CHEMICAL] at the glutamate binding site.",
        "label": 2,
        "major": 2,
        "len": 23
    },
    {
        "text": "[CHEMICAL]Racemic IKM-159[\\CHEMICAL] was crystallized with the ligand-binding domain of [GENE]GluA2[\\GENE], and the structure revealed a complex containing (2R)-IKM-159 at the glutamate binding site.",
        "label": 2,
        "major": 2,
        "len": 23
    },
    {
        "text": "[CHEMICAL](2R)-IKM-159[\\CHEMICAL] locks the [GENE]GluA2[\\GENE] in an open form, consistent with a pharmacological action as competitive antagonist of AMPA receptors.",
        "label": 4,
        "major": 6,
        "len": 19
    },
    {
        "text": "[CHEMICAL](2R)-IKM-159[\\CHEMICAL] locks the GluA2 in an open form, consistent with a pharmacological action as competitive antagonist of [GENE]AMPA receptors[\\GENE].",
        "label": 6,
        "major": 6,
        "len": 19
    },
    {
        "text": "Studies on an (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid [GENE](AMPA) receptor[\\GENE] antagonist [CHEMICAL]IKM-159[\\CHEMICAL]: asymmetric synthesis, neuroactivity, and structural characterization.",
        "label": 6,
        "major": 6,
        "len": 15
    },
    {
        "text": "[CHEMICAL]IKM-159[\\CHEMICAL] was developed and identified as a member of a new class of heterotricyclic glutamate analogues that act as [GENE]AMPA receptor[\\GENE]-selective antagonists.",
        "label": 6,
        "major": 6,
        "len": 22
    },
    {
        "text": "IKM-159 was developed and identified as a member of a new class of heterotricyclic [CHEMICAL]glutamate[\\CHEMICAL] analogues that act as [GENE]AMPA receptor[\\GENE]-selective antagonists.",
        "label": 6,
        "major": 6,
        "len": 22
    },
    {
        "text": "In addition, benzo[c]phenanthrene, [CHEMICAL]fluoranthene[\\CHEMICAL], 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, benzo[c]phenanthrene, fluoranthene, [CHEMICAL]2,3-dihydroxy-2,3-dihydrofluoranthene[\\CHEMICAL], pyrene, 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, [CHEMICAL]pyrene[\\CHEMICAL], 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, [CHEMICAL]1-hydroxypyrene[\\CHEMICAL], 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, [CHEMICAL]1-nitropyrene[\\CHEMICAL], 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, 1-nitropyrene, [CHEMICAL]1-acetylpyrene[\\CHEMICAL], 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, [CHEMICAL]2-acetylpyrene[\\CHEMICAL], 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, [CHEMICAL]2,5,2',5'-tetrachlorobiphenyl[\\CHEMICAL], 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, [CHEMICAL]7-hydroxyflavone[\\CHEMICAL], chrysin, and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, [CHEMICAL]chrysin[\\CHEMICAL], and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and [CHEMICAL]galangin[\\CHEMICAL] were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "In addition, [CHEMICAL]benzo[c]phenanthrene[\\CHEMICAL], fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with [GENE]P450 2A13[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 28
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, [CHEMICAL]flavanone[\\CHEMICAL], chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 3,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by [CHEMICAL]2'-methoxy-5,7-dihydroxyflavone[\\CHEMICAL], 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 3,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, [CHEMICAL]2-ethynylnaphthalene[\\CHEMICAL], 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 3,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, [CHEMICAL]2'-methoxyflavone[\\CHEMICAL], 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, [CHEMICAL]2-naphththalene propargyl ether[\\CHEMICAL], acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, [CHEMICAL]acenaphthene[\\CHEMICAL], acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 3,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, [CHEMICAL]chrysin[\\CHEMICAL], 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 9,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, [CHEMICAL]acenaphthylene[\\CHEMICAL], naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 3,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, [CHEMICAL]naphthalene[\\CHEMICAL], 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, [CHEMICAL]1-acetylpyrene[\\CHEMICAL], flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 9,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, [CHEMICAL]3-ethynylphenanthrene[\\CHEMICAL], flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 9,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, [CHEMICAL]flavone[\\CHEMICAL], and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "Coumarin 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and [CHEMICAL]7-hydroxyflavone[\\CHEMICAL]; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 4,
        "major": 9,
        "len": 37
    },
    {
        "text": "[CHEMICAL]Coumarin[\\CHEMICAL] 7-hydroxylation, catalyzed by [GENE]P450 2A13[\\GENE], was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.",
        "label": 9,
        "major": 9,
        "len": 37
    },
    {
        "text": "Full agonists to the [GENE]peroxisome proliferator-activated receptor (PPAR)\u03b3[\\GENE], such as [CHEMICAL]Rosiglitazone[\\CHEMICAL], have been associated with a series of undesired side effects, such as weight gain, fluid retention, cardiac hypertrophy, and hepatotoxicity.",
        "label": 5,
        "major": 5,
        "len": 31
    },
    {
        "text": "In contrast, the [GENE]EL2[\\GENE] sequence showed well-defined structure only near its [CHEMICAL]C[\\CHEMICAL]-terminal residues.",
        "label": 1,
        "major": -1,
        "len": 13
    },
    {
        "text": "PURPOSE: [CHEMICAL]Omeprazole[\\CHEMICAL] has (R)- and (S)-enantiomers, which exhibit different pharmacokinetics (PK) among patients with [GENE]cytochrome P450 (CYP) 2C19[\\GENE] genotype groups.",
        "label": 9,
        "major": 10,
        "len": 20
    },
    {
        "text": "The [CHEMICAL](R)-omeprazole[\\CHEMICAL] hydroxylation index reflects [GENE]CYP2C19[\\GENE] activity in healthy Japanese volunteers.",
        "label": 9,
        "major": -1,
        "len": 11
    },
    {
        "text": "Additionally, there was a significant difference in plasma concentrations of [CHEMICAL](R)-5-hydroxyomeprazole[\\CHEMICAL] among [GENE]CYP2C19[\\GENE] genotype groups, whereas no significant differences were observed in that of (S)-5-hydroxyomeprazole.",
        "label": 9,
        "major": 10,
        "len": 25
    },
    {
        "text": "Additionally, there was a significant difference in plasma concentrations of (R)-5-hydroxyomeprazole among [GENE]CYP2C19[\\GENE] genotype groups, whereas no significant differences were observed in that of [CHEMICAL](S)-5-hydroxyomeprazole[\\CHEMICAL].",
        "label": 9,
        "major": 10,
        "len": 25
    },
    {
        "text": "CONCLUSION: Our findings demonstrate that [CHEMICAL](R)-omeprazole[\\CHEMICAL] HI correlated better with [GENE]CYP2C19[\\GENE] genotype groups than racemic-omeprazole HI, and these results may be useful for classification among patients in CYP2C19 genotype groups prior to omeprazole treatment.",
        "label": 9,
        "major": 10,
        "len": 34
    },
    {
        "text": "CONCLUSION: Our findings demonstrate that (R)-omeprazole HI correlated better with [GENE]CYP2C19[\\GENE] genotype groups than [CHEMICAL]racemic-omeprazole[\\CHEMICAL] HI, and these results may be useful for classification among patients in CYP2C19 genotype groups prior to omeprazole treatment.",
        "label": 9,
        "major": 10,
        "len": 34
    },
    {
        "text": "Neither [CHEMICAL]oxycodone[\\CHEMICAL] nor its metabolites activated [GENE]PXR[\\GENE], CAR, or AhR.",
        "label": 10,
        "major": 3,
        "len": 10
    },
    {
        "text": "Neither [CHEMICAL]oxycodone[\\CHEMICAL] nor its metabolites activated PXR, [GENE]CAR[\\GENE], or AhR.",
        "label": 10,
        "major": 3,
        "len": 10
    },
    {
        "text": "Neither [CHEMICAL]oxycodone[\\CHEMICAL] nor its metabolites activated PXR, CAR, or [GENE]AhR[\\GENE].",
        "label": 10,
        "major": 3,
        "len": 10
    },
    {
        "text": "Taken together, these findings identify a signature hepatic gene-network associated with repeated oxycodone administration in rats and demonstrate that [CHEMICAL]oxycodone[\\CHEMICAL] alters the expression of many transporters and DMEs (without direct activation of [GENE]PXR[\\GENE], CAR, and AhR), which could lead to undesirable DDIs after coadministration of substrates of these transporters/DMEs with oxycodone.",
        "label": 2,
        "major": 9,
        "len": 51
    },
    {
        "text": "Taken together, these findings identify a signature hepatic gene-network associated with repeated oxycodone administration in rats and demonstrate that [CHEMICAL]oxycodone[\\CHEMICAL] alters the expression of many transporters and DMEs (without direct activation of PXR, [GENE]CAR[\\GENE], and AhR), which could lead to undesirable DDIs after coadministration of substrates of these transporters/DMEs with oxycodone.",
        "label": 2,
        "major": 9,
        "len": 51
    },
    {
        "text": "Taken together, these findings identify a signature hepatic gene-network associated with repeated oxycodone administration in rats and demonstrate that [CHEMICAL]oxycodone[\\CHEMICAL] alters the expression of many transporters and DMEs (without direct activation of PXR, CAR, and [GENE]AhR[\\GENE]), which could lead to undesirable DDIs after coadministration of substrates of these transporters/DMEs with oxycodone.",
        "label": 2,
        "major": 9,
        "len": 51
    },
    {
        "text": "Induction of [GENE]xenobiotic receptors[\\GENE], transporters, and drug metabolizing enzymes by [CHEMICAL]oxycodone[\\CHEMICAL].",
        "label": 2,
        "major": 3,
        "len": 11
    },
    {
        "text": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, [CHEMICAL]all-trans retinoic acid[\\CHEMICAL] (atRA), which regulates the expression of a battery of target genes through several families of [GENE]nuclear receptors[\\GENE] (RARs, RXRs and PPAR\u03b2/\u03b4), polymorphic retinoic acid (RA) response elements and multiple coregulators.",
        "label": 3,
        "major": -1,
        "len": 46
    },
    {
        "text": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, [CHEMICAL]all-trans retinoic acid[\\CHEMICAL] (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors ([GENE]RARs[\\GENE], RXRs and PPAR\u03b2/\u03b4), polymorphic retinoic acid (RA) response elements and multiple coregulators.",
        "label": 3,
        "major": -1,
        "len": 46
    },
    {
        "text": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, [CHEMICAL]all-trans retinoic acid[\\CHEMICAL] (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, [GENE]RXRs[\\GENE] and PPAR\u03b2/\u03b4), polymorphic retinoic acid (RA) response elements and multiple coregulators.",
        "label": 3,
        "major": -1,
        "len": 46
    },
    {
        "text": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, [CHEMICAL]all-trans retinoic acid[\\CHEMICAL] (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPAR\u03b2/\u03b4), [GENE]polymorphic retinoic acid (RA) response elements[\\GENE] and multiple coregulators.",
        "label": 3,
        "major": -1,
        "len": 46
    },
    {
        "text": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid ([CHEMICAL]atRA[\\CHEMICAL]), which regulates the expression of a battery of target genes through several families of [GENE]nuclear receptors[\\GENE] (RARs, RXRs and PPAR\u03b2/\u03b4), polymorphic retinoic acid (RA) response elements and multiple coregulators.",
        "label": 3,
        "major": -1,
        "len": 46
    },
    {
        "text": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid ([CHEMICAL]atRA[\\CHEMICAL]), which regulates the expression of a battery of target genes through several families of nuclear receptors ([GENE]RARs[\\GENE], RXRs and PPAR\u03b2/\u03b4), polymorphic retinoic acid (RA) response elements and multiple coregulators.",
        "label": 3,
        "major": -1,
        "len": 46
    },
    {
        "text": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid ([CHEMICAL]atRA[\\CHEMICAL]), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, [GENE]RXRs[\\GENE] and PPAR\u03b2/\u03b4), polymorphic retinoic acid (RA) response elements and multiple coregulators.",
        "label": 3,
        "major": -1,
        "len": 46
    },
    {
        "text": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid ([CHEMICAL]atRA[\\CHEMICAL]), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPAR\u03b2/\u03b4), [GENE]polymorphic retinoic acid (RA) response elements[\\GENE] and multiple coregulators.",
        "label": 3,
        "major": -1,
        "len": 46
    },
    {
        "text": "Interestingly, [GENE]miR-21[\\GENE] expression positively correlated with urine albumin [CHEMICAL]creatine[\\CHEMICAL] ratio (ACR), TIMP1, collagen IV (ColIV), and fibronectin (FN); while negatively correlated with creatine clearance ratio (Ccr) and MMP-9 protein.",
        "label": 3,
        "major": -1,
        "len": 29
    },
    {
        "text": "Interestingly, [GENE]miR-21[\\GENE] expression positively correlated with urine albumin creatine ratio (ACR), TIMP1, collagen IV (ColIV), and fibronectin (FN); while negatively correlated with [CHEMICAL]creatine[\\CHEMICAL] clearance ratio (Ccr) and MMP-9 protein.",
        "label": 4,
        "major": -1,
        "len": 29
    },
    {
        "text": "Thus, the formation of [CHEMICAL]disulfide[\\CHEMICAL] bonds in [GENE]hSULT2A1[\\GENE] is a potentially important reversible mechanism for alterations in the rates of sulfation of both endogenous and xenobiotic substrates.",
        "label": 1,
        "major": 9,
        "len": 27
    },
    {
        "text": "Modification of the Catalytic Function of [GENE]Human Hydroxysteroid Sulfotransferase hSULT2A1[\\GENE] by Formation of [CHEMICAL]Disulfide[\\CHEMICAL] Bonds.",
        "label": 1,
        "major": -1,
        "len": 15
    },
    {
        "text": "Studies on the kinetics of the [GENE]hSULT2A1[\\GENE]-catalyzed sulfation of [CHEMICAL]dehydroepiandrosterone[\\CHEMICAL] (DHEA) showed the effects of disulfide bond formation on the substrate inhibition characteristics of the enzyme.",
        "label": 9,
        "major": 9,
        "len": 26
    },
    {
        "text": "Studies on the kinetics of the [GENE]hSULT2A1[\\GENE]-catalyzed sulfation of dehydroepiandrosterone ([CHEMICAL]DHEA[\\CHEMICAL]) showed the effects of disulfide bond formation on the substrate inhibition characteristics of the enzyme.",
        "label": 9,
        "major": 9,
        "len": 26
    },
    {
        "text": "The [GENE]human cytosolic sulfotransferase hSULT2A1[\\GENE] catalyzes the sulfation of a broad range of xenobiotics, as well as endogenous [CHEMICAL]hydroxysteroids[\\CHEMICAL] and bile acids.",
        "label": 9,
        "major": 9,
        "len": 22
    },
    {
        "text": "The [GENE]human cytosolic sulfotransferase hSULT2A1[\\GENE] catalyzes the sulfation of a broad range of xenobiotics, as well as endogenous hydroxysteroids and [CHEMICAL]bile acids[\\CHEMICAL].",
        "label": 9,
        "major": 9,
        "len": 22
    },
    {
        "text": "These results provide an example that attachment of a bulky side chain to the C-7\u03b1 position of E2 can produce ER antagonists with [GENE]ER[\\GENE] affinity comparable to that of [CHEMICAL]ICI-182,780[\\CHEMICAL].",
        "label": 2,
        "major": 9,
        "len": 30
    },
    {
        "text": "Computational docking analysis was conducted to model the interaction of these antagonists with the human ER\u03b1 and showed that they could tightly bind to the ER\u03b1 in a manner similar to that of [CHEMICAL]ICI-182,780[\\CHEMICAL], a pure [GENE]ER[\\GENE] antagonist.",
        "label": 6,
        "major": 2,
        "len": 38
    },
    {
        "text": "These results provide an example that attachment of a bulky side chain to the C-7\u03b1 position of E2 can produce ER antagonists with [GENE]ER[\\GENE] affinity comparable to that of [CHEMICAL]ICI-182,780[\\CHEMICAL].",
        "label": 6,
        "major": 9,
        "len": 30
    },
    {
        "text": "[CHEMICAL]7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole[\\CHEMICAL] 11 (TASP0382088) was synthesized and evaluated as transforming growth factor-\u03b2 (TGF-\u03b2) type I receptor (also known as [GENE]activin receptor-like kinase 5[\\GENE] or ALK5) inhibitor.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "[CHEMICAL]7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole[\\CHEMICAL] 11 (TASP0382088) was synthesized and evaluated as transforming growth factor-\u03b2 (TGF-\u03b2) type I receptor (also known as activin receptor-like kinase 5 or [GENE]ALK5[\\GENE]) inhibitor.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "[CHEMICAL]7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole[\\CHEMICAL] 11 (TASP0382088) was synthesized and evaluated as [GENE]transforming growth factor-\u03b2 (TGF-\u03b2) type I receptor[\\GENE] (also known as activin receptor-like kinase 5 or ALK5) inhibitor.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole 11 ([CHEMICAL]TASP0382088[\\CHEMICAL]) was synthesized and evaluated as transforming growth factor-\u03b2 (TGF-\u03b2) type I receptor (also known as [GENE]activin receptor-like kinase 5[\\GENE] or ALK5) inhibitor.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole 11 ([CHEMICAL]TASP0382088[\\CHEMICAL]) was synthesized and evaluated as transforming growth factor-\u03b2 (TGF-\u03b2) type I receptor (also known as activin receptor-like kinase 5 or [GENE]ALK5[\\GENE]) inhibitor.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole 11 ([CHEMICAL]TASP0382088[\\CHEMICAL]) was synthesized and evaluated as [GENE]transforming growth factor-\u03b2 (TGF-\u03b2) type I receptor[\\GENE] (also known as activin receptor-like kinase 5 or ALK5) inhibitor.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "Discovery of [CHEMICAL]7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole[\\CHEMICAL] (TASP0382088): a potent and selective [GENE]transforming growth factor-\u03b2 type I receptor[\\GENE] inhibitor as a topical drug for alopecia.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "Discovery of 7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole ([CHEMICAL]TASP0382088[\\CHEMICAL]): a potent and selective [GENE]transforming growth factor-\u03b2 type I receptor[\\GENE] inhibitor as a topical drug for alopecia.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "Here, we provide evidence that p14ARF physically interacts with AR and functions as an [GENE]AR[\\GENE] corespressor in both an androgen-dependent and [CHEMICAL]androgen[\\CHEMICAL]-independent manner.",
        "label": 10,
        "major": 2,
        "len": 23
    },
    {
        "text": "Furthermore, we demonstrated that p14ARF binds to both the [CHEMICAL]N[\\CHEMICAL]-terminal domain and the ligand-binding domain of [GENE]AR[\\GENE], and the human double minute 2 (HDM2)-binding motif of p14ARF is required for the interaction of p14ARF and AR proteins.",
        "label": 1,
        "major": 2,
        "len": 37
    },
    {
        "text": "p14ARF perturbs the androgen-induced interaction between the [CHEMICAL]N[\\CHEMICAL] terminus and C terminus of [GENE]AR[\\GENE].",
        "label": 1,
        "major": 3,
        "len": 14
    },
    {
        "text": "p14ARF perturbs the androgen-induced interaction between the N terminus and [CHEMICAL]C[\\CHEMICAL] terminus of [GENE]AR[\\GENE].",
        "label": 1,
        "major": 2,
        "len": 14
    },
    {
        "text": "p14ARF perturbs the [CHEMICAL]androgen[\\CHEMICAL]-induced interaction between the N terminus and C terminus of [GENE]AR[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 14
    },
    {
        "text": "Here, we provide evidence that p14ARF physically interacts with AR and functions as an [GENE]AR[\\GENE] corespressor in both an [CHEMICAL]androgen[\\CHEMICAL]-dependent and androgen-independent manner.",
        "label": 2,
        "major": 2,
        "len": 23
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers ([GENE]IL-1\u03b2[\\GENE], IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by [CHEMICAL]7-ketosterols[\\CHEMICAL] (stigmasterol/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, [GENE]IL-8[\\GENE], IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by [CHEMICAL]7-ketosterols[\\CHEMICAL] (stigmasterol/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, [GENE]IL-10[\\GENE], TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by [CHEMICAL]7-ketosterols[\\CHEMICAL] (stigmasterol/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, [GENE]TNF\u03b1[\\GENE]) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by [CHEMICAL]7-ketosterols[\\CHEMICAL] (stigmasterol/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism ([GENE]NPC1L1[\\GENE], ABCG5/8, HMGCoA, ACAT) produced by [CHEMICAL]7-ketosterols[\\CHEMICAL] (stigmasterol/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, [GENE]ABCG5/8[\\GENE], HMGCoA, ACAT) produced by [CHEMICAL]7-ketosterols[\\CHEMICAL] (stigmasterol/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, [GENE]HMGCoA[\\GENE], ACAT) produced by [CHEMICAL]7-ketosterols[\\CHEMICAL] (stigmasterol/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, [GENE]ACAT[\\GENE]) produced by [CHEMICAL]7-ketosterols[\\CHEMICAL] (stigmasterol/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers ([GENE]IL-1\u03b2[\\GENE], IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by 7-ketosterols ([CHEMICAL]stigmasterol[\\CHEMICAL]/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, [GENE]IL-8[\\GENE], IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by 7-ketosterols ([CHEMICAL]stigmasterol[\\CHEMICAL]/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, [GENE]IL-10[\\GENE], TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by 7-ketosterols ([CHEMICAL]stigmasterol[\\CHEMICAL]/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, [GENE]TNF\u03b1[\\GENE]) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by 7-ketosterols ([CHEMICAL]stigmasterol[\\CHEMICAL]/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism ([GENE]NPC1L1[\\GENE], ABCG5/8, HMGCoA, ACAT) produced by 7-ketosterols ([CHEMICAL]stigmasterol[\\CHEMICAL]/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, [GENE]ABCG5/8[\\GENE], HMGCoA, ACAT) produced by 7-ketosterols ([CHEMICAL]stigmasterol[\\CHEMICAL]/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, [GENE]HMGCoA[\\GENE], ACAT) produced by 7-ketosterols ([CHEMICAL]stigmasterol[\\CHEMICAL]/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, [GENE]ACAT[\\GENE]) produced by 7-ketosterols ([CHEMICAL]stigmasterol[\\CHEMICAL]/cholesterol) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers ([GENE]IL-1\u03b2[\\GENE], IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by 7-ketosterols (stigmasterol/[CHEMICAL]cholesterol[\\CHEMICAL]) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, [GENE]IL-8[\\GENE], IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by 7-ketosterols (stigmasterol/[CHEMICAL]cholesterol[\\CHEMICAL]) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, [GENE]IL-10[\\GENE], TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by 7-ketosterols (stigmasterol/[CHEMICAL]cholesterol[\\CHEMICAL]) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, [GENE]TNF\u03b1[\\GENE]) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, ACAT) produced by 7-ketosterols (stigmasterol/[CHEMICAL]cholesterol[\\CHEMICAL]) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism ([GENE]NPC1L1[\\GENE], ABCG5/8, HMGCoA, ACAT) produced by 7-ketosterols (stigmasterol/[CHEMICAL]cholesterol[\\CHEMICAL]) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, [GENE]ABCG5/8[\\GENE], HMGCoA, ACAT) produced by 7-ketosterols (stigmasterol/[CHEMICAL]cholesterol[\\CHEMICAL]) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, [GENE]HMGCoA[\\GENE], ACAT) produced by 7-ketosterols (stigmasterol/[CHEMICAL]cholesterol[\\CHEMICAL]) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "This study evaluates the production of inflammatory biomarkers (IL-1\u03b2, IL-8, IL-10, TNF\u03b1) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism (NPC1L1, ABCG5/8, HMGCoA, [GENE]ACAT[\\GENE]) produced by 7-ketosterols (stigmasterol/[CHEMICAL]cholesterol[\\CHEMICAL]) in Caco-2 cells.",
        "label": 2,
        "major": 9,
        "len": 38
    },
    {
        "text": "In non-pre-treated cells, only efflux transporters were down-regulated by [CHEMICAL]7-ketosterols[\\CHEMICAL], showing a greater influence upon [GENE]ABCG5[\\GENE] expression.",
        "label": 2,
        "major": 4,
        "len": 17
    },
    {
        "text": "Cell-pre-incubation with [GENE]bradykinin[\\GENE] induced changes in ABCG expression levels after [CHEMICAL]7-ketostigmasterol[\\CHEMICAL]-incubation; however, the energetic metabolism inhibition reduced NPC1L1 expression only in 7-ketocholesterol-incubated cells.",
        "label": 2,
        "major": 4,
        "len": 23
    },
    {
        "text": "Cell-pre-incubation with bradykinin induced changes in [GENE]ABCG[\\GENE] expression levels after [CHEMICAL]7-ketostigmasterol[\\CHEMICAL]-incubation; however, the energetic metabolism inhibition reduced NPC1L1 expression only in 7-ketocholesterol-incubated cells.",
        "label": 2,
        "major": 4,
        "len": 23
    },
    {
        "text": "Relative expression of c[GENE]holesterol transport-related proteins[\\GENE] and inflammation markers through the induction of [CHEMICAL]7-ketosterol[\\CHEMICAL]-mediated stress in Caco-2 cells.",
        "label": 2,
        "major": 3,
        "len": 18
    },
    {
        "text": "These results suggest that internalization and excretion of 7-ketostigmasterol is probably influenced by [[CHEMICAL]Ca[\\CHEMICAL]]i, which also could mediate [GENE]HMGCoA[\\GENE] activity in POPs metabolism.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "In non-pre-treated cells, [GENE]HMG-CoA[\\GENE] was up-regulated by both [CHEMICAL]7-ketosterols[\\CHEMICAL].",
        "label": 3,
        "major": -1,
        "len": 9
    },
    {
        "text": "In non-pre-treated cells, only [GENE]efflux transporters[\\GENE] were down-regulated by [CHEMICAL]7-ketosterols[\\CHEMICAL], showing a greater influence upon ABCG5 expression.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "Cell-pre-incubation with bradykinin induced changes in ABCG expression levels after 7-ketostigmasterol-incubation; however, the energetic metabolism inhibition reduced [GENE]NPC1L1[\\GENE] expression only in [CHEMICAL]7-ketocholesterol[\\CHEMICAL]-incubated cells.",
        "label": 4,
        "major": 4,
        "len": 23
    },
    {
        "text": "In lymphocytes, the NTPDase and [GENE]ADA[\\GENE] activities were increased in all groups treated with [CHEMICAL]caffeic acid[\\CHEMICAL] when compared to control (P<0.05).",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "In lymphocytes, the [GENE]NTPDase[\\GENE] and ADA activities were increased in all groups treated with [CHEMICAL]caffeic acid[\\CHEMICAL] when compared to control (P<0.05).",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "We demonstrate that activation of [GENE]STAT3[\\GENE] [CHEMICAL]serine[\\CHEMICAL]-727 and tyrosine-705 phosphorylations is promoted by B-RAF(V600E) activity and that the Mcl-1 promoter is dependent on a STAT consensus-site for B-RAF-mediated activation.",
        "label": 1,
        "major": 3,
        "len": 29
    },
    {
        "text": "We demonstrate that activation of [GENE]STAT3[\\GENE] serine-727 and [CHEMICAL]tyrosine[\\CHEMICAL]-705 phosphorylations is promoted by B-RAF(V600E) activity and that the Mcl-1 promoter is dependent on a STAT consensus-site for B-RAF-mediated activation.",
        "label": 1,
        "major": 3,
        "len": 29
    },
    {
        "text": "When mice were treated ip with the major neonicotinoid [CHEMICAL]imidacloprid[\\CHEMICAL] (IMI), metabolism by [GENE]CYP[\\GENE] oxidation reactions was not appreciably affected, whereas the AOX-generated nitrosoguanidine metabolite was decreased by 30% with tungsten and 56% with hydralazine and 86% in the AOX-deficient mice.",
        "label": 10,
        "major": 4,
        "len": 41
    },
    {
        "text": "When mice were treated ip with the major neonicotinoid imidacloprid ([CHEMICAL]IMI[\\CHEMICAL]), metabolism by [GENE]CYP[\\GENE] oxidation reactions was not appreciably affected, whereas the AOX-generated nitrosoguanidine metabolite was decreased by 30% with tungsten and 56% with hydralazine and 86% in the AOX-deficient mice.",
        "label": 10,
        "major": 4,
        "len": 41
    },
    {
        "text": "The procedure was to reduce liver [GENE]AOX[\\GENE] activity by providing [CHEMICAL]tungsten[\\CHEMICAL] or hydralazine in the drinking water or to use the AOX-deficient DBA/2 mouse strain.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "The procedure was to reduce liver [GENE]AOX[\\GENE] activity by providing tungsten or [CHEMICAL]hydralazine[\\CHEMICAL] in the drinking water or to use the AOX-deficient DBA/2 mouse strain.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "Liver [GENE]AOX[\\GENE] activity was reduced by 45% with [CHEMICAL]tungsten[\\CHEMICAL] and 61% with hydralazine and 81% in AOX-deficient mice relative to controls.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "Liver [GENE]AOX[\\GENE] activity was reduced by 45% with tungsten and 61% with [CHEMICAL]hydralazine[\\CHEMICAL] and 81% in AOX-deficient mice relative to controls.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "When mice were treated ip with the major neonicotinoid imidacloprid (IMI), metabolism by CYP oxidation reactions was not appreciably affected, whereas the [GENE]AOX[\\GENE]-generated nitrosoguanidine metabolite was decreased by 30% with [CHEMICAL]tungsten[\\CHEMICAL] and 56% with hydralazine and 86% in the AOX-deficient mice.",
        "label": 4,
        "major": 10,
        "len": 41
    },
    {
        "text": "When mice were treated ip with the major neonicotinoid imidacloprid (IMI), metabolism by CYP oxidation reactions was not appreciably affected, whereas the [GENE]AOX[\\GENE]-generated nitrosoguanidine metabolite was decreased by 30% with tungsten and 56% with [CHEMICAL]hydralazine[\\CHEMICAL] and 86% in the AOX-deficient mice.",
        "label": 4,
        "major": 10,
        "len": 41
    },
    {
        "text": "When mice were treated ip with the major neonicotinoid imidacloprid (IMI), metabolism by CYP oxidation reactions was not appreciably affected, whereas the [GENE]AOX[\\GENE]-generated [CHEMICAL]nitrosoguanidine[\\CHEMICAL] metabolite was decreased by 30% with tungsten and 56% with hydralazine and 86% in the AOX-deficient mice.",
        "label": 9,
        "major": 10,
        "len": 41
    },
    {
        "text": "Possible [GENE]AOX[\\GENE] involvement in [CHEMICAL]IMI[\\CHEMICAL] metabolism in insects was evaluated using AOX-expressing and AOX-deficient Drosophila, but no differences were found in IMI nitroreduction or sensitivity between the two strains.",
        "label": 9,
        "major": 4,
        "len": 29
    },
    {
        "text": "Possible AOX involvement in [CHEMICAL]IMI[\\CHEMICAL] metabolism in insects was evaluated using [GENE]AOX[\\GENE]-expressing and AOX-deficient Drosophila, but no differences were found in IMI nitroreduction or sensitivity between the two strains.",
        "label": 9,
        "major": 4,
        "len": 29
    },
    {
        "text": "This is the first study to establish the in vivo relevance of [GENE]AOX[\\GENE] in [CHEMICAL]neonicotinoid[\\CHEMICAL] metabolism in mammals and one of the first for xenobiotics in general.",
        "label": 9,
        "major": -1,
        "len": 27
    },
    {
        "text": "Currently, the most important insecticides are [CHEMICAL]neonicotinoids[\\CHEMICAL], which are metabolized in vitro by [GENE]AOX[\\GENE] on reduction of the nitroimino group and by CYPs via oxidation reactions.",
        "label": 9,
        "major": 4,
        "len": 26
    },
    {
        "text": "Currently, the most important insecticides are [CHEMICAL]neonicotinoids[\\CHEMICAL], which are metabolized in vitro by AOX on reduction of the nitroimino group and by [GENE]CYPs[\\GENE] via oxidation reactions.",
        "label": 9,
        "major": 4,
        "len": 26
    },
    {
        "text": "Currently, the most important insecticides are neonicotinoids, which are metabolized in vitro by [GENE]AOX[\\GENE] on reduction of the [CHEMICAL]nitroimino[\\CHEMICAL] group and by CYPs via oxidation reactions.",
        "label": 9,
        "major": 4,
        "len": 26
    },
    {
        "text": "Thus, decreasing liver [GENE]AOX[\\GENE] activity by three quite different procedures gave a corresponding decrease for in vivo reductive metabolites in the liver of [CHEMICAL]IMI[\\CHEMICAL]-treated mice.",
        "label": 9,
        "major": 4,
        "len": 25
    },
    {
        "text": "Recommended management may include use of [GENE]acetylcholinesterase[\\GENE] inhibitors (e.g. [CHEMICAL]neostigmine[\\CHEMICAL]) and wound care on a case-by-case basis.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "Of the compounds active in the present assay system, the most potent compound 7, [CHEMICAL]platyphyllonol-5-O-\u03b2-d-xylopyranoside[\\CHEMICAL], significantly suppressed the induction of peroxisome proliferator activated receptor \u03b3 (PPAR\u03b3 and [GENE]CCAAT/enhancer binding protein \u03b1[\\GENE] (C/EBP\u03b1) protein expression, and inhibited adipocyte differentiation induced by troglitazone, a PPAR\u03b3 agonist.",
        "label": 4,
        "major": 3,
        "len": 44
    },
    {
        "text": "Of the compounds active in the present assay system, the most potent compound 7, [CHEMICAL]platyphyllonol-5-O-\u03b2-d-xylopyranoside[\\CHEMICAL], significantly suppressed the induction of peroxisome proliferator activated receptor \u03b3 (PPAR\u03b3 and CCAAT/enhancer binding protein \u03b1 ([GENE]C/EBP\u03b1[\\GENE]) protein expression, and inhibited adipocyte differentiation induced by troglitazone, a PPAR\u03b3 agonist.",
        "label": 4,
        "major": 3,
        "len": 44
    },
    {
        "text": "Of the compounds active in the present assay system, the most potent compound 7, [CHEMICAL]platyphyllonol-5-O-\u03b2-d-xylopyranoside[\\CHEMICAL], significantly suppressed the induction of [GENE]peroxisome proliferator activated receptor \u03b3[\\GENE] (PPAR\u03b3 and CCAAT/enhancer binding protein \u03b1 (C/EBP\u03b1) protein expression, and inhibited adipocyte differentiation induced by troglitazone, a PPAR\u03b3 agonist.",
        "label": 4,
        "major": 3,
        "len": 44
    },
    {
        "text": "Of the compounds active in the present assay system, the most potent compound 7, [CHEMICAL]platyphyllonol-5-O-\u03b2-d-xylopyranoside[\\CHEMICAL], significantly suppressed the induction of peroxisome proliferator activated receptor \u03b3 ([GENE]PPAR\u03b3[\\GENE] and CCAAT/enhancer binding protein \u03b1 (C/EBP\u03b1) protein expression, and inhibited adipocyte differentiation induced by troglitazone, a PPAR\u03b3 agonist.",
        "label": 4,
        "major": 3,
        "len": 44
    },
    {
        "text": "Of the compounds active in the present assay system, the most potent compound 7, platyphyllonol-5-O-\u03b2-d-xylopyranoside, significantly suppressed the induction of peroxisome proliferator activated receptor \u03b3 (PPAR\u03b3 and CCAAT/enhancer binding protein \u03b1 (C/EBP\u03b1) protein expression, and inhibited adipocyte differentiation induced by [CHEMICAL]troglitazone[\\CHEMICAL], a [GENE]PPAR\u03b3[\\GENE] agonist.",
        "label": 5,
        "major": 3,
        "len": 44
    },
    {
        "text": "Based on our previously published work on CXCR4 antagonists, we have synthesized a series of [CHEMICAL]aryl sulfonamides[\\CHEMICAL] that inhibit the [GENE]CXCR4[\\GENE]/CXCL12 interaction.",
        "label": 4,
        "major": 6,
        "len": 22
    },
    {
        "text": "Based on our previously published work on CXCR4 antagonists, we have synthesized a series of [CHEMICAL]aryl sulfonamides[\\CHEMICAL] that inhibit the CXCR4/[GENE]CXCL12[\\GENE] interaction.",
        "label": 4,
        "major": 2,
        "len": 22
    },
    {
        "text": "These data demonstrate that [CHEMICAL]benzenesulfonamides[\\CHEMICAL] are a unique class of [GENE]CXCR4[\\GENE] inhibitors with high potency.",
        "label": 4,
        "major": 4,
        "len": 15
    },
    {
        "text": "[CHEMICAL]Benzenesulfonamides[\\CHEMICAL]: a unique class of [GENE]chemokine receptor type 4[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 10
    },
    {
        "text": "Measurement of Transport Activities of [CHEMICAL]3\u03b2-Hydroxy-\u0394(5)-bile Acids[\\CHEMICAL] in [GENE]Bile Salt Export Pump[\\GENE] and Multidrug Resistance-Associated Proteins Using LC-MS/MS.",
        "label": 9,
        "major": 9,
        "len": 18
    },
    {
        "text": "Measurement of Transport Activities of [CHEMICAL]3\u03b2-Hydroxy-\u0394(5)-bile Acids[\\CHEMICAL] in Bile Salt Export Pump and [GENE]Multidrug Resistance-Associated Proteins[\\GENE] Using LC-MS/MS.",
        "label": 9,
        "major": 9,
        "len": 18
    },
    {
        "text": "The analytical method was applied to measurements of transport activities in membrane vesicles obtained from human multidrug resistance-associated protein 2-, 3-, and [GENE]human bile salt export pump[\\GENE]-expressing Sf9 cells for conjugated [CHEMICAL]3\u03b2-hydroxy-\u0394(5)-bile acids[\\CHEMICAL].",
        "label": 9,
        "major": 9,
        "len": 33
    },
    {
        "text": "The present study demonstrated that [GENE]human multidrug resistance-associated protein 3[\\GENE] vesicles accepted conjugated [CHEMICAL]3\u03b2-hydroxy-\u0394(5)-bile acids[\\CHEMICAL] along with common bile acids such as glycocholic acid and taurolithocholic acid 3-sulfate.",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "The present study demonstrated that [GENE]human multidrug resistance-associated protein 3[\\GENE] vesicles accepted conjugated 3\u03b2-hydroxy-\u0394(5)-bile acids along with common [CHEMICAL]bile acids[\\CHEMICAL] such as glycocholic acid and taurolithocholic acid 3-sulfate.",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "The present study demonstrated that [GENE]human multidrug resistance-associated protein 3[\\GENE] vesicles accepted conjugated 3\u03b2-hydroxy-\u0394(5)-bile acids along with common bile acids such as [CHEMICAL]glycocholic acid[\\CHEMICAL] and taurolithocholic acid 3-sulfate.",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "The present study demonstrated that [GENE]human multidrug resistance-associated protein 3[\\GENE] vesicles accepted conjugated 3\u03b2-hydroxy-\u0394(5)-bile acids along with common bile acids such as glycocholic acid and [CHEMICAL]taurolithocholic acid 3-sulfate[\\CHEMICAL].",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "Here, we report that a specific 29-[CHEMICAL]amino acid[\\CHEMICAL] peptide derived from the intracellular domain fragment of [GENE]p75(NTR)[\\GENE] interacts with and potentiates binding of NGF to TrkA-expressing cells, leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced Erk1/2 and Akt signaling.",
        "label": 1,
        "major": 2,
        "len": 44
    },
    {
        "text": "An endogenous intracellular domain fragment of [GENE]p75(NTR)[\\GENE] (p75(ICD)) containing these 29 [CHEMICAL]amino acids[\\CHEMICAL] is produced by regulated proteolysis of the full-length receptor.",
        "label": 1,
        "major": 1,
        "len": 22
    },
    {
        "text": "An endogenous intracellular domain fragment of p75(NTR) ([GENE]p75(ICD)[\\GENE]) containing these 29 [CHEMICAL]amino acids[\\CHEMICAL] is produced by regulated proteolysis of the full-length receptor.",
        "label": 1,
        "major": 1,
        "len": 22
    },
    {
        "text": "A series of substituted [CHEMICAL]3-(benzylthio)-5-(1H-indol-3-yl)-4H-1,2,4-triazol-4-amines[\\CHEMICAL] has been synthesised and tested in vitro as potential pro-apoptotic [GENE]Bcl-2[\\GENE]-inhibitory anticancer agents.",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "Active compounds, such as the [CHEMICAL]nitrobenzyl[\\CHEMICAL] analogue 6c, were found to exhibit sub-micromolar IC50 values in [GENE]Bcl-2[\\GENE] expressing human cancer cell lines.",
        "label": 4,
        "major": -1,
        "len": 22
    },
    {
        "text": "Synthesis and evaluation of [CHEMICAL]3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines[\\CHEMICAL] as [GENE]Bcl-2[\\GENE] inhibitory anticancer agents.",
        "label": 4,
        "major": 4,
        "len": 10
    },
    {
        "text": "[GENE]Glutathione-S-transferase[\\GENE], a phase II enzyme, was inhibited by both arsenic and nicotine but no such inhibition was noted in arsenic-treated animals pre-exposed to [CHEMICAL]nicotine[\\CHEMICAL].",
        "label": 10,
        "major": 10,
        "len": 24
    },
    {
        "text": "[GENE]Glutathione-S-transferase[\\GENE], a phase II enzyme, was inhibited by both arsenic and nicotine but no such inhibition was noted in [CHEMICAL]arsenic[\\CHEMICAL]-treated animals pre-exposed to nicotine.",
        "label": 10,
        "major": 10,
        "len": 24
    },
    {
        "text": "Upon [CHEMICAL]nicotine[\\CHEMICAL] pre-exposure, brain [GENE]acetylcholinesterase[\\GENE] increased, while monoamine oxidase (MAO) decreased.",
        "label": 3,
        "major": 3,
        "len": 11
    },
    {
        "text": "Upon [CHEMICAL]nicotine[\\CHEMICAL] pre-exposure, brain acetylcholinesterase increased, while [GENE]monoamine oxidase[\\GENE] (MAO) decreased.",
        "label": 4,
        "major": 4,
        "len": 11
    },
    {
        "text": "Upon [CHEMICAL]nicotine[\\CHEMICAL] pre-exposure, brain acetylcholinesterase increased, while monoamine oxidase ([GENE]MAO[\\GENE]) decreased.",
        "label": 4,
        "major": 4,
        "len": 11
    },
    {
        "text": "The toxic effects of [GENE]MAO[\\GENE] significantly attenuated with [CHEMICAL]nicotine[\\CHEMICAL] pre-exposure.",
        "label": 4,
        "major": -1,
        "len": 10
    },
    {
        "text": "[GENE]Glutathione-S-transferase[\\GENE], a phase II enzyme, was inhibited by both [CHEMICAL]arsenic[\\CHEMICAL] and nicotine but no such inhibition was noted in arsenic-treated animals pre-exposed to nicotine.",
        "label": 4,
        "major": 4,
        "len": 24
    },
    {
        "text": "[GENE]Glutathione-S-transferase[\\GENE], a phase II enzyme, was inhibited by both arsenic and [CHEMICAL]nicotine[\\CHEMICAL] but no such inhibition was noted in arsenic-treated animals pre-exposed to nicotine.",
        "label": 4,
        "major": 10,
        "len": 24
    },
    {
        "text": "The model accurately predicted [GENE]CYP19A[\\GENE] mRNA fold changes for controls and three [CHEMICAL]FAD[\\CHEMICAL] doses (0, 0.5, and 3 \u00b5g/l) and plasma E2 dose response from the 4-day study.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "We developed a computational model of the hypothalamic-pituitary-gonadal (HPG) axis in female fathead minnows to predict dose-response and time-course (DRTC) behaviors for endocrine effects of the [GENE]aromatase[\\GENE] inhibitor, [CHEMICAL]fadrozole[\\CHEMICAL] (FAD).",
        "label": 4,
        "major": 4,
        "len": 30
    },
    {
        "text": "We developed a computational model of the hypothalamic-pituitary-gonadal (HPG) axis in female fathead minnows to predict dose-response and time-course (DRTC) behaviors for endocrine effects of the [GENE]aromatase[\\GENE] inhibitor, fadrozole ([CHEMICAL]FAD[\\CHEMICAL]).",
        "label": 4,
        "major": 4,
        "len": 30
    },
    {
        "text": "Our results suggest that modification of multiple [CHEMICAL]cysteine[\\CHEMICAL] residues by electrophilic compounds can generate both activation and desensitization of the [GENE]TRPA1[\\GENE] channel.",
        "label": 1,
        "major": 3,
        "len": 22
    },
    {
        "text": "Electrophilic chemicals activate both insect and vertebrate [GENE]TRPA1[\\GENE] via covalent modification of [CHEMICAL]cysteine[\\CHEMICAL] residues in the amino-terminal region.",
        "label": 1,
        "major": 3,
        "len": 18
    },
    {
        "text": "Electrophilic chemicals activate both insect and vertebrate [GENE]TRPA1[\\GENE] via covalent modification of cysteine residues in the [CHEMICAL]amino[\\CHEMICAL]-terminal region.",
        "label": 1,
        "major": 3,
        "len": 18
    },
    {
        "text": "We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or [GENE]TRPA1[\\GENE] with three [CHEMICAL]serine[\\CHEMICAL]-substituted cysteines crucial for electrophile activation (C621S, C641S, C665S).",
        "label": 1,
        "major": 3,
        "len": 27
    },
    {
        "text": "We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or TRPA1 with three [CHEMICAL]serine[\\CHEMICAL]-substituted cysteines crucial for electrophile activation ([GENE]C621S[\\GENE], C641S, C665S).",
        "label": 1,
        "major": 3,
        "len": 27
    },
    {
        "text": "We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or TRPA1 with three [CHEMICAL]serine[\\CHEMICAL]-substituted cysteines crucial for electrophile activation (C621S, [GENE]C641S[\\GENE], C665S).",
        "label": 1,
        "major": 3,
        "len": 27
    },
    {
        "text": "We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or TRPA1 with three [CHEMICAL]serine[\\CHEMICAL]-substituted cysteines crucial for electrophile activation (C621S, C641S, [GENE]C665S[\\GENE]).",
        "label": 1,
        "major": 3,
        "len": 27
    },
    {
        "text": "We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or [GENE]TRPA1[\\GENE] with three serine-substituted [CHEMICAL]cysteines[\\CHEMICAL] crucial for electrophile activation (C621S, C641S, C665S).",
        "label": 1,
        "major": 3,
        "len": 27
    },
    {
        "text": "We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or TRPA1 with three serine-substituted [CHEMICAL]cysteines[\\CHEMICAL] crucial for electrophile activation ([GENE]C621S[\\GENE], C641S, C665S).",
        "label": 1,
        "major": 3,
        "len": 27
    },
    {
        "text": "We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or TRPA1 with three serine-substituted [CHEMICAL]cysteines[\\CHEMICAL] crucial for electrophile activation (C621S, [GENE]C641S[\\GENE], C665S).",
        "label": 1,
        "major": 3,
        "len": 27
    },
    {
        "text": "We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or TRPA1 with three serine-substituted [CHEMICAL]cysteines[\\CHEMICAL] crucial for electrophile activation (C621S, C641S, [GENE]C665S[\\GENE]).",
        "label": 1,
        "major": 3,
        "len": 27
    },
    {
        "text": "Benzoquinone Reveals a [CHEMICAL]Cysteine[\\CHEMICAL]-Dependent Desensitization Mechanism of [GENE]TRPA1[\\GENE].",
        "label": 1,
        "major": -1,
        "len": 8
    },
    {
        "text": "Interestingly, following pBQN desensitization, wild-type TRPA1 had dramatically reduced response to the nonelectrophile agonist carvacrol, whereas the triple [CHEMICAL]cysteine[\\CHEMICAL] mutant [GENE]TRPA1[\\GENE] retained its full response.",
        "label": 1,
        "major": 1,
        "len": 25
    },
    {
        "text": "[CHEMICAL]Benzoquinone[\\CHEMICAL] Reveals a Cysteine-Dependent Desensitization Mechanism of [GENE]TRPA1[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 8
    },
    {
        "text": "The current reduction we found at higher [CHEMICAL]pBQN[\\CHEMICAL] concentrations was a cysteine-dependent desensitization of [GENE]TRPA1[\\GENE], and did not require prior activation.",
        "label": 2,
        "major": 10,
        "len": 21
    },
    {
        "text": "Interestingly, following [CHEMICAL]pBQN[\\CHEMICAL] desensitization, wild-type [GENE]TRPA1[\\GENE] had dramatically reduced response to the nonelectrophile agonist carvacrol, whereas the triple cysteine mutant TRPA1 retained its full response.",
        "label": 2,
        "major": 4,
        "len": 25
    },
    {
        "text": "We found that [CHEMICAL]pBQN[\\CHEMICAL] activates [GENE]TRPA1[\\GENE] starting at 10 nM and peaking at 300 nM; higher concentrations caused rapid activation followed by a fast decline.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "Interestingly, following pBQN desensitization, wild-type TRPA1 had dramatically reduced response to the nonelectrophile agonist [CHEMICAL]carvacrol[\\CHEMICAL], whereas the triple cysteine mutant [GENE]TRPA1[\\GENE] retained its full response.",
        "label": 5,
        "major": 4,
        "len": 25
    },
    {
        "text": "Although naturally occurring electrophilic plant compounds, such as mustard oil and [CHEMICAL]cinnamaldehyde[\\CHEMICAL], are [GENE]TRPA1[\\GENE] agonists, it is unknown whether arthropod-produced electrophiles activate mammalian TRPA1.",
        "label": 5,
        "major": 9,
        "len": 24
    },
    {
        "text": "Interestingly, following pBQN desensitization, wild-type [GENE]TRPA1[\\GENE] had dramatically reduced response to the nonelectrophile agonist [CHEMICAL]carvacrol[\\CHEMICAL], whereas the triple cysteine mutant TRPA1 retained its full response.",
        "label": 5,
        "major": 4,
        "len": 25
    },
    {
        "text": "Synthesis and in-silico studies of some [CHEMICAL]diaryltriazole[\\CHEMICAL] derivatives as potential [GENE]cyclooxygenase[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 12
    },
    {
        "text": "We found that, both in a cell-free system and in cells, NO/SNO donors such as S-nitrosocysteine and S-nitrosoglutathione readily induced the [CHEMICAL]S[\\CHEMICAL]-nitrosylation of [GENE]Prx1[\\GENE], causing structural and functional alterations.",
        "label": 1,
        "major": 3,
        "len": 29
    },
    {
        "text": "In particular, nitrosylation promoted disulfide formation involving the pair of catalytic [CHEMICAL]cysteines[\\CHEMICAL] (Cys-52 and Cys-173) and disrupted the oligomeric structure of [GENE]Prx1[\\GENE], leading to loss of peroxidase activity.",
        "label": 1,
        "major": -1,
        "len": 28
    },
    {
        "text": "In particular, nitrosylation promoted disulfide formation involving the pair of catalytic [CHEMICAL]cysteines[\\CHEMICAL] (Cys-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of [GENE]peroxidase[\\GENE] activity.",
        "label": 1,
        "major": -1,
        "len": 28
    },
    {
        "text": "In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines ([CHEMICAL]Cys[\\CHEMICAL]-52 and Cys-173) and disrupted the oligomeric structure of [GENE]Prx1[\\GENE], leading to loss of peroxidase activity.",
        "label": 1,
        "major": -1,
        "len": 28
    },
    {
        "text": "In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines ([CHEMICAL]Cys[\\CHEMICAL]-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of [GENE]peroxidase[\\GENE] activity.",
        "label": 1,
        "major": -1,
        "len": 28
    },
    {
        "text": "In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and [CHEMICAL]Cys[\\CHEMICAL]-173) and disrupted the oligomeric structure of [GENE]Prx1[\\GENE], leading to loss of peroxidase activity.",
        "label": 1,
        "major": -1,
        "len": 28
    },
    {
        "text": "In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and [CHEMICAL]Cys[\\CHEMICAL]-173) and disrupted the oligomeric structure of Prx1, leading to loss of [GENE]peroxidase[\\GENE] activity.",
        "label": 1,
        "major": -1,
        "len": 28
    },
    {
        "text": "Our findings that NO/[CHEMICAL]SNO[\\CHEMICAL] target both [GENE]Prx[\\GENE] and Trx reductase may have implications for understanding the impact of nitrosylation on cellular redox homeostasis.",
        "label": 2,
        "major": 4,
        "len": 23
    },
    {
        "text": "Our findings that NO/[CHEMICAL]SNO[\\CHEMICAL] target both Prx and [GENE]Trx reductase[\\GENE] may have implications for understanding the impact of nitrosylation on cellular redox homeostasis.",
        "label": 2,
        "major": 4,
        "len": 23
    },
    {
        "text": "We found that, both in a cell-free system and in cells, [CHEMICAL]NO[\\CHEMICAL]/SNO donors such as S-nitrosocysteine and S-nitrosoglutathione readily induced the S-nitrosylation of [GENE]Prx1[\\GENE], causing structural and functional alterations.",
        "label": 2,
        "major": 3,
        "len": 29
    },
    {
        "text": "We found that, both in a cell-free system and in cells, NO/[CHEMICAL]SNO[\\CHEMICAL] donors such as S-nitrosocysteine and S-nitrosoglutathione readily induced the S-nitrosylation of [GENE]Prx1[\\GENE], causing structural and functional alterations.",
        "label": 2,
        "major": 3,
        "len": 29
    },
    {
        "text": "We found that, both in a cell-free system and in cells, NO/SNO donors such as [CHEMICAL]S-nitrosocysteine[\\CHEMICAL] and S-nitrosoglutathione readily induced the S-nitrosylation of [GENE]Prx1[\\GENE], causing structural and functional alterations.",
        "label": 2,
        "major": 3,
        "len": 29
    },
    {
        "text": "We found that, both in a cell-free system and in cells, NO/SNO donors such as S-nitrosocysteine and [CHEMICAL]S-nitrosoglutathione[\\CHEMICAL] readily induced the S-nitrosylation of [GENE]Prx1[\\GENE], causing structural and functional alterations.",
        "label": 2,
        "major": 3,
        "len": 29
    },
    {
        "text": "A highly potent inhibition of the peroxidase catalytic reaction by [CHEMICAL]NO[\\CHEMICAL]/SNO was seen in assays employing the coupled [GENE]Prx[\\GENE]-Trx system.",
        "label": 2,
        "major": 4,
        "len": 20
    },
    {
        "text": "A highly potent inhibition of the peroxidase catalytic reaction by [CHEMICAL]NO[\\CHEMICAL]/SNO was seen in assays employing the coupled Prx-[GENE]Trx[\\GENE] system.",
        "label": 2,
        "major": 4,
        "len": 20
    },
    {
        "text": "A highly potent inhibition of the peroxidase catalytic reaction by NO/[CHEMICAL]SNO[\\CHEMICAL] was seen in assays employing the coupled [GENE]Prx[\\GENE]-Trx system.",
        "label": 2,
        "major": 4,
        "len": 20
    },
    {
        "text": "A highly potent inhibition of the peroxidase catalytic reaction by NO/[CHEMICAL]SNO[\\CHEMICAL] was seen in assays employing the coupled Prx-[GENE]Trx[\\GENE] system.",
        "label": 2,
        "major": 4,
        "len": 20
    },
    {
        "text": "This effect appeared to be due to both competition between [CHEMICAL]S-nitrosocysteine[\\CHEMICAL] and Prx1 for the [GENE]Trx[\\GENE] system and direct modulation by S-nitrosocysteine of Trx reductase activity.",
        "label": 2,
        "major": 4,
        "len": 26
    },
    {
        "text": "This effect appeared to be due to both competition between S-nitrosocysteine and Prx1 for the Trx system and direct modulation by [CHEMICAL]S-nitrosocysteine[\\CHEMICAL] of [GENE]Trx reductase[\\GENE] activity.",
        "label": 2,
        "major": 7,
        "len": 26
    },
    {
        "text": "Our findings that [CHEMICAL]NO[\\CHEMICAL]/SNO target both [GENE]Prx[\\GENE] and Trx reductase may have implications for understanding the impact of nitrosylation on cellular redox homeostasis.",
        "label": 2,
        "major": 4,
        "len": 23
    },
    {
        "text": "Our findings that [CHEMICAL]NO[\\CHEMICAL]/SNO target both Prx and [GENE]Trx reductase[\\GENE] may have implications for understanding the impact of nitrosylation on cellular redox homeostasis.",
        "label": 2,
        "major": 4,
        "len": 23
    },
    {
        "text": "A highly potent inhibition of the [GENE]peroxidase[\\GENE] catalytic reaction by [CHEMICAL]NO[\\CHEMICAL]/SNO was seen in assays employing the coupled Prx-Trx system.",
        "label": 4,
        "major": 4,
        "len": 20
    },
    {
        "text": "A highly potent inhibition of the [GENE]peroxidase[\\GENE] catalytic reaction by NO/[CHEMICAL]SNO[\\CHEMICAL] was seen in assays employing the coupled Prx-Trx system.",
        "label": 4,
        "major": 4,
        "len": 20
    },
    {
        "text": "In this setting, [CHEMICAL]S-nitrosocysteine[\\CHEMICAL] (10 \u03bcm) effectively blocked the [GENE]Trx[\\GENE]-mediated regeneration of oxidized Prx1.",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "In this setting, [CHEMICAL]S-nitrosocysteine[\\CHEMICAL] (10 \u03bcm) effectively blocked the Trx-mediated regeneration of [GENE]oxidized Prx1[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 14
    },
    {
        "text": "[CHEMICAL]DMN[\\CHEMICAL] treatment for 4weeks led to marked liver fibrosis as assessed by serum biochemistry, histopathological examination, and hepatic lipid peroxidation and [GENE]collagen[\\GENE] content.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "CK significantly inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in serum [GENE]alanine aminotransferase[\\GENE] (ALT) and aspartate aminotransferase (AST) activities, fibrosis score, and hepatic malondialdehyde and collagen content.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "CK significantly inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in serum alanine aminotransferase ([GENE]ALT[\\GENE]) and aspartate aminotransferase (AST) activities, fibrosis score, and hepatic malondialdehyde and collagen content.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "CK significantly inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in serum alanine aminotransferase (ALT) and [GENE]aspartate aminotransferase[\\GENE] (AST) activities, fibrosis score, and hepatic malondialdehyde and collagen content.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "CK significantly inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in serum alanine aminotransferase (ALT) and aspartate aminotransferase ([GENE]AST[\\GENE]) activities, fibrosis score, and hepatic malondialdehyde and collagen content.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "[CHEMICAL]DMN[\\CHEMICAL]-induced cyclooxygenase-2 (COX-2) expression and [GENE]nuclear factor-kappa B[\\GENE] (NF-\u03baB) activation was reduced by CK treatment.",
        "label": 3,
        "major": 3,
        "len": 15
    },
    {
        "text": "[CHEMICAL]DMN[\\CHEMICAL]-induced cyclooxygenase-2 (COX-2) expression and nuclear factor-kappa B ([GENE]NF-\u03baB[\\GENE]) activation was reduced by CK treatment.",
        "label": 3,
        "major": 3,
        "len": 15
    },
    {
        "text": "CK significantly inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, fibrosis score, and hepatic malondialdehyde and [GENE]collagen[\\GENE] content.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in [GENE]matrix metalloproteinase-13[\\GENE] (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-\u03b1 (TNF-\u03b1) mRNA, and collagen type I and \u03b1-smooth muscle actin protein.",
        "label": 3,
        "major": 3,
        "len": 40
    },
    {
        "text": "Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in matrix metalloproteinase-13 ([GENE]MMP-13[\\GENE]), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-\u03b1 (TNF-\u03b1) mRNA, and collagen type I and \u03b1-smooth muscle actin protein.",
        "label": 3,
        "major": 3,
        "len": 40
    },
    {
        "text": "Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in matrix metalloproteinase-13 (MMP-13), [GENE]tissue inhibitor of metalloproteinase-1[\\GENE] (TIMP-1), and tumor necrosis factor-\u03b1 (TNF-\u03b1) mRNA, and collagen type I and \u03b1-smooth muscle actin protein.",
        "label": 3,
        "major": 3,
        "len": 40
    },
    {
        "text": "Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 ([GENE]TIMP-1[\\GENE]), and tumor necrosis factor-\u03b1 (TNF-\u03b1) mRNA, and collagen type I and \u03b1-smooth muscle actin protein.",
        "label": 3,
        "major": 3,
        "len": 40
    },
    {
        "text": "Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and [GENE]tumor necrosis factor-\u03b1[\\GENE] (TNF-\u03b1) mRNA, and collagen type I and \u03b1-smooth muscle actin protein.",
        "label": 3,
        "major": 3,
        "len": 40
    },
    {
        "text": "Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-\u03b1 ([GENE]TNF-\u03b1[\\GENE]) mRNA, and collagen type I and \u03b1-smooth muscle actin protein.",
        "label": 3,
        "major": 3,
        "len": 40
    },
    {
        "text": "Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-\u03b1 (TNF-\u03b1) mRNA, and [GENE]collagen type I[\\GENE] and \u03b1-smooth muscle actin protein.",
        "label": 3,
        "major": 3,
        "len": 40
    },
    {
        "text": "Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited [CHEMICAL]DMN[\\CHEMICAL]-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-\u03b1 (TNF-\u03b1) mRNA, and collagen type I and [GENE]\u03b1-smooth muscle actin[\\GENE] protein.",
        "label": 3,
        "major": 3,
        "len": 40
    },
    {
        "text": "[CHEMICAL]DMN[\\CHEMICAL]-induced [GENE]cyclooxygenase-2[\\GENE] (COX-2) expression and nuclear factor-kappa B (NF-\u03baB) activation was reduced by CK treatment.",
        "label": 3,
        "major": 3,
        "len": 15
    },
    {
        "text": "[CHEMICAL]DMN[\\CHEMICAL]-induced cyclooxygenase-2 ([GENE]COX-2[\\GENE]) expression and nuclear factor-kappa B (NF-\u03baB) activation was reduced by CK treatment.",
        "label": 3,
        "major": 3,
        "len": 15
    },
    {
        "text": "Further analyses revealed that [CHEMICAL]CdTe[\\CHEMICAL]-QD exposure resulted in apoptosis, indicated by changes in levels of [GENE]caspase-3[\\GENE] activity, poly ADP-ribose polymerase (PARP) cleavage and phosphatidylserine externalization.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Further analyses revealed that [CHEMICAL]CdTe[\\CHEMICAL]-QD exposure resulted in apoptosis, indicated by changes in levels of caspase-3 activity, [GENE]poly ADP-ribose polymerase[\\GENE] (PARP) cleavage and phosphatidylserine externalization.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Further analyses revealed that [CHEMICAL]CdTe[\\CHEMICAL]-QD exposure resulted in apoptosis, indicated by changes in levels of caspase-3 activity, poly ADP-ribose polymerase ([GENE]PARP[\\GENE]) cleavage and phosphatidylserine externalization.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "Extrinsic apoptotic pathway markers such as Fas levels and [GENE]caspase-8[\\GENE] activity increased as a result of [CHEMICAL]CdTe[\\CHEMICAL]-QD exposure.",
        "label": 3,
        "major": 3,
        "len": 18
    },
    {
        "text": "Our findings reveal that [CHEMICAL]CdTe[\\CHEMICAL]-QDs cause oxidative stress, interfere with antioxidant defenses and activate protein [GENE]kinases[\\GENE], leading to apoptosis via both extrinsic and intrinsic pathways.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "Extrinsic apoptotic pathway markers such as [GENE]Fas[\\GENE] levels and caspase-8 activity increased as a result of [CHEMICAL]CdTe[\\CHEMICAL]-QD exposure.",
        "label": 3,
        "major": 3,
        "len": 18
    },
    {
        "text": "A low molecular weight [CHEMICAL]polyethyleneimine[\\CHEMICAL] modified with deoxycholic acid (PEI1.8-DA)-based delivery strategy was suggested for the cardiac application of [GENE]SHP-1[\\GENE] siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles.",
        "label": 2,
        "major": -1,
        "len": 41
    },
    {
        "text": "A low molecular weight polyethyleneimine modified with [CHEMICAL]deoxycholic acid[\\CHEMICAL] (PEI1.8-DA)-based delivery strategy was suggested for the cardiac application of [GENE]SHP-1[\\GENE] siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles.",
        "label": 2,
        "major": -1,
        "len": 41
    },
    {
        "text": "Taken together, our data demonstrate that [CHEMICAL]puerarin[\\CHEMICAL] attenuates MPTP-induced dopaminergic neuronal degeneration via modulating [GENE]GDNF[\\GENE] expression, PI3K/Akt pathway and GSH activation, which subsequently ameliorate MPTP-induced ROS formation and decrease of Lamp 2A expression.",
        "label": 2,
        "major": 3,
        "len": 33
    },
    {
        "text": "Taken together, our data demonstrate that puerarin attenuates [CHEMICAL]MPTP[\\CHEMICAL]-induced dopaminergic neuronal degeneration via modulating [GENE]GDNF[\\GENE] expression, PI3K/Akt pathway and GSH activation, which subsequently ameliorate MPTP-induced ROS formation and decrease of Lamp 2A expression.",
        "label": 2,
        "major": 3,
        "len": 33
    },
    {
        "text": "Taken together, our data demonstrate that [CHEMICAL]puerarin[\\CHEMICAL] attenuates MPTP-induced dopaminergic neuronal degeneration via modulating GDNF expression, [GENE]PI3K[\\GENE]/Akt pathway and GSH activation, which subsequently ameliorate MPTP-induced ROS formation and decrease of Lamp 2A expression.",
        "label": 2,
        "major": 3,
        "len": 33
    },
    {
        "text": "Taken together, our data demonstrate that [CHEMICAL]puerarin[\\CHEMICAL] attenuates MPTP-induced dopaminergic neuronal degeneration via modulating GDNF expression, PI3K/[GENE]Akt[\\GENE] pathway and GSH activation, which subsequently ameliorate MPTP-induced ROS formation and decrease of Lamp 2A expression.",
        "label": 2,
        "major": 3,
        "len": 33
    },
    {
        "text": "Taken together, our data demonstrate that puerarin attenuates [CHEMICAL]MPTP[\\CHEMICAL]-induced dopaminergic neuronal degeneration via modulating GDNF expression, [GENE]PI3K[\\GENE]/Akt pathway and GSH activation, which subsequently ameliorate MPTP-induced ROS formation and decrease of Lamp 2A expression.",
        "label": 2,
        "major": 3,
        "len": 33
    },
    {
        "text": "Taken together, our data demonstrate that puerarin attenuates [CHEMICAL]MPTP[\\CHEMICAL]-induced dopaminergic neuronal degeneration via modulating GDNF expression, PI3K/[GENE]Akt[\\GENE] pathway and GSH activation, which subsequently ameliorate MPTP-induced ROS formation and decrease of Lamp 2A expression.",
        "label": 2,
        "major": 3,
        "len": 33
    },
    {
        "text": "[CHEMICAL]Puerarin[\\CHEMICAL] administration enhanced glutathione (GSH) activity, glial cell line-derived neurotrophic factor (GDNF) expression and [GENE]PI3K[\\GENE]/Akt pathway activation, which might ameliorate MPTP injection-induced progressive elevation of reactive oxygen species (ROS) formation in mice.",
        "label": 3,
        "major": 3,
        "len": 32
    },
    {
        "text": "[CHEMICAL]Puerarin[\\CHEMICAL] administration enhanced glutathione (GSH) activity, glial cell line-derived neurotrophic factor (GDNF) expression and PI3K/[GENE]Akt[\\GENE] pathway activation, which might ameliorate MPTP injection-induced progressive elevation of reactive oxygen species (ROS) formation in mice.",
        "label": 3,
        "major": 3,
        "len": 32
    },
    {
        "text": "[CHEMICAL]Puerarin[\\CHEMICAL] administration enhanced glutathione (GSH) activity, [GENE]glial cell line-derived neurotrophic factor[\\GENE] (GDNF) expression and PI3K/Akt pathway activation, which might ameliorate MPTP injection-induced progressive elevation of reactive oxygen species (ROS) formation in mice.",
        "label": 3,
        "major": 3,
        "len": 32
    },
    {
        "text": "[CHEMICAL]Puerarin[\\CHEMICAL] administration enhanced glutathione (GSH) activity, glial cell line-derived neurotrophic factor ([GENE]GDNF[\\GENE]) expression and PI3K/Akt pathway activation, which might ameliorate MPTP injection-induced progressive elevation of reactive oxygen species (ROS) formation in mice.",
        "label": 3,
        "major": 3,
        "len": 32
    },
    {
        "text": "In addition to the effect on ROS, [CHEMICAL]puerarin[\\CHEMICAL] ameliorated MPTP-reduced lysosome-associated membrane protein type 2A ([GENE]Lamp 2A[\\GENE]) expression.",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "In addition to the effect on ROS, puerarin ameliorated [CHEMICAL]MPTP[\\CHEMICAL]-reduced [GENE]lysosome-associated membrane protein type 2A[\\GENE] (Lamp 2A) expression.",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "In addition to the effect on ROS, puerarin ameliorated [CHEMICAL]MPTP[\\CHEMICAL]-reduced lysosome-associated membrane protein type 2A ([GENE]Lamp 2A[\\GENE]) expression.",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "Taken together, our data demonstrate that [CHEMICAL]puerarin[\\CHEMICAL] attenuates MPTP-induced dopaminergic neuronal degeneration via modulating GDNF expression, PI3K/Akt pathway and GSH activation, which subsequently ameliorate MPTP-induced ROS formation and decrease of [GENE]Lamp 2A[\\GENE] expression.",
        "label": 4,
        "major": 3,
        "len": 33
    },
    {
        "text": "Taken together, our data demonstrate that puerarin attenuates MPTP-induced dopaminergic neuronal degeneration via modulating GDNF expression, PI3K/Akt pathway and GSH activation, which subsequently ameliorate [CHEMICAL]MPTP[\\CHEMICAL]-induced ROS formation and decrease of [GENE]Lamp 2A[\\GENE] expression.",
        "label": 4,
        "major": 3,
        "len": 33
    },
    {
        "text": "After 18\u00a0h incubation with 0.5\u00a0\u03bcM [CHEMICAL]Py3MeO-TBPo[\\CHEMICAL] and subsequent red light irradiation (3.6\u00a0J/cm(2)), a high number of cells die by apoptosis, as evaluated by morphological alterations, immunofluorescent relocalization of [GENE]Bax[\\GENE] from cytosol to mitochondria, and TUNEL assay.",
        "label": 2,
        "major": -1,
        "len": 36
    },
    {
        "text": "The [GENE]gp41[\\GENE] subunit contains several functional domains: the [CHEMICAL]N[\\CHEMICAL]-terminal heptad repeat (NHR) domains fold a triple stranded coiled-coil forming a meta-stable prefusion intermediate.",
        "label": 1,
        "major": -1,
        "len": 23
    },
    {
        "text": "Our results revealed an important role of base excision repair (BER) as the [GENE]ntg1[\\GENE], ntg2, apn1 and apn2 mutants showed pronounced sensitivity to essential oil and [CHEMICAL]nerolidol[\\CHEMICAL].",
        "label": 2,
        "major": 1,
        "len": 27
    },
    {
        "text": "Our results revealed an important role of base excision repair (BER) as the ntg1, [GENE]ntg2[\\GENE], apn1 and apn2 mutants showed pronounced sensitivity to essential oil and [CHEMICAL]nerolidol[\\CHEMICAL].",
        "label": 2,
        "major": 1,
        "len": 27
    },
    {
        "text": "Our results revealed an important role of base excision repair (BER) as the ntg1, ntg2, [GENE]apn1[\\GENE] and apn2 mutants showed pronounced sensitivity to essential oil and [CHEMICAL]nerolidol[\\CHEMICAL].",
        "label": 2,
        "major": 1,
        "len": 27
    },
    {
        "text": "Our results revealed an important role of base excision repair (BER) as the ntg1, ntg2, apn1 and [GENE]apn2[\\GENE] mutants showed pronounced sensitivity to essential oil and [CHEMICAL]nerolidol[\\CHEMICAL].",
        "label": 2,
        "major": 1,
        "len": 27
    },
    {
        "text": "The radioactivity was rapidly and widely distributed throughout the body, and remained detectable in all tissues investigated at later time points (24 and 48 hours for [[CHEMICAL](3)H[\\CHEMICAL]]-[GENE]MRP4[\\GENE] and [(3)H]-SSB siRNA, respectively).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Instead, radiolabeled [CHEMICAL]nucleosides[\\CHEMICAL] resulting from [GENE]nuclease[\\GENE] hydrolysis were observed.",
        "label": 9,
        "major": -1,
        "len": 9
    },
    {
        "text": "We also rescued [CHEMICAL]RO3306[\\CHEMICAL]-resistant clones using exogenous [GENE]Cdk1[\\GENE] without inhibitory phosphorylation sites, indicating that the mitotic surge of Cdk1 activity is dispensable for cell proliferation.",
        "label": 10,
        "major": 4,
        "len": 25
    },
    {
        "text": "We rescued cells lethally depleted of endogenous Cdk1 with an exogenous [GENE]Cdk1[\\GENE] conferring sensitivity to one ATP analogue inhibitor (1NMPP1) and resistance to another ([CHEMICAL]RO3306[\\CHEMICAL]).",
        "label": 10,
        "major": 4,
        "len": 25
    },
    {
        "text": "We rescued cells lethally depleted of endogenous Cdk1 with an exogenous [GENE]Cdk1[\\GENE] conferring sensitivity to one ATP analogue inhibitor ([CHEMICAL]1NMPP1[\\CHEMICAL]) and resistance to another (RO3306).",
        "label": 2,
        "major": 4,
        "len": 25
    },
    {
        "text": "At no [CHEMICAL]1NMPP1[\\CHEMICAL] concentration was mitosis in rescued clones prevented without also inducing endoreduplication, suggesting that these two key roles for [GENE]Cdk1[\\GENE] are not simply controlled by different Cdk1 activity thresholds.",
        "label": 2,
        "major": 10,
        "len": 31
    },
    {
        "text": "A series of [CHEMICAL]N[\\CHEMICAL]-substituted lobelane analogues was synthesized and evaluated for their [(3)H]dihydrotetrabenazine binding affinity at the [GENE]vesicular monoamine transporter[\\GENE] and for their inhibition of vesicular [(3)H]dopamine uptake.",
        "label": 2,
        "major": 2,
        "len": 28
    },
    {
        "text": "A series of N-substituted [CHEMICAL]lobelane[\\CHEMICAL] analogues was synthesized and evaluated for their [(3)H]dihydrotetrabenazine binding affinity at the [GENE]vesicular monoamine transporter[\\GENE] and for their inhibition of vesicular [(3)H]dopamine uptake.",
        "label": 2,
        "major": 2,
        "len": 28
    },
    {
        "text": "A series of N-substituted lobelane analogues was synthesized and evaluated for their [CHEMICAL][(3)H]dihydrotetrabenazine[\\CHEMICAL] binding affinity at the [GENE]vesicular monoamine transporter[\\GENE] and for their inhibition of vesicular [(3)H]dopamine uptake.",
        "label": 2,
        "major": 2,
        "len": 28
    },
    {
        "text": "Exploring the effect of N-substitution in [CHEMICAL]nor-lobelane[\\CHEMICAL] on the interaction with [GENE]VMAT2[\\GENE]: discovery of a potential clinical candidate for treatment of methamphetamine abuse.",
        "label": 2,
        "major": 2,
        "len": 23
    },
    {
        "text": "Exploring the effect of [CHEMICAL]N[\\CHEMICAL]-substitution in nor-lobelane on the interaction with [GENE]VMAT2[\\GENE]: discovery of a potential clinical candidate for treatment of methamphetamine abuse.",
        "label": 2,
        "major": 2,
        "len": 23
    },
    {
        "text": "A series of N-substituted lobelane analogues was synthesized and evaluated for their [(3)H]dihydrotetrabenazine binding affinity at the [GENE]vesicular monoamine transporter[\\GENE] and for their inhibition of vesicular [CHEMICAL][(3)H]dopamine[\\CHEMICAL] uptake.",
        "label": 9,
        "major": 2,
        "len": 28
    },
    {
        "text": "[CHEMICAL]IPI-926[\\CHEMICAL] is highly bound to plasma proteins and has minimal interaction with [GENE]human \u03b1-1-acid glycoprotein[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 15
    },
    {
        "text": "[CHEMICAL]IPI-926[\\CHEMICAL] is both a substrate and inhibitor (IC50\u2009=\u20091.9\u2009\u00b5M) of [GENE]P-glycoprotein[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 10
    },
    {
        "text": "[CHEMICAL]IPI-926[\\CHEMICAL] is both a substrate and inhibitor (IC50\u2009=\u20091.9\u2009\u00b5M) of [GENE]P-glycoprotein[\\GENE].",
        "label": 9,
        "major": 4,
        "len": 10
    },
    {
        "text": "Oral [CHEMICAL]lorcaserin[\\CHEMICAL] (BELVIQ(\u00ae)), a selective serotonin [GENE]5-HT2C[\\GENE] receptor agonist, is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults, or overweight adults with at least one weight-related comorbidity (e.g.",
        "label": 5,
        "major": 5,
        "len": 39
    },
    {
        "text": "Oral lorcaserin ([CHEMICAL]BELVIQ[\\CHEMICAL](\u00ae)), a selective serotonin [GENE]5-HT2C[\\GENE] receptor agonist, is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults, or overweight adults with at least one weight-related comorbidity (e.g.",
        "label": 5,
        "major": 5,
        "len": 39
    },
    {
        "text": "Biological evaluation revealed that most tested compounds were potent dipeptidyl peptidase 4 (DPP-4) inhibitors, among them, the [CHEMICAL]cyclopropyl-substituted phenylalanine[\\CHEMICAL] derivative 11h displayed the most potent [GENE]DPP-4[\\GENE] inhibitory activity with an IC50 value of 0.247 \u03bcM.",
        "label": 4,
        "major": 4,
        "len": 35
    },
    {
        "text": "Design, Synthesis, Biological Evaluation, and Docking Studies of (S)-Phenylalanine Derivatives with a [CHEMICAL]2-Cyanopyrrolidine[\\CHEMICAL] Moiety as Potent [GENE]Dipeptidyl Peptidase 4[\\GENE] Inhibitors.",
        "label": 4,
        "major": 4,
        "len": 20
    },
    {
        "text": "Design, Synthesis, Biological Evaluation, and Docking Studies of [CHEMICAL](S)-Phenylalanine[\\CHEMICAL] Derivatives with a 2-Cyanopyrrolidine Moiety as Potent [GENE]Dipeptidyl Peptidase 4[\\GENE] Inhibitors.",
        "label": 4,
        "major": 4,
        "len": 20
    },
    {
        "text": "[CHEMICAL]TCPOBOP[\\CHEMICAL], a [GENE]CAR[\\GENE] ligand, modestly induced mdr1a.fLUC in pxr(+/+) and pxr(-/-) strains, consistent with CAR's minor role in mdr1a regulation.",
        "label": 2,
        "major": 3,
        "len": 20
    },
    {
        "text": "In the current study, we crossed mdr1a.fLUC mice into the pxr knockout (pxr(-/-)) genetic background and injected mice with [CHEMICAL]pregnenolone-16\u03b1-carbonitrile[\\CHEMICAL] (PCN), a strong [GENE]PXR[\\GENE] ligand, and two therapeutically relevant taxanes, paclitaxel and docetaxel.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "In the current study, we crossed mdr1a.fLUC mice into the pxr knockout (pxr(-/-)) genetic background and injected mice with pregnenolone-16\u03b1-carbonitrile ([CHEMICAL]PCN[\\CHEMICAL]), a strong [GENE]PXR[\\GENE] ligand, and two therapeutically relevant taxanes, paclitaxel and docetaxel.",
        "label": 2,
        "major": -1,
        "len": 33
    },
    {
        "text": "All three agents induced [GENE]mdr1a[\\GENE].fLUC expression (bioluminescence), but only [CHEMICAL]PCN[\\CHEMICAL] and docetaxel appeared to act primarily via PXR.",
        "label": 2,
        "major": 3,
        "len": 18
    },
    {
        "text": "All three agents induced [GENE]mdr1a[\\GENE].fLUC expression (bioluminescence), but only PCN and [CHEMICAL]docetaxel[\\CHEMICAL] appeared to act primarily via PXR.",
        "label": 2,
        "major": 3,
        "len": 18
    },
    {
        "text": "[CHEMICAL]TCPOBOP[\\CHEMICAL], a CAR ligand, modestly induced mdr1a.fLUC in pxr(+/+) and pxr(-/-) strains, consistent with CAR's minor role in [GENE]mdr1a[\\GENE] regulation.",
        "label": 2,
        "major": 3,
        "len": 20
    },
    {
        "text": "All three agents induced mdr1a.fLUC expression (bioluminescence), but only [CHEMICAL]PCN[\\CHEMICAL] and docetaxel appeared to act primarily via [GENE]PXR[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 18
    },
    {
        "text": "All three agents induced mdr1a.fLUC expression (bioluminescence), but only PCN and [CHEMICAL]docetaxel[\\CHEMICAL] appeared to act primarily via [GENE]PXR[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 18
    },
    {
        "text": "[CHEMICAL]TCPOBOP[\\CHEMICAL], a CAR ligand, modestly induced mdr1a.fLUC in pxr(+/+) and pxr(-/-) strains, consistent with [GENE]CAR[\\GENE]'s minor role in mdr1a regulation.",
        "label": 2,
        "major": 3,
        "len": 20
    },
    {
        "text": "[CHEMICAL]TCPOBOP[\\CHEMICAL], a CAR ligand, modestly induced [GENE]mdr1a[\\GENE].fLUC in pxr(+/+) and pxr(-/-) strains, consistent with CAR's minor role in mdr1a regulation.",
        "label": 3,
        "major": 3,
        "len": 20
    },
    {
        "text": "The inhibitory effect of [CHEMICAL]galangin[\\CHEMICAL] on theses pro-inflammatory cytokines was related with [GENE]c-Jun[\\GENE] N-terminal kinases, and p38 mitogen-activated protein kinase, nuclear factor-\u03baB, and caspase-1.",
        "label": 2,
        "major": 4,
        "len": 24
    },
    {
        "text": "The inhibitory effect of [CHEMICAL]galangin[\\CHEMICAL] on theses pro-inflammatory cytokines was related with c-Jun [GENE]N-terminal kinases[\\GENE], and p38 mitogen-activated protein kinase, nuclear factor-\u03baB, and caspase-1.",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "The inhibitory effect of [CHEMICAL]galangin[\\CHEMICAL] on theses pro-inflammatory cytokines was related with c-Jun N-terminal kinases, and [GENE]p38[\\GENE] mitogen-activated protein kinase, nuclear factor-\u03baB, and caspase-1.",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "The inhibitory effect of [CHEMICAL]galangin[\\CHEMICAL] on theses pro-inflammatory cytokines was related with c-Jun N-terminal kinases, and p38 [GENE]mitogen-activated protein kinase[\\GENE], nuclear factor-\u03baB, and caspase-1.",
        "label": 2,
        "major": 4,
        "len": 24
    },
    {
        "text": "The inhibitory effect of [CHEMICAL]galangin[\\CHEMICAL] on theses pro-inflammatory cytokines was related with c-Jun N-terminal kinases, and p38 mitogen-activated protein kinase, [GENE]nuclear factor-\u03baB[\\GENE], and caspase-1.",
        "label": 2,
        "major": 4,
        "len": 24
    },
    {
        "text": "The inhibitory effect of [CHEMICAL]galangin[\\CHEMICAL] on theses pro-inflammatory cytokines was related with c-Jun N-terminal kinases, and p38 mitogen-activated protein kinase, nuclear factor-\u03baB, and [GENE]caspase-1[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "Furthermore, [CHEMICAL]galangin[\\CHEMICAL] attenuated [GENE]IgE[\\GENE]-mediated passive cutaneous anaphylaxis and the expression of histamine receptor 1 at the inflamed tissue.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Galangin[\\CHEMICAL] decreased expression of pro-inflammatory [GENE]cytokines[\\GENE], such as tumor necrosis factor (TNF)-\u03b1, interleukin (IL)-6, IL-1\u03b2, and IL-8.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Galangin[\\CHEMICAL] decreased expression of pro-inflammatory cytokines, such as [GENE]tumor necrosis factor (TNF)-\u03b1[\\GENE], interleukin (IL)-6, IL-1\u03b2, and IL-8.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Galangin[\\CHEMICAL] decreased expression of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-\u03b1, [GENE]interleukin[\\GENE] (IL)-6, IL-1\u03b2, and IL-8.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Galangin[\\CHEMICAL] decreased expression of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-\u03b1, interleukin [GENE](IL)-6[\\GENE], IL-1\u03b2, and IL-8.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Galangin[\\CHEMICAL] decreased expression of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-\u03b1, interleukin (IL)-6, [GENE]IL-1\u03b2[\\GENE], and IL-8.",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "[CHEMICAL]Galangin[\\CHEMICAL] decreased expression of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-\u03b1, interleukin (IL)-6, IL-1\u03b2, and [GENE]IL-8[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 17
    },
    {
        "text": "The inhibitory effect of [CHEMICAL]galangin[\\CHEMICAL] on theses pro-inflammatory [GENE]cytokines[\\GENE] was related with c-Jun N-terminal kinases, and p38 mitogen-activated protein kinase, nuclear factor-\u03baB, and caspase-1.",
        "label": 4,
        "major": 4,
        "len": 24
    },
    {
        "text": "Furthermore, [CHEMICAL]galangin[\\CHEMICAL] attenuated IgE-mediated passive cutaneous anaphylaxis and the expression of [GENE]histamine receptor 1[\\GENE] at the inflamed tissue.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "Our results showed that [CHEMICAL]galangin[\\CHEMICAL] down-regulates mast cell-derived allergic inflammatory reactions by blocking histamine release and expression of pro-inflammatory [GENE]cytokines[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 20
    },
    {
        "text": "[GENE]HP1\u03b1[\\GENE] responded only to [CHEMICAL]BHA[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 5
    },
    {
        "text": "Furthermore, [CHEMICAL]nobiletin[\\CHEMICAL] could inhibit HGF-induced the membrane localization of phosphorylated c-Met, ERK2, and Akt, but not phosphorylated JNK1/2 and [GENE]p38[\\GENE].",
        "label": 10,
        "major": 3,
        "len": 20
    },
    {
        "text": "Next, [CHEMICAL]nobiletin[\\CHEMICAL] significantly decreased the levels of [GENE]phospho-ERK2[\\GENE] and phospho-Akt in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration.",
        "label": 4,
        "major": 4,
        "len": 26
    },
    {
        "text": "Next, [CHEMICAL]nobiletin[\\CHEMICAL] significantly decreased the levels of phospho-ERK2 and [GENE]phospho-Akt[\\GENE] in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration.",
        "label": 4,
        "major": 4,
        "len": 26
    },
    {
        "text": "Next, [CHEMICAL]nobiletin[\\CHEMICAL] significantly decreased the levels of phospho-ERK2 and phospho-Akt in [GENE]ERK2[\\GENE] or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration.",
        "label": 4,
        "major": 4,
        "len": 26
    },
    {
        "text": "Next, [CHEMICAL]nobiletin[\\CHEMICAL] significantly decreased the levels of phospho-ERK2 and phospho-Akt in ERK2 or [GENE]Akt[\\GENE] siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration.",
        "label": 4,
        "major": 4,
        "len": 26
    },
    {
        "text": "[CHEMICAL]Nobiletin[\\CHEMICAL] attenuates metastasis via both [GENE]ERK[\\GENE] and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "[CHEMICAL]Nobiletin[\\CHEMICAL] attenuates metastasis via both ERK and [GENE]PI3K[\\GENE]/Akt pathways in HGF-treated liver cancer HepG2 cells.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "[CHEMICAL]Nobiletin[\\CHEMICAL] attenuates metastasis via both ERK and PI3K/[GENE]Akt[\\GENE] pathways in HGF-treated liver cancer HepG2 cells.",
        "label": 4,
        "major": -1,
        "len": 15
    },
    {
        "text": "In conclusion, [CHEMICAL]nobiletin[\\CHEMICAL] attenuates [GENE]HGF[\\GENE]-induced HepG2 cells metastasis involving both ERK and PI3K/Akt pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma.",
        "label": 4,
        "major": 3,
        "len": 26
    },
    {
        "text": "In conclusion, [CHEMICAL]nobiletin[\\CHEMICAL] attenuates HGF-induced HepG2 cells metastasis involving both [GENE]ERK[\\GENE] and PI3K/Akt pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma.",
        "label": 4,
        "major": 3,
        "len": 26
    },
    {
        "text": "In conclusion, [CHEMICAL]nobiletin[\\CHEMICAL] attenuates HGF-induced HepG2 cells metastasis involving both ERK and [GENE]PI3K[\\GENE]/Akt pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma.",
        "label": 4,
        "major": 3,
        "len": 26
    },
    {
        "text": "In conclusion, [CHEMICAL]nobiletin[\\CHEMICAL] attenuates HGF-induced HepG2 cells metastasis involving both ERK and PI3K/[GENE]Akt[\\GENE] pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma.",
        "label": 4,
        "major": 3,
        "len": 26
    },
    {
        "text": "Among them, [CHEMICAL]nobiletin[\\CHEMICAL] markedly inhibited [GENE]HGF[\\GENE]-induced the abilities of the adhesion, invasion, and migration by cell-matrix adhesion assay and transwell-chamber invasion/migration assay under non-cytotoxic concentrations.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "Data also showed [CHEMICAL]nobiletin[\\CHEMICAL] inhibited [GENE]HGF[\\GENE]-induced cell scattering and cytoskeleton changed such as filopodia and lamellipodia.",
        "label": 4,
        "major": 4,
        "len": 16
    },
    {
        "text": "Furthermore, [CHEMICAL]nobiletin[\\CHEMICAL] could inhibit [GENE]HGF[\\GENE]-induced the membrane localization of phosphorylated c-Met, ERK2, and Akt, but not phosphorylated JNK1/2 and p38.",
        "label": 4,
        "major": 4,
        "len": 20
    },
    {
        "text": "Furthermore, [CHEMICAL]nobiletin[\\CHEMICAL] could inhibit HGF-induced the membrane localization of phosphorylated [GENE]c-Met[\\GENE], ERK2, and Akt, but not phosphorylated JNK1/2 and p38.",
        "label": 4,
        "major": 4,
        "len": 20
    },
    {
        "text": "Furthermore, [CHEMICAL]nobiletin[\\CHEMICAL] could inhibit HGF-induced the membrane localization of phosphorylated c-Met, [GENE]ERK2[\\GENE], and Akt, but not phosphorylated JNK1/2 and p38.",
        "label": 4,
        "major": 10,
        "len": 20
    },
    {
        "text": "Furthermore, [CHEMICAL]nobiletin[\\CHEMICAL] could inhibit HGF-induced the membrane localization of phosphorylated c-Met, ERK2, and [GENE]Akt[\\GENE], but not phosphorylated JNK1/2 and p38.",
        "label": 4,
        "major": 3,
        "len": 20
    },
    {
        "text": "In contrast, the latter pathway likely involves [GENE]MHC[\\GENE] binding peptides displayed as a consequence of abacavir exposure, but not [CHEMICAL]abacavir[\\CHEMICAL] itself.",
        "label": 10,
        "major": 2,
        "len": 21
    },
    {
        "text": "These data suggest that T-cells can be activated by [CHEMICAL]abacavir[\\CHEMICAL] through a direct interaction with surface and intracellular [GENE]major histocompatibility complex[\\GENE] (MHC) molecules.",
        "label": 2,
        "major": 2,
        "len": 23
    },
    {
        "text": "These data suggest that T-cells can be activated by [CHEMICAL]abacavir[\\CHEMICAL] through a direct interaction with surface and intracellular major histocompatibility complex ([GENE]MHC[\\GENE]) molecules.",
        "label": 2,
        "major": 2,
        "len": 23
    },
    {
        "text": "With the former, [CHEMICAL]abacavir[\\CHEMICAL] seemingly participates in the [GENE]MHC[\\GENE] T-cell receptor binding interaction.",
        "label": 2,
        "major": 2,
        "len": 13
    },
    {
        "text": "With the former, [CHEMICAL]abacavir[\\CHEMICAL] seemingly participates in the MHC [GENE]T-cell receptor[\\GENE] binding interaction.",
        "label": 2,
        "major": 2,
        "len": 13
    },
    {
        "text": "In contrast, the latter pathway likely involves [GENE]MHC[\\GENE] binding peptides displayed as a consequence of [CHEMICAL]abacavir[\\CHEMICAL] exposure, but not abacavir itself.",
        "label": 2,
        "major": 10,
        "len": 21
    },
    {
        "text": "Seventy-four CD8+ clones expressing different [GENE]V\u03b2 receptors[\\GENE] were shown to proliferate and kill target cells via different mechanisms when exposed to [CHEMICAL]abacavir[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Excess of [CHEMICAL]cholesterol[\\CHEMICAL] converted into 24OHC may up-regulate ApoE synthesis which is a scavenger for [GENE]A\u03b2[\\GENE] and Tau.",
        "label": 2,
        "major": 9,
        "len": 18
    },
    {
        "text": "Excess of [CHEMICAL]cholesterol[\\CHEMICAL] converted into 24OHC may up-regulate ApoE synthesis which is a scavenger for A\u03b2 and [GENE]Tau[\\GENE].",
        "label": 2,
        "major": 9,
        "len": 18
    },
    {
        "text": "Excess of [CHEMICAL]cholesterol[\\CHEMICAL] converted into 24OHC may up-regulate [GENE]ApoE[\\GENE] synthesis which is a scavenger for A\u03b2 and Tau.",
        "label": 3,
        "major": 9,
        "len": 18
    },
    {
        "text": "Excess of cholesterol converted into [CHEMICAL]24OHC[\\CHEMICAL] may up-regulate [GENE]ApoE[\\GENE] synthesis which is a scavenger for A\u03b2 and Tau.",
        "label": 3,
        "major": 9,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Cholesterol[\\CHEMICAL] also increases [GENE]Amyloid \u03b2[\\GENE] (A\u03b2) deposition and tau pathology.",
        "label": 4,
        "major": 3,
        "len": 10
    },
    {
        "text": "[CHEMICAL]Cholesterol[\\CHEMICAL] also increases Amyloid \u03b2 ([GENE]A\u03b2[\\GENE]) deposition and tau pathology.",
        "label": 4,
        "major": 3,
        "len": 10
    },
    {
        "text": "[CHEMICAL]Cholesterol[\\CHEMICAL] also increases Amyloid \u03b2 (A\u03b2) deposition and [GENE]tau[\\GENE] pathology.",
        "label": 4,
        "major": 3,
        "len": 10
    },
    {
        "text": "While the function of [GENE]N-type calcium channels[\\GENE] within astrocytes is controversial, these voltage-gated calcium channels have been linked to [CHEMICAL]calcium[\\CHEMICAL]-dependent vesicular gliotransmitter release.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "While the function of N-type calcium channels within astrocytes is controversial, these [GENE]voltage-gated calcium channels[\\GENE] have been linked to [CHEMICAL]calcium[\\CHEMICAL]-dependent vesicular gliotransmitter release.",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "In the current study, we extend these findings to show that the ability of astrocytes to buffer extracellular [CHEMICAL]glutamate[\\CHEMICAL] is reduced when [GENE]CaMKII[\\GENE] is inhibited.",
        "label": 9,
        "major": 4,
        "len": 25
    },
    {
        "text": "Remarkably, [CHEMICAL]3-HPT[\\CHEMICAL] gives no inhibition of [GENE]HDAC 1[\\GENE].",
        "label": 10,
        "major": 4,
        "len": 8
    },
    {
        "text": "We have identified [CHEMICAL]3-hydroxypyridin-2-thione[\\CHEMICAL] (3-HPT) as a novel ZBG that is compatible with [GENE]HDAC[\\GENE] inhibition.",
        "label": 4,
        "major": 4,
        "len": 15
    },
    {
        "text": "We have identified 3-hydroxypyridin-2-thione ([CHEMICAL]3-HPT[\\CHEMICAL]) as a novel ZBG that is compatible with [GENE]HDAC[\\GENE] inhibition.",
        "label": 4,
        "major": 4,
        "len": 15
    },
    {
        "text": "[CHEMICAL]3-HPT[\\CHEMICAL] inhibits [GENE]HDAC 6[\\GENE] and HDAC 8 with an IC50 of 681 and 3675 nM, respectively.",
        "label": 4,
        "major": 4,
        "len": 16
    },
    {
        "text": "[CHEMICAL]3-HPT[\\CHEMICAL] inhibits HDAC 6 and [GENE]HDAC 8[\\GENE] with an IC50 of 681 and 3675 nM, respectively.",
        "label": 4,
        "major": 4,
        "len": 16
    },
    {
        "text": "Small molecules bearing hydroxamic acid as the [CHEMICAL]zinc[\\CHEMICAL] binding group (ZBG) have been the most effective [GENE]histone deacetylase[\\GENE] inhibitors (HDACi) to date.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "Small molecules bearing hydroxamic acid as the [CHEMICAL]zinc[\\CHEMICAL] binding group (ZBG) have been the most effective histone deacetylase inhibitors ([GENE]HDAC[\\GENE]i) to date.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "Subsequent optimization led to several novel [CHEMICAL]3HPT[\\CHEMICAL]-based [GENE]HDAC[\\GENE]i that are selective for HDAC 6 and HDAC 8.",
        "label": 4,
        "major": -1,
        "len": 17
    },
    {
        "text": "Subsequent optimization led to several novel [CHEMICAL]3HPT[\\CHEMICAL]-based HDACi that are selective for [GENE]HDAC 6[\\GENE] and HDAC 8.",
        "label": 4,
        "major": -1,
        "len": 17
    },
    {
        "text": "Subsequent optimization led to several novel [CHEMICAL]3HPT[\\CHEMICAL]-based HDACi that are selective for HDAC 6 and [GENE]HDAC 8[\\GENE].",
        "label": 4,
        "major": -1,
        "len": 17
    },
    {
        "text": "[CHEMICAL]3-Hydroxypyridin-2-thione[\\CHEMICAL] as Novel Zinc Binding Group for Selective [GENE]Histone Deacetylase[\\GENE] Inhibition.",
        "label": 4,
        "major": 4,
        "len": 11
    },
    {
        "text": "3-Hydroxypyridin-2-thione as Novel [CHEMICAL]Zinc[\\CHEMICAL] Binding Group for Selective [GENE]Histone Deacetylase[\\GENE] Inhibition.",
        "label": 4,
        "major": 4,
        "len": 11
    },
    {
        "text": "Native GLP-1 stimulates [GENE]insulin[\\GENE] secretion in a [CHEMICAL]glucose[\\CHEMICAL]-dependent manner, as well as suppressing glucagon production and slowing gastric emptying.",
        "label": 2,
        "major": 9,
        "len": 19
    },
    {
        "text": "Maqui berry (Aristotelia chilensis) and the constituent [CHEMICAL]delphinidin glycoside[\\CHEMICAL] inhibit [GENE]photoreceptor[\\GENE] cell death induced by visible light.",
        "label": 3,
        "major": 4,
        "len": 17
    },
    {
        "text": "These findings indicate that MBE and its [CHEMICAL]anthocyanidins[\\CHEMICAL] suppress the light-induced photoreceptor cell death by inhibiting ROS production, suggesting that the inhibition of [GENE]phosphorylated-p38[\\GENE] may be involved in the underlying mechanism.",
        "label": 4,
        "major": 3,
        "len": 31
    },
    {
        "text": "Moreover, [CHEMICAL]curcumin[\\CHEMICAL] could also down-regulate the expression and activity of [GENE]matrix metalloproteinase-9[\\GENE] (MMP-9).",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Moreover, [CHEMICAL]curcumin[\\CHEMICAL] could also down-regulate the expression and activity of matrix metalloproteinase-9 ([GENE]MMP-9[\\GENE]).",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Moreover, [CHEMICAL]curcumin[\\CHEMICAL] could also down-regulate the expression and activity of [GENE]matrix metalloproteinase-9[\\GENE] (MMP-9).",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Moreover, [CHEMICAL]curcumin[\\CHEMICAL] could also down-regulate the expression and activity of matrix metalloproteinase-9 ([GENE]MMP-9[\\GENE]).",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of [GENE]Histone 3[\\GENE] at [CHEMICAL]Ser[\\CHEMICAL]10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.",
        "label": 1,
        "major": 3,
        "len": 44
    },
    {
        "text": "Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of [GENE]Cdk1[\\GENE] at [CHEMICAL]Tyr[\\CHEMICAL]15, expression of cyclin B1, and decreased expression of Cdc25c.",
        "label": 1,
        "major": 4,
        "len": 44
    },
    {
        "text": "Treatment with [CHEMICAL]EVn-50[\\CHEMICAL] or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of [GENE]Histone 3[\\GENE] at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.",
        "label": 3,
        "major": 3,
        "len": 44
    },
    {
        "text": "Treatment with [CHEMICAL]EVn-50[\\CHEMICAL] or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of [GENE]Cdk1[\\GENE] at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.",
        "label": 3,
        "major": 4,
        "len": 44
    },
    {
        "text": "Treatment with EVn-50 or [CHEMICAL]VB1[\\CHEMICAL] resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of [GENE]Histone 3[\\GENE] at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.",
        "label": 3,
        "major": 4,
        "len": 44
    },
    {
        "text": "Treatment with EVn-50 or [CHEMICAL]VB1[\\CHEMICAL] resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of [GENE]Cdk1[\\GENE] at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.",
        "label": 3,
        "major": 4,
        "len": 44
    },
    {
        "text": "Treatment with [CHEMICAL]EVn-50[\\CHEMICAL] or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of [GENE]cyclin B1[\\GENE], and decreased expression of Cdc25c.",
        "label": 3,
        "major": 4,
        "len": 44
    },
    {
        "text": "Treatment with EVn-50 or [CHEMICAL]VB1[\\CHEMICAL] resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of [GENE]cyclin B1[\\GENE], and decreased expression of Cdc25c.",
        "label": 3,
        "major": 4,
        "len": 44
    },
    {
        "text": "Treatment with [CHEMICAL]EVn-50[\\CHEMICAL] or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of [GENE]Cdc25c[\\GENE].",
        "label": 4,
        "major": 3,
        "len": 44
    },
    {
        "text": "Treatment with EVn-50 or [CHEMICAL]VB1[\\CHEMICAL] resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of [GENE]Cdc25c[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 44
    },
    {
        "text": "Finally, the involvement of [GENE]PKC[\\GENE] and PKA was also studied, and we showed that both play a role in the antinociceptive mechanism of [CHEMICAL]CAT[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Finally, the involvement of PKC and [GENE]PKA[\\GENE] was also studied, and we showed that both play a role in the antinociceptive mechanism of [CHEMICAL]CAT[\\CHEMICAL].",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "Conclusion The results of this work contribute information regarding the antinociceptive properties of CAT on acute pain and show that, at least in part, [GENE]TRPV1[\\GENE], TRPM8, ASIC, glutamate receptors, PKC and PKA participate in [CHEMICAL]CAT[\\CHEMICAL]'s antinociceptive mechanism.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Conclusion The results of this work contribute information regarding the antinociceptive properties of CAT on acute pain and show that, at least in part, TRPV1, [GENE]TRPM8[\\GENE], ASIC, glutamate receptors, PKC and PKA participate in [CHEMICAL]CAT[\\CHEMICAL]'s antinociceptive mechanism.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Conclusion The results of this work contribute information regarding the antinociceptive properties of CAT on acute pain and show that, at least in part, TRPV1, TRPM8, [GENE]ASIC[\\GENE], glutamate receptors, PKC and PKA participate in [CHEMICAL]CAT[\\CHEMICAL]'s antinociceptive mechanism.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Conclusion The results of this work contribute information regarding the antinociceptive properties of CAT on acute pain and show that, at least in part, TRPV1, TRPM8, ASIC, [GENE]glutamate receptors[\\GENE], PKC and PKA participate in [CHEMICAL]CAT[\\CHEMICAL]'s antinociceptive mechanism.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Conclusion The results of this work contribute information regarding the antinociceptive properties of CAT on acute pain and show that, at least in part, TRPV1, TRPM8, ASIC, glutamate receptors, [GENE]PKC[\\GENE] and PKA participate in [CHEMICAL]CAT[\\CHEMICAL]'s antinociceptive mechanism.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "Conclusion The results of this work contribute information regarding the antinociceptive properties of CAT on acute pain and show that, at least in part, TRPV1, TRPM8, ASIC, glutamate receptors, PKC and [GENE]PKA[\\GENE] participate in [CHEMICAL]CAT[\\CHEMICAL]'s antinociceptive mechanism.",
        "label": 2,
        "major": -1,
        "len": 37
    },
    {
        "text": "In an investigation into the participation of [GENE]TRP channels[\\GENE] and ASICs in [CHEMICAL]CAT[\\CHEMICAL]'s antinociceptive mechanism, we used capsaicin (2.2\u03bcg/paw), cinnamaldehyde (10mmol/paw), menthol (1.2mmol/paw) and acidified saline (2% acetic acid, pH 1.98).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In an investigation into the participation of TRP channels and [GENE]ASICs[\\GENE] in [CHEMICAL]CAT[\\CHEMICAL]'s antinociceptive mechanism, we used capsaicin (2.2\u03bcg/paw), cinnamaldehyde (10mmol/paw), menthol (1.2mmol/paw) and acidified saline (2% acetic acid, pH 1.98).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In an investigation into the participation of [GENE]TRP channels[\\GENE] and ASICs in CAT's antinociceptive mechanism, we used [CHEMICAL]capsaicin[\\CHEMICAL] (2.2\u03bcg/paw), cinnamaldehyde (10mmol/paw), menthol (1.2mmol/paw) and acidified saline (2% acetic acid, pH 1.98).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In an investigation into the participation of TRP channels and [GENE]ASICs[\\GENE] in CAT's antinociceptive mechanism, we used [CHEMICAL]capsaicin[\\CHEMICAL] (2.2\u03bcg/paw), cinnamaldehyde (10mmol/paw), menthol (1.2mmol/paw) and acidified saline (2% acetic acid, pH 1.98).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In an investigation into the participation of [GENE]TRP channels[\\GENE] and ASICs in CAT's antinociceptive mechanism, we used capsaicin (2.2\u03bcg/paw), [CHEMICAL]cinnamaldehyde[\\CHEMICAL] (10mmol/paw), menthol (1.2mmol/paw) and acidified saline (2% acetic acid, pH 1.98).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In an investigation into the participation of TRP channels and [GENE]ASICs[\\GENE] in CAT's antinociceptive mechanism, we used capsaicin (2.2\u03bcg/paw), [CHEMICAL]cinnamaldehyde[\\CHEMICAL] (10mmol/paw), menthol (1.2mmol/paw) and acidified saline (2% acetic acid, pH 1.98).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In an investigation into the participation of [GENE]TRP channels[\\GENE] and ASICs in CAT's antinociceptive mechanism, we used capsaicin (2.2\u03bcg/paw), cinnamaldehyde (10mmol/paw), [CHEMICAL]menthol[\\CHEMICAL] (1.2mmol/paw) and acidified saline (2% acetic acid, pH 1.98).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In an investigation into the participation of TRP channels and [GENE]ASICs[\\GENE] in CAT's antinociceptive mechanism, we used capsaicin (2.2\u03bcg/paw), cinnamaldehyde (10mmol/paw), [CHEMICAL]menthol[\\CHEMICAL] (1.2mmol/paw) and acidified saline (2% acetic acid, pH 1.98).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In an investigation into the participation of [GENE]TRP channels[\\GENE] and ASICs in CAT's antinociceptive mechanism, we used capsaicin (2.2\u03bcg/paw), cinnamaldehyde (10mmol/paw), menthol (1.2mmol/paw) and acidified saline (2% [CHEMICAL]acetic acid[\\CHEMICAL], pH 1.98).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "In an investigation into the participation of TRP channels and [GENE]ASICs[\\GENE] in CAT's antinociceptive mechanism, we used capsaicin (2.2\u03bcg/paw), cinnamaldehyde (10mmol/paw), menthol (1.2mmol/paw) and acidified saline (2% [CHEMICAL]acetic acid[\\CHEMICAL], pH 1.98).",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Importantly, 2-hydroxychalcone and xanthohumol exerted more potent inhibitory effects on the proliferation, [GENE]MMP-9[\\GENE] expression and invasive phenotype of MDA-MB-231 than [CHEMICAL]chalcone[\\CHEMICAL].",
        "label": 2,
        "major": 4,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Xanthohumol[\\CHEMICAL] and 2-hydroxychalcone induced apoptosis by [GENE]Bcl-2[\\GENE] downregulation.",
        "label": 4,
        "major": 3,
        "len": 8
    },
    {
        "text": "Xanthohumol and [CHEMICAL]2-hydroxychalcone[\\CHEMICAL] induced apoptosis by [GENE]Bcl-2[\\GENE] downregulation.",
        "label": 4,
        "major": 4,
        "len": 8
    },
    {
        "text": "Importantly, [CHEMICAL]2-hydroxychalcone[\\CHEMICAL] and xanthohumol exerted more potent inhibitory effects on the proliferation, [GENE]MMP-9[\\GENE] expression and invasive phenotype of MDA-MB-231 than chalcone.",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "Importantly, 2-hydroxychalcone and [CHEMICAL]xanthohumol[\\CHEMICAL] exerted more potent inhibitory effects on the proliferation, [GENE]MMP-9[\\GENE] expression and invasive phenotype of MDA-MB-231 than chalcone.",
        "label": 4,
        "major": 10,
        "len": 21
    },
    {
        "text": "[CHEMICAL]3-Hydroxy-5-(2-phenylethyl)pyridine-2(1H)-one[\\CHEMICAL] exhibited the predicted binding mode and demonstrated high inhibitory activity for [GENE]human DAAO[\\GENE] in enzyme- and cell-based assays.",
        "label": 2,
        "major": 4,
        "len": 19
    },
    {
        "text": "[CHEMICAL]3-Hydroxy-5-(2-phenylethyl)pyridine-2(1H)-one[\\CHEMICAL] exhibited the predicted binding mode and demonstrated high inhibitory activity for [GENE]human DAAO[\\GENE] in enzyme- and cell-based assays.",
        "label": 4,
        "major": 4,
        "len": 19
    },
    {
        "text": "[CHEMICAL]4-Hydroxypyridazin-3(2H)-one[\\CHEMICAL] Derivatives as Novel [GENE]d-Amino Acid Oxidase[\\GENE] Inhibitors.",
        "label": 4,
        "major": 4,
        "len": 8
    },
    {
        "text": "We identified a series of [CHEMICAL]4-hydroxypyridazin-3(2H)-one[\\CHEMICAL] derivatives as novel [GENE]DAAO[\\GENE] inhibitors with high potency and substantial cell permeability using fragment-based drug design.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "d-Amino acid oxidase (DAAO) catalyzes the oxidation of d-amino acids including [CHEMICAL]d-serine[\\CHEMICAL], a coagonist of the [GENE]N-methyl-d-aspartate receptor[\\GENE].",
        "label": 5,
        "major": 9,
        "len": 18
    },
    {
        "text": "[GENE]d-Amino acid oxidase[\\GENE] (DAAO) catalyzes the oxidation of d-amino acids including [CHEMICAL]d-serine[\\CHEMICAL], a coagonist of the N-methyl-d-aspartate receptor.",
        "label": 9,
        "major": 1,
        "len": 18
    },
    {
        "text": "d-Amino acid oxidase ([GENE]DAAO[\\GENE]) catalyzes the oxidation of d-amino acids including [CHEMICAL]d-serine[\\CHEMICAL], a coagonist of the N-methyl-d-aspartate receptor.",
        "label": 9,
        "major": 9,
        "len": 18
    },
    {
        "text": "[GENE]d-Amino acid oxidase[\\GENE] (DAAO) catalyzes the oxidation of [CHEMICAL]d-amino acids[\\CHEMICAL] including d-serine, a coagonist of the N-methyl-d-aspartate receptor.",
        "label": 9,
        "major": 9,
        "len": 18
    },
    {
        "text": "d-Amino acid oxidase ([GENE]DAAO[\\GENE]) catalyzes the oxidation of [CHEMICAL]d-amino acids[\\CHEMICAL] including d-serine, a coagonist of the N-methyl-d-aspartate receptor.",
        "label": 9,
        "major": 9,
        "len": 18
    },
    {
        "text": "Fourteen of 17 parabens exhibited hER\u03b1 and/or hER\u03b2 agonistic activity at concentrations of \u2a7d1\u00d710(-5)M, whereas none of the 17 [CHEMICAL]parabens[\\CHEMICAL] showed [GENE]AR[\\GENE] agonistic or antagonistic activity.",
        "label": 10,
        "major": 6,
        "len": 26
    },
    {
        "text": "Comparative study on transcriptional activity of 17 [CHEMICAL]parabens[\\CHEMICAL] mediated by estrogen receptor \u03b1 and \u03b2 and [GENE]androgen receptor[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "Among 12 parabens with linear alkyl chains ranging in length from C1 to C12, [CHEMICAL]heptylparaben[\\CHEMICAL] (C7) and pentylparaben (C5) showed the most potent [GENE]ER\u03b1[\\GENE] and ER\u03b2 agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12.",
        "label": 5,
        "major": 4,
        "len": 56
    },
    {
        "text": "Among 12 parabens with linear alkyl chains ranging in length from C1 to C12, [CHEMICAL]heptylparaben[\\CHEMICAL] (C7) and pentylparaben (C5) showed the most potent ER\u03b1 and [GENE]ER\u03b2[\\GENE] agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12.",
        "label": 5,
        "major": 5,
        "len": 56
    },
    {
        "text": "Among 12 parabens with linear alkyl chains ranging in length from C1 to C12, heptylparaben (C7) and [CHEMICAL]pentylparaben[\\CHEMICAL] (C5) showed the most potent [GENE]ER\u03b1[\\GENE] and ER\u03b2 agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12.",
        "label": 5,
        "major": 4,
        "len": 56
    },
    {
        "text": "Among 12 parabens with linear alkyl chains ranging in length from C1 to C12, heptylparaben (C7) and [CHEMICAL]pentylparaben[\\CHEMICAL] (C5) showed the most potent ER\u03b1 and [GENE]ER\u03b2[\\GENE] agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12.",
        "label": 5,
        "major": 5,
        "len": 56
    },
    {
        "text": "Most [CHEMICAL]parabens[\\CHEMICAL] showing estrogenic activity exhibited [GENE]ER\u03b2[\\GENE]-agonistic activity at lower concentrations than those inducing ER\u03b1-agonistic activity.",
        "label": 5,
        "major": 3,
        "len": 16
    },
    {
        "text": "Most [CHEMICAL]parabens[\\CHEMICAL] showing estrogenic activity exhibited ER\u03b2-agonistic activity at lower concentrations than those inducing [GENE]ER\u03b1[\\GENE]-agonistic activity.",
        "label": 5,
        "major": 3,
        "len": 16
    },
    {
        "text": "These results indicate that [CHEMICAL]parabens[\\CHEMICAL] are selective agonists for [GENE]ER\u03b2[\\GENE] over ER\u03b1; their interactions with ER\u03b1/\u03b2 are dependent on the size and bulkiness of the alkyl groups; and they are metabolized by carboxylesterases, leading to attenuation of their estrogenic activity.",
        "label": 5,
        "major": 2,
        "len": 40
    },
    {
        "text": "These results indicate that [CHEMICAL]parabens[\\CHEMICAL] are selective agonists for ER\u03b2 over [GENE]ER\u03b1[\\GENE]; their interactions with ER\u03b1/\u03b2 are dependent on the size and bulkiness of the alkyl groups; and they are metabolized by carboxylesterases, leading to attenuation of their estrogenic activity.",
        "label": 5,
        "major": 5,
        "len": 40
    },
    {
        "text": "Fourteen of 17 [CHEMICAL]parabens[\\CHEMICAL] exhibited [GENE]hER\u03b1[\\GENE] and/or hER\u03b2 agonistic activity at concentrations of \u2a7d1\u00d710(-5)M, whereas none of the 17 parabens showed AR agonistic or antagonistic activity.",
        "label": 5,
        "major": 6,
        "len": 26
    },
    {
        "text": "Fourteen of 17 [CHEMICAL]parabens[\\CHEMICAL] exhibited hER\u03b1 and/or [GENE]hER\u03b2[\\GENE] agonistic activity at concentrations of \u2a7d1\u00d710(-5)M, whereas none of the 17 parabens showed AR agonistic or antagonistic activity.",
        "label": 5,
        "major": 6,
        "len": 26
    },
    {
        "text": "Among 12 [CHEMICAL]parabens[\\CHEMICAL] with linear alkyl chains ranging in length from C1 to C12, heptylparaben (C7) and pentylparaben (C5) showed the most potent [GENE]ER\u03b1[\\GENE] and ER\u03b2 agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12.",
        "label": 5,
        "major": 5,
        "len": 56
    },
    {
        "text": "Among 12 [CHEMICAL]parabens[\\CHEMICAL] with linear alkyl chains ranging in length from C1 to C12, heptylparaben (C7) and pentylparaben (C5) showed the most potent ER\u03b1 and [GENE]ER\u03b2[\\GENE] agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12.",
        "label": 5,
        "major": 4,
        "len": 56
    },
    {
        "text": "Among 12 parabens with linear [CHEMICAL]alkyl[\\CHEMICAL] chains ranging in length from C1 to C12, heptylparaben (C7) and pentylparaben (C5) showed the most potent [GENE]ER\u03b1[\\GENE] and ER\u03b2 agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12.",
        "label": 5,
        "major": 5,
        "len": 56
    },
    {
        "text": "Among 12 parabens with linear [CHEMICAL]alkyl[\\CHEMICAL] chains ranging in length from C1 to C12, heptylparaben (C7) and pentylparaben (C5) showed the most potent ER\u03b1 and [GENE]ER\u03b2[\\GENE] agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12.",
        "label": 5,
        "major": 5,
        "len": 56
    },
    {
        "text": "These results indicate that [CHEMICAL]parabens[\\CHEMICAL] are selective agonists for ER\u03b2 over ER\u03b1; their interactions with ER\u03b1/\u03b2 are dependent on the size and bulkiness of the alkyl groups; and they are metabolized by [GENE]carboxylesterases[\\GENE], leading to attenuation of their estrogenic activity.",
        "label": 9,
        "major": 5,
        "len": 40
    },
    {
        "text": "Wattakaka volubilis [CHEMICAL]steroidal glycoside[\\CHEMICAL] mixture (WVSM) and PPG (1-50\u03bcM) significantly inhibited the [GENE]COX-2[\\GENE] and iNOS enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells.",
        "label": 4,
        "major": 3,
        "len": 30
    },
    {
        "text": "Wattakaka volubilis [CHEMICAL]steroidal glycoside[\\CHEMICAL] mixture (WVSM) and PPG (1-50\u03bcM) significantly inhibited the COX-2 and [GENE]iNOS[\\GENE] enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells.",
        "label": 4,
        "major": 3,
        "len": 30
    },
    {
        "text": "Wattakaka volubilis steroidal glycoside mixture (WVSM) and [CHEMICAL]PPG[\\CHEMICAL] (1-50\u03bcM) significantly inhibited the [GENE]COX-2[\\GENE] and iNOS enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells.",
        "label": 4,
        "major": 3,
        "len": 30
    },
    {
        "text": "Wattakaka volubilis steroidal glycoside mixture (WVSM) and [CHEMICAL]PPG[\\CHEMICAL] (1-50\u03bcM) significantly inhibited the COX-2 and [GENE]iNOS[\\GENE] enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells.",
        "label": 4,
        "major": 3,
        "len": 30
    },
    {
        "text": "[GENE]E-cadherin[\\GENE] is a transmembrane glycoprotein that mediates [CHEMICAL]calcium[\\CHEMICAL]-dependent interactions between adjacent epithelial cells.",
        "label": 2,
        "major": 2,
        "len": 13
    },
    {
        "text": "However, the precise mechanism by which quercetin counteracts [GENE]CYP2E1[\\GENE]-mediated [CHEMICAL]ethanol[\\CHEMICAL] hepatotoxicity through HO-1 system is still remained unclear.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "CO scavenging blocked the suppression of [CHEMICAL]quercetin[\\CHEMICAL] only on [GENE]CYP2E1[\\GENE] activity.",
        "label": 2,
        "major": -1,
        "len": 11
    },
    {
        "text": "Quercetin suppressed [GENE]CYP2E1[\\GENE]-dependent [CHEMICAL]ethanol[\\CHEMICAL] hepatotoxicity via depleting heme pool and releasing CO.",
        "label": 2,
        "major": -1,
        "len": 12
    },
    {
        "text": "Thus, [GENE]CYP2E1[\\GENE]-mediated [CHEMICAL]ethanol[\\CHEMICAL] hepatotoxicity was alleviated by quercetin through HO-1 induction.",
        "label": 2,
        "major": 3,
        "len": 11
    },
    {
        "text": "However, the precise mechanism by which [CHEMICAL]quercetin[\\CHEMICAL] counteracts CYP2E1-mediated ethanol hepatotoxicity through [GENE]HO-1[\\GENE] system is still remained unclear.",
        "label": 2,
        "major": -1,
        "len": 18
    },
    {
        "text": "Our data showed that chronic [CHEMICAL]ethanol[\\CHEMICAL] over-activated [GENE]CYP2E1[\\GENE] but suppressed HO-1 with concurrent hepatic oxidative damage, which was partially normalized by quercetin (100mg/kg.bw.).",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] (100\u03bcM) induced [GENE]HO-1[\\GENE] and depleted heme pool when incubated to human hepatocytes.",
        "label": 3,
        "major": 3,
        "len": 13
    },
    {
        "text": "[CHEMICAL]Ethanol[\\CHEMICAL]-stimulated (100mM) [GENE]CYP2E1[\\GENE] upregulation was suppressed by quercetin but further enhanced by HO-1 inhibition with resultant heme accumulation.",
        "label": 3,
        "major": 3,
        "len": 18
    },
    {
        "text": "CO donor dose-dependently inactivated [GENE]CYP2E1[\\GENE] of [CHEMICAL]ethanol[\\CHEMICAL]-incubated microsome, which was mimicked by HO-1 substrate but abolished by CO scavenger.",
        "label": 3,
        "major": 3,
        "len": 19
    },
    {
        "text": "Thus, CYP2E1-mediated ethanol hepatotoxicity was alleviated by [CHEMICAL]quercetin[\\CHEMICAL] through [GENE]HO-1[\\GENE] induction.",
        "label": 3,
        "major": 3,
        "len": 11
    },
    {
        "text": "Our data showed that chronic [CHEMICAL]ethanol[\\CHEMICAL] over-activated CYP2E1 but suppressed [GENE]HO-1[\\GENE] with concurrent hepatic oxidative damage, which was partially normalized by quercetin (100mg/kg.bw.).",
        "label": 4,
        "major": 3,
        "len": 23
    },
    {
        "text": "Ethanol-stimulated (100mM) [GENE]CYP2E1[\\GENE] upregulation was suppressed by [CHEMICAL]quercetin[\\CHEMICAL] but further enhanced by HO-1 inhibition with resultant heme accumulation.",
        "label": 4,
        "major": 3,
        "len": 18
    },
    {
        "text": "[CHEMICAL]CO[\\CHEMICAL] scavenging blocked the suppression of quercetin only on [GENE]CYP2E1[\\GENE] activity.",
        "label": 4,
        "major": -1,
        "len": 11
    },
    {
        "text": "[CHEMICAL]CO[\\CHEMICAL] donor dose-dependently inactivated [GENE]CYP2E1[\\GENE] of ethanol-incubated microsome, which was mimicked by HO-1 substrate but abolished by CO scavenger.",
        "label": 4,
        "major": 9,
        "len": 19
    },
    {
        "text": "[CHEMICAL]Quercetin[\\CHEMICAL] suppressed [GENE]CYP2E1[\\GENE]-dependent ethanol hepatotoxicity via depleting heme pool and releasing CO.",
        "label": 4,
        "major": -1,
        "len": 12
    },
    {
        "text": "CO donor dose-dependently inactivated [GENE]CYP2E1[\\GENE] of ethanol-incubated microsome, which was mimicked by HO-1 substrate but abolished by [CHEMICAL]CO[\\CHEMICAL] scavenger.",
        "label": 4,
        "major": 9,
        "len": 19
    },
    {
        "text": "However, the precise mechanism by which [CHEMICAL]quercetin[\\CHEMICAL] counteracts [GENE]CYP2E1[\\GENE]-mediated ethanol hepatotoxicity through HO-1 system is still remained unclear.",
        "label": 4,
        "major": -1,
        "len": 18
    },
    {
        "text": "[CHEMICAL]Ethanol[\\CHEMICAL]-stimulated (100mM) CYP2E1 upregulation was suppressed by quercetin but further enhanced by [GENE]HO-1[\\GENE] inhibition with resultant heme accumulation.",
        "label": 4,
        "major": 3,
        "len": 18
    },
    {
        "text": "Depleted heme pool and [CHEMICAL]CO[\\CHEMICAL] releasing limited protein synthesis and inhibited enzymatic activity of [GENE]CYP2E1[\\GENE], respectively.",
        "label": 4,
        "major": 4,
        "len": 16
    },
    {
        "text": "Ethanol-stimulated (100mM) CYP2E1 upregulation was suppressed by quercetin but further enhanced by [GENE]HO-1[\\GENE] inhibition with resultant [CHEMICAL]heme[\\CHEMICAL] accumulation.",
        "label": 9,
        "major": 3,
        "len": 18
    },
    {
        "text": "Novel racemic [CHEMICAL]tetrahydrocurcuminoid dihydropyrimidinone[\\CHEMICAL] analogues as potent [GENE]acetylcholinesterase[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 9
    },
    {
        "text": "Both [CHEMICAL]ICI[\\CHEMICAL] treatments, induced a significant decrease (p<0.01) in uterine estrogen receptor alpha (ER\u03b1) content, had no effect on uterine [GENE]progesterone receptor[\\GENE] (PR) protein expression and caused marked nuclear localization of cyclin D1, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals.",
        "label": 10,
        "major": 3,
        "len": 45
    },
    {
        "text": "Both [CHEMICAL]ICI[\\CHEMICAL] treatments, induced a significant decrease (p<0.01) in uterine estrogen receptor alpha (ER\u03b1) content, had no effect on uterine progesterone receptor ([GENE]PR[\\GENE]) protein expression and caused marked nuclear localization of cyclin D1, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals.",
        "label": 10,
        "major": 4,
        "len": 45
    },
    {
        "text": "We observed that the administration of ICI at 08:00h on proestrus day produced a 15% inhibition of luminal epithelial cell proliferation, reduced uterine wet weight by 21% and caused reduction of [GENE]Akt[\\GENE] phosphorylation at [CHEMICAL]Ser[\\CHEMICAL] 473 as compared to vehicle-treated animals, whereas ICI treatment at 00:00h on estrus day had no effect on these parameters.",
        "label": 1,
        "major": 4,
        "len": 55
    },
    {
        "text": "Both [CHEMICAL]ICI[\\CHEMICAL] treatments, induced a significant decrease (p<0.01) in uterine estrogen receptor alpha (ER\u03b1) content, had no effect on uterine progesterone receptor (PR) protein expression and caused marked nuclear localization of [GENE]cyclin D1[\\GENE], in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals.",
        "label": 2,
        "major": 3,
        "len": 45
    },
    {
        "text": "Furthermore, we detected that [CHEMICAL]ICI[\\CHEMICAL] treatment induced glycogen synthase kinase (Gsk3-\u03b2) Ser 9 phosphorylation, which correlates with [GENE]cyclin D1[\\GENE] nuclear localization.",
        "label": 2,
        "major": 3,
        "len": 21
    },
    {
        "text": "Furthermore, we detected that [CHEMICAL]ICI[\\CHEMICAL] treatment induced [GENE]glycogen synthase kinase[\\GENE] (Gsk3-\u03b2) Ser 9 phosphorylation, which correlates with cyclin D1 nuclear localization.",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "Furthermore, we detected that [CHEMICAL]ICI[\\CHEMICAL] treatment induced glycogen synthase kinase ([GENE]Gsk3-\u03b2[\\GENE]) Ser 9 phosphorylation, which correlates with cyclin D1 nuclear localization.",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "Agonistic activity of [CHEMICAL]ICI 182 780[\\CHEMICAL] on activation of GSK 3\u03b2/[GENE]AKT[\\GENE] pathway in the rat uterus during the estrous cycle.",
        "label": 3,
        "major": 3,
        "len": 20
    },
    {
        "text": "The overall results indicate that [CHEMICAL]ICI[\\CHEMICAL] may exert agonistic and antagonistic effects on uterine cell proliferation through differential activation of the [GENE]Akt[\\GENE] pathway depending on the administration period during the estrous cycle, and indicates that the mechanism of cell proliferation during the physiological conditions of the estrous cycle, is under a different and more complex regulation than in the ovariectomized +E2 animal model.",
        "label": 3,
        "major": 6,
        "len": 63
    },
    {
        "text": "Both [CHEMICAL]ICI[\\CHEMICAL] treatments, induced a significant decrease (p<0.01) in uterine [GENE]estrogen receptor alpha[\\GENE] (ER\u03b1) content, had no effect on uterine progesterone receptor (PR) protein expression and caused marked nuclear localization of cyclin D1, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals.",
        "label": 4,
        "major": 3,
        "len": 45
    },
    {
        "text": "Both [CHEMICAL]ICI[\\CHEMICAL] treatments, induced a significant decrease (p<0.01) in uterine estrogen receptor alpha ([GENE]ER\u03b1[\\GENE]) content, had no effect on uterine progesterone receptor (PR) protein expression and caused marked nuclear localization of cyclin D1, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals.",
        "label": 4,
        "major": 4,
        "len": 45
    },
    {
        "text": "We observed that the administration of [CHEMICAL]ICI[\\CHEMICAL] at 08:00h on proestrus day produced a 15% inhibition of luminal epithelial cell proliferation, reduced uterine wet weight by 21% and caused reduction of [GENE]Akt[\\GENE] phosphorylation at Ser 473 as compared to vehicle-treated animals, whereas ICI treatment at 00:00h on estrus day had no effect on these parameters.",
        "label": 4,
        "major": 4,
        "len": 55
    },
    {
        "text": "Agonistic activity of [CHEMICAL]ICI 182 780[\\CHEMICAL] on activation of [GENE]GSK 3\u03b2[\\GENE]/AKT pathway in the rat uterus during the estrous cycle.",
        "label": 5,
        "major": 3,
        "len": 20
    },
    {
        "text": "A series of [CHEMICAL]aminopropylindenes[\\CHEMICAL], designed as mimics of a cationic high energy intermediate in the oxidosqualene cyclase(1) ([GENE]OSC[\\GENE])-mediated cyclization of 2,3-oxidosqualen to lanosterol was prepared from Grundmann's ketone.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "A series of [CHEMICAL]aminopropylindenes[\\CHEMICAL], designed as mimics of a cationic high energy intermediate in the [GENE]oxidosqualene cyclase(1)[\\GENE] (OSC)-mediated cyclization of 2,3-oxidosqualen to lanosterol was prepared from Grundmann's ketone.",
        "label": 2,
        "major": -1,
        "len": 28
    },
    {
        "text": "A [CHEMICAL]N,N-dimethylaminopropyl[\\CHEMICAL] derivative showed promising inhibition of [GENE]Trypanosoma cruzi OSC[\\GENE] in combination with low cytotoxicity, and showed significant reduction of cholesterol biosynthesis in a human cell line.",
        "label": 4,
        "major": 4,
        "len": 27
    },
    {
        "text": "[CHEMICAL]Aminopropylindenes[\\CHEMICAL] derived from Grundmann's ketone as a novel chemotype of [GENE]oxidosqualene cyclase[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Aminopropylindenes derived from [CHEMICAL]Grundmann's ketone[\\CHEMICAL] as a novel chemotype of [GENE]oxidosqualene cyclase[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "A series of aminopropylindenes, designed as mimics of a cationic high energy intermediate in the oxidosqualene cyclase(1) ([GENE]OSC[\\GENE])-mediated cyclization of 2,3-oxidosqualen to [CHEMICAL]lanosterol[\\CHEMICAL] was prepared from Grundmann's ketone.",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "A series of aminopropylindenes, designed as mimics of a cationic high energy intermediate in the [GENE]oxidosqualene cyclase(1)[\\GENE] (OSC)-mediated cyclization of 2,3-oxidosqualen to [CHEMICAL]lanosterol[\\CHEMICAL] was prepared from Grundmann's ketone.",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "A N,N-dimethylaminopropyl derivative showed promising inhibition of [GENE]Trypanosoma cruzi OSC[\\GENE] in combination with low cytotoxicity, and showed significant reduction of [CHEMICAL]cholesterol[\\CHEMICAL] biosynthesis in a human cell line.",
        "label": 9,
        "major": 4,
        "len": 27
    },
    {
        "text": "A series of aminopropylindenes, designed as mimics of a cationic high energy intermediate in the oxidosqualene cyclase(1) ([GENE]OSC[\\GENE])-mediated cyclization of [CHEMICAL]2,3-oxidosqualen[\\CHEMICAL] to lanosterol was prepared from Grundmann's ketone.",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "A series of aminopropylindenes, designed as mimics of a cationic high energy intermediate in the [GENE]oxidosqualene cyclase(1)[\\GENE] (OSC)-mediated cyclization of [CHEMICAL]2,3-oxidosqualen[\\CHEMICAL] to lanosterol was prepared from Grundmann's ketone.",
        "label": 9,
        "major": -1,
        "len": 28
    },
    {
        "text": "MRS2179, a P2Y1R blocker, prevented potentiation in EDL, but not soleus muscles, suggesting that in fast muscles [CHEMICAL]ATP[\\CHEMICAL] activates P2Y1 but not [GENE]P2X receptors[\\GENE].",
        "label": 10,
        "major": 10,
        "len": 24
    },
    {
        "text": "Phosphorylation on [CHEMICAL]Ser[\\CHEMICAL] and Thr residues of [GENE]pannexin1[\\GENE] was increased during potentiation, possibly mediating HC opening.",
        "label": 1,
        "major": 3,
        "len": 16
    },
    {
        "text": "Phosphorylation on Ser and [CHEMICAL]Thr[\\CHEMICAL] residues of [GENE]pannexin1[\\GENE] was increased during potentiation, possibly mediating HC opening.",
        "label": 1,
        "major": 3,
        "len": 16
    },
    {
        "text": "Immunocytochemical analyses and function were consistent with [GENE]pannexin1[\\GENE] localization to T-tubules intercalated with [CHEMICAL]dihydropyridine[\\CHEMICAL] and ryanodine receptors in slow (soleus) and fast (extensor digitorum longus, EDL) muscles.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "During repetitive stimulation of skeletal muscle, extracellular [CHEMICAL]ATP[\\CHEMICAL] levels raise, activating [GENE]purinergic receptors[\\GENE], increasing Ca(2+) influx, and enhancing contractile force, a response called potentiation.",
        "label": 3,
        "major": 3,
        "len": 24
    },
    {
        "text": "MRS2179, a P2Y1R blocker, prevented potentiation in EDL, but not soleus muscles, suggesting that in fast muscles [CHEMICAL]ATP[\\CHEMICAL] activates [GENE]P2Y1[\\GENE] but not P2X receptors.",
        "label": 3,
        "major": 10,
        "len": 24
    },
    {
        "text": "Consistent with two [CHEMICAL]glucose[\\CHEMICAL] uptake pathways, induced uptake of 2-NBDG, a fluorescent glucose derivative, was decreased by inhibition of HCs or [GENE]glucose transporter[\\GENE] (GLUT4), and blocked by dual blockade.",
        "label": 9,
        "major": 4,
        "len": 29
    },
    {
        "text": "Consistent with two [CHEMICAL]glucose[\\CHEMICAL] uptake pathways, induced uptake of 2-NBDG, a fluorescent glucose derivative, was decreased by inhibition of HCs or glucose transporter ([GENE]GLUT4[\\GENE]), and blocked by dual blockade.",
        "label": 9,
        "major": 4,
        "len": 29
    },
    {
        "text": "Consistent with two glucose uptake pathways, induced uptake of [CHEMICAL]2-NBDG[\\CHEMICAL], a fluorescent glucose derivative, was decreased by inhibition of HCs or [GENE]glucose transporter[\\GENE] (GLUT4), and blocked by dual blockade.",
        "label": 9,
        "major": 4,
        "len": 29
    },
    {
        "text": "Consistent with two glucose uptake pathways, induced uptake of [CHEMICAL]2-NBDG[\\CHEMICAL], a fluorescent glucose derivative, was decreased by inhibition of HCs or glucose transporter ([GENE]GLUT4[\\GENE]), and blocked by dual blockade.",
        "label": 9,
        "major": 4,
        "len": 29
    },
    {
        "text": "The [CHEMICAL]ATP[\\CHEMICAL] required for potentiation of skeletal muscle contraction is released via [GENE]pannexin[\\GENE] hemichannels.",
        "label": 9,
        "major": -1,
        "len": 14
    },
    {
        "text": "Opening of [GENE]Panx1[\\GENE] HCs during repetitive activation allows efflux of [CHEMICAL]ATP[\\CHEMICAL], influx of glucose and possibly Ca(2+) too, which are required for potentiation of contraction.",
        "label": 9,
        "major": 3,
        "len": 25
    },
    {
        "text": "Opening of [GENE]Panx1[\\GENE] HCs during repetitive activation allows efflux of ATP, influx of [CHEMICAL]glucose[\\CHEMICAL] and possibly Ca(2+) too, which are required for potentiation of contraction.",
        "label": 9,
        "major": 3,
        "len": 25
    },
    {
        "text": "Opening of [GENE]Panx1[\\GENE] HCs during repetitive activation allows efflux of ATP, influx of glucose and possibly [CHEMICAL]Ca(2+)[\\CHEMICAL] too, which are required for potentiation of contraction.",
        "label": 9,
        "major": 3,
        "len": 25
    },
    {
        "text": "The rate limiting enzyme of beta-oxidation ([GENE]ACOX1[\\GENE]) was significantly over-expressed in the liver with [CHEMICAL]tBHQ[\\CHEMICAL] treatment.",
        "label": 3,
        "major": -1,
        "len": 16
    },
    {
        "text": "These results indicate that [CHEMICAL]tBHQ[\\CHEMICAL] suppresses body weight gain in mice, possibly at least related to the up-regulation of [GENE]ACOX1[\\GENE] gene expression.",
        "label": 3,
        "major": -1,
        "len": 22
    },
    {
        "text": "When dual angiogenic growth factors (GFs), such as platelet-derived GF (PDGF) and vascular endothelial GF (VEGF), are encapsulated separately in the core and shell domains, respectively, the [GENE]VEGF[\\GENE] release rate is much greater than that of PDGF, and the difference of the cumulative release percentage between the two GFs is about 30% on day 7 with LMW core [CHEMICAL]PLGA[\\CHEMICAL] and more than 45% with HMW core PLGA.",
        "label": 3,
        "major": -1,
        "len": 67
    },
    {
        "text": "When dual angiogenic growth factors (GFs), such as platelet-derived GF (PDGF) and vascular endothelial GF (VEGF), are encapsulated separately in the core and shell domains, respectively, the VEGF release rate is much greater than that of [GENE]PDGF[\\GENE], and the difference of the cumulative release percentage between the two GFs is about 30% on day 7 with LMW core [CHEMICAL]PLGA[\\CHEMICAL] and more than 45% with HMW core PLGA.",
        "label": 3,
        "major": -1,
        "len": 67
    },
    {
        "text": "When dual angiogenic growth factors (GFs), such as platelet-derived GF (PDGF) and vascular endothelial GF (VEGF), are encapsulated separately in the core and shell domains, respectively, the [GENE]VEGF[\\GENE] release rate is much greater than that of PDGF, and the difference of the cumulative release percentage between the two GFs is about 30% on day 7 with LMW core PLGA and more than 45% with HMW core [CHEMICAL]PLGA[\\CHEMICAL].",
        "label": 3,
        "major": -1,
        "len": 67
    },
    {
        "text": "When dual angiogenic growth factors (GFs), such as platelet-derived GF (PDGF) and vascular endothelial GF (VEGF), are encapsulated separately in the core and shell domains, respectively, the VEGF release rate is much greater than that of [GENE]PDGF[\\GENE], and the difference of the cumulative release percentage between the two GFs is about 30% on day 7 with LMW core PLGA and more than 45% with HMW core [CHEMICAL]PLGA[\\CHEMICAL].",
        "label": 3,
        "major": -1,
        "len": 67
    },
    {
        "text": "Potency switch between CHK1 and [GENE]MK2[\\GENE]: Discovery of [CHEMICAL]imidazo[1,2-a]pyrazine[\\CHEMICAL]- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Potency switch between CHK1 and MK2: Discovery of [CHEMICAL]imidazo[1,2-a]pyrazine[\\CHEMICAL]- and imidazo[1,2-c]pyrimidine-based [GENE]kinase[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Potency switch between [GENE]CHK1[\\GENE] and MK2: Discovery of [CHEMICAL]imidazo[1,2-a]pyrazine[\\CHEMICAL]- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Potency switch between CHK1 and [GENE]MK2[\\GENE]: Discovery of imidazo[1,2-a]pyrazine- and [CHEMICAL]imidazo[1,2-c]pyrimidine[\\CHEMICAL]-based kinase inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and [CHEMICAL]imidazo[1,2-c]pyrimidine[\\CHEMICAL]-based [GENE]kinase[\\GENE] inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Potency switch between [GENE]CHK1[\\GENE] and MK2: Discovery of imidazo[1,2-a]pyrazine- and [CHEMICAL]imidazo[1,2-c]pyrimidine[\\CHEMICAL]-based kinase inhibitors.",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "In the present report, we show that Fer associates with the activated [GENE]PDGFbeta receptor[\\GENE] (PDGFRbeta) through multiple autophosphorylation sites, i.e. [CHEMICAL]Tyr[\\CHEMICAL]579, Tyr581, Tyr740 and Tyr1021.",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "In the present report, we show that Fer associates with the activated PDGFbeta receptor ([GENE]PDGFRbeta[\\GENE]) through multiple autophosphorylation sites, i.e. [CHEMICAL]Tyr[\\CHEMICAL]579, Tyr581, Tyr740 and Tyr1021.",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "In the present report, we show that Fer associates with the activated [GENE]PDGFbeta receptor[\\GENE] (PDGFRbeta) through multiple autophosphorylation sites, i.e. Tyr579, [CHEMICAL]Tyr[\\CHEMICAL]581, Tyr740 and Tyr1021.",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "In the present report, we show that Fer associates with the activated PDGFbeta receptor ([GENE]PDGFRbeta[\\GENE]) through multiple autophosphorylation sites, i.e. Tyr579, [CHEMICAL]Tyr[\\CHEMICAL]581, Tyr740 and Tyr1021.",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "In the present report, we show that Fer associates with the activated [GENE]PDGFbeta receptor[\\GENE] (PDGFRbeta) through multiple autophosphorylation sites, i.e. Tyr579, Tyr581, [CHEMICAL]Tyr[\\CHEMICAL]740 and Tyr1021.",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "In the present report, we show that Fer associates with the activated PDGFbeta receptor ([GENE]PDGFRbeta[\\GENE]) through multiple autophosphorylation sites, i.e. Tyr579, Tyr581, [CHEMICAL]Tyr[\\CHEMICAL]740 and Tyr1021.",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "In the present report, we show that Fer associates with the activated [GENE]PDGFbeta receptor[\\GENE] (PDGFRbeta) through multiple autophosphorylation sites, i.e. Tyr579, Tyr581, Tyr740 and [CHEMICAL]Tyr[\\CHEMICAL]1021.",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "In the present report, we show that Fer associates with the activated PDGFbeta receptor ([GENE]PDGFRbeta[\\GENE]) through multiple autophosphorylation sites, i.e. Tyr579, Tyr581, Tyr740 and [CHEMICAL]Tyr[\\CHEMICAL]1021.",
        "label": 1,
        "major": 3,
        "len": 25
    },
    {
        "text": "A series of structurally novel [CHEMICAL]aryl ureas[\\CHEMICAL] was derived from optimization of the HTS lead as selective [GENE]histamine H3 receptor[\\GENE] (H3R) antagonists.",
        "label": 6,
        "major": 6,
        "len": 22
    },
    {
        "text": "A series of structurally novel [CHEMICAL]aryl ureas[\\CHEMICAL] was derived from optimization of the HTS lead as selective histamine H3 receptor ([GENE]H3R[\\GENE]) antagonists.",
        "label": 6,
        "major": 6,
        "len": 22
    },
    {
        "text": "Discovery of [CHEMICAL]aryl ureas[\\CHEMICAL] and aryl amides as potent and selective [GENE]histamine H3 receptor[\\GENE] antagonists for the treatment of obesity (Part I).",
        "label": 6,
        "major": 6,
        "len": 22
    },
    {
        "text": "Discovery of aryl ureas and [CHEMICAL]aryl amides[\\CHEMICAL] as potent and selective [GENE]histamine H3 receptor[\\GENE] antagonists for the treatment of obesity (Part I).",
        "label": 6,
        "major": 6,
        "len": 22
    },
    {
        "text": "An increase in the energy required to remove the same anion from the [GENE]tridentate receptor[\\GENE] when compared to the bidentate and monodentate receptors is explained as being due to the increase in [CHEMICAL]halogen[\\CHEMICAL] bonding interactions.",
        "label": 2,
        "major": 3,
        "len": 35
    },
    {
        "text": "In terms of the mechanisms, we found that fatty acid amide hydrolase ([GENE]FAAH[\\GENE]) which degrades [CHEMICAL]anandamide[\\CHEMICAL], was upregulated after nerve injury at both ages, so that this upregulation likely did not account for the age-dependent differences.",
        "label": 9,
        "major": 3,
        "len": 36
    },
    {
        "text": "In terms of the mechanisms, we found that [GENE]fatty acid amide hydrolase[\\GENE] (FAAH) which degrades [CHEMICAL]anandamide[\\CHEMICAL], was upregulated after nerve injury at both ages, so that this upregulation likely did not account for the age-dependent differences.",
        "label": 9,
        "major": 10,
        "len": 36
    },
    {
        "text": "However, enzymes contributing to oxidative metabolism of [CHEMICAL]anandamide[\\CHEMICAL], namely [GENE]cyclooxygenase-1[\\GENE] and Cyp2D6, were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of anandamide.",
        "label": 9,
        "major": 3,
        "len": 27
    },
    {
        "text": "However, enzymes contributing to oxidative metabolism of [CHEMICAL]anandamide[\\CHEMICAL], namely cyclooxygenase-1 and [GENE]Cyp2D6[\\GENE], were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of anandamide.",
        "label": 9,
        "major": 3,
        "len": 27
    },
    {
        "text": "However, enzymes contributing to oxidative metabolism of anandamide, namely [GENE]cyclooxygenase-1[\\GENE] and Cyp2D6, were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of [CHEMICAL]anandamide[\\CHEMICAL].",
        "label": 9,
        "major": 3,
        "len": 27
    },
    {
        "text": "However, enzymes contributing to oxidative metabolism of anandamide, namely cyclooxygenase-1 and [GENE]Cyp2D6[\\GENE], were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of [CHEMICAL]anandamide[\\CHEMICAL].",
        "label": 9,
        "major": 3,
        "len": 27
    },
    {
        "text": "When the expression of ABCA1 and ABCG1 was induced, [CHEMICAL]24-OHC[\\CHEMICAL] efflux was stimulated in the presence of high density lipoprotein (HDL), whereas [GENE]apolipoprotein A-I[\\GENE] was not an efficient acceptor.",
        "label": 10,
        "major": 3,
        "len": 29
    },
    {
        "text": "The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and [CHEMICAL]retinoic acid[\\CHEMICAL], which are ligands of the [GENE]nuclear receptors[\\GENE] LXR/RXR.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and [CHEMICAL]retinoic acid[\\CHEMICAL], which are ligands of the nuclear receptors [GENE]LXR[\\GENE]/RXR.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and [CHEMICAL]retinoic acid[\\CHEMICAL], which are ligands of the nuclear receptors LXR/[GENE]RXR[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as [CHEMICAL]TO901317[\\CHEMICAL] and retinoic acid, which are ligands of the [GENE]nuclear receptors[\\GENE] LXR/RXR.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as [CHEMICAL]TO901317[\\CHEMICAL] and retinoic acid, which are ligands of the nuclear receptors [GENE]LXR[\\GENE]/RXR.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as [CHEMICAL]TO901317[\\CHEMICAL] and retinoic acid, which are ligands of the nuclear receptors LXR/[GENE]RXR[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "When the expression of ABCA1 and ABCG1 was induced, [CHEMICAL]24-OHC[\\CHEMICAL] efflux was stimulated in the presence of [GENE]high density lipoprotein[\\GENE] (HDL), whereas apolipoprotein A-I was not an efficient acceptor.",
        "label": 2,
        "major": 3,
        "len": 29
    },
    {
        "text": "When the expression of ABCA1 and ABCG1 was induced, [CHEMICAL]24-OHC[\\CHEMICAL] efflux was stimulated in the presence of high density lipoprotein ([GENE]HDL[\\GENE]), whereas apolipoprotein A-I was not an efficient acceptor.",
        "label": 2,
        "major": 3,
        "len": 29
    },
    {
        "text": "To confirm the role of each transporter, we analyzed HEK293 cells stably expressing human ABCA1 or ABCG1; we clearly observed [CHEMICAL]24-OHC[\\CHEMICAL] efflux in the presence of [GENE]HDL[\\GENE], whereas efflux in the presence of apolipoprotein A-I was marginal.",
        "label": 2,
        "major": 9,
        "len": 37
    },
    {
        "text": "To confirm the role of each transporter, we analyzed HEK293 cells stably expressing human ABCA1 or ABCG1; we clearly observed [CHEMICAL]24-OHC[\\CHEMICAL] efflux in the presence of HDL, whereas efflux in the presence of [GENE]apolipoprotein A-I[\\GENE] was marginal.",
        "label": 2,
        "major": 9,
        "len": 37
    },
    {
        "text": "These results suggest that ABCA1 actively eliminates [CHEMICAL]24-OHC[\\CHEMICAL] in the presence of [GENE]HDL[\\GENE] as a lipid acceptor and protects neuronal cells.",
        "label": 2,
        "major": -1,
        "len": 21
    },
    {
        "text": "The expression of [GENE]ABCA1[\\GENE] and ABCG1 was induced by 24-OHC, as well as TO901317 and [CHEMICAL]retinoic acid[\\CHEMICAL], which are ligands of the nuclear receptors LXR/RXR.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "The expression of ABCA1 and [GENE]ABCG1[\\GENE] was induced by 24-OHC, as well as TO901317 and [CHEMICAL]retinoic acid[\\CHEMICAL], which are ligands of the nuclear receptors LXR/RXR.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "The expression of [GENE]ABCA1[\\GENE] and ABCG1 was induced by [CHEMICAL]24-OHC[\\CHEMICAL], as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "The expression of ABCA1 and [GENE]ABCG1[\\GENE] was induced by [CHEMICAL]24-OHC[\\CHEMICAL], as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "The expression of [GENE]ABCA1[\\GENE] and ABCG1 was induced by 24-OHC, as well as [CHEMICAL]TO901317[\\CHEMICAL] and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "The expression of ABCA1 and [GENE]ABCG1[\\GENE] was induced by 24-OHC, as well as [CHEMICAL]TO901317[\\CHEMICAL] and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "Because [CHEMICAL]24(S)-hydroxycholesterol[\\CHEMICAL] (24-OHC), produced by [GENE]24-hydroxylase[\\GENE], induces apoptosis of neuronal cells, it is vital to eliminate it rapidly from cells.",
        "label": 9,
        "major": 3,
        "len": 20
    },
    {
        "text": "Because 24(S)-hydroxycholesterol ([CHEMICAL]24-OHC[\\CHEMICAL]), produced by [GENE]24-hydroxylase[\\GENE], induces apoptosis of neuronal cells, it is vital to eliminate it rapidly from cells.",
        "label": 9,
        "major": 3,
        "len": 20
    },
    {
        "text": "To confirm the role of each transporter, we analyzed HEK293 cells stably expressing [GENE]human ABCA1[\\GENE] or ABCG1; we clearly observed [CHEMICAL]24-OHC[\\CHEMICAL] efflux in the presence of HDL, whereas efflux in the presence of apolipoprotein A-I was marginal.",
        "label": 9,
        "major": 9,
        "len": 37
    },
    {
        "text": "To confirm the role of each transporter, we analyzed HEK293 cells stably expressing human ABCA1 or [GENE]ABCG1[\\GENE]; we clearly observed [CHEMICAL]24-OHC[\\CHEMICAL] efflux in the presence of HDL, whereas efflux in the presence of apolipoprotein A-I was marginal.",
        "label": 9,
        "major": 9,
        "len": 37
    },
    {
        "text": "[CHEMICAL]24(S)-hydroxycholesterol[\\CHEMICAL] is actively eliminated from neuronal cells by [GENE]ABCA1[\\GENE].",
        "label": 9,
        "major": -1,
        "len": 9
    },
    {
        "text": "These results suggest that [GENE]ABCA1[\\GENE] actively eliminates [CHEMICAL]24-OHC[\\CHEMICAL] in the presence of HDL as a lipid acceptor and protects neuronal cells.",
        "label": 9,
        "major": -1,
        "len": 21
    },
    {
        "text": "High [CHEMICAL]cholesterol[\\CHEMICAL] turnover catalyzed by [GENE]cholesterol 24-hydroxylase[\\GENE] is essential for neural functions, especially learning.",
        "label": 9,
        "major": 9,
        "len": 14
    },
    {
        "text": "Molecular docking studies were performed with [GENE]Human Serum Albumin[\\GENE] (HSA: PDB 1E78), showing binding pattern with [CHEMICAL]amino acid[\\CHEMICAL] residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.",
        "label": 1,
        "major": 2,
        "len": 41
    },
    {
        "text": "Molecular docking studies were performed with Human Serum Albumin ([GENE]HSA[\\GENE]: PDB 1E78), showing binding pattern with [CHEMICAL]amino acid[\\CHEMICAL] residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.",
        "label": 1,
        "major": 2,
        "len": 41
    },
    {
        "text": "Molecular docking studies were performed with [GENE]Human Serum Albumin[\\GENE] (HSA: PDB 1E78), showing binding pattern with amino acid residues [CHEMICAL]Arg[\\CHEMICAL]218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.",
        "label": 1,
        "major": 2,
        "len": 41
    },
    {
        "text": "Molecular docking studies were performed with Human Serum Albumin ([GENE]HSA[\\GENE]: PDB 1E78), showing binding pattern with amino acid residues [CHEMICAL]Arg[\\CHEMICAL]218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.",
        "label": 1,
        "major": 2,
        "len": 41
    },
    {
        "text": "Molecular docking studies were performed with [GENE]Human Serum Albumin[\\GENE] (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, [CHEMICAL]Arg[\\CHEMICAL]222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.",
        "label": 1,
        "major": 2,
        "len": 41
    },
    {
        "text": "Molecular docking studies were performed with Human Serum Albumin ([GENE]HSA[\\GENE]: PDB 1E78), showing binding pattern with amino acid residues Arg218, [CHEMICAL]Arg[\\CHEMICAL]222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.",
        "label": 1,
        "major": 2,
        "len": 41
    },
    {
        "text": "Molecular docking studies were performed with [GENE]Human Serum Albumin[\\GENE] (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and [CHEMICAL]Lys[\\CHEMICAL]444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.",
        "label": 1,
        "major": 2,
        "len": 41
    },
    {
        "text": "Molecular docking studies were performed with Human Serum Albumin ([GENE]HSA[\\GENE]: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and [CHEMICAL]Lys[\\CHEMICAL]444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.",
        "label": 1,
        "major": 2,
        "len": 41
    },
    {
        "text": "These experiments show that in striatonigral projections, [GENE]CaMKII\u03b1[\\GENE] inhibits the action of D3 receptors in a [CHEMICAL]Ca(2+)[\\CHEMICAL] dependent manner blocking their modulatory effects on GABA release.",
        "label": 2,
        "major": 7,
        "len": 26
    },
    {
        "text": "These experiments show that in striatonigral projections, CaMKII\u03b1 inhibits the action of [GENE]D3 receptors[\\GENE] in a [CHEMICAL]Ca(2+)[\\CHEMICAL] dependent manner blocking their modulatory effects on GABA release.",
        "label": 2,
        "major": 7,
        "len": 26
    },
    {
        "text": "Immunoblot studies showed that K(+)-depolarization increased CaMKII\u03b1 phosphorylation in a [CHEMICAL]KN-62[\\CHEMICAL] sensitive manner and promoted [GENE]CaMKII\u03b1[\\GENE] binding to D3 receptors.",
        "label": 2,
        "major": 2,
        "len": 20
    },
    {
        "text": "Immunoblot studies showed that K(+)-depolarization increased CaMKII\u03b1 phosphorylation in a [CHEMICAL]KN-62[\\CHEMICAL] sensitive manner and promoted CaMKII\u03b1 binding to [GENE]D3 receptors[\\GENE].",
        "label": 2,
        "major": 2,
        "len": 20
    },
    {
        "text": "Immunoblot studies showed that K(+)-depolarization increased [GENE]CaMKII\u03b1[\\GENE] phosphorylation in a [CHEMICAL]KN-62[\\CHEMICAL] sensitive manner and promoted CaMKII\u03b1 binding to D3 receptors.",
        "label": 2,
        "major": 3,
        "len": 20
    },
    {
        "text": "Immunoblot studies showed that [CHEMICAL]K(+)[\\CHEMICAL]-depolarization increased [GENE]CaMKII\u03b1[\\GENE] phosphorylation in a KN-62 sensitive manner and promoted CaMKII\u03b1 binding to D3 receptors.",
        "label": 2,
        "major": 3,
        "len": 20
    },
    {
        "text": "Presynaptic [GENE]CaMKII\u03b1[\\GENE] modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a [CHEMICAL]Ca(2+)[\\CHEMICAL] dependent manner.",
        "label": 2,
        "major": 3,
        "len": 19
    },
    {
        "text": "Presynaptic CaMKII\u03b1 modulates [GENE]dopamine D3 receptor[\\GENE] activation in striatonigral terminals of the rat brain in a [CHEMICAL]Ca(2+)[\\CHEMICAL] dependent manner.",
        "label": 2,
        "major": 7,
        "len": 19
    },
    {
        "text": "The selective [GENE]CaMKII\u03b1[\\GENE] inhibitor [CHEMICAL]KN-62[\\CHEMICAL] reversed the blockade produced by ionomycin and K(+)-depolarization.",
        "label": 4,
        "major": 9,
        "len": 13
    },
    {
        "text": "The selective [GENE]CaMKII\u03b1[\\GENE] inhibitor KN-62 reversed the blockade produced by [CHEMICAL]ionomycin[\\CHEMICAL] and K(+)-depolarization.",
        "label": 4,
        "major": 9,
        "len": 13
    },
    {
        "text": "In K(+)-depolarized tissues, D3 receptors potentiated D1 receptor-induced stimulation of [(3)H]GABA release only when [GENE]CaMKII\u03b1[\\GENE] was blocked with [CHEMICAL]KN-62[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 19
    },
    {
        "text": "In the presence of this inhibitor, the selective [GENE]D3[\\GENE] agonist [CHEMICAL]PD 128,907[\\CHEMICAL] reduced the ED50 for the D1 agonist SKF 38393 from 56 to 4\u00a0nM.",
        "label": 5,
        "major": 4,
        "len": 25
    },
    {
        "text": "In the presence of this inhibitor, the selective D3 agonist PD 128,907 reduced the ED50 for the [GENE]D1[\\GENE] agonist [CHEMICAL]SKF 38393[\\CHEMICAL] from 56 to 4\u00a0nM.",
        "label": 5,
        "major": 4,
        "len": 25
    },
    {
        "text": "Additionally, treatment with [CHEMICAL]glucose[\\CHEMICAL]/iron showed a higher [GENE]HO[\\GENE] activity.",
        "label": 3,
        "major": -1,
        "len": 9
    },
    {
        "text": "Additionally, treatment with glucose/[CHEMICAL]iron[\\CHEMICAL] showed a higher [GENE]HO[\\GENE] activity.",
        "label": 3,
        "major": -1,
        "len": 9
    },
    {
        "text": "The [GENE]Bcl2[\\GENE]/Bax ratio increased and Mfn2 expression decreased in MIN6 cells after [CHEMICAL]glucose[\\CHEMICAL] stimulation.",
        "label": 3,
        "major": 3,
        "len": 14
    },
    {
        "text": "The Bcl2/[GENE]Bax[\\GENE] ratio increased and Mfn2 expression decreased in MIN6 cells after [CHEMICAL]glucose[\\CHEMICAL] stimulation.",
        "label": 3,
        "major": 3,
        "len": 14
    },
    {
        "text": "Our study revealed that high [CHEMICAL]glucose[\\CHEMICAL]/Fe concentrations in MIN6 cells induced an increase of the [GENE]Bcl2[\\GENE]/Bax ratio, an indicator of increased cell apoptosis.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "Our study revealed that high [CHEMICAL]glucose[\\CHEMICAL]/Fe concentrations in MIN6 cells induced an increase of the Bcl2/[GENE]Bax[\\GENE] ratio, an indicator of increased cell apoptosis.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "Our study revealed that high glucose/[CHEMICAL]Fe[\\CHEMICAL] concentrations in MIN6 cells induced an increase of the [GENE]Bcl2[\\GENE]/Bax ratio, an indicator of increased cell apoptosis.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "Our study revealed that high glucose/[CHEMICAL]Fe[\\CHEMICAL] concentrations in MIN6 cells induced an increase of the Bcl2/[GENE]Bax[\\GENE] ratio, an indicator of increased cell apoptosis.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "The Bcl2/Bax ratio increased and [GENE]Mfn2[\\GENE] expression decreased in MIN6 cells after [CHEMICAL]glucose[\\CHEMICAL] stimulation.",
        "label": 4,
        "major": 3,
        "len": 14
    },
    {
        "text": "Targeted disruption of the gene encoding the [GENE]N-glycosyltransferase[\\GENE], prlH, abolished [CHEMICAL]pyralomicin[\\CHEMICAL] production, and recombinant expression of PrlA confirms the activity of this enzyme as a sugar phosphate cyclase involved in the formation of the C7-cyclitol moiety.",
        "label": 9,
        "major": 9,
        "len": 36
    },
    {
        "text": "Targeted disruption of the gene encoding the N-glycosyltransferase, [GENE]prlH[\\GENE], abolished [CHEMICAL]pyralomicin[\\CHEMICAL] production, and recombinant expression of PrlA confirms the activity of this enzyme as a sugar phosphate cyclase involved in the formation of the C7-cyclitol moiety.",
        "label": 9,
        "major": 9,
        "len": 36
    },
    {
        "text": "Targeted disruption of the gene encoding the N-glycosyltransferase, prlH, abolished pyralomicin production, and recombinant expression of [GENE]PrlA[\\GENE] confirms the activity of this enzyme as a sugar phosphate cyclase involved in the formation of the [CHEMICAL]C7[\\CHEMICAL]-cyclitol moiety.",
        "label": 9,
        "major": 9,
        "len": 36
    },
    {
        "text": "Targeted disruption of the gene encoding the N-glycosyltransferase, prlH, abolished pyralomicin production, and recombinant expression of PrlA confirms the activity of this enzyme as a [GENE]sugar phosphate cyclase[\\GENE] involved in the formation of the [CHEMICAL]C7[\\CHEMICAL]-cyclitol moiety.",
        "label": 9,
        "major": 9,
        "len": 36
    },
    {
        "text": "Targeted disruption of the gene encoding the N-glycosyltransferase, prlH, abolished pyralomicin production, and recombinant expression of [GENE]PrlA[\\GENE] confirms the activity of this enzyme as a sugar phosphate cyclase involved in the formation of the C7-[CHEMICAL]cyclitol[\\CHEMICAL] moiety.",
        "label": 9,
        "major": 9,
        "len": 36
    },
    {
        "text": "Targeted disruption of the gene encoding the N-glycosyltransferase, prlH, abolished pyralomicin production, and recombinant expression of PrlA confirms the activity of this enzyme as a [GENE]sugar phosphate cyclase[\\GENE] involved in the formation of the C7-[CHEMICAL]cyclitol[\\CHEMICAL] moiety.",
        "label": 9,
        "major": 9,
        "len": 36
    },
    {
        "text": "This includes [GENE]nonribosomal peptide synthetases[\\GENE] (NRPS) and polyketide synthases (PKS) required for the formation of the [CHEMICAL]benzopyranopyrrole[\\CHEMICAL] core unit, as well as a suite of tailoring enzymes (e.g., four halogenases, an O-methyltransferase, and an N-glycosyltransferase) necessary for further modifications of the core structure.",
        "label": 9,
        "major": -1,
        "len": 43
    },
    {
        "text": "This includes nonribosomal peptide synthetases ([GENE]NRPS[\\GENE]) and polyketide synthases (PKS) required for the formation of the [CHEMICAL]benzopyranopyrrole[\\CHEMICAL] core unit, as well as a suite of tailoring enzymes (e.g., four halogenases, an O-methyltransferase, and an N-glycosyltransferase) necessary for further modifications of the core structure.",
        "label": 9,
        "major": -1,
        "len": 43
    },
    {
        "text": "This includes nonribosomal peptide synthetases (NRPS) and [GENE]polyketide synthases[\\GENE] (PKS) required for the formation of the [CHEMICAL]benzopyranopyrrole[\\CHEMICAL] core unit, as well as a suite of tailoring enzymes (e.g., four halogenases, an O-methyltransferase, and an N-glycosyltransferase) necessary for further modifications of the core structure.",
        "label": 9,
        "major": -1,
        "len": 43
    },
    {
        "text": "This includes nonribosomal peptide synthetases (NRPS) and polyketide synthases ([GENE]PKS[\\GENE]) required for the formation of the [CHEMICAL]benzopyranopyrrole[\\CHEMICAL] core unit, as well as a suite of tailoring enzymes (e.g., four halogenases, an O-methyltransferase, and an N-glycosyltransferase) necessary for further modifications of the core structure.",
        "label": 9,
        "major": -1,
        "len": 43
    },
    {
        "text": "This includes nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) required for the formation of the [CHEMICAL]benzopyranopyrrole[\\CHEMICAL] core unit, as well as a suite of tailoring enzymes (e.g., four [GENE]halogenases[\\GENE], an O-methyltransferase, and an N-glycosyltransferase) necessary for further modifications of the core structure.",
        "label": 9,
        "major": -1,
        "len": 43
    },
    {
        "text": "This includes nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) required for the formation of the [CHEMICAL]benzopyranopyrrole[\\CHEMICAL] core unit, as well as a suite of tailoring enzymes (e.g., four halogenases, an [GENE]O-methyltransferase[\\GENE], and an N-glycosyltransferase) necessary for further modifications of the core structure.",
        "label": 9,
        "major": -1,
        "len": 43
    },
    {
        "text": "This includes nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) required for the formation of the [CHEMICAL]benzopyranopyrrole[\\CHEMICAL] core unit, as well as a suite of tailoring enzymes (e.g., four halogenases, an O-methyltransferase, and an [GENE]N-glycosyltransferase[\\GENE]) necessary for further modifications of the core structure.",
        "label": 9,
        "major": -1,
        "len": 43
    },
    {
        "text": "Here, we report that [GENE]synaptotagmin-1[\\GENE] is necessary for expression of the vesicular [CHEMICAL]Ca(2+)[\\CHEMICAL] /H(+) -antiport.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "Here, we report that [GENE]synaptotagmin-1[\\GENE] is necessary for expression of the vesicular Ca(2+) /[CHEMICAL]H(+)[\\CHEMICAL] -antiport.",
        "label": 2,
        "major": -1,
        "len": 15
    },
    {
        "text": "The results were congruent and highly significant: [CHEMICAL]Ca(2+)[\\CHEMICAL] /H(+) -antiport activity is detectable only in acidic organelles expressing functional [GENE]synaptotagmin-1[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "The results were congruent and highly significant: Ca(2+) /[CHEMICAL]H(+)[\\CHEMICAL] -antiport activity is detectable only in acidic organelles expressing functional [GENE]synaptotagmin-1[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 20
    },
    {
        "text": "[GENE]Synaptotagmin 1[\\GENE] is required for vesicular [CHEMICAL]Ca(2+)[\\CHEMICAL] /H(+) -antiport activity.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "[GENE]Synaptotagmin 1[\\GENE] is required for vesicular Ca(2+) /[CHEMICAL]H(+)[\\CHEMICAL] -antiport activity.",
        "label": 2,
        "major": -1,
        "len": 10
    },
    {
        "text": "Therefore, in addition to its previously described functions, [GENE]synaptotagmin-1[\\GENE] is involved in a rapid vesicular [CHEMICAL]Ca(2+)[\\CHEMICAL] sequestration through a Ca(2+) /H(+) antiport.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Therefore, in addition to its previously described functions, [GENE]synaptotagmin-1[\\GENE] is involved in a rapid vesicular Ca(2+) sequestration through a [CHEMICAL]Ca(2+)[\\CHEMICAL] /H(+) antiport.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Therefore, in addition to its previously described functions, [GENE]synaptotagmin-1[\\GENE] is involved in a rapid vesicular Ca(2+) sequestration through a Ca(2+) /[CHEMICAL]H(+)[\\CHEMICAL] antiport.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "[GENE]Synaptotagmin-1[\\GENE], a vesicular protein interacting with membranes upon low-affinity [CHEMICAL]Ca(2+)[\\CHEMICAL] -binding, plays a major role in excitation-release coupling, by synchronizing calcium entry with fast neurotransmitter release.",
        "label": 2,
        "major": 2,
        "len": 26
    },
    {
        "text": "[GENE]Synaptotagmin-1[\\GENE], a vesicular protein interacting with membranes upon low-affinity Ca(2+) -binding, plays a major role in excitation-release coupling, by synchronizing [CHEMICAL]calcium[\\CHEMICAL] entry with fast neurotransmitter release.",
        "label": 2,
        "major": 2,
        "len": 26
    },
    {
        "text": "Estradiol replacement enhances [CHEMICAL]cocaine[\\CHEMICAL]-stimulated locomotion in female C57BL/6 mice through [GENE]estrogen receptor alpha[\\GENE].",
        "label": 2,
        "major": 1,
        "len": 13
    },
    {
        "text": "These results suggest that E2 enhances [CHEMICAL]cocaine[\\CHEMICAL]-stimulated locomotion in mice predominantly through [GENE]ER\u03b1[\\GENE].",
        "label": 2,
        "major": 3,
        "len": 13
    },
    {
        "text": "To examine receptor mediation of estradiol effects, Ovx mice replaced for 2 days with either the [GENE]ER\u03b1[\\GENE]-selective agonist [CHEMICAL]PPT[\\CHEMICAL] or the ER\u03b2-selective agonist DPN were compared to Sham mice, and mice lacking either ER\u03b1 (\u03b1ERKO) or ER\u03b2 (\u03b2ERKO) were compared to WT littermates.",
        "label": 5,
        "major": 5,
        "len": 43
    },
    {
        "text": "To examine receptor mediation of estradiol effects, Ovx mice replaced for 2 days with either the ER\u03b1-selective agonist PPT or the [GENE]ER\u03b2[\\GENE]-selective agonist [CHEMICAL]DPN[\\CHEMICAL] were compared to Sham mice, and mice lacking either ER\u03b1 (\u03b1ERKO) or ER\u03b2 (\u03b2ERKO) were compared to WT littermates.",
        "label": 5,
        "major": 5,
        "len": 43
    },
    {
        "text": "The [GENE]Intermediate-conductance Calcium-activated Potassium Channel KCa3.1[\\GENE] Regulates Vascular Smooth Muscle Cell Proliferation via Controlling [CHEMICAL]Calcium[\\CHEMICAL]-dependent Signaling.",
        "label": 9,
        "major": 3,
        "len": 16
    },
    {
        "text": "The current study examined the bioactivation potential of [GENE]ghrelin receptor[\\GENE] inverse agonists, 1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(imidazo[2,1-b]thiazol-6-yl)ethanone (1) and [CHEMICAL]1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(2-methylimidazo[2,1-b]thiazol-6-yl)ethanone[\\CHEMICAL] (2), containing a fused imidazo[2,1-b]thiazole motif in the core structure.",
        "label": 5,
        "major": 3,
        "len": 26
    },
    {
        "text": "The current study examined the bioactivation potential of [GENE]ghrelin receptor[\\GENE] inverse agonists, 1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(imidazo[2,1-b]thiazol-6-yl)ethanone (1) and 1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(2-methylimidazo[2,1-b]thiazol-6-yl)ethanone (2), containing a fused [CHEMICAL]imidazo[2,1-b]thiazole[\\CHEMICAL] motif in the core structure.",
        "label": 5,
        "major": 5,
        "len": 26
    },
    {
        "text": "The current study examined the bioactivation potential of [GENE]ghrelin receptor[\\GENE] inverse agonists, [CHEMICAL]1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(imidazo[2,1-b]thiazol-6-yl)ethanone[\\CHEMICAL] (1) and 1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(2-methylimidazo[2,1-b]thiazol-6-yl)ethanone (2), containing a fused imidazo[2,1-b]thiazole motif in the core structure.",
        "label": 5,
        "major": 3,
        "len": 26
    },
    {
        "text": "Reactive Metabolite Trapping Studies on [CHEMICAL]Imidazo- and 2-Methylimidazo[2,1-b]thiazole[\\CHEMICAL]-based Inverse Agonists of the [GENE]Ghrelin Receptor[\\GENE].",
        "label": 5,
        "major": 5,
        "len": 14
    },
    {
        "text": "Moreover, the active permethylated [CHEMICAL]vancomycin[\\CHEMICAL] aglycon derivatives examined exhibit [GENE]VanB[\\GENE] VRE antimicrobial activity at levels that approach (typically within 2-fold) their activity against sensitive bacteria.",
        "label": 2,
        "major": -1,
        "len": 25
    },
    {
        "text": "[CHEMICAL]DEHP[\\CHEMICAL] exposure significantly decreased the levels of these four FAs only in pregnant [GENE]mPPAR\u03b1[\\GENE] mice.",
        "label": 2,
        "major": 4,
        "len": 15
    },
    {
        "text": "Taken together, the levels of plasma four FAs with shorter carbon chains were higher in pregnant mPPAR\u03b1 mice than in other genotypes, and [CHEMICAL]DEHP[\\CHEMICAL] exposure decreased these specific FA concentrations only in [GENE]mPPAR\u03b1[\\GENE] mice, similarly to triglyceride levels.",
        "label": 2,
        "major": 10,
        "len": 38
    },
    {
        "text": "Interestingly, [CHEMICAL]polySia[\\CHEMICAL] chains of secreted [GENE]NCAM[\\GENE] neutralized the cytotoxic activity of extracellular histones as well as DNA/histone-network-containing \"neutrophil extracellular traps\", which are formed during invasion of microorganisms.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "In mature lung tissue of healthy donors, [CHEMICAL]polySia[\\CHEMICAL] was exclusively attached to the transmembrane isoform [GENE]NCAM-140[\\GENE] and located to intracellular compartments of epithelial cells.",
        "label": 2,
        "major": -1,
        "len": 24
    },
    {
        "text": "As shown in a cell culture model, [CHEMICAL]polySia[\\CHEMICAL]-[GENE]NCAM-140[\\GENE] was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by IL-1\u03b2 or lipopolysaccharide induced metalloprotease-mediated ectodomain shedding, resulting in the secretion of soluble polySia-NCAM.",
        "label": 2,
        "major": 3,
        "len": 36
    },
    {
        "text": "Interestingly, [CHEMICAL]polySia[\\CHEMICAL] chains of secreted NCAM neutralized the cytotoxic activity of extracellular [GENE]histones[\\GENE] as well as DNA/histone-network-containing \"neutrophil extracellular traps\", which are formed during invasion of microorganisms.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "Interestingly, [CHEMICAL]polySia[\\CHEMICAL] chains of secreted NCAM neutralized the cytotoxic activity of extracellular histones as well as DNA/[GENE]histone[\\GENE]-network-containing \"neutrophil extracellular traps\", which are formed during invasion of microorganisms.",
        "label": 2,
        "major": -1,
        "len": 27
    },
    {
        "text": "Processing of [GENE]polysialylated NCAM[\\GENE] was reproduced in a mouse model by [CHEMICAL]bleomycin[\\CHEMICAL] administration leading to an activation of the inflammasome and secretion of interleukin (IL)-1\u03b2.",
        "label": 2,
        "major": 9,
        "len": 25
    },
    {
        "text": "Posttranslational modification of the [GENE]neural cell adhesion molecule[\\GENE] (NCAM) by polysialic acid ([CHEMICAL]polySia[\\CHEMICAL]) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration, axon fasciculation, and synaptic plasticity.",
        "label": 2,
        "major": 7,
        "len": 38
    },
    {
        "text": "Posttranslational modification of the neural cell adhesion molecule ([GENE]NCAM[\\GENE]) by polysialic acid ([CHEMICAL]polySia[\\CHEMICAL]) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration, axon fasciculation, and synaptic plasticity.",
        "label": 2,
        "major": 7,
        "len": 38
    },
    {
        "text": "Posttranslational modification of the [GENE]neural cell adhesion molecule[\\GENE] (NCAM) by [CHEMICAL]polysialic acid[\\CHEMICAL] (polySia) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration, axon fasciculation, and synaptic plasticity.",
        "label": 2,
        "major": 7,
        "len": 38
    },
    {
        "text": "Posttranslational modification of the neural cell adhesion molecule ([GENE]NCAM[\\GENE]) by [CHEMICAL]polysialic acid[\\CHEMICAL] (polySia) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration, axon fasciculation, and synaptic plasticity.",
        "label": 2,
        "major": 7,
        "len": 38
    },
    {
        "text": "Processing of polysialylated NCAM was reproduced in a mouse model by [CHEMICAL]bleomycin[\\CHEMICAL] administration leading to an activation of the inflammasome and secretion of [GENE]interleukin (IL)-1\u03b2[\\GENE].",
        "label": 3,
        "major": 3,
        "len": 25
    },
    {
        "text": "[CHEMICAL]Vildagliptin[\\CHEMICAL]+metformin were more effective than placebo+metformin in reducing body weight and BMI, glycemic control, HOMA-IR, [GENE]glucagon[\\GENE] and insulin resistance measurements.",
        "label": 2,
        "major": 4,
        "len": 20
    },
    {
        "text": "[CHEMICAL]Vildagliptin[\\CHEMICAL]+metformin were more effective than placebo+metformin in reducing body weight and BMI, glycemic control, HOMA-IR, glucagon and [GENE]insulin[\\GENE] resistance measurements.",
        "label": 2,
        "major": 4,
        "len": 20
    },
    {
        "text": "Vildagliptin+[CHEMICAL]metformin[\\CHEMICAL] were more effective than placebo+metformin in reducing body weight and BMI, glycemic control, HOMA-IR, [GENE]glucagon[\\GENE] and insulin resistance measurements.",
        "label": 2,
        "major": 4,
        "len": 20
    },
    {
        "text": "Vildagliptin+[CHEMICAL]metformin[\\CHEMICAL] were more effective than placebo+metformin in reducing body weight and BMI, glycemic control, HOMA-IR, glucagon and [GENE]insulin[\\GENE] resistance measurements.",
        "label": 2,
        "major": 4,
        "len": 20
    },
    {
        "text": "Vildagliptin+metformin were more effective than placebo+[CHEMICAL]metformin[\\CHEMICAL] in reducing body weight and BMI, glycemic control, HOMA-IR, [GENE]glucagon[\\GENE] and insulin resistance measurements.",
        "label": 2,
        "major": 4,
        "len": 20
    },
    {
        "text": "Vildagliptin+metformin were more effective than placebo+[CHEMICAL]metformin[\\CHEMICAL] in reducing body weight and BMI, glycemic control, HOMA-IR, glucagon and [GENE]insulin[\\GENE] resistance measurements.",
        "label": 2,
        "major": 4,
        "len": 20
    },
    {
        "text": "We also recorded a significant correlation between M value increase and the decrease of [GENE]vaspin[\\GENE], visfatin, and omentin-1 obtained with [CHEMICAL]vildagliptin[\\CHEMICAL]+metformin.",
        "label": 2,
        "major": 3,
        "len": 21
    },
    {
        "text": "We also recorded a significant correlation between M value increase and the decrease of vaspin, [GENE]visfatin[\\GENE], and omentin-1 obtained with [CHEMICAL]vildagliptin[\\CHEMICAL]+metformin.",
        "label": 2,
        "major": 3,
        "len": 21
    },
    {
        "text": "We also recorded a significant correlation between M value increase and the decrease of vaspin, visfatin, and [GENE]omentin-1[\\GENE] obtained with [CHEMICAL]vildagliptin[\\CHEMICAL]+metformin.",
        "label": 2,
        "major": 4,
        "len": 21
    },
    {
        "text": "We also recorded a significant correlation between M value increase and the decrease of [GENE]vaspin[\\GENE], visfatin, and omentin-1 obtained with vildagliptin+[CHEMICAL]metformin[\\CHEMICAL].",
        "label": 2,
        "major": 4,
        "len": 21
    },
    {
        "text": "We also recorded a significant correlation between M value increase and the decrease of vaspin, [GENE]visfatin[\\GENE], and omentin-1 obtained with vildagliptin+[CHEMICAL]metformin[\\CHEMICAL].",
        "label": 2,
        "major": 3,
        "len": 21
    },
    {
        "text": "We also recorded a significant correlation between M value increase and the decrease of vaspin, visfatin, and [GENE]omentin-1[\\GENE] obtained with vildagliptin+[CHEMICAL]metformin[\\CHEMICAL].",
        "label": 2,
        "major": 4,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Vildagliptin[\\CHEMICAL], in addition to metformin, proved to be effective in improving \u03b2-cell function and in reducing [GENE]insulin[\\GENE] resistance measurements.",
        "label": 2,
        "major": 4,
        "len": 19
    },
    {
        "text": "Vildagliptin, in addition to [CHEMICAL]metformin[\\CHEMICAL], proved to be effective in improving \u03b2-cell function and in reducing [GENE]insulin[\\GENE] resistance measurements.",
        "label": 2,
        "major": 4,
        "len": 19
    },
    {
        "text": "[CHEMICAL]4-Hydroxytamoxifen[\\CHEMICAL] (OHT, tamoxifen's active form) failed to prevent E2-induced proteolysis of [GENE]cyclin E[\\GENE] and migration, but rather triggered cyclin E cleavage coincident with augmented migration.",
        "label": 10,
        "major": 3,
        "len": 25
    },
    {
        "text": "4-Hydroxytamoxifen ([CHEMICAL]OHT[\\CHEMICAL], tamoxifen's active form) failed to prevent E2-induced proteolysis of [GENE]cyclin E[\\GENE] and migration, but rather triggered cyclin E cleavage coincident with augmented migration.",
        "label": 10,
        "major": 3,
        "len": 25
    },
    {
        "text": "4-Hydroxytamoxifen (OHT, [CHEMICAL]tamoxifen[\\CHEMICAL]'s active form) failed to prevent E2-induced proteolysis of [GENE]cyclin E[\\GENE] and migration, but rather triggered cyclin E cleavage coincident with augmented migration.",
        "label": 10,
        "major": 3,
        "len": 25
    },
    {
        "text": "[CHEMICAL]4-Hydroxytamoxifen[\\CHEMICAL] (OHT, tamoxifen's active form) failed to prevent E2-induced proteolysis of cyclin E and migration, but rather triggered [GENE]cyclin E[\\GENE] cleavage coincident with augmented migration.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "4-Hydroxytamoxifen ([CHEMICAL]OHT[\\CHEMICAL], tamoxifen's active form) failed to prevent E2-induced proteolysis of cyclin E and migration, but rather triggered [GENE]cyclin E[\\GENE] cleavage coincident with augmented migration.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "4-Hydroxytamoxifen (OHT, [CHEMICAL]tamoxifen[\\CHEMICAL]'s active form) failed to prevent E2-induced proteolysis of cyclin E and migration, but rather triggered [GENE]cyclin E[\\GENE] cleavage coincident with augmented migration.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "[CHEMICAL]OHT[\\CHEMICAL]-induced [GENE]cyclin E[\\GENE] truncation also occurred in SK-BR-3 cells that express GPR30 and lack ER\u03b1, but not in MDA-MB-231 cells that express neither GPR30 nor ER\u03b1.",
        "label": 2,
        "major": 3,
        "len": 26
    },
    {
        "text": "Furthermore, [CHEMICAL]OHT[\\CHEMICAL]-stimulated cleavage of [GENE]cyclin E[\\GENE] and migration were tremendously attenuated by G15, a GPR30 antagonist, or siRNA against GPR30.",
        "label": 2,
        "major": 3,
        "len": 20
    },
    {
        "text": "In addition, inhibitors for EGFR or ERK1/2 remarkably suppressed [CHEMICAL]OHT[\\CHEMICAL]-induced truncation of [GENE]cyclin E[\\GENE], suggesting involvement of EGFR signaling.",
        "label": 2,
        "major": 4,
        "len": 19
    },
    {
        "text": "In addition, inhibitors for EGFR or ERK1/2 remarkably suppressed [CHEMICAL]OHT[\\CHEMICAL]-induced truncation of cyclin E, suggesting involvement of [GENE]EGFR[\\GENE] signaling.",
        "label": 2,
        "major": 3,
        "len": 19
    },
    {
        "text": "[CHEMICAL]OHT[\\CHEMICAL]-induced cyclin E truncation also occurred in SK-BR-3 cells that express [GENE]GPR30[\\GENE] and lack ER\u03b1, but not in MDA-MB-231 cells that express neither GPR30 nor ER\u03b1.",
        "label": 2,
        "major": 3,
        "len": 26
    },
    {
        "text": "[CHEMICAL]4-Hydroxytamoxifen[\\CHEMICAL]-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 ([GENE]GPR30)[\\GENE] and accompanied by enhanced migration in MCF-7 breast cancer cells.",
        "label": 2,
        "major": 3,
        "len": 23
    },
    {
        "text": "[CHEMICAL]4-Hydroxytamoxifen[\\CHEMICAL]-stimulated processing of cyclin E is mediated via [GENE]G protein-coupled receptor 30[\\GENE] (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells.",
        "label": 2,
        "major": 3,
        "len": 23
    },
    {
        "text": "Collectively, our data indicate that [CHEMICAL]OHT[\\CHEMICAL] contributes to the production of proteolyzed cyclin E via [GENE]GPR30[\\GENE] with augmented migration in MCF-7 cells.",
        "label": 2,
        "major": 9,
        "len": 22
    },
    {
        "text": "[CHEMICAL]4-Hydroxytamoxifen[\\CHEMICAL]-stimulated processing of [GENE]cyclin E[\\GENE] is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells.",
        "label": 3,
        "major": 3,
        "len": 23
    },
    {
        "text": "[CHEMICAL]17\u03b2-Estradiol[\\CHEMICAL] (E2) has been recently shown to induce [GENE]cyclin E[\\GENE] processing in breast cancer cells.",
        "label": 3,
        "major": 3,
        "len": 15
    },
    {
        "text": "Collectively, our data indicate that [CHEMICAL]OHT[\\CHEMICAL] contributes to the production of proteolyzed [GENE]cyclin E[\\GENE] via GPR30 with augmented migration in MCF-7 cells.",
        "label": 3,
        "major": 9,
        "len": 22
    },
    {
        "text": "NMR spectroscopy was also used to examine the hSOD1 mutants C57A, C146A, and C57A/C146A, which are unable to form the structurally conserved disulfide bond in SOD1, in order to investigate the role of these [CHEMICAL]cysteines[\\CHEMICAL] during [GENE]hSOD1[\\GENE] copper acquisition.",
        "label": 1,
        "major": 1,
        "len": 39
    },
    {
        "text": "We recently showed that the first domain of [GENE]human CCS[\\GENE] (hCCSD1) is responsible for [CHEMICAL]copper[\\CHEMICAL] transfer to its protein partner, human SOD1 (hSOD1).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "We recently showed that the first domain of human CCS ([GENE]hCCSD1[\\GENE]) is responsible for [CHEMICAL]copper[\\CHEMICAL] transfer to its protein partner, human SOD1 (hSOD1).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "We recently showed that the first domain of human CCS (hCCSD1) is responsible for [CHEMICAL]copper[\\CHEMICAL] transfer to its protein partner, [GENE]human SOD1[\\GENE] (hSOD1).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "We recently showed that the first domain of human CCS (hCCSD1) is responsible for [CHEMICAL]copper[\\CHEMICAL] transfer to its protein partner, human SOD1 ([GENE]hSOD1[\\GENE]).",
        "label": 2,
        "major": -1,
        "len": 23
    },
    {
        "text": "The NMR solution structure of the [CHEMICAL]copper(I)[\\CHEMICAL]-loaded form of [GENE]hCCSD1[\\GENE] reported here contributes further to characterization of the copper-transfer mechanism to hSOD1.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Together, the information on both hCCS and hSOD1, along with a sequence analysis of eukaryotic CCSD1, allows us to propose important mechanistic aspects regarding the [CHEMICAL]copper[\\CHEMICAL]-transfer process from [GENE]hCCS[\\GENE] to hSOD1.",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Together, the information on both hCCS and hSOD1, along with a sequence analysis of eukaryotic CCSD1, allows us to propose important mechanistic aspects regarding the [CHEMICAL]copper[\\CHEMICAL]-transfer process from hCCS to [GENE]hSOD1[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 31
    },
    {
        "text": "Mechanistic Aspects of [GENE]hSOD1[\\GENE] Maturation from the Solution Structure of [CHEMICAL]Cu(I)[\\CHEMICAL] -Loaded hCCS Domain 1 and Analysis of Disulfide-Free hSOD1 Mutants.",
        "label": 2,
        "major": 1,
        "len": 21
    },
    {
        "text": "Mechanistic Aspects of hSOD1 Maturation from the Solution Structure of [CHEMICAL]Cu(I)[\\CHEMICAL] -Loaded [GENE]hCCS Domain 1[\\GENE] and Analysis of Disulfide-Free hSOD1 Mutants.",
        "label": 2,
        "major": 1,
        "len": 21
    },
    {
        "text": "Design, Synthesis and Biological Evaluation of [CHEMICAL]Aminoalkylindole[\\CHEMICAL] Derivatives as [GENE]Cannabinoid Receptor[\\GENE] Ligands with Potential for Treatment of Alcohol Abuse.",
        "label": 2,
        "major": -1,
        "len": 19
    },
    {
        "text": "In the current study, we show that systematic modification of an [CHEMICAL]aminoalkylindole[\\CHEMICAL] scaffold identifies two new compounds with dual CB1R antagonist/[GENE]CB2R[\\GENE] agonist activity.",
        "label": 5,
        "major": 5,
        "len": 23
    },
    {
        "text": "Collectively, these initial findings suggest that design and systematic modification of [CHEMICAL]aminoalkylindoles[\\CHEMICAL] such as 3 may lead to development of novel cannabinoid ligands with dual CB1R antagonist/[GENE]CB2R[\\GENE] agonist activity with potential for use as treatments of alcohol abuse.",
        "label": 5,
        "major": 6,
        "len": 38
    },
    {
        "text": "We have recently reported that a mono-hydroxylated metabolite of the synthetic [CHEMICAL]aminoalkylindole[\\CHEMICAL] cannabinoid JHW-073 (3) exhibits neutral antagonist activity at [GENE]CB1Rs[\\GENE] and thus may serve as a promising lead for the development of novel alcohol abuse therapies.",
        "label": 6,
        "major": 6,
        "len": 37
    },
    {
        "text": "We have recently reported that a mono-hydroxylated metabolite of the synthetic aminoalkylindole cannabinoid [CHEMICAL]JHW-073[\\CHEMICAL] (3) exhibits neutral antagonist activity at [GENE]CB1Rs[\\GENE] and thus may serve as a promising lead for the development of novel alcohol abuse therapies.",
        "label": 6,
        "major": 6,
        "len": 37
    },
    {
        "text": "In the current study, we show that systematic modification of an [CHEMICAL]aminoalkylindole[\\CHEMICAL] scaffold identifies two new compounds with dual [GENE]CB1R[\\GENE] antagonist/CB2R agonist activity.",
        "label": 6,
        "major": 5,
        "len": 23
    },
    {
        "text": "Collectively, these initial findings suggest that design and systematic modification of [CHEMICAL]aminoalkylindoles[\\CHEMICAL] such as 3 may lead to development of novel cannabinoid ligands with dual [GENE]CB1R[\\GENE] antagonist/CB2R agonist activity with potential for use as treatments of alcohol abuse.",
        "label": 6,
        "major": 5,
        "len": 38
    },
    {
        "text": "Immunoregulatory effects of [CHEMICAL]Glycyrrhizic acid[\\CHEMICAL] exerts anti-asthmatic effects via modulation of Th1/Th2 cytokines and enhancement of CD4(+)CD25(+)Foxp3(+) regulatory T cells in [GENE]ovalbumin[\\GENE]-sensitized mice.",
        "label": 2,
        "major": 7,
        "len": 23
    },
    {
        "text": "Immunoregulatory effects of [CHEMICAL]Glycyrrhizic acid[\\CHEMICAL] exerts anti-asthmatic effects via modulation of Th1/Th2 [GENE]cytokines[\\GENE] and enhancement of CD4(+)CD25(+)Foxp3(+) regulatory T cells in ovalbumin-sensitized mice.",
        "label": 2,
        "major": 7,
        "len": 23
    },
    {
        "text": "The improved survival rates for obese mice chronically treated with [CHEMICAL]vildagliptin[\\CHEMICAL] suggest that chronic [GENE]DPP4[\\GENE] inhibition potentially results in additional quality-adjusted life-years for individuals with type 2 diabetes, which is the primary goal of any diabetes therapy.",
        "label": 4,
        "major": 4,
        "len": 37
    },
    {
        "text": "METHODS: After 1\u00a0month of HFD alone, the mice were given the [GENE]DPP4[\\GENE] inhibitor [CHEMICAL]vildagliptin[\\CHEMICAL] for a further 11\u00a0months.",
        "label": 4,
        "major": 4,
        "len": 18
    },
    {
        "text": "Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the [GENE]dipeptidyl peptidase-4[\\GENE] inhibitor [CHEMICAL]vildagliptin[\\CHEMICAL] in an advanced-aged diet-induced obesity mouse model.",
        "label": 4,
        "major": 4,
        "len": 23
    },
    {
        "text": "Protein levels of the [GENE]glucose transporter[\\GENE] (GLUT4) involved in [CHEMICAL]glucose[\\CHEMICAL] transport via these two pathways were also increased.",
        "label": 9,
        "major": 9,
        "len": 18
    },
    {
        "text": "Protein levels of the glucose transporter ([GENE]GLUT4[\\GENE]) involved in [CHEMICAL]glucose[\\CHEMICAL] transport via these two pathways were also increased.",
        "label": 9,
        "major": 3,
        "len": 18
    },
    {
        "text": "Using small interfering double-stranded RNA technology, we further demonstrate that the effects of [CHEMICAL]puerarin[\\CHEMICAL] on proliferation, differentiation and survival are mediated by both [GENE]ER\u03b1[\\GENE] and ER\u03b2.",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Using small interfering double-stranded RNA technology, we further demonstrate that the effects of [CHEMICAL]puerarin[\\CHEMICAL] on proliferation, differentiation and survival are mediated by both ER\u03b1 and [GENE]ER\u03b2[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 26
    },
    {
        "text": "Here we show that puerarin increases proliferation and differentiation and opposes [CHEMICAL]cisplatin[\\CHEMICAL]-induced apoptosis in human osteoblastic MG-63 cells containing two [GENE]estrogen receptor[\\GENE] (ER) isoforms.",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "Here we show that puerarin increases proliferation and differentiation and opposes [CHEMICAL]cisplatin[\\CHEMICAL]-induced apoptosis in human osteoblastic MG-63 cells containing two estrogen receptor ([GENE]ER[\\GENE]) isoforms.",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "Treatment with the [GENE]ER[\\GENE] antagonist ICI 182,780 abolishes the above actions of [CHEMICAL]puerarin[\\CHEMICAL] on osteoblast-derived cells.",
        "label": 2,
        "major": 6,
        "len": 16
    },
    {
        "text": "[CHEMICAL]Puerarin[\\CHEMICAL] stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via [GENE]ER[\\GENE]-dependent MEK/ERK and PI3K/Akt activation.",
        "label": 2,
        "major": 3,
        "len": 21
    },
    {
        "text": "Here we show that [CHEMICAL]puerarin[\\CHEMICAL] increases proliferation and differentiation and opposes cisplatin-induced apoptosis in human osteoblastic MG-63 cells containing two [GENE]estrogen receptor[\\GENE] (ER) isoforms.",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "Here we show that [CHEMICAL]puerarin[\\CHEMICAL] increases proliferation and differentiation and opposes cisplatin-induced apoptosis in human osteoblastic MG-63 cells containing two estrogen receptor ([GENE]ER[\\GENE]) isoforms.",
        "label": 2,
        "major": 3,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Puerarin[\\CHEMICAL] stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent [GENE]MEK[\\GENE]/ERK and PI3K/Akt activation.",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Puerarin[\\CHEMICAL] stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/[GENE]ERK[\\GENE] and PI3K/Akt activation.",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Puerarin[\\CHEMICAL] stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and [GENE]PI3K[\\GENE]/Akt activation.",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Puerarin[\\CHEMICAL] stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/[GENE]Akt[\\GENE] activation.",
        "label": 3,
        "major": 3,
        "len": 21
    },
    {
        "text": "Moreover, we also demonstrate that [CHEMICAL]puerarin[\\CHEMICAL] functions at least partially through activation of [GENE]MEK[\\GENE]/ERK and PI3K/Akt signaling.",
        "label": 3,
        "major": 3,
        "len": 17
    },
    {
        "text": "Moreover, we also demonstrate that [CHEMICAL]puerarin[\\CHEMICAL] functions at least partially through activation of MEK/[GENE]ERK[\\GENE] and PI3K/Akt signaling.",
        "label": 3,
        "major": 3,
        "len": 17
    },
    {
        "text": "Puerarin promotes proliferation by altering cell cycle distribution whereas [CHEMICAL]puerarin[\\CHEMICAL]-mediated survival may be associated with up-regulation of [GENE]Bcl-xL[\\GENE] expression.",
        "label": 3,
        "major": -1,
        "len": 19
    },
    {
        "text": "Moreover, we also demonstrate that [CHEMICAL]puerarin[\\CHEMICAL] functions at least partially through activation of MEK/ERK and [GENE]PI3K[\\GENE]/Akt signaling.",
        "label": 3,
        "major": 3,
        "len": 17
    },
    {
        "text": "Moreover, we also demonstrate that [CHEMICAL]puerarin[\\CHEMICAL] functions at least partially through activation of MEK/ERK and PI3K/[GENE]Akt[\\GENE] signaling.",
        "label": 3,
        "major": 3,
        "len": 17
    },
    {
        "text": "Treatment with the [GENE]ER[\\GENE] antagonist [CHEMICAL]ICI 182,780[\\CHEMICAL] abolishes the above actions of puerarin on osteoblast-derived cells.",
        "label": 6,
        "major": 6,
        "len": 16
    },
    {
        "text": "The preventive effect of uncarboxylated osteocalcin against [CHEMICAL]free fatty acid[\\CHEMICAL]-induced endothelial apoptosis through the activation of [GENE]phosphatidylinositol 3-kinase[\\GENE]/Akt signaling pathway: Uncarboxylated osteocalcin and endothelial apoptosis.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "The preventive effect of uncarboxylated osteocalcin against [CHEMICAL]free fatty acid[\\CHEMICAL]-induced endothelial apoptosis through the activation of phosphatidylinositol 3-kinase/[GENE]Akt[\\GENE] signaling pathway: Uncarboxylated osteocalcin and endothelial apoptosis.",
        "label": 2,
        "major": 3,
        "len": 25
    },
    {
        "text": "RESULTS: Pretreatment of ucOC (30ng/ml) prevented LA-induced apoptosis in insulin-stimulated endothelial cells; effects were abolished by pretreatment with the [GENE]phosphatidylinositol 3-kinase[\\GENE] (PI3-kinase) inhibitor, [CHEMICAL]wortmannin[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 24
    },
    {
        "text": "RESULTS: Pretreatment of ucOC (30ng/ml) prevented LA-induced apoptosis in insulin-stimulated endothelial cells; effects were abolished by pretreatment with the phosphatidylinositol 3-kinase ([GENE]PI3-kinase[\\GENE]) inhibitor, [CHEMICAL]wortmannin[\\CHEMICAL].",
        "label": 4,
        "major": 3,
        "len": 24
    },
    {
        "text": "Chronic exposure to [CHEMICAL]oxyfluorfen[\\CHEMICAL] provoked then structural changes but also functional changes in the capacity of biofilm [GENE]CAT[\\GENE] activity to respond to a sudden increase in concentration, suggesting a selection of species with higher antioxidant capacity.",
        "label": 2,
        "major": 3,
        "len": 36
    },
    {
        "text": "In addition, during acute exposure tests performed at the end of the chronic exposure, biofilms chronically exposed to 75 and 150\u03bcgL(-1) [CHEMICAL]oxyfluorfen[\\CHEMICAL] showed a higher [GENE]CAT[\\GENE] activity than controls.",
        "label": 3,
        "major": -1,
        "len": 29
    },
    {
        "text": "The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using [GENE]D1[\\GENE]/D5 ([CHEMICAL]SCH23390[\\CHEMICAL]), D2/D3 (raclopride, amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.",
        "label": 6,
        "major": 6,
        "len": 39
    },
    {
        "text": "The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/[GENE]D5[\\GENE] ([CHEMICAL]SCH23390[\\CHEMICAL]), D2/D3 (raclopride, amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.",
        "label": 6,
        "major": 6,
        "len": 39
    },
    {
        "text": "The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), [GENE]D2[\\GENE]/D3 ([CHEMICAL]raclopride[\\CHEMICAL], amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.",
        "label": 6,
        "major": 6,
        "len": 39
    },
    {
        "text": "The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/[GENE]D3[\\GENE] ([CHEMICAL]raclopride[\\CHEMICAL], amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.",
        "label": 6,
        "major": 6,
        "len": 39
    },
    {
        "text": "The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), [GENE]D2[\\GENE]/D3 (raclopride, [CHEMICAL]amisulpride[\\CHEMICAL]) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.",
        "label": 6,
        "major": 6,
        "len": 39
    },
    {
        "text": "The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/[GENE]D3[\\GENE] (raclopride, [CHEMICAL]amisulpride[\\CHEMICAL]) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.",
        "label": 6,
        "major": 6,
        "len": 39
    },
    {
        "text": "The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/D3 (raclopride, amisulpride) and [GENE]D3[\\GENE] ([CHEMICAL]S33084[\\CHEMICAL]) receptor antagonists, and by using D2 receptor knockout mice.",
        "label": 6,
        "major": 6,
        "len": 39
    },
    {
        "text": "These results show that haloperidol promotes mTORC1- and S6K1-dependent phosphorylation of [GENE]rpS6[\\GENE] at [CHEMICAL]Ser[\\CHEMICAL]240/244, in a subpopulation of striatal MSNs expressing D2Rs.",
        "label": 1,
        "major": -1,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Haloperidol[\\CHEMICAL] promotes [GENE]mTORC1[\\GENE]-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1.",
        "label": 2,
        "major": 4,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Haloperidol[\\CHEMICAL] promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via [GENE]dopamine- and cAMP-regulated phosphoprotein of 32 kDa[\\GENE] and inhibition of protein phosphatase-1.",
        "label": 2,
        "major": 4,
        "len": 21
    },
    {
        "text": "These results show that [CHEMICAL]haloperidol[\\CHEMICAL] promotes [GENE]mTORC1[\\GENE]- and S6K1-dependent phosphorylation of rpS6 at Ser240/244, in a subpopulation of striatal MSNs expressing D2Rs.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "These results show that [CHEMICAL]haloperidol[\\CHEMICAL] promotes mTORC1- and [GENE]S6K1[\\GENE]-dependent phosphorylation of rpS6 at Ser240/244, in a subpopulation of striatal MSNs expressing D2Rs.",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "These results show that [CHEMICAL]haloperidol[\\CHEMICAL] promotes mTORC1- and S6K1-dependent phosphorylation of rpS6 at Ser240/244, in a subpopulation of striatal MSNs expressing [GENE]D2Rs[\\GENE].",
        "label": 2,
        "major": -1,
        "len": 22
    },
    {
        "text": "Administration of [CHEMICAL]haloperidol[\\CHEMICAL] increased Ser240/244 phosphorylation in a subpopulation of GABA-ergic medium spiny neurons (MSNs), which express [GENE]dopamine D2 receptors[\\GENE] (D2Rs).",
        "label": 2,
        "major": 3,
        "len": 21
    },
    {
        "text": "Administration of [CHEMICAL]haloperidol[\\CHEMICAL] increased Ser240/244 phosphorylation in a subpopulation of GABA-ergic medium spiny neurons (MSNs), which express dopamine D2 receptors ([GENE]D2Rs[\\GENE]).",
        "label": 2,
        "major": 3,
        "len": 21
    },
    {
        "text": "[CHEMICAL]Haloperidol[\\CHEMICAL] promotes mTORC1-dependent phosphorylation of [GENE]ribosomal protein S6[\\GENE] via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1.",
        "label": 3,
        "major": 4,
        "len": 21
    },
    {
        "text": "These results show that [CHEMICAL]haloperidol[\\CHEMICAL] promotes mTORC1- and S6K1-dependent phosphorylation of [GENE]rpS6[\\GENE] at Ser240/244, in a subpopulation of striatal MSNs expressing D2Rs.",
        "label": 3,
        "major": -1,
        "len": 22
    },
    {
        "text": "This effect was prevented by [CHEMICAL]rapamycin[\\CHEMICAL], an inhibitor of the [GENE]mammalian target of rapamycin complex 1[\\GENE] (mTORC1), or by PF470867, a selective inhibitor of the p70 ribosomal S6 kinase 1 (S6K1).",
        "label": 4,
        "major": 4,
        "len": 31
    },
    {
        "text": "This effect was prevented by [CHEMICAL]rapamycin[\\CHEMICAL], an inhibitor of the mammalian target of rapamycin complex 1 ([GENE]mTORC1[\\GENE]), or by PF470867, a selective inhibitor of the p70 ribosomal S6 kinase 1 (S6K1).",
        "label": 4,
        "major": 4,
        "len": 31
    },
    {
        "text": "This effect was prevented by rapamycin, an inhibitor of the mammalian target of rapamycin complex 1 (mTORC1), or by [CHEMICAL]PF470867[\\CHEMICAL], a selective inhibitor of the [GENE]p70 ribosomal S6 kinase 1[\\GENE] (S6K1).",
        "label": 4,
        "major": 4,
        "len": 31
    },
    {
        "text": "This effect was prevented by rapamycin, an inhibitor of the mammalian target of rapamycin complex 1 (mTORC1), or by [CHEMICAL]PF470867[\\CHEMICAL], a selective inhibitor of the p70 ribosomal S6 kinase 1 ([GENE]S6K1[\\GENE]).",
        "label": 4,
        "major": 4,
        "len": 31
    },
    {
        "text": "In line with this observation, incubation of striatal slices with [CHEMICAL]okadaic acid[\\CHEMICAL] and calyculin A, two inhibitors of [GENE]PP-1[\\GENE], increased Ser240/244 phosphorylation.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "[CHEMICAL]Haloperidol[\\CHEMICAL] promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of [GENE]protein phosphatase-1[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 21
    },
    {
        "text": "In line with this observation, incubation of striatal slices with okadaic acid and [CHEMICAL]calyculin A[\\CHEMICAL], two inhibitors of [GENE]PP-1[\\GENE], increased Ser240/244 phosphorylation.",
        "label": 4,
        "major": 3,
        "len": 22
    },
    {
        "text": "These compounds resulted from our efforts to merge the pharmacophores of selective factor Xa inhibitor rivaroxaban with a mimic of the [CHEMICAL]Arg-Gly-Asp[\\CHEMICAL] (RGD) sequence of [GENE]fibrinogen[\\GENE] to obtain designed multiple ligands with potential antithrombotic activity.",
        "label": 1,
        "major": 4,
        "len": 35
    },
    {
        "text": "These compounds resulted from our efforts to merge the pharmacophores of selective [GENE]factor Xa[\\GENE] inhibitor [CHEMICAL]rivaroxaban[\\CHEMICAL] with a mimic of the Arg-Gly-Asp (RGD) sequence of fibrinogen to obtain designed multiple ligands with potential antithrombotic activity.",
        "label": 4,
        "major": 4,
        "len": 35
    },
    {
        "text": "Resulting from this study, a structurally novel class of submicromolar fibrinogen [GENE]GPIIb/IIIa[\\GENE] binding inhibitor bearing [CHEMICAL]1,2,4-oxadiazol-5(4H)-one[\\CHEMICAL] moiety is also described.",
        "label": 4,
        "major": 4,
        "len": 20
    },
    {
        "text": "The [GENE]caspase-3[\\GENE] immunopositivity was increased in degenerating neurons of the [CHEMICAL]Cd[\\CHEMICAL] group.",
        "label": 3,
        "major": 3,
        "len": 12
    },
    {
        "text": "Rats intoxicated with [CHEMICAL]Cd[\\CHEMICAL] for 30 days, significantly increased tissue malondialdehyde (MDA) levels and significantly decreased enzymatic antioxidants [GENE]superoxide dismutase[\\GENE], glutathione peroxidase and catalase in the frontal cortex tissue.",
        "label": 4,
        "major": 4,
        "len": 29
    },
    {
        "text": "Rats intoxicated with [CHEMICAL]Cd[\\CHEMICAL] for 30 days, significantly increased tissue malondialdehyde (MDA) levels and significantly decreased enzymatic antioxidants superoxide dismutase, [GENE]glutathione peroxidase[\\GENE] and catalase in the frontal cortex tissue.",
        "label": 4,
        "major": 3,
        "len": 29
    },
    {
        "text": "Rats intoxicated with [CHEMICAL]Cd[\\CHEMICAL] for 30 days, significantly increased tissue malondialdehyde (MDA) levels and significantly decreased enzymatic antioxidants superoxide dismutase, glutathione peroxidase and [GENE]catalase[\\GENE] in the frontal cortex tissue.",
        "label": 4,
        "major": 4,
        "len": 29
    },
    {
        "text": "In contrast, TSH-induced differentiation of progenitor cells, in particular the expression of the [GENE]sodium iodide symporter[\\GENE], was significantly inhibited by [CHEMICAL]17beta-oestradiol[\\CHEMICAL].In conclusion, oestrogen stimulated growth and simultaneously inhibited differentiation of thyroid nodules derived stem/progenitor cells.",
        "label": 4,
        "major": 3,
        "len": 35
    },
    {
        "text": "The editing of [GENE]ndhD-2[\\GENE] is also completely lost in albino mutants and [CHEMICAL]norflurazon[\\CHEMICAL]-treated seedlings.",
        "label": 2,
        "major": 1,
        "len": 14
    },
    {
        "text": "In addition, the expression of nucleus-encoded [GENE]RNA polymerase[\\GENE] dependent transcripts is specifically induced by [CHEMICAL]lincomycin[\\CHEMICAL], and the splicing of ndhB transcripts is significantly reduced in the albino mutants and inhibitor-treated seedlings.",
        "label": 2,
        "major": 4,
        "len": 31
    },
    {
        "text": "In addition, the expression of nucleus-encoded RNA polymerase dependent transcripts is specifically induced by [CHEMICAL]lincomycin[\\CHEMICAL], and the splicing of [GENE]ndhB[\\GENE] transcripts is significantly reduced in the albino mutants and inhibitor-treated seedlings.",
        "label": 2,
        "major": 4,
        "len": 31
    },
    {
        "text": "By contrast, the editing of some sites is completely lost or significantly reduced in other non-green tissues; for instance, the editing of [GENE]ndhB-149[\\GENE], ndhB-1255, and ndhD-2 is completely lost in roots and in [CHEMICAL]lincomycin[\\CHEMICAL]-treated seedlings.",
        "label": 2,
        "major": 4,
        "len": 35
    },
    {
        "text": "By contrast, the editing of some sites is completely lost or significantly reduced in other non-green tissues; for instance, the editing of ndhB-149, [GENE]ndhB-1255[\\GENE], and ndhD-2 is completely lost in roots and in [CHEMICAL]lincomycin[\\CHEMICAL]-treated seedlings.",
        "label": 2,
        "major": 4,
        "len": 35
    },
    {
        "text": "By contrast, the editing of some sites is completely lost or significantly reduced in other non-green tissues; for instance, the editing of ndhB-149, ndhB-1255, and [GENE]ndhD-2[\\GENE] is completely lost in roots and in [CHEMICAL]lincomycin[\\CHEMICAL]-treated seedlings.",
        "label": 2,
        "major": 4,
        "len": 35
    },
    {
        "text": "Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent [GENE]CYP3A[\\GENE] inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or [CHEMICAL]boceprevir[\\CHEMICAL], and therefore their coadministration is contraindicated.",
        "label": 4,
        "major": 4,
        "len": 39
    },
    {
        "text": "All HIV PIs except nelfinavir are coadministered with a low dose of [CHEMICAL]ritonavir[\\CHEMICAL], a potent [GENE]CYP3A[\\GENE] inhibitor to improve their pharmacokinetic properties.",
        "label": 4,
        "major": 4,
        "len": 22
    },
    {
        "text": "The HCV-PIs [CHEMICAL]boceprevir[\\CHEMICAL] and telaprevir are both, to different extents, inhibitors of [GENE]CYP3A[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "The HCV-PIs boceprevir and [CHEMICAL]telaprevir[\\CHEMICAL] are both, to different extents, inhibitors of [GENE]CYP3A[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 13
    },
    {
        "text": "Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent [GENE]CYP3A[\\GENE] inhibitors such as [CHEMICAL]ritonavir[\\CHEMICAL]- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.",
        "label": 4,
        "major": 4,
        "len": 39
    },
    {
        "text": "Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent [GENE]CYP3A[\\GENE] inhibitors such as ritonavir- or [CHEMICAL]cobicistat[\\CHEMICAL]-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.",
        "label": 4,
        "major": 4,
        "len": 39
    },
    {
        "text": "Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent [GENE]CYP3A[\\GENE] inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, [CHEMICAL]telaprevir[\\CHEMICAL] or boceprevir, and therefore their coadministration is contraindicated.",
        "label": 4,
        "major": 2,
        "len": 39
    },
    {
        "text": "[CHEMICAL]Atorvastatin[\\CHEMICAL] is also a [GENE]CYP3A[\\GENE] substrate, but less potent drug-drug interactions have been reported with CYP3A inhibitors.",
        "label": 9,
        "major": 4,
        "len": 17
    },
    {
        "text": "Drug-drug interactions are dependent on statins' pharmacokinetic profile: [CHEMICAL]simvastatin[\\CHEMICAL], lovastatin and atorvastatin are metabolized through [GENE]cytochrome P450 (CYP) 3A[\\GENE], while the metabolism of the other statins is independent of this CYP.",
        "label": 9,
        "major": 2,
        "len": 31
    },
    {
        "text": "Drug-drug interactions are dependent on statins' pharmacokinetic profile: simvastatin, [CHEMICAL]lovastatin[\\CHEMICAL] and atorvastatin are metabolized through [GENE]cytochrome P450 (CYP) 3A[\\GENE], while the metabolism of the other statins is independent of this CYP.",
        "label": 9,
        "major": 2,
        "len": 31
    },
    {
        "text": "Drug-drug interactions are dependent on statins' pharmacokinetic profile: simvastatin, lovastatin and [CHEMICAL]atorvastatin[\\CHEMICAL] are metabolized through [GENE]cytochrome P450 (CYP) 3A[\\GENE], while the metabolism of the other statins is independent of this CYP.",
        "label": 9,
        "major": 2,
        "len": 31
    },
    {
        "text": "[CHEMICAL]Simvastatin[\\CHEMICAL] and lovastatin metabolized through [GENE]CYP3A[\\GENE] have the highest potency for drug-drug interaction with potent CYP3A inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.",
        "label": 9,
        "major": 4,
        "len": 39
    },
    {
        "text": "Simvastatin and [CHEMICAL]lovastatin[\\CHEMICAL] metabolized through [GENE]CYP3A[\\GENE] have the highest potency for drug-drug interaction with potent CYP3A inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.",
        "label": 9,
        "major": 2,
        "len": 39
    },
    {
        "text": "The synthesis, preclinical profile, and in vivo efficacy in rat xenograft models of the novel and selective [GENE]anaplastic lymphoma kinase[\\GENE] inhibitor 15b ([CHEMICAL]LDK378[\\CHEMICAL]) are described.",
        "label": 4,
        "major": 4,
        "len": 25
    },
    {
        "text": "In this initial report, preliminary structure-activity relationships (SARs) are described as well as the rational design strategy employed to overcome the development deficiencies of the first generation [GENE]ALK[\\GENE] inhibitor 4 ([CHEMICAL]TAE684[\\CHEMICAL]).",
        "label": 4,
        "major": 4,
        "len": 31
    },
    {
        "text": "Given its efficacy and tolerability, once-daily, oral [CHEMICAL]ibrutinib[\\CHEMICAL] is an emerging treatment option for patients with relapsed/refractory MCL or CLL and CLL patients with del 17p or [GENE]TP53[\\GENE] mutation.",
        "label": 2,
        "major": 1,
        "len": 29
    },
    {
        "text": "Oral [CHEMICAL]ibrutinib[\\CHEMICAL] is indicated for the treatment of patients with relapsed/refractory mantle cell lymphoma (MCL) or chronic lymphocytic leukaemia (CLL) and for the treatment of patients with CLL and a chromosome 17 deletion (del 17p) or [GENE]TP53[\\GENE] mutation.",
        "label": 2,
        "major": 1,
        "len": 38
    },
    {
        "text": "[CHEMICAL]Ibrutinib[\\CHEMICAL] (Imbruvica(R)) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton's tyrosine kinase (BTK) that inhibits [GENE]B-cell antigen receptor[\\GENE] signalling downstream of BTK.",
        "label": 4,
        "major": 4,
        "len": 24
    },
    {
        "text": "Ibrutinib ([CHEMICAL]Imbruvica(R)[\\CHEMICAL]) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton's tyrosine kinase (BTK) that inhibits [GENE]B-cell antigen receptor[\\GENE] signalling downstream of BTK.",
        "label": 4,
        "major": 4,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Ibrutinib[\\CHEMICAL] (Imbruvica(R)) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton's tyrosine kinase ([GENE]BTK[\\GENE]) that inhibits B-cell antigen receptor signalling downstream of BTK.",
        "label": 4,
        "major": 4,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Ibrutinib[\\CHEMICAL] (Imbruvica(R)) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton's tyrosine kinase (BTK) that inhibits B-cell antigen receptor signalling downstream of [GENE]BTK[\\GENE].",
        "label": 4,
        "major": 4,
        "len": 24
    },
    {
        "text": "[CHEMICAL]Ibrutinib[\\CHEMICAL] (Imbruvica(R)) is a first-in-class, potent, orally administered, covalent inhibitor of [GENE]Bruton's tyrosine kinase[\\GENE] (BTK) that inhibits B-cell antigen receptor signalling downstream of BTK.",
        "label": 4,
        "major": 4,
        "len": 24
    },
    {
        "text": "Ibrutinib ([CHEMICAL]Imbruvica(R)[\\CHEMICAL]) is a first-in-class, potent, orally administered, covalent inhibitor of Bruton's tyrosine kinase ([GENE]BTK[\\GENE]) that inhibits B-cell antigen receptor signalling downstream of BTK.",
        "label": 4,
        "major": 4,
        "len": 24
    },
    {
        "text": "Ibrutinib ([CHEMICAL]Imbruvica(R)[\\CHEMICAL]) is a first-in-class, potent, orally administered, covalent inhibitor of [GENE]Bruton's tyrosine kinase[\\GENE] (BTK) that inhibits B-cell antigen receptor signalling downstream of BTK.",
        "label": 4,
        "major": 4,
        "len": 24
    }
]